000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|þpakki||N05AX08|01.04.2000||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|909|1952|lyfalmen|V1070|1767|00|20|0|Vistor hf|Janssen-Cilag AB|2| 000020|J07AL0201|Prevenar|stl|| |0,5|ml|1|hgl||J07AL02|01.10.2002||R|K|2|0|0|0|0|WLV|0|0|0|100|USD|3435|5925|lyfalmen|||02|0,5|0|Icepharma hf|Wyeth Lederle Vaccines SA|| 000054|B03XA0103|NeoRecormon |stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|28905|37854|lyfsjukr|||00|1,8|0|Icepharma hf|Roche|24| 000055|B03XA0103|NeoRecormon |sts|60000|ae/rörly|1|ml|1|rörlyk|+leysir|B03XA01|01.11.2003||R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|69290|88134|lyfsjukr|||00|1|0|Icepharma hf|Roche|60| 000145|B03XA0103|NeoRecormon |stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|43357|55847|lyfsjukr|||00|1,8|0|Icepharma hf|Roche|36| 000195|QJ01XX9201|Tiamutin, vet.|lausn|125|mg/ml|1000|ml|1|fl|til bl.í drykkjarvatn|QJ01XX92|01.01.1996||R|A|3|0|0|0|0|NOD|0|0|0|100|DKK|8245|15877|vetalmen|||16|1000|0|Vistor hf|Novartis Healthcare -dyralyf|| 000211|J07AL0201|Prevenar|stl|| |0,5|ml|1|spr|áfyllt sprauta|J07AL02|01.04.2006||R|K|2|0|0|0|0|WLV|0|0|0|100|USD|3435|5925|lyfalmen|||02|0,5|0|Icepharma hf|Wyeth Lederle Vaccines SA|| 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|3334|4773|lyfsjukr|||00|0,9|0|Vistor hf|Ferring|0,04| 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|4284|8332|vetalmen|||00|100|0|Vistor hf|Boehringer Ingelheim|| 000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|9930|14217|lyfsjukr|||00|5|0|Vistor hf|Ferring|0,23| 000240|D07AC1301|Elocon|áburður|1|mg/g|50|ml|1|glas||D07AC13|01.04.1994||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1106|2362|lyfalmen|||20|50|0|Vistor hf|Schering-Plough|50| 000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|11408|16928|lyfalmen|||00|0,36|0|Icepharma hf|N.V. Organon|1,44| 000315|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|30|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3112|4456|lyfsjukr|||00|3000|0|Icepharma hf|Fresenius Kabi|3| 000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|22630|31225|lyfalmen|||00|0,72|0|Icepharma hf|N.V. Organon|5,76| 000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|þpakki||N02CC04|01.03.1999||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|3813|6476|lyfalmen|||00|6|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|6| 000484|QJ01XX9201|Tiamutin, vet.|stl|200|mg/ml|100|ml|1|hgl||QJ01XX92|01.01.1996||R|A|3|0|0|0|0|NOD|0|0|0|100|DKK|2507|4947|vetalmen|||16|100|0|Vistor hf|Novartis Healthcare -dyralyf|| 000513|B05BB0211|Rehydrex m.glucos 25mg/ml|irl|| |500|ml|12|plpok||B05BB02|01.07.1995||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1738|2488|lyfsjukr|||02|6000|0|Icepharma hf|Fresenius Kabi|| 000516|QJ01XX9201|Tiamutin, vet.|duft|20|mg/g|5|kg|1|poki|til fóðuríblöndunar|QJ01XX92|01.01.1996||R|A|3|0|0|0|0|NOD|0|0|0|100|DKK|6264|12103|vetalmen|||16|5|0|Vistor hf|Novartis Healthcare -dyralyf|| 000530|J07BF0301|Imovax Polio|bóluefni|| |0,5|ml|20|spr|án nála|J07BF03|01.06.2005||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|15798|22719|lyfalmen|||02|10|0|Icepharma hf|Sanofi Pasteur MSD|| 000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1124|2399|lyfalmen|||06|5|0|Vistor hf|Novartis Healthcare A/S-|| 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|3009|5304|lyfalmen|||23|2|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|2| 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2724|4872|lyfalmen|||00|60|0|Vistor hf|Janssen-Cilag AB|3| 000561|QJ01XX9201|Tiamutin, vet.|duft|20|mg/g|25|kg|1|poki|til fóðuríblöndunar|QJ01XX92|01.01.1996||R|A|3|0|0|0|0|NOD|0|0|0|100|DKK|27664|52867|vetalmen|||16|25|0|Vistor hf|Novartis Healthcare -dyralyf|| 000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|A|2|0|0|0|0|NOH|0|0|0|100|DKK|1420|2891|lyfalmen|||00|8|0|Vistor hf|Novartis Healthcare A/S-|| 000573|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|3774|6419|lyfalmen|||00|24|0|Vistor hf|Novartis Healthcare A/S-|| 000629|B05BA0201|Intralipid 100 mg/ml|irl|100|mg/ml|500|ml|12|plastf|fleyti|B05BA02|01.04.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|15665|21370|lyfsjukr|||00|6000|0|Icepharma hf|Fresenius Kabi|6| 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|8432|12073|lyfsjukr|||00|1000|0|Icepharma hf|Fresenius Kabi|1| 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|2583|4658|lyfalmen|V0311|4579|00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|60| 000663|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|plastf|fleyti|B05BA02|01.04.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|26412|34750|lyfsjukr|||00|6000|0|Icepharma hf|Fresenius Kabi|6| 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|2136|3979|lyfalmen|||23|2|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|1| 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|A|3|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||00|125|0|Vistor hf|Pfizer Denmark PCH ApS|1,75| 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|106337|134257|lyfsjukr|||00|6|0|Gróco ehf|Serono Nordic|122,7907| 000891|M05BA0101|Didronate|töflur|200|mg|60|stk|1|þpakki||M05BA01|01.04.1996||R|A|4|0|0|E|0|PGA|0|0|0|100|DKK|7856|12187|lyfalmen|||00|60|0|Sofus Consulting AB|Procter & Gamble-|30| 000957|H01AC0101|Genotropin|sts|| |5|mg|1|hgl|+ leysir 1 ml|H01AC01|01.05.2001||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|19214|25789|lyfsjukr|||02|5|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|7,4963| 001043|L03AB1001|PegIntron|sts|150|mcg/hgl|4|hgl|1|pakki|+ leysir|L03AB10|01.02.2001||R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|145235|182685|lyfsjukr|||00|4|0|Vistor hf|Schering-Plough|| 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|3564|5103|lyfsjukr|||02|0,5|0|Icepharma hf|N.V. Organon|1| 001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|þpakki||M01AH01|01.03.2003||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|984|2108|lyfalmen|||00|10|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|10| 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|6672|10536|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|240| 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|13853|20297|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|800| 001324|C09CA0201|Teveten|töflur|600|mg|98|stk|1|þpakki||C09CA02|01.08.2001||R|A|3|0|0|B|0|SOP|0|0|0|100|XEU|6642|10494|lyfalmen|||00|98|0|Icepharma hf|Solvay Pharmaceuticals|98| 001337|V08CA0901|Gadovist|stl|1|mmol/ml|30|ml|10|hgl||V08CA09|01.12.2003||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|260139|325741|lyfsjukr|||02|300|0|Icepharma hf|Bayer Schering Pharma AG|| 001346|C09CA0201|Teveten|töflur|400|mg|56|stk|1|þpakki||C09CA02|01.10.2001||R|A|3|0|0|B|0|SOP|0|0|0|100|XEU|2702|4839|lyfalmen|||00|56|0|Icepharma hf|Solvay Pharmaceuticals|37,333| 001386|C10AA0102|Sivacor|töflur|10|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1400|2861|lyfalmen|V0459|2861|00|28|0|Actavis Group hf|Actavis hf|18,6667| 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|18303|24655|lyfsjukr|||02|2,5|0|Icepharma hf|N.V. Organon|5| 001409|C10AA0102|Sivacor|töflur|20|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1855|3552|lyfalmen|V0458|3552|00|28|0|Actavis Group hf|Actavis hf|37,3333| 001442|C10AA0102|Sivacor|töflur|40|mg|98|stk|1|plglas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|3582|6139|lyfalmen|V0367|6120|00|98|0|Actavis Group hf|Actavis hf|261,3333| 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|3757|6394|lyfalmen|||02|15|0|Vistor hf|Novo-Nordisk|37,5| 001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|2819|5016|lyfalmen|||10|100|0|Vistor hf|Sanofi-aventis Norge AS|40| 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|15095|20661|lyfsjukr|||00|4104|0|Icepharma hf|Fresenius Kabi|| 001599|B03AC0201|Venofer|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.07.2005||R|A|3|0|0|E|0|SKY|0|0|1|100|CHF|7509|11703|lyfalmen|||00|25|0|Icepharma hf|SkyPharma PLC|5| 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|20457|27336|lyfsjukr|||00|6160|0|Icepharma hf|Fresenius Kabi|6,16| 001611|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|2|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|12806|17811|lyfsjukr|||00|4106|0|Icepharma hf|Fresenius Kabi|4,1| 001622|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|2|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|13882|19151|lyfsjukr|||00|5132|0|Icepharma hf|Fresenius Kabi|5,13| 001685|B05AA0108|Albuminativ 200 g/l|irl|200|mg/ml|50|ml|1|hgl||B05AA01|01.03.1981||R|A|5|0|0|0|1|OCT|0|0|0|100|DKK|3899|5582|lyfsjukr|||02|50|0|Vistor hf|Octapharma AB|| 001693|B05AA0108|Albuminativ 200 g/l|irl|200|mg/ml|100|ml|1|hgl||B05AA01|01.03.1981||R|A|5|0|0|0|1|OCT|0|0|0|100|DKK|6226|8914|lyfsjukr|||02|100|0|Vistor hf|Octapharma AB|| 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|K|3|0|0|0|1|NOH|0|0|0|100|DKK|731|1047|lyfsjukr|||02|10|0|Vistor hf|Novartis Healthcare A/S-|10| 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|2096|3918|lyfalmen|||06|15|0|K.Pétursson hf|Alcon|75| 001894|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|glas|300+150+300 mg|J05AR04|01.08.2003||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|54113|69238|lyfsjukr|||00|60|0|GlaxoSmithKline ehf|Glaxo Group Limited|| 001895|B05AA0704|Voluven|irl|60|mg/ml|500|ml|15|pokar|Freeflex umbúðir|B05AA07|01.04.2005||R|A|5|0|0|0|1|FRP|0|0|0|100|DKK|15742|21466|lyfsjukr|||00|7500|0|Icepharma hf|Fresenius Kabi|7,5| 001906|B05AA0704|Voluven|irl|60|mg/ml|500|ml|15|pokar||B05AA07|01.03.2001||R|A|5|0|0|0|1|FRP|0|0|0|100|DKK|15471|21129|lyfsjukr|||00|7500|0|Icepharma hf|Fresenius Kabi|7,5| 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|A|3|0|0|0|0|BIG|0|0|0|100|SEK|2908|5152|lyfalmen|||00|45|0|Icepharma hf|Bioglan AB|45| 001974|J01CA0801|Selexid|töflur|200|mg|100|stk|1|glas||J01CA08|01.10.1990||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|5073|8306|lyfalmen|V0456|8239|43|100|0|Vistor hf|LEO Pharma A/S|33,3333| 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|IKR|2598|4681|lyfalmen|V0084|4524|00|28|0|Vistor hf|AstraZeneca A/S DK|18,67| 001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|IKR|5165|8435|lyfalmen|V0086|8291|00|56|0|Vistor hf|AstraZeneca A/S DK|37,33| 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|IKR|3369|5829|lyfalmen|V0085|5731|00|28|0|Vistor hf|AstraZeneca A/S DK|37,33| 002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.01.2000||R|A|2|0|0|B|0|SCH|0|0|0|100|SEK|3080|5408|lyfalmen|||00|100|0|Icepharma hf|Schering Oy|26,6667| 002169|B05BA1010|Kabiven Peripheral|irþ|| |2400|ml|2|pokar|3ja hólfa poki |B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|12054|16875|lyfsjukr|||00|4800|0|Icepharma hf|Fresenius Kabi|4,8| 002186|B05BA1010|Kabiven Peripheral|irþ|| |1920|ml|2|pokar|3ja hólfa poki|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|10781|15290|lyfsjukr|||00|3840|0|Icepharma hf|Fresenius Kabi|3,84| 002194|B05BA1010|Kabiven Peripheral|irþ|| |1440|ml|4|pokar|3ja hólfa poki|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|17642|23832|lyfsjukr|||00|5760|0|Icepharma hf|Fresenius Kabi|5,76| 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|A|2|0|0|*|0|NON|0|0|0|100|DKK|2201|4078|lyfalmen|||02|10|0|Vistor hf|Novo-Nordisk|25| 002237|D05AX0201|Daivonex|smyrsli|50|mcg/g|60|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|2342|4292|lyfalmen|||00|60|0|Vistor hf|LEO Pharma A/S|| 002263|D05AX0201|Daivonex|smyrsli|50|mcg/g|120|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|3828|6497|lyfalmen|||00|120|0|Vistor hf|LEO Pharma A/S|| 002265|D05AX0201|Daivonex|krem|50|mcg/g|120|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4012|6765|lyfalmen|||00|120|0|Vistor hf|LEO Pharma A/S|120| 002276|D05AX0201|Daivonex|krem|50|mcg/g|60|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|2335|4281|lyfalmen|||00|60|0|Vistor hf|LEO Pharma A/S|60| 002294|R03DC0301|Singulair|tuggutfl|4|mg|28|stk|1|þpakki||R03DC03|01.08.2002||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|3376|5839|lyfalmen|||00|28|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|11,2| 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|11818|17474|lyfalmen|||00|98|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|39,2| 002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|63965|81504|lyfsjukr|||00|1|0|ZLB Behring AB|Bayer HealthCare AG-|2| 002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|32131|41871|lyfsjukr|||00|1|0|ZLB Behring AB|Bayer HealthCare AG-|1| 002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|18418|24798|lyfsjukr|||00|1|0|ZLB Behring AB|Bayer HealthCare AG-|0,5| 002391|G03AA1201|Yasmin|töflur|| |63|stk|1|þpakki|3+0,03 mg|G03AA12|01.02.2001||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|1718|3344|lyfalmen|V1040|3292|00|63|0|Icepharma hf|Bayer Schering Pharma AG|84| 002413|G03AA1204|Yasmin 28|töflur|| |84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2007||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|1718|3344|lyfalmen|||00|84|0|Icepharma hf|Bayer Schering Pharma AG|| 002616|S01LA0101|Visudyne|irs|15|mg/hgl|1|hgl|1|pakki||S01LA01|01.12.2000||R|A|4|0|1|0|1|NOO|0|0|0|100|DKK|111630|140847|lyfsjukr|||00|1|0|Vistor hf|Novartis Ophthalmics Europe Ltd.|| 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|A|1,5|0|0|*|0|SAO|0|0|0|100|XEU|805|1736|lyfalmen|||07|5|0|Icepharma hf|Santen Oy|25| 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|K|3|0|1|0|1|ALL|0|0|0|100|SEK|19659|26343|lyfsjukr|||02|1|0|Vistor hf|Allergan|| 002875|G03GA0202|Menopur|sts|| |75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|11763|17401|lyfalmen|||00|375|0|Vistor hf|Ferring Lægemidler A/S|12,5| 002892|G03GA0202|Menopur|sts|| |75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|20928|29106|lyfalmen|||00|750|0|Vistor hf|Ferring Lægemidler A/S|25| 002966|G03GA0502|Gonal-f|sts|1050|ae|1|hgl|1|pakki|á 1,75 ml + leysir |G03GA05|01.02.2002||R|A|1|0|1|E|0|SEN|0|0|0|100|SEK|41132|54260|lyfalmen|||00|1|0|Gróco ehf|Serono Nordic|14| 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|10416|15606|lyfalmen|||00|98|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|196| 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|7576|11797|lyfalmen|||00|100|0|Vistor hf|U.C.B|12,5| 003099|L01DB0104|Myocet|irl|50|mg|2|sett|1|pakki||L01DB01|01.07.2006||R|K|1,5|0|1|0|1|ZEP|0|0|0|100|DKK|156991|197321|lyfsjukr|||02|2|0|Icepharma hf|Zeneus Pharma Limited-|| 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|11233|16695|lyfalmen|||00|100|0|Vistor hf|U.C.B|25| 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|25434|34716|lyfalmen|||00|100|0|Vistor hf|U.C.B|50| 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|2,5|0|1|*|0|PFP|0|0|0|100|SEK|5528|8941|lyfalmen|||00|1|0|Vistor hf|Pierre Fabre Pharma|| 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|2,5|0|1|*|0|PFP|0|0|0|100|SEK|8247|12717|lyfalmen|||00|1|0|Vistor hf|Pierre Fabre Pharma|| 003195|B03XA0201|Aranesp |stl|10|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|10574|15032|lyfsjukr|||00|1,6|0|Vistor hf|Amgen|8,89| 003208|B03XA0201|Aranesp |stl|15|mcg/spr|0,375|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|15753|21480|lyfsjukr|||00|1,5|0|Vistor hf|Amgen|13,33| 003230|B03XA0201|Aranesp |stl|20|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|17802|24031|lyfsjukr|||00|2|0|Vistor hf|Amgen|17,78| 003252|B03XA0201|Aranesp |stl|30|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|26432|34775|lyfsjukr|||00|1,2|0|Vistor hf|Amgen|26,67| 003274|B03XA0201|Aranesp |stl|40|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|34680|45044|lyfsjukr|||00|1,6|0|Vistor hf|Amgen|35,56| 003296|B03XA0201|Aranesp |stl|50|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|42694|55022|lyfsjukr|||00|2|0|Vistor hf|Amgen|44,44| 003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|129172|162687|lyfsjukr|||02|150|0|Icepharma hf|Bayer Schering Pharma AG|| 003318|B03XA0201|Aranesp |stl|60|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|58795|75067|lyfsjukr|||00|1,2|0|Vistor hf|Amgen|53,33| 003340|B03XA0201|Aranesp |stl|80|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|77681|98580|lyfsjukr|||00|1,6|0|Vistor hf|Amgen|71,11| 003353|L04AA1001|Rapamune|töflur|1|mg|100|stk|1|þpakki||L04AA10|01.04.2004||R|A|1,5|0|1|0|1|WTE|0|0|0|100|USD|35520|46090|lyfsjukr|||00|100|0|Icepharma hf|Wyeth Europe|33,33| 003362|B03XA0201|Aranesp |stl|100|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|83048|105262|lyfsjukr|||00|2|0|Vistor hf|Amgen|88,89| 003386|B03XA0201|Aranesp |stl|150|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|124352|156686|lyfsjukr|||00|1,2|0|Vistor hf|Amgen|133,33| 003395|B03XA0201|Aranesp |stl|300|mcg/spr|0,6|ml|1|spr|áfyllt sprauta|B03XA02|01.12.2003||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|62220|79331|lyfsjukr|||00|0,6|0|Vistor hf|Amgen|66,67| 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|A|3|0|0|E|0|PFI|0|0|0|30|DKK|2014|3794|lyfalmen|||00|60|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|15| 003869|R01BA5202|Clarinase|forðatfl|10|mg|10|stk|1|pakki|þp 10+240 mg|R01BA52|01.09.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|498|1098|lyfalmen|||00|10|0|Vistor hf|Schering-Plough|10| 003910|B03XA0102|Eprex|stl|6000|ae/spr|0,6|ml|6|spr||B03XA01|01.01.2002||R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|39779|51392|lyfsjukr|||51|3,6|0|Vistor hf|Janssen-Cilag AB|36| 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|1547|3084|lyfalmen|V0931|3084|00|28|0|Actavis Group hf|Actavis hf|28| 003932|B03XA0102|Eprex|stl|8000|ae/spr|0,8|ml|6|spr||B03XA01|01.01.2002||R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|49731|63783|lyfsjukr|||51|4,8|0|Vistor hf|Janssen-Cilag AB|48| 003974|J05AE0601|Kaletra|mixtúra|100|mg/ml|60|ml|1|glas|80 + 20 mg/ml|J05AE06|01.08.2003||R|A|2|0|1|0|1|ABL|0|0|0|100|DKK|53605|68606|lyfsjukr|||00|60|0|Vistor hf|Abbott Laboratories A/S|7,5| 004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|18905|25404|lyfsjukr|||00|50|0|Vistor hf|Novartis Healthcare A/S-|10| 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|4515|7498|lyfalmen|||00|250|0|Vistor hf|Novartis Healthcare A/S-|15| 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|A|5|0|0|0|0|JAS|0|0|0|100|SEK|||lyfalmen|||00|100|0|Vistor hf|Janssen-Cilag AB|2| 004050|R03AK0601|Seretide|innúðal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|A|1|0|0|B|0|GSK|0|0|0|100|GBP|2799|4986|lyfalmen|||23|120|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30| 004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|þpakki||N06AB06|01.05.2003||R|A|5|0|0|B|0|PFI|0|1|0|30|DKK|338|765|lyfalmen|||00|7|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|3,5| 004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|þpakki||N05CD01|01.12.2000||R|A|5|0|0|0|0|VAL|0|0|1|100|DKK|604|1318|lyfalmen|||10|30|0|Icepharma hf|Valeant Pharmaceuticals B.V.|15| 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|þpakki|hart hylki|N05AE04|01.03.2003||R|A|4|0|0|0|0|PFI|0|1|0|100|DKK|3528|6060|lyfalmen|||00|14|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|7| 004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|4085|6872|lyfalmen|||23|120|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30| 004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|5685|9160|lyfalmen|||23|120|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30| 004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|428|952|lyfalmen|||00|10|0|Vistor hf|Schering-Plough|10| 004301|N06AX1101|Remeron|mixtúra|15|mg/ml|66|ml|1|fl|lausn|N06AX11|01.01.2003||R|A|2|0|0|B|0|ORG|0|1|0|100|DKK|3381|5846|lyfalmen|||00|66|0|Icepharma hf|N.V. Organon|33| 004338|B03XA0102|Eprex|stl|1000|ae/spr|0,5|ml|6|spr|einnotaspr|B03XA01|01.10.1994||R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|6899|9878|lyfsjukr|||51|3|0|Vistor hf|Janssen-Cilag AB|6| 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|15727|21448|lyfsjukr|||00|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|0,5| 004364|B03XA0102|Eprex|stl|2000|ae/spr|0,5|ml|6|spr|einnotaspr|B03XA01|01.10.1994||R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|13808|19058|lyfsjukr|||51|3|0|Vistor hf|Janssen-Cilag AB|12| 004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1235|2610|lyfalmen|V1901|2574|00|30|0|Vistor hf|Schering-Plough|30| 004372|B03XA0102|Eprex|stl|4000|ae/spr|0,4|ml|6|spr|einnotaspr|B03XA01|01.10.1994||R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|27323|35885|lyfsjukr|||51|2,4|0|Vistor hf|Janssen-Cilag AB|24| 004375|B03XA0102|Eprex|stl|3000|ae/spr|0,3|ml|6|spr|einnotaspr|B03XA01|01.10.1994||R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|20661|27590|lyfsjukr|||51|1,8|0|Vistor hf|Janssen-Cilag AB|18| 004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|2977|5256|lyfalmen|V1902|5167|00|100|0|Vistor hf|Schering-Plough|100| 004383|B03XA0102|Eprex|stl|10000|ae/spr|1|ml|6|spr|einnotaspr|B03XA01|01.10.1994||R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|54939|70267|lyfsjukr|||51|6|0|Vistor hf|Janssen-Cilag AB|60| 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|| |5|ml|20|spr||QJ51RC25|01.12.1978||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|2605|5133|vetalmen|||16|100|0|Vistor hf|Boehringer Ingelheim|| 004455|N02AX0208|Zytram|forðatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|1852|3548|lyfalmen|||00|56|0|Icepharma hf|Norpharma |14| 004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|þpakki||C01DA08|01.06.1980||R|A|3|0|0|B|0|REP|0|0|0|100|DKK|358|807|lyfalmen|||00|100|0|Vistor hf|Recip AB|8,3333| 004468|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|1823|3504|lyfalmen|||51|0,5|0|Icepharma hf|Sanofi Pasteur MSD|| 004478|N02AX0208|Zytram|forðatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|2470|4486|lyfalmen|||00|56|0|Icepharma hf|Norpharma |18,6667| 004487|L01BC0301|Uft|hylki|324|mg|21|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|18738|25196|lyfsjukr|||00|21|0|Merck AB|Merck KgaA (M)|| 004489|N02AX0208|Zytram|forðatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|3490|6005|lyfalmen|||00|56|0|Icepharma hf|Norpharma |28| 004500|N02AX0208|Zytram|forðatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|4645|7687|lyfalmen|||00|56|0|Icepharma hf|Norpharma |37,3333| 004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|SEK|1361|2802|lyfalmen|||00|0,5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 004532|L01BC0301|Uft|hylki|324|mg|35|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|31230|40749|lyfsjukr|||00|35|0|Merck AB|Merck KgaA (M)|| 004543|L01BC0301|Uft|hylki|324|mg|42|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|37476|48525|lyfsjukr|||00|42|0|Merck AB|Merck KgaA (M)|| 004565|L01BC0301|Uft|hylki|324|mg|28|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|24984|32973|lyfsjukr|||00|28|0|Merck AB|Merck KgaA (M)|| 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|4477|7443|lyfalmen|||00|90|0|Vistor hf|Aventis Pharma |180| 004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|SEN|0|0|0|100|SEK|24117|31893|lyfsjukr|||00|1|0|Gróco ehf|Serono Nordic|4| 004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|A|2|0|0|0|0|AGT|0|0|1|100|DKK|1096|2341|lyfalmen|||20|25|0|Actavis Group hf|Actavis Group hf|25| 004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|dæla|einnotadæl|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|SEK|1764|3414|lyfalmen|||00|1|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 004623|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2798|4984|lyfalmen|||51|1|0|Icepharma hf|Sanofi Pasteur MSD|| 004625|N06AB0402|Oropram|töflur|40|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|2400|4380|lyfalmen|V0927|4380|00|28|0|Actavis Group hf|Actavis hf|56| 004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|1659|3254|lyfalmen|V0923|3254|00|28|0|Actavis Group hf|Actavis hf|28| 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|24381|32222|lyfsjukr|||00|4,69|0|Vistor hf|Amgen|7| 004699|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|spr||L04AC03|01.04.2007||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|93865|118729|lyfsjukr|||00|18,76|0|Vistor hf|Amgen|28| 004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|SEN|0|0|0|100|SEK|120583|151993|lyfsjukr|||00|5|0|Gróco ehf|Serono Nordic|20| 004746|A10AE0401|Lantus [OptiPen]|stl|100|ein/ml|3|ml|5|rörlyk|fyrir OptiPen |A10AE04|01.06.2004||R|K|2|0|0|0|0|SDE|0|0|0|100|NOK|5976|9565|lyfalmen|||00|15|0|Vistor hf|Sanofi - aventis Deutschland GmbH|37,5| 004811|J01XD0105|Metronidazol Actavis|irl|5|mg/ml|100|ml|10|poki||J01XD01|01.04.1990||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|6211|8893|lyfsjukr|||00|1000|0|Actavis Group hf|Actavis Group hf|3,3333| 004822|J01XD0105|Metronidazol Actavis|irl|5|mg/ml|200|ml|10|poki||J01XD01|01.04.1990||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|11568|16270|lyfsjukr|||00|2000|0|Actavis Group hf|Actavis Group hf|6,6667| 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|370|832|lyfalmen|||41|24|0|Actavis Group hf|Actavis Group hf|3| 004863|R03DX0501|Xolair|sts|150|mg|2|ml|1|hgl|+ leysir, lausn|R03DX05|01.01.2006||R|A|4|0|1|0|1|NOE|0|0|0|100|XEU|39391|50909|lyfsjukr|||00|2|0|Vistor hf|Novartis Europharm Ltd|9,38| 004880|J01FA1001|Zitromax|irs|500|mg/hgl|1|hgl|1|pakki||J01FA10|01.05.2003||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|3174|4544|lyfsjukr|||00|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|1| 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|219|518|lyfalmen|||41|8|0|Actavis Group hf|Actavis Group hf|2| 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|374|840|lyfalmen|||41|14|0|Actavis Group hf|Actavis Group hf|3,5| 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|708|1534|lyfalmen|||41|30|0|Actavis Group hf|Actavis Group hf|7,5| 005085|J07AJ5205|Boostrix|stl|| |0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1180|2516|lyfalmen|||00|0,5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 005108|G04CA0201|Omnic|forðahlk|0,4|mg|90|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|5859|9402|lyfalmen|V0437|7657|00|90|0|Vistor hf|Yamanouchi Europe|90| 005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|A|2|0|0|E|0|LEP|0|0|1|100|DKK|643|1399|lyfalmen|||00|2,4|0|Vistor hf|LEO Pharma A/S|| 005380|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.04.2004||R|K|1|0|1|E|0|PHO|0|0|0|100|NOK|18281|25810|lyfalmen|||00|2|0|Icepharma hf|PhotoCure ASA|| 005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|A|3|0|0|B|0|BOI|0|0|0|100|DKK|847|1823|lyfalmen|||24|200|0|Vistor hf|Boehringer Ingelheim|33,33| 005507|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|4|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|3112|5454|lyfalmen|||00|4|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|28| 005538|G03AA0702|Microgyn|töflur|| |63|stk|1|þpakki||G03AA07|01.06.1977||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|667|1449|lyfalmen|||23|63|0|Icepharma hf|Bayer Schering Pharma AG|84| 005565|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|8288|12771|lyfalmen|V0718|12473|00|12|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|84| 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|3884|6579|lyfalmen|||00|30|0|Vistor hf|Boehringer Ingelheim Internationl |30| 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|4132|6940|lyfalmen|V0985|6819|00|30|0|Vistor hf|Boehringer Ingelheim Internationl |30| 005606|J07AH0703|NeisVac-C|bóluefni|| |0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|K|3,5|0|0|0|0|BAX|0|0|0|100|USD|2106|3933|lyfalmen|||00|0,5|0|Icepharma hf|Baxter|| 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|927|1990|lyfalmen|||00|30|0|Icepharma hf|Servier|5,63| 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|1589|3148|lyfalmen|||00|60|0|Icepharma hf|Servier|11,25| 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|4217|7064|lyfalmen|||00|180|0|Icepharma hf|Servier|33,75| 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|2318|4255|lyfalmen|||00|90|0|Icepharma hf|Servier|16,88| 005747|G03CA0317|Aerodiol|nefúði|150|mcg/sk|180|skammtar|1|pakki|60 skammtar x 3|G03CA03|01.01.2003||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|3414|5894|lyfalmen|||00|180|0|Icepharma hf|Servier|90| 005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LUN|0|1|0|30|DKK|1357|2796|lyfalmen|||00|28|0|Lundbeck Export A/S|Lundbeck|14| 005766|H01CC0201|Cetrotide|sts|0,25|mg/hgl|1|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|2956|4232|lyfsjukr|||00|1|0|Gróco ehf|Serono Nordic|| 005782|L01BB0501|Fludara|filmhtfl|10|mg|15|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|43940|56573|lyfsjukr|||00|15|0|Icepharma hf|Bayer Schering Pharma AG|| 005787|H01CC0201|Cetrotide|sts|0,25|mg/hgl|7|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|22557|29951|lyfsjukr|||00|7|0|Gróco ehf|Serono Nordic|| 005789|H01CC0201|Cetrotide|sts|3|mg/hgl|1|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|22557|29951|lyfsjukr|||00|1|0|Gróco ehf|Serono Nordic|| 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LUN|0|1|0|30|DKK|4153|6971|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|50| 005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LUN|0|1|0|30|DKK|1847|3540|lyfalmen|V0939|3485|00|28|0|Lundbeck Export A/S|Lundbeck|28| 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|9443|16342|vetorma|||16|5|0|Vistor hf|Merial (MSD)|| 005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LUN|0|1|0|30|DKK|3661|6254|lyfalmen|||00|56|0|Lundbeck Export A/S|Lundbeck|56| 005836|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|48990|62860|lyfsjukr|||00|20|0|Icepharma hf|Bayer Schering Pharma AG|| 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LUN|0|1|0|30|DKK|6485|10275|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|100| 005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LUN|0|1|0|30|DKK|3229|5625|lyfalmen|||00|28|0|Lundbeck Export A/S|Lundbeck|42| 005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|þpakki||P01BC02|01.01.1993||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|1702|3320|lyfalmen|||59|8|0|Icepharma hf|Roche|2| 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LUN|0|1|0|30|DKK|12318|18386|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|150| 005910|C09CA0301|Diovan|töflur|80|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|2098|3921|lyfalmen|||00|28|0|Vistor hf|Novartis Healthcare A/S-|28| 005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LUN|0|1|0|30|DKK|3948|6672|lyfalmen|V1039|6557|00|28|0|Lundbeck Export A/S|Lundbeck|56| 005932|C09CA0301|Diovan|töflur|80|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|6108|9750|lyfalmen|V1110|7915|00|98|0|Vistor hf|Novartis Healthcare A/S-|98| 005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LUN|0|1|0|30|DKK|8019|12413|lyfalmen|||00|56|0|Lundbeck Export A/S|Lundbeck|112| 005954|C09CA0301|Diovan|töflur|160|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|2748|4908|lyfalmen|||00|28|0|Vistor hf|Novartis Healthcare A/S-|56| 005976|C09CA0301|Diovan|töflur|160|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|8840|13507|lyfalmen|V1111|10921|00|98|0|Vistor hf|Novartis Healthcare A/S-|196| 006000|R07AA0201|Curosurf|innönd.l|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|48581|62351|lyfsjukr|||00|1,5|0|Gróco ehf|Nycomed Danmark A/S|0,75| 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|3588|6148|lyfalmen|||02|15|0|Vistor hf|Novo-Nordisk|37,5| 006026|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|20859|27837|lyfsjukr|||00|60|0|Icepharma hf|Mayne Pharma Plc|| 006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|70700|89889|lyfsjukr|||00|1|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|1,4| 006098|B05BB0211|Rehydrex m.glucos 25mg/ml|irl|| |1000|ml|8|plpok||B05BB02|01.07.1995||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1329|1903|lyfsjukr|||02|8000|0|Icepharma hf|Fresenius Kabi|| 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|A|2,5|0|0|*|0|NON|0|0|0|100|DKK|3510|6034|lyfalmen|||02|15|0|Vistor hf|Novo-Nordisk|37,5| 006111|R07AA0201|Curosurf|innönd.l|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|97231|122920|lyfsjukr|||00|3|0|Gróco ehf|Nycomed Danmark A/S|1,5| 006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|55495|70959|lyfsjukr|||00|1|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|1| 006178|A10AE0402|Lantus [Optiset]|stl|100|ein/ml|3|ml|5|pennar||A10AE04|01.11.2005||R|K|2|0|0|0|0|SDE|0|0|0|100|NOK|5552|8974|lyfalmen|||00|15|0|Vistor hf|Sanofi - aventis Deutschland GmbH|37,5| 006212|J01MA0202|Ciproxin|irl|2|mg/ml|100|ml|12|pokar||J01MA02|01.12.2001||R|A|3|0|0|0|1|BHC|0|0|0|100|DKK|24084|31852|lyfsjukr|||00|1200|0|Vistor hf|Bayer HealthCare AG|| 006226|J01MA0202|Ciproxin|irl|2|mg/ml|200|ml|12|pokar||J01MA02|01.12.2001||R|A|3|0|0|0|1|BHC|0|0|0|100|DKK|41407|53419|lyfsjukr|||00|2400|0|Vistor hf|Bayer HealthCare AG|| 006289|N02AB0302|Actiq|pinni|200|mcg|3|stk|1|pakki||N02AB03|01.02.2002||R|A|3|1|0|0|0|CUL|0|0|0|100|DKK|3385|5852|lyfalmen|||00|3|0|Swedish Orphan International AB|Cephalon UK Limited (S)|1| 006336|N02AB0302|Actiq|pinni|400|mcg|3|stk|1|pakki||N02AB03|01.02.2002||R|A|3|1|0|0|0|CUL|0|0|0|100|DKK|3385|5852|lyfalmen|||00|3|0|Swedish Orphan International AB|Cephalon UK Limited (S)|2| 006346|N03AG0101|Depakine|sh-tfl|500|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1497|3008|lyfalmen|||43|40|0|Vistor hf|Sanofi-aventis Norge AS|13,3333| 006380|N02AB0302|Actiq|pinni|600|mcg|3|stk|1|pakki||N02AB03|01.02.2002||R|A|3|1|0|0|0|CUL|0|0|0|100|DKK|3385|5852|lyfalmen|||00|3|0|Swedish Orphan International AB|Cephalon UK Limited (S)|3| 006422|N02AB0302|Actiq|pinni|800|mcg|3|stk|1|pakki||N02AB03|01.02.2002||R|A|3|1|0|0|0|CUL|0|0|0|100|DKK|3385|5852|lyfalmen|||00|3|0|Swedish Orphan International AB|Cephalon UK Limited (S)|4| 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|5028|9749|vetalmen|||00|50|0|Vistor hf|Boehringer Ingelheim|| 006466|N02AB0302|Actiq|pinni|1200|mcg|3|stk|1|pakki||N02AB03|01.02.2002||R|A|3|1|0|0|0|CUL|0|0|0|100|DKK|3385|5852|lyfalmen|||00|3|0|Swedish Orphan International AB|Cephalon UK Limited (S)|6| 006512|N02AB0302|Actiq|pinni|1600|mcg|3|stk|1|pakki||N02AB03|01.02.2002||R|A|3|1|0|0|0|CUL|0|0|0|100|DKK|3385|5852|lyfalmen|||00|3|0|Swedish Orphan International AB|Cephalon UK Limited (S)|8| 006579|D05AX5201|Daivobet|smyrsli|| |60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|5337|8674|lyfalmen|V0391|8531|00|60|0|Vistor hf|LEO Pharma A/S|| 006637|D05AX5201|Daivobet|smyrsli|| |120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|9145|13913|lyfalmen|||00|120|0|Vistor hf|LEO Pharma A/S|| 006650|A04AA0301|Navoban|stl|1|mg/ml|5|ml|10|lykjur||A04AA03|01.04.1993||R|A|5|0|0|0|1|NOH|0|0|0|100|DKK|19989|26754|lyfsjukr|||02|50|0|Vistor hf|Novartis Healthcare A/S-|10| 006785|G03AC0303|NorLevo|töflur|750|mcg|2|stk|1|þpakki||G03AC03|01.01.2005||L|A|3|0|0|0|0|LHP|0|0|0|100|SEK|||lyfalmen|||23|2|0|Gróco ehf|Laboratoire HRA Pharma|| 006825|A04AA0301|Navoban|hylki|5|mg|5|stk|1|þpakki||A04AA03|01.04.1993||R|A|5|0|0|0|1|NOH|0|0|0|100|DKK|8856|12680|lyfsjukr|||10|5|0|Vistor hf|Novartis Healthcare A/S-|5| 006903|L03AX1301|Copaxone|sts|20|mg/hgl|28|hgl|1|pakki|+ leysir|L03AX13|01.01.2001||R|K|2|0|1|0|1|TEP|0|0|0|100|NOK|89395|113164|lyfsjukr|||00|28|0|Vistor hf|Teva Pharmaceuticals Limited|28| 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|10162|15268|lyfalmen|||00|98|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|196| 007104|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|632|1376|lyfalmen|||00|100|0|Vistor hf|Sanofi-aventis Norge AS|1,6667| 007123|V03AE0201|Renagel|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.01.2004||R|A|2|0|0|0|0|GZE|0|0|0|100|XEU|17966|25418|lyfalmen|||00|180|0|Vistor hf|Genzyme Europe B.V.|22,5| 007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|13801|26460|vetalmen|||27|20|0|Vistor hf|Boehringer Ingelheim Danmark|| 007138|N05AA0201|Nozinan|töflur|25|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|1641|3227|lyfalmen|||00|100|0|Vistor hf|Sanofi-aventis Norge AS|8,3333| 007161|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|3663|6257|lyfalmen|||00|100|0|Vistor hf|Sanofi-aventis Norge AS|33,3333| 007195|B05BA0106|Vamin 18 g N/l elektrolytfri|irl|| |1000|ml|6|fl||B05BA01|01.09.1998||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|15064|20622|lyfsjukr|||00|6000|0|Icepharma hf|Fresenius Kabi|6| 007223|B01AX0001|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AX00|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|97602|123382|lyfsjukr|||00|1|0|Icepharma hf|Baxter|| 007268|B01AX0001|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AX00|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|172411|216519|lyfsjukr|||00|1|0|Icepharma hf|Baxter|| 007278|C08CA0302|Lomir Retard|forðahlk|2,5|mg|30|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|1202|2560|lyfalmen|||10|30|0|Vistor hf|Novartis Healthcare A/S-|15| 007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|1723|3352|lyfalmen|||00|3|0|Vistor hf|Allergan|30| 007337|H01CB0302|Ipstyl Autogel|stl|60|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|85221|107968|lyfsjukr|||00|1|0|Icepharma hf|Institut Produits Synthése (IPSEN) AB|20| 007360|H01CB0302|Ipstyl Autogel|stl|120|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|131157|165158|lyfsjukr|||00|1|0|Icepharma hf|Institut Produits Synthése (IPSEN) AB|40| 007363|H01CB0302|Ipstyl Autogel|stl|90|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|114028|143832|lyfsjukr|||00|1|0|Icepharma hf|Institut Produits Synthése (IPSEN) AB|30| 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|74406|94503|lyfsjukr|||00|3000|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|5| 007394|J05AF0501|Epivir|filmhtfl|300|mg|30|stk|1|plglas||J05AF05|01.11.2003||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|16978|23005|lyfsjukr|||00|30|0|GlaxoSmithKline ehf|Glaxo Group Limited|30| 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|187455|235249|lyfsjukr|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|15| 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|K|2|0|0|*|0|PFI|0|0|0|100|DKK|2019|3801|lyfalmen|V0988|3740|06|2,5|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 007448|B05XC04|Cernevit|sts|| |5|ml|10|hgl||B05XC|01.05.2002||R|A|3|0|0|0|1|CPS|0|0|0|100|SEK|4641|6645|lyfsjukr|||02|50|0|Icepharma hf|Clintec parenteral SA|| 007449|V03AB0001|Fomepizole OPi|irþ|5|mg/ml|20|ml|5|hgl||V03AB00|01.09.2003||R|A|2|0|0|0|1|OPO|0|0|0|100|XEU|68941|87699|lyfsjukr|||00|100|0|Swedish Orphan International AB|OPi Orphan Pharma international (S)|| 007462|N01AB0801|Sevorane|innönd.l|| |250|ml|1|plastf||N01AB08|01.03.2002||R|A|3|0|0|0|1|ABS|0|0|0|100|DKK|14676|20139|lyfsjukr|||00|250|0|Vistor hf|Abbott Scandinavia AB|| 007494|QP52AA0101|Droncit, vet.|hlaup|9|%|6,67|g|1|dæla|til inntöku|QP52AA01|01.04.2002||L|A|2|0|0|0|0|BHC|0|0|0||DKK|1142|1976|vetorma|||16|6,67|0|Vistor hf|Bayer HealthCare AG|| 007505|G04BD0702|Detrusitol Retard|forðahlk|1,4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|3925|6639|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|10,5| 007516|R03BA0701|Asmanex Twisthaler|innúðadu|200|mcg|60|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|2904|5145|lyfalmen|||00|60|0|Vistor hf|Schering-Plough Europe|30| 007538|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|2904|5145|lyfalmen|||00|30|0|Vistor hf|Schering-Plough Europe|30| 007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|A|2|0|0|0|1|BRS|0|0|0|100|DKK|5188|7428|lyfsjukr|||00|1200|0|Vistor hf|Bristol-Myers Squibb|4| 007541|J07BL0101|Stamaril|bóluefni|| |0,5|ml|10|lykjur|+leysir|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|12279|18338|lyfalmen|||02|5|0|Icepharma hf|Sanofi Pasteur MSD|| 007549|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|5510|8916|lyfalmen|||00|60|0|Vistor hf|Schering-Plough Europe|60| 007575|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|1443|2066|lyfsjukr|||02|9000|0|Icepharma hf|Fresenius Kabi|| 007657|QH02AB0602|Prednisolonacetat, vet."Intervet"|stl|10|mg/ml|50|ml|1|hgl||QH02AB06|01.05.1998||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|1093|2157|vetalmen|||58|50|0|Icepharma hf|Intervet International B.V.|| 007760|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|4370|7287|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|21| 007769|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|13269|19570|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|70| 007852|G02BB0101|NuvaRing|sk-hring|| |3|stk|1|pakki|með forðaverkun|G02BB01|01.11.2002||R|A|3,3|0|0|0|0|ORG|0|0|0|100|DKK|2354|4310|lyfalmen|V1060|4239|00|3|0|Icepharma hf|N.V. Organon|84| 007920|S01EX0601|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EX06|01.02.2004||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|1331|2756|lyfalmen|||00|2,5|0|K.Pétursson hf|Alcon|| 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|670|1455|lyfalmen|||00|5|0|K.Pétursson hf|Alcon|| 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|XEU|||lyfalmen|||20|15|0|Vistor hf|Astellas Pharma A/S|15| 007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|12707|17688|lyfsjukr|||00|10|0|Ísaga ehf|AGA AB|| 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|378|848|lyfalmen|||00|30|0|Icepharma hf|Merck Santé s.a.s.|15| 008028|J05AH0201|Tamiflu|mixtduft|12|mg/ml|1|stk|1|fl|750 mg í flösku|J05AH02|01.11.2002||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|2020|3803|lyfalmen|||00|1|0|Icepharma hf|Roche Registration Limited|5| 008058|B05BA1011|Oliclinomel N4 550E|irl|| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|15793|21530|lyfsjukr|||00|6000|0|Icepharma hf|Baxter Medical AB|| 008069|B05BA1011|Oliclinomel N4 550E|irl|| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|19742|26446|lyfsjukr|||00|8000|0|Icepharma hf|Baxter Medical AB|| 008086|D07AC0101|Betnovat|krem|1|mg/g|30|g|1|túpa||D07AC01|01.01.1985||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|301|688|lyfalmen|||20|30|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30| 008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|þpakki||N02CC04|01.03.2003||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|3849|6528|lyfalmen|||00|6|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|3| 008101|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|52740|67529|lyfsjukr|||00|4|0|Vistor hf|Schering-Plough|26,67| 008102|D07AC0101|Betnovat|krem|1|mg/g|100|g|1|túpa||D07AC01|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|950|2037|lyfalmen|||20|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|100| 008108|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|106029|133874|lyfsjukr|||00|4|0|Vistor hf|Schering-Plough|53,33| 008123|J07AH0701|Meningitec|stl|10|mcg/hgl|0,5|ml|1|hgl||J07AH07|01.05.2002||R|K|3|0|0|0|0|WAB|0|0|0|100|USD|1783|3443|lyfalmen|||00|0,5|0|Icepharma hf|Wyeth AB|| 008131|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|76888|97593|lyfsjukr|||00|4|0|Vistor hf|Schering-Plough|42,67| 008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|113176|142772|lyfsjukr|||00|4|0|Vistor hf|Schering-Plough|64| 008145|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|132121|166358|lyfsjukr|||00|4|0|Vistor hf|Schering-Plough|80| 008157|B05BA1012|Oliclinomel N5 800E|irl|| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|20117|26913|lyfsjukr|||00|8000|0|Icepharma hf|Baxter Medical AB|| 008182|J07AH0701|Meningitec|stl|10|mcg/hgl|0,5|ml|10|hgl||J07AH07|01.05.2002||R|K|3|0|0|0|0|WAB|0|0|0|100|USD|17830|25249|lyfalmen|||00|5|0|Icepharma hf|Wyeth AB|| 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|XEU|||lyfalmen|||20|30|0|Vistor hf|Astellas Pharma A/S|30| 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|1161|2476|lyfalmen|||20|100|0|Vistor hf|Astellas Pharma A/S|100| 008197|R06AX2701|Aerius|saft|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2002||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|662|1439|lyfalmen|||00|120|0|Vistor hf|Schering-Plough|12| 008219|D07AC0101|Betnovat|áburður|1|mg/ml|20|ml|1|glas||D07AC01|01.12.1980||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|191|459|lyfalmen|||20|20|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|20| 008223|B05BA1013|Oliclinomel N6 900E|irl|| |1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|20799|27762|lyfsjukr|||00|6000|0|Icepharma hf|Baxter Medical AB|| 008234|B05BA1013|Oliclinomel N6 900E|irl|| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|16240|22086|lyfsjukr|||00|6000|0|Icepharma hf|Baxter Medical AB|| 008243|D07AC0101|Betnovat|áburður|1|mg/g|30|ml|1|glas|í hársvörð|D07AC01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|314|715|lyfalmen|||33|30|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30| 008245|B05BA1013|Oliclinomel N6 900E|irl|| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|20353|27207|lyfsjukr|||00|8000|0|Icepharma hf|Baxter Medical AB|| 008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|822|1771|lyfalmen|V0733|1771|00|20|0|Actavis Group hf|Actavis hf|6,67| 008326|D07AC0101|Betnovat|áburður|1|mg/g|100|ml|1|glas|í hársvörð|D07AC01|01.07.1988||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|936|2008|lyfalmen|||33|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|100| 008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|3293|5718|lyfalmen|V0734|5718|00|100|0|Actavis Group hf|Actavis hf|33,33| 008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|4788|7896|lyfalmen|V0736|7896|00|100|0|Actavis Group hf|Actavis hf|50| 008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|6305|10024|lyfalmen|V0738|10024|00|100|0|Actavis Group hf|Actavis hf|66,67| 008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|K|3|0|1|0|1|GEZ|0|0|0|100|XEU|118162|148979|lyfsjukr|||02|2|0|Vistor hf|Genzyme BV|| 008383|D07AC0101|Betnovat|smyrsli|1|mg/g|30|g|1|túpa||D07AC01|01.01.1985||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|301|688|lyfalmen|||20|30|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30| 008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MKA|0|0|0|100|XEU|444|985|lyfalmen|V0431|985|00|100|0|NM Pharma ehf|Merck KgaA|33,33| 008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MKA|0|0|0|100|XEU|376|844|lyfalmen|V0430|844|00|100|0|NM Pharma ehf|Merck KgaA|66,67| 008466|D07AC0101|Betnovat|smyrsli|1|mg/g|100|g|1|túpa||D07AC01|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|950|2037|lyfalmen|||20|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|100| 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|1|0|0|100|USD|2581|4467|vetorma|||00|1000|0|Icepharma hf|Chanelle Pharmaceuticals || 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|A|5|0|0|0|0|CHP|1|0|0|100|XEU|6229|12036|vetalmen|||00|50|0|Icepharma hf|Chanelle Pharmaceuticals || 008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|E|0|ALF|0|0|1|100|NOK|345|780|lyfalmen|||00|10|0|Gróco ehf|Almirall-Prodesfarma S.A.|10| 008523|R06AX2201|Kestine|töflur|10|mg|100|stk|1|þpakki||R06AX22|01.04.1998||R|A|3|0|0|E|0|ALF|0|0|1|100|NOK|2924|5176|lyfalmen|||00|100|0|Gróco ehf|Almirall-Prodesfarma S.A.|100| 008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|E|0|ALF|0|0|1|100|NOK|940|2017|lyfalmen|||00|30|0|Gróco ehf|Almirall-Prodesfarma S.A.|30| 008545|G03FB0506|NovoFem|filmhtfl|| |84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|1648|3238|lyfalmen|||23|84|0|Vistor hf|Novo-Nordisk|84| 008565|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|lykja||J06BA01|01.08.2003||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|7875|11275|lyfsjukr|||17|10|0|Vistor hf|Octapharma AB|| 008664|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|lykjur||J06BA01|01.08.2003||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|78754|99916|lyfsjukr|||17|100|0|Vistor hf|Octapharma AB|| 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|74943|95172|lyfsjukr|||00|2|0|Icepharma hf|Roche Registration Limited|| 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|78120|99127|lyfsjukr|||00|2|0|Icepharma hf|Roche Registration Limited|27,69| 008785|QP52AC1303|Zerofen, vet.|mixtúra|10|%|500|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|1|0|0|100|USD|1322|2288|vetorma|||00|500|0|Icepharma hf|Chanelle Pharmaceuticals || 008831|D11AX1501|Elidel|krem|1|%|15|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|0|0|NOH|0|0|1|100|DKK|1755|3400|lyfalmen|||00|15|0|Vistor hf|Novartis Healthcare A/S-|15| 008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburður, lausn|D10AF01|01.01.1994||R|A|2,5|0|0|0|0|PFI|0|0|0|100|DKK|1305|2717|lyfalmen|||20|60|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|60| 008990|J07AH0702|Menjugate|sts|10|mcg/hgl|0,5|ml|1|hgl|+leysir|J07AH07|01.07.2002||R|K|3|0|0|0|0|NVD|0|0|0|100|XEU|3025|5328|lyfalmen|||00|0,5|0|Novartis Vaccines and Diagnostics S.r.l.|Novartis Vaccines and Diagnostics S.r.l.|| 009065|D11AX1501|Elidel|krem|1|%|30|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|0|0|NOH|0|0|1|100|DKK|3134|5486|lyfalmen|||00|30|0|Vistor hf|Novartis Healthcare A/S-|30| 009079|D11AX1501|Elidel|krem|1|%|100|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|0|0|NOH|0|0|1|100|DKK|9190|13973|lyfalmen|||00|100|0|Vistor hf|Novartis Healthcare A/S-|100| 009137|M05BA0302|Pamidronatdinatrium Mayne 3 mg/ml|irþ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|18428|24810|lyfsjukr|||00|25|0|Icepharma hf|Mayne Pharma Plc|1,25| 009192|M01AH0401|Dynastat|sts|40|mg/hgl|5|hgl|1|pakki|+leysir 2ml/lykju |M01AH04|01.06.2002||R|A|3|0|0|0|0|PFL|0|0|1|100|DKK|4189|7023|lyfalmen|||03|5|0|Vistor hf|Pfizer Limited|5| 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|A|3|0|0|0|0|PFL|0|0|1|100|DKK|7952|12321|lyfalmen|||03|10|0|Vistor hf|Pfizer Limited|10| 009275|M05BA0302|Pamidronatdinatrium Mayne 3 mg/ml|irþ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|7599|10880|lyfsjukr|||00|10|0|Icepharma hf|Mayne Pharma Plc|0,5| 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|34748|45129|lyfsjukr|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 009282|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyflausa|||02|400|0|Icepharma hf|Fresenius Kabi|| 009285|D11AX1401|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AX14|01.07.2003||R|A|3|0|1|0|0|ASP|0|0|0|100|XEU|3341|5788|lyfalmen|||00|30|0|Vistor hf|Astellas Pharma A/S|| 009286|M05BA0303|Pamidronatdinatrium Mayne 6 mg/ml|irþ|6|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|16036|21832|lyfsjukr|||00|10|0|Icepharma hf|Mayne Pharma Plc|1| 009297|M05BA0304|Pamidronatdinatrium Mayne 9 mg/ml|irþ|9|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|21363|28464|lyfsjukr|||00|10|0|Icepharma hf|Mayne Pharma Plc|1,5| 009340|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|| |20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||00|400|0|Icepharma hf|Fresenius Kabi|| 009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|776|1676|lyfalmen|||23|8|0|Vistor hf|Novartis Healthcare A/S-|21| 009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|834|1796|lyfalmen|||23|8|0|Vistor hf|Novartis Healthcare A/S-|28| 009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1000|2141|lyfalmen|||23|8|0|Vistor hf|Novartis Healthcare A/S-|42| 009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1131|2414|lyfalmen|||23|8|0|Vistor hf|Novartis Healthcare A/S-|56| 009522|N02BE0101|Panodil|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GCH|0|0|1|100|DKK|||lyfalmen|||04|10|0|Icepharma hf|GlaxoSmithKline CH A/S|1,6667| 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|138804|174678|lyfsjukr|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|15| 009649|D11AX1401|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AX14|01.07.2003||R|A|3|0|1|0|0|ASP|0|0|0|100|XEU|3722|6343|lyfalmen|||00|30|0|Vistor hf|Astellas Pharma A/S|| 009672|J05AB0102|Zovir|töflur|400|mg|55|stk|1|þpakki||J05AB01|01.09.2003||R|A|5|0|0|E|0|GSK|0|0|1|30|GBP|6800|10714|lyfalmen|||00|55|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|5,5| 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|A|3|0|1|0|1|GSC|0|0|0|100|DKK|40095|51786|lyfsjukr|||00|30|0|Swedish Orphan International AB|Gilead Science International (S) |30| 009828|B05AA0705|HyperHAES|irl|| |250|ml|20|pokar||B05AA07|01.12.2002||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|36777|47655|lyfsjukr|||00|5000|0|Icepharma hf|Fresenius Kabi|5| 009830|B03XA0103|NeoRecormon |stl|20000|ae/spr|0,6|ml|1|spr||B03XA01|01.05.2006||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|23557|31196|lyfsjukr|||00|0,6|0|Icepharma hf|Roche|20| 009881|A10BD0201|Glucovance|filmhtfl|502,5|mg|30|stk|1|þpakki|500+2,5 mg|A10BD02|01.03.2003||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|481|1062|lyfalmen|||00|30|0|Icepharma hf|Merck Santé s.a.s.|15| 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|3756|6392|lyfalmen|||02|180|0|Vistor hf|Dentsply Limited|| 009905|N01BB5402|Citanest Dental Octapressin|stl|| |1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|3687|6292|lyfalmen|||00|180|0|Vistor hf|Dentsply Limited|| 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|4369|7285|lyfalmen|||17|180|0|Vistor hf|Dentsply Limited|| 009913|N06AX1102|Remeron Smelt|munndr.t|15|mg|6|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|313|713|lyfalmen|||00|6|0|Icepharma hf|N.V. Organon|3| 009942|N01BB5402|Citanest Dental Octapressin|stl|| |1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|3979|6717|lyfalmen|||00|180|0|Vistor hf|Dentsply Limited|| 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|4510|7491|lyfalmen|||17|180|0|Vistor hf|Dentsply Limited|| 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|3374|5836|lyfalmen|||02|180|0|Vistor hf|Dentsply Limited|| 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|1753|3397|lyfalmen|V1151|2058|00|30|0|Icepharma hf|N.V. Organon|15| 010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|2359|4318|lyfalmen|V1152|3060|00|30|0|Icepharma hf|N.V. Organon|30| 010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|5037|8256|lyfalmen|||00|30|0|Icepharma hf|N.V. Organon|45| 010070|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|áfyllt sprauta, lausn|L03AA13|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|128262|161554|lyfsjukr|||00|0,6|0|Vistor hf|Amgen Europe B.V.|20| 010102|G03GA0502|Gonal-f|sts|75|ae|1|hgl|1|pakki|(5,5 mcg) + leysir|G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|3027|5331|lyfalmen|||00|1|0|Gróco ehf|Serono Europe|1| 010135|A10BD0201|Glucovance|filmhtfl|505|mg|30|stk|1|þpakki|500+5 mg|A10BD02|01.03.2003||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|688|1493|lyfalmen|||00|30|0|Icepharma hf|Merck Santé s.a.s.|15| 010159|G03GA0502|Gonal-f|sts|75|ae|10|hgl|1|pakki|(5,5 mcg) + leysir |G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|30266|40731|lyfalmen|||00|10|0|Gróco ehf|Serono Europe|10| 010164|G03GA0502|Gonal-f|sts|450|ae|1|hgl|1|pakki|á 0,75ml + leysir|G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|18161|25661|lyfalmen|||00|1|0|Gróco ehf|Serono Europe|6| 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|A|3|0|0|0|1|RRL|0|0|0|30|DKK|138403|174179|lyfsjukr|||00|60|0|Icepharma hf|Roche Registration Limited|30| 010187|H01AX0101|Somavert|sts|10|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|239240|299721|lyfsjukr|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30| 010203|B03XA0201|Aranesp |stl|500|mcg/spr|1|ml|1|spr|áfyllt sprauta|B03XA02|01.04.2005||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|111857|141129|lyfsjukr|||00|1|0|Vistor hf|Amgen|111,11| 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|4290|6142|lyfsjukr|||00|1|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|| 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|7818|12134|lyfalmen|V1153|8828|00|96|0|Icepharma hf|N.V. Organon|96| 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|14492|21093|lyfalmen|||00|96|0|Icepharma hf|N.V. Organon|144| 010312|N06DX0101|Ebixa|töflur|10|mg|30|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|0|0|LUN|0|0|0|100|DKK|4896|8053|lyfalmen|||00|30|0|Lundbeck Export A/S|Lundbeck|15| 010323|N06DX0101|Ebixa|töflur|10|mg|50|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|0|0|LUN|0|0|0|100|DKK|7997|12384|lyfalmen|||00|50|0|Lundbeck Export A/S|Lundbeck|25| 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|0|0|LUN|0|0|0|100|DKK|14397|20975|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|50| 010348|J07BB0203|Vaxigrip|bóluefni|| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1995||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|5107|8354|lyfalmen|||51|5|0|Icepharma hf|Sanofi Pasteur MSD|| 010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|BAM|0|0|0|100|SEK|7932|11357|lyfsjukr|||00|2500|0|Icepharma hf|Baxter Medical AB|| 010534|B05BA0108|Vaminolac|irl|| |100|ml|10|fl||B05BA01|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4766|6824|lyfsjukr|||00|1000|0|Icepharma hf|Fresenius Kabi|1| 010573|S01AX1901|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AX19|01.08.2002||R|A|3|0|0|0|0|SAO|0|0|1|100|XEU|760|1642|lyfalmen|||00|5|0|Icepharma hf|Santen Oy|| 010591|M05BA0702|Optinate Septimum|filmhtfl|35|mg|4|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|E|0|AVP|0|0|0|100|NOK|3048|5361|lyfalmen|||00|4|0|Vistor hf|Aventis Pharma |28| 010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4202|6016|lyfsjukr|||00|7500|0|Icepharma hf|Baxter Medical AB|7,5| 010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|7706|11033|lyfsjukr|||00|5000|0|Icepharma hf|Baxter Medical AB|5| 010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|3013|4314|lyfsjukr|||00|10000|0|Icepharma hf|Baxter Medical AB|10| 010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|1681|2407|lyfsjukr|||00|10000|0|Icepharma hf|Baxter Medical AB|10| 010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|4792|7902|lyfalmen|||00|9|0|Vistor hf|Allergan|90| 010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|7706|11033|lyfsjukr|||00|5000|0|Icepharma hf|Baxter Medical AB|5| 010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4230|6056|lyfsjukr|||00|7500|0|Icepharma hf|Baxter Medical AB|7,5| 010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2897|4148|lyfsjukr|||00|10000|0|Icepharma hf|Baxter Medical AB|10| 010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|E|0|AVP|0|0|0|100|NOK|8349|12853|lyfalmen|V1080|12630|00|12|0|Vistor hf|Aventis Pharma |84| 010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|1565|2241|lyfsjukr|||00|10000|0|Icepharma hf|Baxter Medical AB|10| 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|SEK|279123|349376|lyfsjukr|||00|56|0|Swedish Orphan International AB|Actelion Registration Ltd. (S)|14| 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|SEK|279123|349376|lyfsjukr|||00|56|0|Swedish Orphan International AB|Actelion Registration Ltd. (S)|28| 010837|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|357557|447026|lyfsjukr|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|45| 010848|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|475870|594326|lyfsjukr|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|60| 010900|A01AB0301|Corsodyl|lausn|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|A|3|0|0|0|0|GCH|0|0|1|100|SEK|||lyflausa|||00|300|0|Icepharma hf|GlaxoSmithKline CH A/S|20| 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|K|3,5|0|1|0|1|BAM|0|0|0|100|SEK|30581|39941|lyfsjukr|||03|10|0|Icepharma hf|Baxter Medical AB|| 010938|A02BC0304|Lanzo Melt|munndr.t|15|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|1491|2999|lyfalmen|||00|28|0|Icepharma hf|Wyeth AB|14| 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|12681|18838|lyfalmen|||00|28|0|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|18,67| 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|12681|18838|lyfalmen|||00|28|0|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|28| 010959|A01AB0301|Corsodyl|hlaup|10|mg/g|50|g|1|túpa||A01AB03|01.09.1982||L|A|3|0|0|0|0|GCH|0|0|1|100|SEK|||lyflausa|||00|50|0|Icepharma hf|GlaxoSmithKline CH A/S|16,6667| 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|21223|29473|lyfalmen|||00|56|0|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|37,33| 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|21223|29473|lyfalmen|||00|56|0|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|56| 011047|N06AB1001|Cipralex|töflur|10|mg|200|stk|1|plglas||N06AB10|01.12.2003||R|A|3|0|0|B|0|LUN|0|1|0|30|DKK|14874|21568|lyfalmen|||00|200|0|Lundbeck Export A/S|Lundbeck|200| 011078|B05AA0702|Hemohes 6%|irl|60|mg/ml|500|ml|1|plpoki|án PVC (Ecobag)|B05AA07|01.05.2002||R|A|2|0|0|0|1|BRA|0|0|0|100|XEU|932|1334|lyfsjukr|||00|500|0|Actavis Group hf|Braun|0,5| 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|0|0|MSD|0|0|1|100|XEU|3372|5833|lyfalmen|||00|28|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|28| 011216|M01AH0501|Arcoxia|filmhtfl|60|mg|98|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|0|0|MSD|0|0|1|100|XEU|11678|17287|lyfalmen|||00|98|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|98| 011270|A10BB0101|Daonil|töflur|1,75|mg|100|stk|1|þpakki||A10BB01|01.12.1983||R|A|5|0|0|*|0|SNO|0|0|0|100|NOK|793|1711|lyfalmen|||44|100|0|Vistor hf|Sanofi-aventis Norge AS|25| 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|0|0|MSD|0|0|1|100|XEU|3372|5833|lyfalmen|||00|28|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|42| 011282|M01AH0501|Arcoxia|filmhtfl|90|mg|98|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|0|0|MSD|0|0|1|100|XEU|9477|14355|lyfalmen|||00|98|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|147| 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LUN|0|1|0|30|DKK|13728|20142|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|200| 011353|N05AF0502|Cisordinol Depot|stl|500|mg/ml|1|ml|5|lykjur||N05AF05|01.10.1988||R|A|4|0|0|*|0|LUN|0|1|0|100|DKK|7030|11035|lyfalmen|||02|5|0|Lundbeck Export A/S|Lundbeck|166,6667| 011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1730|3362|lyfalmen|V0196|3362|00|28|0|Actavis Group hf|Actavis hf|28| 011453|G04BE0901|Levitra|filmhtfl|5|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|6660|10519|lyfalmen|||00|12|0|Vistor hf|Bayer AG-|6| 011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|3885|6580|lyfalmen|||00|30|0|Vistor hf|Janssen-Cilag AB|18| 011526|R03DC0301|Singulair|kyrni|4|mg|28|sk-pokar|1|pakki||R03DC03|01.07.2004||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|3377|5840|lyfalmen|||00|28|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|11,2| 011528|A10BB0101|Daonil|töflur|3,5|mg|100|stk|1|þpakki||A10BB01|01.12.1983||R|A|5|0|0|*|0|SNO|0|0|0|100|NOK|1290|2694|lyfalmen|||44|100|0|Vistor hf|Sanofi-aventis Norge AS|50| 011532|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.11.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4908|7027|lyfsjukr|||02|10000|0|Icepharma hf|Baxter Medical AB|| 011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PFI|0|0|0|100|DKK|1004|1437|lyfsjukr|||00|50|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 011547|M01AH0501|Arcoxia|filmhtfl|120|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|0|0|MSD|0|0|1|100|XEU|3372|5833|lyfalmen|||00|28|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|56| 011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|5110|8358|lyfalmen|||00|30|0|Vistor hf|Janssen-Cilag AB|36| 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|A|5|0|0|0|0|CHP|1|0|0|100|USD|832|1642|vetalmen|||00|25|0|Icepharma hf|Chanelle Pharmaceuticals || 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PFI|0|0|0|100|DKK|1906|2729|lyfsjukr|||00|20|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|sk|1|fl|með skammtadælu|G03CA03|01.03.2000||R|A|2|0|0|E|0|OLF|0|0|0|100|SEK|864|1859|lyfalmen|||00|64|0|Gróco ehf|Oy Leiras Finland Ab|28,8| 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|A|3|0|1|0|1|RRL|0|0|0|30|DKK|60819|77587|lyfsjukr|||00|168|0|Icepharma hf|Roche Registration Limited|33,6| 011810|D11AX1501|Elidel|krem|1|%|60|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|0|0|NOH|0|0|1|100|DKK|5891|9447|lyfalmen|||00|60|0|Vistor hf|Novartis Healthcare A/S-|60| 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|2647|4755|lyfalmen|V0935|4755|00|28|0|Actavis Group hf|Actavis hf|56| 011986|C10AA0403|Lescol depot|forðatfl|80|mg|28|stk|1|þpakki||C10AA04|01.06.2004||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|2554|4614|lyfalmen|||00|28|0|Vistor hf|Novartis Healthcare A/S-|56| 011997|C10AA0403|Lescol depot|forðatfl|80|mg|98|stk|1|þpakki||C10AA04|01.06.2004||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|8793|13444|lyfalmen|||00|98|0|Vistor hf|Novartis Healthcare A/S-|196| 012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|25895|34107|lyfsjukr|||00|30|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|30| 012209|G04CB0201|Avodart|hylki|0,5|mg|90|stk|1|pakki|mjúk hylki|G04CB02|01.05.2003||R|A|3|0|0|E|0|GSK|0|0|0|100|XEU|7811|12124|lyfalmen|||00|90|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|90| 012309|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|2999|5190|vetorma|||00|20|0|Icepharma hf|Icepharma hf|| 012310|A10BB1201|Amaryl|töflur|1|mg|30|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|508|1118|lyfalmen|||00|30|0|Vistor hf|Aventis Pharma |15| 012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|6405|10164|lyfalmen|||00|30|0|Vistor hf|Janssen-Cilag AB|54| 012640|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|13721|23745|vetorma|||00|100|0|Icepharma hf|Icepharma hf|| 012677|A07AA0904|Vancomycin Alpharma|hylki|250|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996||R|A|2|0|0|E|0|ALP|0|0|1|100|DKK|26171|35633|lyfalmen|V0126|26087|00|28|0|Actavis Group hf|Alpharma ApS|3,5| 012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|A|3|0|1|0|1|WTE|0|0|0|100|USD|269364|337226|lyfsjukr|||00|1|0|Icepharma hf|Wyeth Europe|| 012770|G04BE0901|Levitra|filmhtfl|5|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|2375|4342|lyfalmen|||00|4|0|Vistor hf|Bayer AG-|2| 012792|G04BE0901|Levitra|filmhtfl|10|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|2698|4833|lyfalmen|||00|4|0|Vistor hf|Bayer AG-|4| 012816|G04BE0901|Levitra|filmhtfl|10|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|7739|12024|lyfalmen|||00|12|0|Vistor hf|Bayer AG-|12| 012838|G04BE0901|Levitra|filmhtfl|20|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|3346|5795|lyfalmen|||00|4|0|Vistor hf|Bayer AG-|8| 012860|G04BE0901|Levitra|filmhtfl|20|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|9418|14277|lyfalmen|||00|12|0|Vistor hf|Bayer AG-|24| 012921|G03AA1301|Evra|forðapl|| |9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|A|2|0|0|0|0|JCI|0|0|0|100|SEK|2589|4667|lyfalmen|||00|9|0|Vistor hf|Janssen-Cilag International N.V.|| 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|A|3|0|0|0|0|LBI|0|0|0|100|SEK|3920|6631|lyfalmen|||00|30|0|Icepharma hf|Laboratoires Besins International|30| 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|3437|5928|lyfalmen|||00|30|0|Vistor hf|Novartis Healthcare A/S-|20| 013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PFA|0|0|0|100|DKK|3869|7541|vetalmen|||00|100|0|Icepharma hf|Pfizer Animal Health|| 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|5836|9370|lyfalmen|||00|30|0|Vistor hf|Novartis Healthcare A/S-|40| 013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PFA|0|0|0|100|DKK|1021|2015|vetalmen|||00|20|0|Icepharma hf|Pfizer Animal Health|| 013097|A02BC0301|Lanzo|munndr.t|15|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|682|1480|lyfalmen|||00|14|0|Icepharma hf|Wyeth AB|7| 013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|12707|17688|lyfsjukr|||00|2|0|Ísaga ehf|AGA AB|| 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|K|3|0|0|0|1|ZLB|0|0|0|100|SEK|5736|8213|lyfsjukr|||17|2|0|Icepharma hf|ZLB GmbH|| 013259|B02BD0402|BeneFIX|sts|| |250|ae|1|hgl|+leysir|B02BD04|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|17806|24036|lyfsjukr|||00|250|0|Icepharma hf|Wyeth Europe|0,83| 013270|B02BD0402|BeneFIX|sts|| |500|ae|1|hgl|+leysir|B02BD04|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|35615|46208|lyfsjukr|||00|500|0|Icepharma hf|Wyeth Europe|1,43| 013307|B02BD0402|BeneFIX|sts|| |1000|ae|1|hgl|+leysir|B02BD04|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|71229|90548|lyfsjukr|||00|1000|0|Icepharma hf|Wyeth Europe|2,86| 013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PFA|0|0|0|100|DKK|2541|5011|vetalmen|||00|100|0|Icepharma hf|Pfizer Animal Health|| 013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PFA|0|0|0|100|DKK|6108|11806|vetalmen|||00|100|0|Icepharma hf|Pfizer Animal Health|| 013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PFA|0|0|0|100|DKK|641|1265|vetalmen|||00|20|0|Icepharma hf|Pfizer Animal Health|| 013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BAL|0|0|0|100|SEK|117669|148365|lyfsjukr|||00|1|0|Lyfjaver ehf|Baxter Medical AB (L)|3| 013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|19611|26283|lyfsjukr|||00|1|0|Lyfjaver ehf|Baxter AG (L)|0,5| 013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|78446|99533|lyfsjukr|||00|1|0|Lyfjaver ehf|Baxter AG (L)|2| 013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|38202|49429|lyfsjukr|||00|1|0|Lyfjaver ehf|Baxter AG (L)|2| 013386|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|þpakki||C10AX09|01.05.2003||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|3686|6291|lyfalmen|||00|28|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|28| 013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.05.2003||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|11958|17660|lyfalmen|||00|98|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|98| 013544|L04AB0401|Humira|stl|40|mg/spr|0,8|ml|2|spr||L04AB04|01.12.2003||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|116274|146629|lyfsjukr|||00|1,6|0|Vistor hf|Abbott|27,59| 013593|A01AA3001|Xerodent|munnstfl|| |90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|A|2|0|0|0|0|AGT|0|0|1|100|IKR|388|869|lyfalmen|||00|90|0|Actavis Group hf|Actavis Group hf|| 013660|A10AD0116|Mixtard 30 InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar sprautur|A10AD01|01.03.2002||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|3977|6714|lyfalmen|||00|15|0|Vistor hf|Novo-Nordisk|37,5| 013672|N03AG0101|Depakine|mixtúra|200|mg/ml|40|ml|1|glas||N03AG01|01.12.1978||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|784|1692|lyfalmen|||00|40|0|Vistor hf|Sanofi-aventis Norge AS|5,3333| 013718|M05BA0801|Zometa|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.05.2004||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|26178|34459|lyfsjukr|||00|5|0|Vistor hf|Novartis Europharm Ltd|1| 013720|A10AD0118|Mixtard 30|stl|100|ae/ml|10|ml|1|hgl||A10AD01|01.10.1985||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|1509|3027|lyfalmen|||50|10|0|Vistor hf|Novo-Nordisk|25| 013756|C09DA0304|Diovan Comp 160/25 mg|filmhtfl|| |28|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|B|0|NOH|0|0|0|100|DKK|2759|4925|lyfalmen|||00|28|0|Vistor hf|Novartis Healthcare A/S-|56| 013767|C09DA0304|Diovan Comp 160/25 mg|filmhtfl|| |98|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|B|0|NOH|0|0|0|100|DKK|9238|14037|lyfalmen|||00|98|0|Vistor hf|Novartis Healthcare A/S-|196| 013804|A10AC0105|Insulatard Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AC01|01.07.1993||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2703|4840|lyfalmen|||50|15|0|Vistor hf|Novo-Nordisk|37,5| 013879|A10AD0120|Mixtard 40 NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AD01|01.10.1992||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|3087|5418|lyfalmen|||50|15|0|Vistor hf|Novo-Nordisk|37,5| 013881|A10AD0122|Mixtard 20 NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AD01|01.10.1992||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|3205|5590|lyfalmen|||50|15|0|Vistor hf|Novo-Nordisk|37,5| 013890|A10AD0119|Mixtard 50 NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AD01|01.10.1992||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|3170|5539|lyfalmen|||50|15|0|Vistor hf|Novo-Nordisk|37,5| 013901|A10AC0108|Insulatard InnoLet |stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|3977|6714|lyfalmen|||00|15|0|Vistor hf|Novo-Nordisk|37,5| 013909|A10AD0117|Actrapid NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AD01|01.08.2003||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|3091|5424|lyfalmen|||51|15|0|Vistor hf|Novo-Nordisk|37,5| 013913|A10AD0121|Mixtard 30 NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AD01|01.10.1992||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2918|5167|lyfalmen|||50|15|0|Vistor hf|Novo-Nordisk|37,5| 013945|A10AD0123|Mixtard 10 NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AD01|01.04.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|3240|5641|lyfalmen|||50|15|0|Vistor hf|Novo-Nordisk|37,5| 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|1514|3034|lyfalmen|||51|10|0|Vistor hf|Novo-Nordisk|25| 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2925|5177|lyfalmen|||00|15|0|Vistor hf|Novo-Nordisk|37,5| 013958|A10AB0103|Actrapid Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AB01|01.02.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2682|4808|lyfalmen|||51|15|0|Vistor hf|Novo-Nordisk|37,5| 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|125970|158700|lyfsjukr|||00|60|0|Vistor hf|Novartis Europharm Ltd|| 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|222731|279168|lyfsjukr|||00|30|0|Vistor hf|Novartis Europharm Ltd|| 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|1501|3014|lyfalmen|||71|10|0|Vistor hf|Novo-Nordisk|25| 014081|N03AX1401|Keppra|mixtúra|100|mg|300|ml|1|glas||N03AX14|01.12.2006||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|13418|19756|lyfalmen|||00|300|0|Vistor hf|U.C.B|20| 014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|20560|27465|lyfsjukr|||00|5908|0|Icepharma hf|Fresenius Kabi|| 014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|A|3|0|0|0|0|IGB|0|0|0|100|SEK|828|1784|lyfalmen|||00|30|0|Icepharma hf|Intendis GmbH Berlin|30| 014285|B05BA1020|StructoKabiven elektrolyfri|irl|2100|kcal|1970|ml|2|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|12665|17635|lyfsjukr|||00|3940|0|Icepharma hf|Fresenius Kabi|| 014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|A|2|0|0|0|0|JAS|0|0|0|100|SEK|||lyfalmen|||29|4|0|Vistor hf|Janssen-Cilag AB|| 014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|13946|19230|lyfsjukr|||00|3944|0|Icepharma hf|Fresenius Kabi|| 014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|18251|24590|lyfsjukr|||00|5908|0|Icepharma hf|Fresenius Kabi|| 014372|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|2|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|12665|17635|lyfsjukr|||00|3940|0|Icepharma hf|Fresenius Kabi|| 014541|QA02BX1201|Orbeseal|spenalyf|2,6|g/dælu|24|dælur|1|pakki||QA02BX12|01.04.2005||R|A|5|0|0|0|0|PFI|0|0|0|100|XEU|3264|6389|vetalmen|||16|24|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 014583|J05AX0701|Fuzeon|sts|90|mg/ml|60|hgl|1|pakki|+ leysir|J05AX07|01.12.2003||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|167411|210294|lyfsjukr|||00|60|0|Icepharma hf|Roche Registration Limited|| 014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|1379|2829|lyfalmen|||10|28|0|Icepharma hf|Norpharma |1,86| 014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2|0|1|0|1|AEU|0|0|0|100|DKK|43153|55593|lyfsjukr|||00|2,5|0|Vistor hf|Amgen Europe B.V.|4,29| 014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2|0|1|0|1|AEU|0|0|0|100|DKK|66803|85037|lyfsjukr|||00|2,5|0|Vistor hf|Amgen Europe B.V.|6,86| 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|0|0|NOV|0|0|0|100|DKK|13074|19327|lyfalmen|||00|60|0|Icepharma hf|Novartis Healthcare A/S|10| 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|0|0|NOV|0|0|0|100|DKK|39223|51883|lyfalmen|||00|60|0|Icepharma hf|Novartis Healthcare A/S|30| 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|0|0|NOV|0|0|0|100|DKK|26149|35606|lyfalmen|||00|60|0|Icepharma hf|Novartis Healthcare A/S|20| 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|K|2|0|0|0|0|NON|0|0|0|100|DKK|6040|9655|lyfalmen|||00|15|0|Vistor hf|Novo-Nordisk|37,5| 015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|623|1358|lyfalmen|||23|8|0|Vistor hf|Novartis Healthcare A/S-|14| 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2572|4641|lyfalmen|V0832|4251|00|6|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|12| 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|3755|6391|lyfalmen|V0831|5845|00|12|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|12| 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|K|2|0|0|0|0|NON|0|0|0|100|DKK|6060|9683|lyfalmen|||00|15|0|Vistor hf|Novo-Nordisk|37,5| 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|3507|6030|lyfalmen|||00|30|0|Vistor hf|Orion Corporation|3,33| 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|11640|17237|lyfalmen|||00|100|0|Vistor hf|Orion Corporation|11,11| 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|3507|6030|lyfalmen|||00|30|0|Vistor hf|Orion Corporation|10| 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|11640|17237|lyfalmen|||00|100|0|Vistor hf|Orion Corporation|33,33| 015677|N05CF0201|Stilnoct|töflur|10|mg|1000|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|20897|29067|lyfalmen|||00|1000|0|Vistor hf|Sanofi-aventis Norge AS|1000| 015679|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|45755|58832|lyfsjukr|||43|60|0|Vistor hf|Bristol-Myers Squibb|| 015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|45755|58832|lyfsjukr|||43|60|0|Vistor hf|Bristol-Myers Squibb|| 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|3507|6030|lyfalmen|||00|30|0|Vistor hf|Orion Corporation|6,67| 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|10327|15488|lyfalmen|||00|100|0|Vistor hf|Orion Corporation|22,22| 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|15887|22830|lyfalmen|||00|120|0|Vistor hf|Novartis Healthcare A/S-|10| 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|27631|37451|lyfalmen|||00|120|0|Vistor hf|Novartis Healthcare A/S-|21,6| 015800|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA04|01.01.1977||R|A|2|0|0|E|0|ALC|0|0|0|100|USD|499|1100|lyfalmen|||06|15|0|K.Pétursson hf|Alcon|| 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|1604|2776|vetorma|||16|2,4|0|Vistor hf|Bayer HealthCare AG|| 015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|2563|4435|vetorma|||16|12|0|Vistor hf|Bayer HealthCare AG|| 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|1359|2352|vetorma|||16|1,2|0|Vistor hf|Bayer HealthCare AG|| 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|1832|3170|vetorma|||16|3|0|Vistor hf|Bayer HealthCare AG|| 015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|þpakki||M01CC01|01.05.1978||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|2599|4682|lyfalmen|||10|50|0|Swedish Orphan International AB|Sandoz GmbH (S)|25| 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|2286|3956|vetorma|||16|7,5|0|Vistor hf|Bayer HealthCare AG|| 015923|D11AX1401|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AX14|01.10.2007||R|A|3|0|1|0|0|ASP|0|0|0|100|XEU|1332|2758|lyfalmen|||00|10|0|Vistor hf|Astellas Pharma A/S|| 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1060|2266|lyfalmen|||02|10|0|Icepharma hf|Martindale Pharmaceuticals|3,33| 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|1541|2667|vetorma|||16|1,2|0|Vistor hf|Bayer HealthCare AG|| 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|A|3|0|0|B|0|GSK|0|1|0|30|GBP|1020|2183|lyfalmen|||00|28|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|14| 015985|C09AA0401|Coversyl|töflur|8|mg|90|stk|1|þpakki||C09AA04|01.06.2005||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|8866|13541|lyfalmen|||00|90|0|Icepharma hf|Servier|180| 016000|N02CC0501|Almogran|töflur|12,5|mg|6|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|XEU|2912|5158|lyfalmen|||00|6|0|Gróco ehf|Laboratorios Almirall S.A.|6| 016003|C09AA0401|Coversyl|töflur|8|mg|30|stk|1|þpakki||C09AA04|01.06.2005||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|3063|5383|lyfalmen|||00|30|0|Icepharma hf|Servier|60| 016011|N02CC0501|Almogran|töflur|12,5|mg|9|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|XEU|4014|6768|lyfalmen|||00|9|0|Gróco ehf|Laboratorios Almirall S.A.|9| 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|774|1672|lyfalmen|||02|10|0|Icepharma hf|Martindale Pharmaceuticals|1,25| 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|820|1767|lyfalmen|||02|20|0|Icepharma hf|Martindale Pharmaceuticals|2,5| 016038|N02CC0501|Almogran|töflur|12,5|mg|3|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|XEU|1464|2958|lyfalmen|||00|3|0|Gróco ehf|Laboratorios Almirall S.A.|3| 016125|M02AA1001|Orudis|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.03.2000||L|A|2|0|0|0|0|SNO|0|0|1|100|NOK|||lyfalmen|||00|60|0|Vistor hf|Sanofi-aventis Norge AS|| 016178|A10BD0301|Avandamet|filmhtfl|502|mg|112|stk|1|þpakki|500+2mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|5419|8789|lyfalmen|||00|112|0|GlaxoSmithKline ehf|SmithKline Beecham PLC|56| 016209|N05AX0801|Risperdal|töflur|2|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.09.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|4781|7886|lyfalmen|||00|28|0|Vistor hf|Janssen-Cilag AB|11,2| 016228|A10BD0301|Avandamet|filmhtfl|501|mg|56|stk|1|þpakki|500+1mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|1549|3087|lyfalmen|||00|56|0|GlaxoSmithKline ehf|SmithKline Beecham PLC|28| 016239|A10BD0301|Avandamet|filmhtfl|501|mg|112|stk|1|þpakki|500+1mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|3099|5435|lyfalmen|||00|112|0|GlaxoSmithKline ehf|SmithKline Beecham PLC|56| 016250|A10BD0301|Avandamet|filmhtfl|502|mg|56|stk|1|þpakki|500+2mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|2709|4849|lyfalmen|||00|56|0|GlaxoSmithKline ehf|SmithKline Beecham PLC|28| 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|1881|3592|lyfalmen|||00|14|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|7| 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3997|6744|lyfalmen|||00|56|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|14| 016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|K|2|0|1|E|0|SEE|0|0|0|100|SEK|3054|5370|lyfalmen|||00|0,5|0|Gróco ehf|Serono Europe|1| 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|6084|9716|lyfalmen|||00|56|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|28| 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|1263|2653|lyfalmen|||00|14|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|3,5| 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|8922|13616|lyfalmen|||00|56|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|56| 016337|C08CA0302|Lomir Retard|forðahlk|5|mg|100|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|6389|10141|lyfalmen|||10|100|0|Vistor hf|Novartis Healthcare A/S-|100| 016353|N05AX0801|Risperdal|töflur|1|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.08.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|2766|4936|lyfalmen|||00|28|0|Vistor hf|Janssen-Cilag AB|5,6| 016363|L01BC0108|Cytarabine Pfizer|stl/irl|20|mg/ml|5|ml|5|hgl||L01BC01|01.11.2000||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|2727|3904|lyfsjukr|||00|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 016364|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|2|ml|5|hgl||L01BA01|01.10.1995||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|3360|4811|lyfsjukr|||00|10|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 016374|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|20|ml|1|hgl||L01BC01|01.10.1995||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|9759|13972|lyfsjukr|||00|20|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|A|1,5|0|0|0|1|PFI|0|0|0|100|DKK|80466|102048|lyfsjukr|||00|70|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|7| 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|4880|6987|lyfsjukr|||00|10|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|1880|3590|lyfalmen|||00|56|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|5,42| 016396|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1995||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|4513|6461|lyfsjukr|||00|20|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 016474|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|5|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|15297|20912|lyfsjukr|||00|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||23|30|0|Vistor hf|Pfizer Denmark PCH ApS|2| 016506|N07BA0111|Nicorette Classic|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||23|30|0|Vistor hf|Pfizer Denmark PCH ApS|4| 016516|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|45|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|128463|161804|lyfsjukr|||00|225|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||23|210|0|Vistor hf|Pfizer Denmark PCH ApS|28| 016534|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|15|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|45054|57960|lyfsjukr|||00|75|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 016561|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||23|105|0|Vistor hf|Pfizer Denmark PCH ApS|7| 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||00|210|0|Vistor hf|Pfizer Denmark PCH ApS|14| 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||23|30|0|Vistor hf|Pfizer Denmark PCH ApS|4| 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||23|30|0|Vistor hf|Pfizer Denmark PCH ApS|2| 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|12681|18838|lyfalmen|||00|28|0|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|6,2| 016605|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||23|105|0|Vistor hf|Pfizer Denmark PCH ApS|14| 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||00|210|0|Vistor hf|Pfizer Denmark PCH ApS|28| 016622|A06AG1101|Microlax|innhl|| |5|ml|50|túpa||A06AG11|01.09.2005||L|A|5|0|0|0|0|PFD|0|0|0|100|DKK|2656|4769|lyfalmen|||56|250|0|Vistor hf|Pfizer Denmark PCH ApS|50| 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|25318|34571|lyfalmen|||00|56|0|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|12,4| 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1174|2503|lyfalmen|V0466|2426|00|12|0|Actavis Group hf|LEK Pharmaceuticals d.d.|12| 016640|B03XA0103|NeoRecormon |stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|137521|173081|lyfsjukr|||00|2,4|0|Icepharma hf|Roche|180| 016671|N05AH0303|Zyprexa (Lyfjaver)|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.09.2003||R|A|2|0|0|*|0|LVR|0|1|0|100|IKR|3911|6618|lyfalmen|V0809|6618|00|28|0|Lyfjaver ehf|Lyfjaver ehf|7| 016680|N07BA0112|Nicorette Orange|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|3|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||23|210|0|Vistor hf|Pfizer Denmark PCH ApS|28| 016682|N05AH0303|Zyprexa (Lyfjaver)|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.09.2003||R|A|3|0|0|*|0|LVR|0|1|0|100|IKR|5412|8779|lyfalmen|V0810|8779|00|28|0|Lyfjaver ehf|Lyfjaver ehf|14| 016686|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|3|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|120225|151548|lyfsjukr|||00|6|0|Icepharma hf|Ipsen Ltd.|| 016699|A10BA0202|Glucophage (Lyfjaver)|töflur|500|mg|400|stk|1|plglas||A10BA02|01.09.2003||R|A|5|0|0|*|0|LVR|0|0|0|100|NOK|1713|3336|lyfalmen|||00|400|0|Lyfjaver ehf|Lyfjaver ehf|100| 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|4702|7770|lyfalmen|||00|30|0|Vistor hf|Novartis Healthcare A/S-|30| 016728|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|1|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|40075|51761|lyfsjukr|||00|2|0|Icepharma hf|Ipsen Ltd.|| 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|2134|3976|lyfalmen|V0789|3976|10|200|0|Lyfjaver ehf|Lyfjaver ehf|40| 016739|N07BA0112|Nicorette Orange|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|3|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||23|30|0|Vistor hf|Pfizer Denmark PCH ApS|2| 016761|N07BA0112|Nicorette Orange|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|3|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||23|210|0|Vistor hf|Pfizer Denmark PCH ApS|14| 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|3892|6591|lyfalmen|V0713|6591|10|200|0|Lyfjaver ehf|Lyfjaver ehf|80| 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|36932|49031|lyfalmen|||00|28|0|Vistor hf|Amgen Europe B.V.|28| 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|54590|71015|lyfalmen|||00|28|0|Vistor hf|Amgen Europe B.V.|42| 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|20298|28321|lyfalmen|||00|28|0|Vistor hf|Amgen Europe B.V.|| 016892|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|33962|45333|lyfalmen|||00|1,5|0|Gróco ehf|Serono Europe|12| 016927|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|12991|19224|lyfalmen|||00|0,5|0|Gróco ehf|Serono Europe|4| 016938|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|19484|27308|lyfalmen|||00|0,75|0|Gróco ehf|Serono Europe|6| 016943|A02BC0301|Lanzo|munndr.t|30|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|1263|2653|lyfalmen|||00|14|0|Icepharma hf|Wyeth AB|14| 016954|A02BC0301|Lanzo|munndr.t|30|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|2451|4457|lyfalmen|||00|28|0|Icepharma hf|Wyeth AB|28| 016957|A02BC0301|Lanzo|munndr.t|15|mg|98|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|4773|7874|lyfalmen|||00|98|0|Icepharma hf|Wyeth AB|49| 016965|A02BC0301|Lanzo|munndr.t|30|mg|56|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|4809|7926|lyfalmen|||00|56|0|Icepharma hf|Wyeth AB|56| 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|A|3|0|1|0|1|GSC|0|0|0|100|XEU|23121|30653|lyfsjukr|||00|30|0|Swedish Orphan International AB|Gilead Science International (S) |30| 016976|A02BC0301|Lanzo|munndr.t|30|mg|98|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|8424|12953|lyfalmen|||00|98|0|Icepharma hf|Wyeth AB|98| 016979|N02AE0103|Norspan|forðapl|5|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|1992|3760|lyfalmen|||00|4|0|Icepharma hf|Norpharma |16,67| 016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|60|dælur|1|pakki||QA02BX12|01.12.2006||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|10789|20723|vetalmen|||16|60|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|18668|25109|lyfsjukr|||00|4824|0|Icepharma hf|Fresenius Kabi|| 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|894|1921|lyfalmen|||03|3|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|21,4286| 017111|A09AA0201|Combizym|töflur|| |100|stk|1|þpakki||A09AA02|01.07.1988||R|A|2|0|0|E|0|DSG|0|0|0|100|XEU|890|1913|lyfalmen|||10|100|0|Icepharma hf|Daiichi Sankyo Europe GmbH|25| 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|K|2|0|1|0|1|SKY|0|0|0|100|DKK|165360|207741|lyfsjukr|||00|5|0|Icepharma hf|SkyPharma PLC|| 017145|C08DB0102|Cardizem Retard|forðatfl|180|mg|60|stk|1|glas||C08DB01|01.04.1990||R|A|2|0|0|B|0|FRO|0|0|0|100|DKK|3981|6720|lyfalmen|||10|60|0|Vistor hf|Ferrosan A/S|45| 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|A|3|0|1|0|1|JCI|0|0|0|100|SEK|118007|148786|lyfsjukr|||00|1|0|Vistor hf|Janssen-Cilag International N.V.|| 017203|M05BA0601|Bondronat|irþ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|26070|34325|lyfsjukr|||00|6|0|Icepharma hf|Roche|1| 017204|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|3|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|19295|25890|lyfsjukr|||00|5712|0|Icepharma hf|Fresenius Kabi|| 017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|828|1784|lyfalmen|V0221|1784|00|100|0|Gróco ehf|Nycomed Danmark A/S|33,3333| 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|K|1,5|0|1|0|1|BIF|0|0|0|100|XEU|86488|109545|lyfsjukr|||00|2|0|Icepharma hf|Biogen Frances S.A.|27,91| 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|29094|39272|lyfalmen|||00|28|0|Icepharma hf|Roche|| 017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|86841|111167|lyfalmen|||00|84|0|Icepharma hf|Roche|| 017260|L01XX1903|Irinotecan Mayne|irþ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.04.2007||R|A|3|0|1|0|1|MAY|0|0|0|100|SEK|5983|8566|lyfsjukr|||00|2|0|Icepharma hf|Mayne Pharma Plc|| 017266|N02AE0103|Norspan|forðapl|10|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|3526|6057|lyfalmen|||00|4|0|Icepharma hf|Norpharma |33,33| 017271|L01XX1903|Irinotecan Mayne|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2007||R|A|3|0|1|0|1|MAY|0|0|0|100|SEK|14174|19514|lyfsjukr|||00|5|0|Icepharma hf|Mayne Pharma Plc|| 017294|N03AX1202|Gabapentin NM Pharma|hylki|300|mg|100|stk|1|glas||N03AX12|01.10.2007||R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|3720|6340|lyfalmen|V0714|6340|00|100|0|Merck NM|Merck NM AB|16,6667| 017305|N03AX1202|Gabapentin NM Pharma|hylki|400|mg|100|stk|1|glas||N03AX12|01.10.2007||R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|5080|8316|lyfalmen|V0715|8316|00|100|0|Merck NM|Merck NM AB|22,22| 017326|N02AE0103|Norspan|forðapl|20|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|6585|10415|lyfalmen|||00|4|0|Icepharma hf|Norpharma |66,66| 017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|1550|3089|lyfalmen|||00|100|0|Gróco ehf|Nycomed Danmark A/S|66,6667| 017331|A04AD1201|Emend|hylki|| |3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|A|2,5|0|0|0|1|MSD|0|0|0|100|XEU|5892|8436|lyfsjukr|||00|3|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|| 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|A|2|0|0|E|0|REP|0|0|1|100|SEK|1852|3548|lyfalmen|||00|30|0|Vistor hf|Recip AB|150| 017422|N06BA0404|Equasym|töflur|5|mg|30|stk|1|þpakki||N06BA04|01.05.2004||R|A|3|1|0|0|0|UCB|0|0|0|100|DKK|460|1019|lyfalmen|||00|30|0|Vistor hf|U.C.B|5| 017499|N06BA0404|Equasym|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.05.2004||R|A|3|1|0|0|0|UCB|0|0|0|100|DKK|689|1495|lyfalmen|V0953|1486|00|30|0|Vistor hf|U.C.B|10| 017510|N06BA0404|Equasym|töflur|20|mg|30|stk|1|þpakki||N06BA04|01.05.2004||R|A|3|1|0|0|0|UCB|0|0|0|100|DKK|1379|2829|lyfalmen|||00|30|0|Vistor hf|U.C.B|20| 017541|N07CA0101|Betaserc|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.06.1999||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|4155|6974|lyfalmen|||00|100|0|Medico ehf|Solvay Duphar |66,6667| 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|3850|7505|vetalmen|||00|100|0|Vistor hf|Boehringer Ingelheim|| 017763|N06DA0401|Reminyl|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|0|0|JAS|0|0|0|100|SEK|27199|36913|lyfalmen|||00|84|0|Vistor hf|Janssen-Cilag AB|84| 017773|N06DA0401|Reminyl|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|0|0|JAS|0|0|0|100|SEK|9287|14102|lyfalmen|||00|28|0|Vistor hf|Janssen-Cilag AB|14| 017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|6444|10218|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30| 017809|N06DA0401|Reminyl|forðahlk|24|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|0|0|JAS|0|0|0|100|SEK|28655|38726|lyfalmen|||00|84|0|Vistor hf|Janssen-Cilag AB|126| 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|6444|10218|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|15| 018268|G03FA1701|Angemin|töflur|| |84|stk|1|þpakki|2+1 mg|G03FA17|01.06.2005||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|3868|6556|lyfalmen|||00|84|0|Icepharma hf|Bayer Schering Pharma AG|84| 018311|C09CA0801|Olmetec|filmhtfl|10|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|1554|3095|lyfalmen|||00|28|0|Gróco ehf|Daiichi Sankyo Europe GmbH-|14| 018446|C09CA0801|Olmetec|filmhtfl|40|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|2294|4219|lyfalmen|||00|28|0|Gróco ehf|Daiichi Sankyo Europe GmbH-|56| 018502|C09CA0801|Olmetec|filmhtfl|40|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|7184|11250|lyfalmen|||00|98|0|Gróco ehf|Daiichi Sankyo Europe GmbH-|196| 018512|C09CA0801|Olmetec|filmhtfl|10|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|5046|8269|lyfalmen|||00|98|0|Gróco ehf|Daiichi Sankyo Europe GmbH-|49| 018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|1449|2935|lyfalmen|||02|0,25|0|Icepharma hf|Baxter AG|| 018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|1570|3119|lyfalmen|||02|0,5|0|Icepharma hf|Baxter AG|| 018534|C09CA0801|Olmetec|filmhtfl|20|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|5927|9497|lyfalmen|||00|98|0|Gróco ehf|Daiichi Sankyo Europe GmbH-|98| 018558|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|5|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|10521|14966|lyfsjukr|||00|5|0|Icepharma hf|Mayne Pharma Plc|| 018569|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|52022|66635|lyfsjukr|||00|25|0|Icepharma hf|Mayne Pharma Plc|| 018586|C09CA0801|Olmetec|filmhtfl|20|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|1930|3666|lyfalmen|||00|28|0|Gróco ehf|Daiichi Sankyo Europe GmbH-|28| 018591|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|35145|45623|lyfsjukr|||00|16,7|0|Icepharma hf|Mayne Pharma Plc|| 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|4760|7855|lyfalmen|||00|30|0|Vistor hf|Astellas Pharma A/S|60| 018617|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|103852|131163|lyfsjukr|||00|50|0|Icepharma hf|Mayne Pharma Plc|| 018663|J01DD0401|Rocephalin|stþ|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|7864|11259|lyfsjukr|||03|5|0|Icepharma hf|Roche|2,5| 018670|C09CA0301|Diovan|filmhtfl|40|mg|14|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|839|1807|lyfalmen|||00|14|0|Vistor hf|Novartis Healthcare A/S-|7| 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|14017|20501|lyfalmen|||00|90|0|Vistor hf|Astellas Pharma A/S|180| 018681|C09CA0301|Diovan|filmhtfl|40|mg|28|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|1679|3285|lyfalmen|||00|28|0|Vistor hf|Novartis Healthcare A/S-|14| 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|11.06.2004||R|A|3|0|0|B|0|MKA|0|0|1|100|XEU|639|1391|lyfalmen|||00|100|0|NM Pharma ehf|Merck KgaA|50| 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|3809|6470|lyfalmen|||00|30|0|Vistor hf|Astellas Pharma A/S|30| 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|11215|16671|lyfalmen|||00|90|0|Vistor hf|Astellas Pharma A/S|90| 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|21483|29797|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|100| 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|K|2|0|1|0|1|TEP|0|0|0|100|NOK|86201|109188|lyfsjukr|||00|28|0|Vistor hf|Teva Pharmaceuticals Limited|| 018803|C10AA0502|Lipitor (Lyfjaver)|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.01.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|DKK|11661|17265|lyfalmen|V0338|11380|00|100|0|Lyfjaver ehf|Lyfjaver ehf|200| 018814|C10AA0502|Lipitor (Lyfjaver)|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.01.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|DKK|13702|20109|lyfalmen|V0339|14060|00|100|0|Lyfjaver ehf|Lyfjaver ehf|400| 018894|N06DA0202|Aricept (Lyfjaver)|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.01.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|DKK|27561|37364|lyfalmen|V0375|37364|00|98|0|Lyfjaver ehf|Lyfjaver ehf|65,33| 018908|N06DA0202|Aricept (Lyfjaver)|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.01.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|DKK|29918|40298|lyfalmen|V0376|40297|00|98|0|Lyfjaver ehf|Lyfjaver ehf|130,67| 018927|M05BA0402|Fosamax (Lyfjaver)|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.03.2004||R|A|2|0|0|E|0|LVR|0|0|0|100|XEU|8228|12691|lyfalmen|V0718|12473|00|12|0|Lyfjaver ehf|Lyfjaver ehf|84| 018956|R06AX2201|Kestine|töflur|20|mg|30|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|1790|3453|lyfalmen|||00|30|0|Gróco ehf|Almirall-Prodesfarma S.A.|60| 018967|R06AX2201|Kestine|töflur|20|mg|100|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|5537|8953|lyfalmen|||00|100|0|Gróco ehf|Almirall-Prodesfarma S.A.|200| 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|39879|51517|lyfsjukr|||43|60|0|GlaxoSmithKline ehf|Glaxo Group Limited|30| 018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|343|775|lyfalmen|||00|100|0|Gróco ehf|Nycomed Danmark A/S|50| 018979|C10AA0502|Lipitor (Lyfjaver)|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.01.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|DKK|8071|12482|lyfalmen|V0337|8383|00|100|0|Lyfjaver ehf|Lyfjaver ehf|100| 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|714|1409|vetalmen|||27|100|0|Icepharma hf|Kela Laboratoria NV|| 018995|N02AB0301|Durogesic|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|8482|13030|lyfalmen|||00|5|0|Vistor hf|Janssen-Cilag AB|62,5| 019034|J01CA0402|Amoxicillin NM Pharma|hylki|250|mg|20|stk|1|glas||J01CA04|01.04.1993||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|345|780|lyfalmen|||10|20|0|Merck NM|Merck NM AB|5| 019065|N06DA0302|Exelon (Lyfjaver)|hylki|6|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|0|0|LVR|0|0|0|100|DKK|8449|12986|lyfalmen|||00|56|0|Lyfjaver ehf|Lyfjaver ehf|37,33| 019079|N06DA0302|Exelon (Lyfjaver)|hylki|4,5|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|0|0|LVR|0|0|0|100|DKK|8449|12986|lyfalmen|||00|56|0|Lyfjaver ehf|Lyfjaver ehf|28| 019082|N06DA0302|Exelon (Lyfjaver)|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|0|0|LVR|0|0|0|100|DKK|8283|12765|lyfalmen|||00|56|0|Lyfjaver ehf|Lyfjaver ehf|18,67| 019094|N02AB0301|Durogesic|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|5502|8905|lyfalmen|||00|5|0|Vistor hf|Janssen-Cilag AB|41,6667| 019102|N06DA0302|Exelon (Lyfjaver)|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|0|0|LVR|0|0|0|100|DKK|4225|7076|lyfalmen|||00|28|0|Lyfjaver ehf|Lyfjaver ehf|4,6667| 019108|N02AB0301|Durogesic|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|2974|5252|lyfalmen|||00|5|0|Vistor hf|Janssen-Cilag AB|20,8333| 019167|N02AB0301|Durogesic|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|9509|14398|lyfalmen|||00|5|0|Vistor hf|Janssen-Cilag AB|83,3333| 019293|B02BC0001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC00|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|DKK|32710|42591|lyfsjukr|||00|1|0|Gróco ehf|Nycomed Danmark A/S|| 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|þykkni, lausn|B01AE06|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|XEU|427198|533729|lyfsjukr|||00|10|0|Gróco ehf|Nycomed Danmark A/S|| 019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|37100|48057|lyfsjukr|||AC|4|0|Icepharma hf|Roche Registration Limited|| 019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|344|777|lyfalmen|||00|100|0|Gróco ehf|Nycomed Danmark A/S|100| 019589|C09CA0401|Aprovel|filmhtfl|150|mg|28|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|2289|4211|lyfalmen|||00|28|0|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|28| 019600|C09CA0401|Aprovel|filmhtfl|150|mg|98|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|7995|12381|lyfalmen|||00|98|0|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|98| 019611|C09CA0401|Aprovel|filmhtfl|300|mg|28|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|3264|5676|lyfalmen|||00|28|0|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|56| 019622|C09CA0401|Aprovel|filmhtfl|300|mg|98|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|10895|16244|lyfalmen|||00|98|0|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|196| 019699|C09DA0401|CoAprovel|filmhtfl|162,5|mg|28|stk|1|þpakki|150+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|2289|4211|lyfalmen|||00|28|0|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|28| 019710|C09DA0401|CoAprovel|filmhtfl|162,5|mg|98|stk|1|þpakki|150+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|7995|12381|lyfalmen|||00|98|0|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|98| 019721|C09DA0401|CoAprovel|filmhtfl|312,5|mg|28|stk|1|þpakki|300+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|3264|5676|lyfalmen|||00|28|0|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|56| 019732|C09DA0401|CoAprovel|filmhtfl|312,5|mg|98|stk|1|þpakki|300+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|10895|16244|lyfalmen|||00|98|0|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|196| 019745|C03CA0101|Furix|töflur|40|mg|250|stk|1|glas|til vélskömmtunar|C03CA01|01.04.2005||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|360|811|lyfalmen|||00|250|0|Gróco ehf|Nycomed Danmark A/S|250| 019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|135752|170879|lyfsjukr|||AC|16|0|Icepharma hf|Roche Registration Limited|| 019786|J01CA0402|Amoxicillin NM Pharma|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|603|1316|lyfalmen|||10|20|0|Merck NM|Merck NM AB|10| 019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|34303|45757|lyfalmen|||00|1,08|0|Icepharma hf|N.V. Organon|12| 019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|A|2|0|1|0|1|AEU|0|0|0|100|DKK|450995|563356|lyfsjukr|||02|6|0|Vistor hf|Amgen Europe B.V.|8,93| 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|263|609|lyfalmen|||00|12|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|0,5| 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|45191|58130|lyfsjukr|||00|30|0|GlaxoSmithKline ehf|Glaxo Group Limited|| 019968|J01CA0410|Amoxicillin Merck NM|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|901|1936|lyfalmen|||10|30|0|Merck NM|Merck NM AB|15| 020238|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|30|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|2632|4732|lyfalmen|||00|30|0|Vistor hf|Astellas Pharma A/S|30| 020244|J07CA0204|Boostrix Polio|stl|| |0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|17620|24987|lyfalmen|||00|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 020261|A10BD0301|Avandamet|filmhtfl|1002|mg|56|stk|1|þpakki|1000+2mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|3039|5348|lyfalmen|||00|56|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 020272|A10BD0301|Avandamet|filmhtfl|1004|mg|56|stk|1|þpakki|1000+4mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|5312|8640|lyfalmen|||00|56|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stil|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|A|5|0|0|0|0|LVR|0|0|0|100|NOK|1520|3043|lyfalmen|||04|50|0|Lyfjaver ehf|Lyfjaver ehf|50| 020277|N06AX1602|Efexor Depot|forðahlk|37,5|mg|7|stk|1|þpakki||N06AX16|01.02.2007||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|436|969|lyfalmen|||00|7|0|Icepharma hf|Wyeth AB|2,63| 020338|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|90|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|5632|9086|lyfalmen|||00|90|0|Vistor hf|Astellas Pharma A/S|90| 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|A|2|0|1|*|0|ASP|0|0|0|100|XEU|40000|52850|lyfalmen|||02|2|0|Vistor hf|Astellas Pharma A/S|| 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.06.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|2772|4945|lyfalmen|||00|84|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|7| 020398|N06AB1001|Cipralex|dropar|10|mg/ml|28|ml|1|glas||N06AB10|01.11.2005||R|A|2|0|0|B|0|LUN|0|1|0|30|DKK|2082|3897|lyfalmen|||00|28|0|Lundbeck Export A/S|Lundbeck|28| 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|8014|12406|lyfalmen|||00|84|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|28| 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|A|2|0|1|*|0|ASP|0|0|0|100|XEU|14157|20676|lyfalmen|||02|2|0|Vistor hf|Astellas Pharma A/S|| 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|417|929|lyfalmen|||20|30|0|Vistor hf|Astellas Pharma A/S|30| 020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|3971|6706|lyfalmen|||00|28|0|Icepharma hf|Servier|28| 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|1215|2580|lyfalmen|||20|100|0|Vistor hf|Astellas Pharma A/S|100| 020472|C09CA0103|Cozaar (Lyfjaver)|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.09.2004||R|A|3|0|0|B|0|LVR|0|0|0|100|XEU|6283|9994|lyfalmen|V0197|8649|00|98|0|Lyfjaver ehf|Lyfjaver ehf|98| 020483|C09DA0103|Cozaar Comp (Lyfjaver)|töflur|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.08.2004||R|A|3|0|0|B|0|LVR|0|0|0|100|XEU|6292|10006|lyfalmen|V0198|10006|00|98|0|Lyfjaver ehf|Lyfjaver ehf|98| 020494|N03AX1102|Topimax (Lyfjaver)|töflur|25|mg|60|stk|1|plglas||N03AX11|01.08.2004||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|2864|5085|lyfalmen|V0709|5085|00|60|0|Lyfjaver ehf|Lyfjaver ehf|5| 020510|N03AX1102|Topimax (Lyfjaver)|töflur|50|mg|60|stk|1|plglas||N03AX11|01.07.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|4064|6841|lyfalmen|V0710|6841|00|60|0|Lyfjaver ehf|Lyfjaver ehf|10| 020516|N03AX1102|Topimax (Lyfjaver)|töflur|100|mg|60|stk|1|plglas||N03AX11|01.09.2004||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|8102|12524|lyfalmen|V0711|12147|00|60|0|Lyfjaver ehf|Lyfjaver ehf|20| 020523|N06AB1002|Cipralex (D.A.C.)|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.07.2004||R|A|3|0|0|B|0|DAC|0|1|0|30|DKK|1811|3485|lyfalmen|V0939|3485|00|28|0|D.A.C. ehf|D.A.C. ehf|28| 020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|11649|17249|lyfalmen|||00|84|0|Icepharma hf|Servier|84| 020582|M01AB0511|Voltaren Rapid (D.A.C.)|töflur|50|mg|30|stk|1|þpakki||M01AB05|01.07.2004||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|696|1509|lyfalmen|V0609|1200|67|30|0|D.A.C. ehf|D.A.C. ehf|15| 020616|G03CA0319|Vagifem (D.A.C.)|sk-tfl|25|mcg|15|stk|1|þpakki|+stjaka|G03CA03|01.07.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|1133|2418|lyfalmen|V0418|2418|05|15|0|D.A.C. ehf|D.A.C. ehf|15| 020647|N03AX1203|Neurontin (D.A.C.)|filmhtfl|600|mg|50|stk|1|þpakki||N03AX12|01.05.2005||R|A|2|0|0|E|0|DAC|0|0|0|100|DKK|4837|7967|lyfalmen|||00|50|0|D.A.C. ehf|D.A.C. ehf|16,67| 020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|þpakki||R06AX22|01.10.2005||L|A|3|0|0|0|0|ALF|0|0|1|100|DKK|589|1287|lyfalmen|||00|10|0|Gróco ehf|Almirall-Prodesfarma S.A.|20| 020649|N03AX1203|Neurontin (D.A.C.)|hylki|300|mg|50|stk|1|þpakki||N03AX12|01.07.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|2461|4473|lyfalmen|||10|50|0|D.A.C. ehf|D.A.C. ehf|8,34| 020700|L04AA2101|Raptiva|sts|100|mg/ml|125|mg|4|hgl|+ leysir|L04AA21|01.05.2005||R|K|3|0|1|0|1|SEE|0|0|0|100|SEK|121353|152952|lyfsjukr|||00|500|0|Gróco ehf|Serono Europe|50| 020770|QP54AA5101|Eqvalan Duo|pasta|| |7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|A|3|0|0|0|0|MES|0|0|0|100|XEU|1277|2210|vetorma|||16|7,74|0|Vistor hf|Merial SAS|| 020774|L04AB0101|Enbrel|sts|| |50|mg|4|hgl|+ leysir|L04AB01|01.10.2005||R|K|3|0|1|0|1|WTE|0|0|0|100|USD|95801|121140|lyfsjukr|||00|200|0|Icepharma hf|Wyeth Europe|28,57| 020796|R03AK0604|Seretide Diskus (D.A.C.)|innúðadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.09.2007||R|A|1,5|0|0|B|0|DAC|0|0|0|100|GBP|3814|6477|lyfalmen|V0992|6477|23|60|0|D.A.C. ehf|D.A.C. ehf|30| 020826|N06AX1601|Efexor|töflur|37,5|mg|28|stk|1|þpakki||N06AX16|01.10.1996||R|A|3|0|0|B|0|WLN|0|1|0|100|USD|1300|2709|lyfalmen|||00|28|0|Icepharma hf|Wyeth Lederle Nordiska|10,5| 020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.09.2007||R|A|2|0|0|0|0|DAC|0|0|1|100|DKK|1581|3136|lyfalmen|V0429|3112|00|3|0|D.A.C. ehf|D.A.C. ehf|5| 021048|R03DC0301|Singulair|filmhtfl|10|mg|28|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|3376|5839|lyfalmen|||63|28|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|28| 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|1386|2840|lyfalmen|||00|60|0|Icepharma hf|Galderma Nordic AB|60| 021091|S01ED5107|Xalacom (D.A.C.)|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.11.2004||R|K|2|0|0|*|0|DAC|0|0|0|100|DKK|1979|3740|lyfalmen|V0988|3740|06|2,5|0|D.A.C. ehf|D.A.C. ehf|| 021120|N03AX1103|Topamax (D.A.C.)|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.11.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|SEK|7827|12147|lyfalmen|V0711|12147|00|60|0|D.A.C. ehf|D.A.C. ehf|20| 021149|J01CR0203|Augmentine (D.A.C.)|töflur|1000|mg|12|stk|1|þpakki|875+125 mg|J01CR02|01.05.2005||R|A|1,5|0|0|0|0|DAC|0|0|1|100|IKR|1211|2574|lyfalmen|V0466|2426|00|12|0|D.A.C. ehf|D.A.C. ehf|12| 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|A|2|0|0|E|0|GEM|0|0|0|100|XEU|584|1276|lyfalmen|||00|10|0|Actavis Group hf|Gerhard Mann|| 021213|N03AX0902|Lamictal (D.A.C.)|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.11.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|IKR|4689|7752|lyfalmen|V0705|7639|00|56|0|D.A.C. ehf|D.A.C. ehf|18,6667| 021226|N06AB0603|Zoloft (D.A.C.)|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.09.2007||R|A|5|0|0|B|0|DAC|0|1|0|30|DKK|2226|4116|lyfalmen|V0931|3084|00|28|0|D.A.C. ehf|D.A.C. ehf|28| 021232|N06AB0603|Zoloft (D.A.C.)|filmhtfl|100|mg|28|stk|1|þpakki||N06AB06|01.11.2004||R|A|5|0|0|B|0|DAC|0|1|0|30|DKK|3473|5980|lyfalmen|V0935|4755|00|28|0|D.A.C. ehf|D.A.C. ehf|56| 021257|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2005||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|11167|16607|lyfalmen|||02|4|0|Icepharma hf|Bayer Schering Pharma AG|55,56| 021267|J05AB1102|Valtrex (D.A.C.)|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.11.2004||R|A|3|0|0|E|0|DAC|0|0|1|30|GBP|8475|13021|lyfalmen|V0508|13021|00|42|0|D.A.C. ehf|D.A.C. ehf|7| 021325|R03BB0402|Spiriva (D.A.C.)|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.11.2004||R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|4049|6819|lyfalmen|V0985|6819|00|30|0|D.A.C. ehf|D.A.C. ehf|30| 021341|R03AK0603|Seretide Diskus (Lyfjaver)|innúðadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.07.2005||R|A|1,5|0|0|B|0|LVR|0|0|0|100|GBP|5261|8568|lyfalmen|V0993|8423|23|60|0|Lyfjaver ehf|Lyfjaver ehf|30| 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|10793|16108|lyfalmen|||63|98|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|98| 021351|J01FA1002|Zitromax (D.A.C.)|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.2004||R|A|2|0|0|0|0|DAC|0|0|1|100|DKK|1565|3112|lyfalmen|V0429|3112|00|3|0|D.A.C. ehf|D.A.C. ehf|5| 021365|R03AK0603|Seretide Diskus (Lyfjaver)|innúðadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.07.2005||R|A|1,5|0|0|B|0|LVR|0|0|0|100|GBP|3892|6591|lyfalmen|V0992|6477|23|60|0|Lyfjaver ehf|Lyfjaver ehf|30| 021373|A02BC0504|Nexium Mups (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.04.2006||R|A|3|0|0|E|0|DAC|0|0|0|30|IKR|3302|5731|lyfalmen|V0085|5731|00|28|0|D.A.C. ehf|D.A.C. ehf|37,33| 021398|L02BB0303|Casodex (D.A.C.)|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.11.2004||R|A|5|0|0|*|0|DAC|0|0|0|100|IKR|13549|19919|lyfalmen|V0560|16551|00|30|0|D.A.C. ehf|D.A.C. ehf|30| 021426|N04BX0203|Comtan (D.A.C.)|filmhtfl|200|mg|100|stk|1|glas||N04BX02|01.11.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|8232|12697|lyfalmen|V0729|12697|00|100|0|D.A.C. ehf|D.A.C. ehf|20| 021428|A06AB0201|Dulcolax|eþ-stil|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|A|5|0|0|0|0|BOI|0|0|0|100|DKK|259|601|lyfalmen|||04|6|0|Vistor hf|Boehringer Ingelheim|6| 021447|N04BC0402|Requip (D.A.C.)|töflur|2|mg|84|stk|1|plglas||N04BC04|01.11.2004||R|A|2|0|0|E|0|DAC|0|0|0|100|SEK|7977|12356|lyfalmen|V0728|12356|00|84|0|D.A.C. ehf|D.A.C. ehf|28| 021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|12976|19205|lyfalmen|||63|98|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|49| 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1931|2765|lyfsjukr|||02|100|0|Icepharma hf|Fresenius Kabi|| 021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|2738|4893|lyfalmen|||00|30|0|Vistor hf|Ferring Lægemidler A/S|4,5| 021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|8422|12950|lyfalmen|||00|100|0|Vistor hf|Ferring Lægemidler A/S|15| 021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FAB|0|0|0|100|DKK|4966|8155|lyfalmen|||00|30|0|Vistor hf|Ferring AB, Svíþjóð|9| 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|19163|25725|lyfsjukr|||02|1000|0|Icepharma hf|Fresenius Kabi|| 021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|14336|20899|lyfalmen|||00|100|0|Vistor hf|Ferring Lægemidler A/S|30| 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|20909|27899|lyfsjukr|||02|500|0|Icepharma hf|Fresenius Kabi|| 021659|V01AA0304|Alutard SQ, derm. pter.|stl|| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|13952|20420|lyfalmen|||02|20|0|Vistor hf|ALK-Abello A/S|| 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|9840|14088|lyfsjukr|||02|500|0|Icepharma hf|Fresenius Kabi|| 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|2702|3869|lyfsjukr|||02|50|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|2,5| 021698|A08AB0102|Xenical (D.A.C.)|hylki|120|mg|84|stk|1|þpakki||A08AB01|01.11.2006||R|A|3|0|0|0|0|DAC|0|0|0|100|DKK|5205|8490|lyfalmen|V0133|8490|00|84|0|D.A.C. ehf|D.A.C. ehf|28| 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|11170|16611|lyfalmen|||02|5|0|Vistor hf|ALK-Abello A/S|| 021771|J05AB1102|Valtrex (D.A.C.)|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.05.2005||R|A|3|0|0|E|0|DAC|0|0|1|30|GBP|2030|3818|lyfalmen|V0507|3818|00|10|0|D.A.C. ehf|D.A.C. ehf|1,67| 021829|H01BA0203|Minirin (D.A.C.)|töflur|0,2|mg|30|stk|1|plglas||H01BA02|01.08.2006||R|A|2|0|0|E|0|DAC|0|0|0|100|DKK|5122|8375|lyfalmen|||00|30|0|D.A.C. ehf|D.A.C. ehf|15| 021862|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.02.2007||R|A|3|0|0|E|0|DAC|0|0|0|30|IKR|3302|5731|lyfalmen|V0085|5731|00|28|0|D.A.C. ehf|D.A.C. ehf|37,33| 021950|B05AA0705|HyperHAES|irl|| |250|ml|10|pokar||B05AA07|01.07.2005||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|14661|20120|lyfsjukr|||00|2500|0|Icepharma hf|Fresenius Kabi|2,5| 022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|11170|16611|lyfalmen|||02|5|0|Vistor hf|ALK-Abello A/S|| 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|52058|66680|lyfsjukr|||00|30|0|Icepharma hf|Roche Registration Limited|| 022087|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.10.1995||R|A|5|0|0|0|0|LAH|0|0|0|100|DKK|360|710|vetalmen|||16|20|0|Vistor hf|LEO Animal Health A/S|| 022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||00|200|0|Actavis Group hf|Actavis Group hf|45,45| 022132|C10BA0201|Inegy|töflur|30|mg|98|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|16754|23909|lyfalmen|||00|98|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|| 022135|C10BA0201|Inegy|töflur|30|mg|28|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|4570|7578|lyfalmen|||00|28|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|| 022157|C10BA0201|Inegy|töflur|50|mg|28|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|5569|8998|lyfalmen|||00|28|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|| 022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|19587|27436|lyfalmen|||00|98|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|| 022181|C10BA0201|Inegy|töflur|90|mg|98|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|20704|28827|lyfalmen|||00|98|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|| 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|180058|226040|lyfsjukr|||00|30|0|Icepharma hf|Roche Registration Limited|| 022204|N06AX1603|Efexor XR (D.A.C.)|forðahlk|150|mg|30|stk|1|þpakki||N06AX16|01.05.2005||R|A|2|0|0|B|0|DAC|0|1|0|100|USD|4676|7733|lyfalmen|V0954|7733|00|30|0|D.A.C. ehf|D.A.C. ehf|45| 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|214355|268739|lyfsjukr|||00|30|0|Icepharma hf|Roche Registration Limited|| 022207|A10AB0603|Apidra [optiset]|stl|100|ein/ml|3|ml|5|lyfjap|áflylltir|A10AB06|01.04.2007||R|K|2|0|0|0|0|SAA|0|0|0|100|NOK|3312|5746|lyfalmen|||02|15|0|Vistor hf|Sanofi - Aventis|37,5| 022218|QP52AA5102|Drontal Comp.vet.|töflur|| |24|stk|1|þpakki||QP52AA51|01.01.2006||R|A|5|0|0|0|0|BHC|0|0|0|100|DKK|5715|9890|vetorma|||00|24|0|Vistor hf|Bayer HealthCare AG|| 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|1294|2239|vetorma|||00|2,24|0|Vistor hf|Bayer HealthCare AG|| 022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|1672|3274|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30| 022281|QP52AA5102|Drontal Comp.vet.|töflur|| |2|stk|1|þpakki||QP52AA51|01.10.1991||L|A|5|0|0|0|0|BHC|0|0|0|100|DKK|555|960|vetorma|||00|2|0|Vistor hf|Bayer HealthCare AG|| 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|3902|6605|lyfalmen|V0308|4146|00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|100| 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|6053|9673|lyfalmen|V0310|6253|00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|200| 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|1197|2071|vetorma|||00|1,4|0|Vistor hf|Bayer HealthCare AG|| 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|427|950|lyfalmen|||20|30|0|Vistor hf|Astellas Pharma A/S|30| 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|1241|2620|lyfalmen|||20|100|0|Vistor hf|Astellas Pharma A/S|100| 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|792|1371|vetorma|||00|0,7|0|Vistor hf|Bayer HealthCare AG|| 022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|| |28|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|2759|4925|lyfalmen|||00|28|0|Vistor hf|Novartis Healthcare A/S-|56| 022585|L04AX0304|Metotrexato Lederle (D.A.C.)|töflur|2,5|mg|50|stk|1|glas||L04AX03|01.08.2005||R|A|3|0|0|*|0|DAC|0|0|0|100|USD|739|1599|lyfalmen|||00|50|0|D.A.C. ehf|D.A.C. ehf|50| 022609|A07EC0205|Pentasa (D.A.C)|forðatfl|500|mg|60|stk|1|þpakki||A07EC02|01.08.2006||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|2231|4123|lyfalmen|||10|60|0|D.A.C. ehf|D.A.C. ehf|20| 022620|R01AD0802|Flixonase (D.A.C.)|nefúði|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.2007||R|A|2|0|0|E|0|DAC|0|0|1|100|GBP|907|1948|lyfalmen|V0967|1948|24|16|0|D.A.C. ehf|D.A.C. ehf|30| 022708|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|| |98|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|8864|13539|lyfalmen|||00|98|0|Vistor hf|Novartis Healthcare A/S-|196| 022802|L01XC0401|MabCampath|irþ|30|mg/ml|1|ml|3|hgl||L01XC04|01.07.2007||R|K|2|0|1|0|1|GEU|0|0|0|100|SEK|147388|185366|lyfsjukr|||00|3|0|Icepharma hf|Genzyme Europe B.V. (I)|| 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|A|3|0|0|E|0|SAO|0|0|0|100|XEU|779|1682|lyfalmen|||00|15|0|Icepharma hf|Santen Oy|| 022928|N05AH0304|Zyprexa (D.A.C.)|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.08.2005||R|A|3|0|0|*|0|DAC|0|1|0|100|IKR|5525|8937|lyfalmen|V0810|8779|00|28|0|D.A.C. ehf|D.A.C. ehf|14| 022952|C08CA0103|Norvas (D.A.C.)|töflur|10|mg|30|stk|1|þpakki||C08CA01|01.08.2006||R|A|4|0|0|B|0|DAC|0|0|0|100|DKK|2531|4579|lyfalmen|V0311|4579|00|30|0|D.A.C. ehf|D.A.C. ehf|60| 022962|V01AA1104|Alutard SQ, hrossaværur|stl|| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|13952|20420|lyfalmen|||02|20|0|Vistor hf|ALK-Abello A/S|| 022970|V01AA1104|Alutard SQ, hrossaværur|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|11170|16611|lyfalmen|||02|5|0|Vistor hf|ALK-Abello A/S|| 023036|R03BB0101|Atrovent|innúðadu|40|mcg|100|stk|1|pakki|þp+M-úðari|R03BB01|01.07.1992||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|2258|4164|lyfalmen|||19|100|0|Vistor hf|Boehringer Ingelheim|33,3333| 023047|G04BD1001|Emselex|forðatfl|7,5|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|3335|5779|lyfalmen|||00|28|0|Vistor hf|Novartis Europharm Ltd|28| 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|A|2|0|1|0|1|GSI|0|0|0|100|DKK|69014|87790|lyfsjukr|||00|30|0|Lyfjaver ehf|Gilead Science International (L)|| 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|17256|24534|lyfalmen|||00|90|0|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|20| 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|23053|31751|lyfalmen|||00|90|0|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|30| 023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|11674|17282|lyfalmen|||00|98|0|Vistor hf|Novartis Europharm Ltd|| 023146|G04BD1001|Emselex|forðatfl|15|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|3369|5829|lyfalmen|||00|28|0|Vistor hf|Novartis Europharm Ltd|56| 023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|11793|17441|lyfalmen|||00|98|0|Vistor hf|Novartis Europharm Ltd|| 023325|V03AB2501|Lanexat|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.07.1989||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|11970|16770|lyfsjukr|||02|25|0|Icepharma hf|Roche|| 023329|N03AX1204|Gabapentin Merck NM|hylki|300|mg|100|stk|1|glas||N03AX12|01.05.2004||R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|3720|6340|lyfalmen|V0714|6340|00|100|0|Merck NM|Merck NM AB|16,6667| 023376|N03AX1204|Gabapentin Merck NM|hylki|400|mg|100|stk|1|glas||N03AX12|01.05.2004||R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|5080|8316|lyfalmen|V0715|8316|00|100|0|Merck NM|Merck NM AB|22,22| 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|A|3|0|0|0|0|DED|0|0|0|100|XEU|9487|14369|lyfalmen|||00|34|0|Vistor hf|Dentsply DeTrey GmbH|| 023414|B03XA0201|Aranesp |stl|20|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|4934|7064|lyfsjukr|||00|0,5|0|Vistor hf|Amgen|4,44| 023419|B03XA0201|Aranesp |stl|80|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|19421|26047|lyfsjukr|||00|0,4|0|Vistor hf|Amgen|17,78| 023425|B03XA0201|Aranesp |stl|60|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|14699|20168|lyfsjukr|||00|0,3|0|Vistor hf|Amgen|13,33| 023441|B03XA0201|Aranesp |stl|150|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|34992|45433|lyfsjukr|||00|0,3|0|Vistor hf|Amgen|33,33| 023447|B03XA0201|Aranesp |stl|100|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|23361|30952|lyfsjukr|||00|0,5|0|Vistor hf|Amgen|22,22| 023448|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|5166|7396|lyfsjukr|||00|10|0|Icepharma hf|Baxter AG|| 023452|B03XA0201|Aranesp |stl|300|mcg/pen|0,6|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|69939|88942|lyfsjukr|||00|0,6|0|Vistor hf|Amgen|66,67| 023459|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|12916|17948|lyfsjukr|||00|25|0|Icepharma hf|Baxter AG|| 023463|B03XA0201|Aranesp |stl|40|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|9607|13755|lyfsjukr|||00|0,4|0|Vistor hf|Amgen|8,89| 023468|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|20|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|8668|13278|lyfalmen|||00|10|0|GlaxoSmithKline ehf|Glaxo Group Limited|20| 023470|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|25830|34026|lyfsjukr|||00|50|0|Icepharma hf|Baxter AG|| 023476|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|51660|66184|lyfsjukr|||00|100|0|Icepharma hf|Baxter AG|| 023479|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|6068|9694|lyfalmen|||00|2,8|0|GlaxoSmithKline ehf|Glaxo Group Limited|14| 023480|B03XA0201|Aranesp |stl|500|mcg/pen|1|ml|1|penni|áfyllur penni|B03XA02|01.07.2007||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|111857|141129|lyfsjukr|||00|1|0|Vistor hf|Amgen|111,11| 023487|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|103319|130500|lyfsjukr|||00|200|0|Icepharma hf|Baxter AG|| 023491|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|12135|18158|lyfalmen|||00|5,6|0|GlaxoSmithKline ehf|Glaxo Group Limited|28| 023501|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|9102|13856|lyfalmen|||00|4,2|0|GlaxoSmithKline ehf|Glaxo Group Limited|21| 023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|80034|101510|lyfsjukr|||00|120|0|Vistor hf|Boehringer Ingelheim Internationl |30| 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|15276|22069|lyfalmen|||00|100|0|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|100| 023544|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|3034|5341|lyfalmen|||00|3,5|0|GlaxoSmithKline ehf|Glaxo Group Limited|7| 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|A|2,5|0|0|*|0|SAO|0|0|0|100|XEU|2073|3883|lyfalmen|||00|12|0|Icepharma hf|Santen Oy|60| 023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|37360|48381|lyfsjukr|||00|120|0|Icepharma hf|Roche|100| 023809|A10AE0404|Lantus [OptiClik]|stl|100|ein/ml|3|ml|5|rörlyk|fyrir OptiClik|A10AE04|01.04.2007||R|K|2|0|0|0|0|SDE|0|0|0|100|NOK|5972|9560|lyfalmen|||00|15|0|Vistor hf|Sanofi - aventis Deutschland GmbH|37,5| 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|A|5|0|1|0|1|PFL|0|0|0|100|DKK|63214|81752|lyfalmen|||00|90|0|Vistor hf|Pfizer Limited|36| 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|2193|4065|lyfalmen|||00|100|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|16,6667| 024024|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.02.2007||R|A|1,5|0|0|0|1|WTE|0|0|0|100|USD|46836|60178|lyfsjukr|||00|10|0|Icepharma hf|Wyeth Europe|5| 024056|N02AB0301|Durogesic|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.02.2006||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|2567|4634|lyfalmen|||00|5|0|Vistor hf|Janssen-Cilag AB|9,99| 024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|11344|16842|lyfalmen|||00|30|0|Lundbeck Export A/S|Teva Pharma GmbH|30| 024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|| |1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|1343|1923|lyfsjukr|||00|10000|0|Icepharma hf|Baxter Medical AB|10| 024147|A10BD0301|Avandamet|filmhtfl|1002|mg|112|stk|1|þpakki|1000+2mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|6076|9705|lyfalmen|||00|112|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 024169|A10BD0301|Avandamet|filmhtfl|1004|mg|112|stk|1|þpakki|1000+4mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|10625|15885|lyfalmen|||00|112|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|37814|50129|lyfalmen|||00|100|0|Lundbeck Export A/S|Teva Pharma GmbH|100| 024307|V01AA1105|Alutard SQ, hundahar|stl|| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|13952|20420|lyfalmen|||02|20|0|Vistor hf|ALK-Abello A/S|| 024478|V04CL0024|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|4392|7319|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S|| 024482|V04CL0025|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|4392|7319|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S|| 024504|V04CL0011|Soluprick SQ ALK106 - Rauðölur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7401|11553|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S|| 024510|V04CL0012|Soluprick SQ ALK107 - Gráölur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7401|11553|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S|| 024526|V04CL0014|Soluprick SQ ALK113 - Hesliviður|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7413|11569|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S|| 024532|V04CL0015|Soluprick SQ ALK203 - Háliðagras|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7401|11553|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S|| 024559|V04CL0016|Soluprick SQ ALK214 -Axhnoðapunktur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7401|11553|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S|| 024565|V04CL0017|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7489|11675|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S|| 024576|V04CL0018|Soluprick SQ ALK223 - Vallarrýgresi|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7401|11553|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S|| 024583|V04CL0019|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|4392|7319|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S|| 024589|V04CL0020|Soluprick SQ ALK228 - Vallarsveifgras|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7401|11553|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S|| 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|41807|53917|lyfsjukr|||00|100|0|Vistor hf|Novartis Europharm Ltd|125| 024600|V04CL0021|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7489|11675|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S|| 024603|V04CL0009|Soluprick Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|918|1971|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S|| 024622|V04CL0013|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|4392|7319|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S|| 024644|V04CL0023|Soluprick SQ ALK552 - Hrossaværur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|4392|7319|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S|| 024670|V04CL0022|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|4392|7319|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S|| 024681|V04CL0010|Soluprick Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|918|1971|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S|| 025093|C01BD0102|Trangorex (D.A.C.)|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.08.2006||R|A|3|0|0|B|0|DAC|0|0|0|100|NOK|642|1397|lyfalmen|V0143|1397|70|30|0|D.A.C. ehf|D.A.C. ehf|30| 025126|M05BB0301|Fosavance|töflur|| |4|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|E|0|MSD|0|0|0|100|XEU|3112|5454|lyfalmen|||00|4|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|| 025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|528|1160|lyfalmen|||20|30|0|Vistor hf|Astellas Pharma A/S|30| 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|11170|16611|lyfalmen|||02|5|0|Vistor hf|ALK-Abello A/S|| 025174|D07AB0202|Locoid Crelo|lausn|1|mg/g|100|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|1509|3027|lyfalmen|||20|100|0|Vistor hf|Astellas Pharma A/S|100| 025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|11170|16611|lyfalmen|||02|5|0|Vistor hf|ALK-Abello A/S|| 025306|M05BB0301|Fosavance|töflur|| |12|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|E|0|MSD|0|0|0|100|XEU|9050|13787|lyfalmen|||00|12|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|| 025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|57455|73399|lyfsjukr|||00|30|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |60| 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|56801|72585|lyfsjukr|||00|30|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |30| 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|5535|10715|vetalmen|||00|20|0|Vistor hf|Boehringer Ingelheim|| 025444|C09CA0301|Diovan|filmhtfl|320|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|12470|18575|lyfalmen|||00|98|0|Vistor hf|Novartis Healthcare A/S-|392| 025455|C09CA0301|Diovan|töflur|320|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|3637|6219|lyfalmen|||00|28|0|Vistor hf|Novartis Healthcare A/S-|112| 025471|N06AB1002|Cipralex (D.A.C.)|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.12.2006||R|A|3|0|0|B|0|DAC|0|1|0|30|DKK|3869|6557|lyfalmen|V1039|6557|00|28|0|D.A.C. ehf|D.A.C. ehf|56| 025555|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|0|0|JAS|0|1|0|100|SEK|18889|26567|lyfalmen|||00|1|0|Vistor hf|Janssen-Cilag AB|27,78| 025578|S01EC0302|Trusopt (D.A.C.)|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.01.2007||R|A|2|0|0|*|0|DAC|0|0|0|100|XEU|1004|2150|lyfalmen|V1090|2150|06|5|0|D.A.C. ehf|D.A.C. ehf|16,6667| 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|3114|5457|lyfalmen|||00|1|0|Icepharma hf|Roche Registration Limited|30| 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|8838|13504|lyfalmen|||00|3|0|Icepharma hf|Roche Registration Limited|90| 025608|N07BA0202|Zyban (D.A.C.)|forðatfl|150|mg|60|stk|1|þpakki||N07BA02|01.12.2006||R|A|2|0|0|0|0|DAC|0|1|1|100|GBP|4969|8159|lyfalmen|||00|60|0|D.A.C. ehf|D.A.C. ehf|30| 025677|S01ED5109|Cosopt (D.A.C.)|augndr|5|mg/ml|5|ml|1|glas||S01ED51|01.04.2006||R|A|2|0|0|*|0|DAC|0|0|0|100|XEU|1442|2925|lyfalmen|V0989|2925|06|5|0|D.A.C. ehf|D.A.C. ehf|| 025698|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|0|0|JAS|0|1|0|100|SEK|10084|15164|lyfalmen|||00|1|0|Vistor hf|Janssen-Cilag AB|13,89| 025709|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|0|0|JAS|0|1|0|100|SEK|14585|21209|lyfalmen|||00|1|0|Vistor hf|Janssen-Cilag AB|20,83| 025841|V01AA1106|Alutard SQ, kattahar|stl|| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|13952|20420|lyfalmen|||02|20|0|Vistor hf|ALK-Abello A/S|| 025958|M01AE0215|Naproxen Merck NM|töflur|250|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|547|1200|lyfalmen|||00|100|0|Merck NM|Merck NM AB|50| 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|2020|3496|vetorma|||16|1|0|Vistor hf|Merial (MSD)|| 025985|M01AE0215|Naproxen Merck NM|töflur|500|mg|50|stk|1|þpakki||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|564|1235|lyfalmen|||00|50|0|Merck NM|Merck NM AB|50| 025994|M01AE0215|Naproxen Merck NM|töflur|500|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|1023|2189|lyfalmen|||00|100|0|Merck NM|Merck NM AB|100| 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|4571|7910|vetorma|||16|2,5|0|Vistor hf|Merial (MSD)|| 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|11170|16611|lyfalmen|||02|5|0|Vistor hf|ALK-Abello A/S|| 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1148|2449|lyfalmen|||00|100|0|Vistor hf|Recip AB|25| 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|235|551|lyfalmen|||00|50|0|Vistor hf|Recip AB|1,25| 027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|þpakki||M01CC01|01.06.1982||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|1560|3104|lyfalmen|||10|50|0|Swedish Orphan International AB|Sandoz GmbH (S)|15| 027235|G03HA0103|Cyproteron Merck NM|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|4514|7497|lyfalmen|||00|50|0|Merck NM|Merck NM AB|25| 027559|N03AX1501|Zonegran|hylki|25|mg|14|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|1147|2447|lyfalmen|||00|14|0|Vistor hf|Eisai Ltd|1,75| 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|4589|7606|lyfalmen|||00|56|0|Vistor hf|Eisai Ltd|7| 027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|6143|9798|lyfalmen|||00|56|0|Vistor hf|Eisai Ltd|14| 027604|N03AX1501|Zonegran|hylki|100|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|8114|12540|lyfalmen|||00|56|0|Vistor hf|Eisai Ltd|28| 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|509|1121|lyfalmen|V0431|985|00|100|0|Gróco ehf|Nycomed Danmark A/S|33,33| 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|485|1071|lyfalmen|V0430|844|00|100|0|Gróco ehf|Nycomed Danmark A/S|66,6667| 027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|A|2|0|1|0|1|SPP|0|0|0|100|DKK|71130|90424|lyfsjukr|||00|105|0|Icepharma hf|SP Europe|0,75| 027938|C07AA0701|Sotacor|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1992||R|A|4|0|0|B|0|BRS|0|0|0|100|DKK|734|1588|lyfalmen|V0272|1405|00|100|0|Vistor hf|Bristol-Myers Squibb|50| 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|13690|20094|lyfalmen|||00|28|0|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|18,67| 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|13690|20094|lyfalmen|||00|28|0|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|28| 028150|J01CA0409|Flemoxin (D.A.C.)|mixtúrud|50|mg/ml|80|ml|1|glas||J01CA04|01.12.2006||R|A|4|0|0|0|0|DAC|0|0|1|100|XEU|623|1358|lyfalmen|||08|80|0|D.A.C. ehf|D.A.C. ehf|| 028351|J07BL0101|Stamaril|sts|| |0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|12279|18338|lyfalmen|||02|5|0|Icepharma hf|Sanofi Pasteur MSD|| 028360|J07BG0101|Rabies - Imovax|bóluefni|| |1|ml|1|hgl||J07BG01|01.01.1996||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|4698|7765|lyfalmen|||02|1|0|Icepharma hf|Aventis Pasteur MSD A/S|| 028405|M01AE0216|Naproxen-E Merck NM |sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|1154|2462|lyfalmen|||10|50|0|Merck NM|Merck NM AB|50| 028498|C08DB0102|Cardizem Retard|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.04.1987||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|3414|5894|lyfalmen|||10|60|0|Vistor hf|Ferrosan A/S|30| 028597|D07BB0401|Locoidol|krem|| |30|g|1|túpa||D07BB04|01.01.1990||R|A|4|0|0|B|0|ASP|0|0|1|100|XEU|522|1148|lyfalmen|||20|30|0|Vistor hf|Astellas Pharma A/S|30| 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|A|3|0|0|0|0|OCO|0|0|0|100|DKK|4593|8920|vetalmen|||27|10|0|Icepharma hf|Orion Corporation (I)|| 028761|A03FA0101|Primperan|stl|5|mg/ml|2|ml|12|lykjur||A03FA01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|566|1239|lyfalmen|||02|24|0|Vistor hf|Sanofi-aventis Norge AS|4| 028787|A04AA0201|Kytril|töflur|1|mg|10|stk|1|þpakki||A04AA02|01.10.1994||R|A|3|0|0|0|1|ROA|0|0|0|100|DKK|7612|10898|lyfsjukr|||00|10|0|Icepharma hf|Roche as|5| 029025|D07AC0301|Ibaril|smyrsli|2,5|mg/g|50|g|1|túpa||D07AC03|01.12.1978||R|A|1,5|0|0|B|0|SNO|0|0|1|100|NOK|1297|2705|lyfalmen|||20|50|0|Vistor hf|Sanofi-aventis Norge AS|50| 029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.1992||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|926|1988|lyfalmen|V0967|1948|24|16|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30| 029116|A03FA0101|Primperan|töflur|10|mg|40|stk|1|þpakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|599|1308|lyfalmen|||00|40|0|Vistor hf|Sanofi-aventis Norge AS|13,3333| 029298|D07AB0101|Emovat|krem|0,5|mg/g|25|g|1|túpa||D07AB01|01.01.1985||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|326|740|lyfalmen|||20|25|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|25| 029307|A07EA0603|Entocort enema (D.A.C.)|endaþ.dr|0,02|mg/ml|7|stk|1|þpakki||A07EA06|01.01.2007||R|A|2|0|0|B|0|DAC|0|0|0|100|IKR|3794|6448|lyfalmen|V0297|6448|00|7|0|D.A.C. ehf|D.A.C. ehf|| 029334|J05AG0302|Stocrin (Lyfjaver)|töflur|600|mg|30|stk|1|glas||J05AG03|01.09.2005||R|A|2|0|1|0|1|LVR|0|0|0|100|XEU|27541|36156|lyfsjukr|||00|30|0|Lyfjaver ehf|Lyfjaver ehf|30| 029343|L03AB0802|Betaferon (Lyfjaver)|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.09.2005||R|A|2|0|1|0|1|LVR|0|0|0|100|SEK|91985|116389|lyfsjukr|||00|15|0|Lyfjaver ehf|Lyfjaver ehf|30| 029352|C10AA0103|Zocor (Lyfjaver)|töflur|10|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|4838|7969|lyfalmen|V0358|3633|00|98|0|Lyfjaver ehf|Lyfjaver ehf|65,3333| 029361|C10AA0103|Zocor (Lyfjaver)|töflur|20|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|4379|7300|lyfalmen|V0365|4239|00|98|0|Lyfjaver ehf|Lyfjaver ehf|130,6667| 029370|C10AA0103|Zocor (Lyfjaver)|töflur|40|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|6881|10827|lyfalmen|V0367|6120|00|98|0|Lyfjaver ehf|Lyfjaver ehf|261,3333| 029379|C10AA0103|Zocor (Lyfjaver)|töflur|80|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|1,5|0|0|0|0|LVR|0|0|0|100|XEU|9676|14620|lyfalmen|V0369|14620|00|98|0|Lyfjaver ehf|Lyfjaver ehf|522,6667| 029769|D07AB0101|Emovat|krem|0,5|mg/g|100|g|1|túpa||D07AB01|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1284|2685|lyfalmen|||20|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|100| 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||23|30|0|Vistor hf|Pfizer Denmark PCH ApS|2| 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||23|105|0|Vistor hf|Pfizer Denmark PCH ApS|7| 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||00|210|0|Vistor hf|Pfizer Denmark PCH ApS|14| 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||23|30|0|Vistor hf|Pfizer Denmark PCH ApS|4| 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||23|105|0|Vistor hf|Pfizer Denmark PCH ApS|14| 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||00|210|0|Vistor hf|Pfizer Denmark PCH ApS|28| 030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|14192|20719|lyfalmen|||00|98|0|Vistor hf|Eisai Ltd|49| 030361|D07AB0101|Emovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AB01|01.01.1985||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|326|740|lyfalmen|||20|25|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|25| 030387|D07AB0101|Emovat|smyrsli|0,5|mg/g|100|g|1|túpa||D07AB01|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1284|2685|lyfalmen|||20|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|100| 030588|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.07.2006||L|A|3|0|0|0|0|NAV|0|0|1|100|IKR|0|0|lyfalmen|||00|60|0|Icepharma hf|Navamedic ASA|25| 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|6055|9676|lyfalmen|V1400|9507|00|100|0|Vistor hf|Novartis Healthcare A/S-|33,3333| 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|2044|3839|lyfalmen|||00|100|0|Vistor hf|Novartis Healthcare A/S-|8,3333| 030650|B05BA0108|Vaminolac|irl|| |100|ml|12|fl||B05BA01|01.07.1990||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7516|10761|lyfsjukr|||00|1200|0|Icepharma hf|Fresenius Kabi|1,2| 030940|C07AB0207|Metoprolol Merck NM|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MNA|0|0|0|100|SEK|541|1187|lyfalmen|||00|100|0|Merck NM|Merck NM AB|33,3333| 031039|C07AB0207|Metoprolol Merck NM|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MNA|0|0|0|100|SEK|789|1703|lyfalmen|||00|100|0|Merck NM|Merck NM AB|66,6667| 031070|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||R|A|2|0|0|E|0|NHE|0|0|1|100|DKK|482|1064|lyfalmen|||23|2|0|Artasan ehf|Novartis Healthcare A/S-A|2| 031261|A10AB0604|Apidra [opticlik]|stl|100|ein/ml|3|ml|5|rörlyk||A10AB06|01.04.2007||R|K|2|0|0|0|0|SAA|0|0|0|100|NOK|2961|5232|lyfalmen|||02|15|0|Vistor hf|Sanofi - Aventis|37,5| 031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|A|3|0|0|B|0|REP|0|0|0|100|DKK|1144|2441|lyfalmen|||00|100|0|Vistor hf|Recip AB|33,3333| 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|3630|6209|lyfalmen|||02|15|0|Vistor hf|Novo-Nordisk|37,5| 031971|C07AA0704|Sotalol Merck NM|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|1124|2399|lyfalmen|V0274|2399|00|100|0|Merck NM|Merck NM AB|100| 031997|C07AA0704|Sotalol Merck NM|töflur|80|mg|100|stk|1|glas||C07AA07|01.03.2000||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|646|1405|lyfalmen|V0272|1405|00|100|0|Merck NM|Merck NM AB|50| 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|K|2|0|0|*|0|OTS|0|1|0|100|DKK|14217|20750|lyfalmen|||00|150|0|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|10| 032649|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|50|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|2202|3811|vetorma|||27|50|0|Vistor hf|Merial (MSD)|| 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|7832|13554|vetorma|||27|200|0|Vistor hf|Merial (MSD)|| 033159|S01FA0103|Isopto Atropin 1 %|augndr|1|%|5|ml|1|glas||S01FA01|01.05.1983||R|A|3|0|0|E|0|ALC|0|0|0|100|USD|242|565|lyfalmen|||06|5|0|K.Pétursson hf|Alcon|| 033251|S01CA0102|Tobradex|augndr|| |5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|647|1407|lyfalmen|||00|5|0|K.Pétursson hf|Alcon|| 034157|J07AM5104|Diftavax|bóluefni|| |0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|K|3|0|0|0|0|SPM|0|0|1|100|XEU|433|963|lyfalmen|||AC|0,5|0|Icepharma hf|Sanofi Pasteur MSD|| 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|1080|2308|lyfalmen|||00|6|0|Vistor hf|Novartis Healthcare A/S-|| 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|1820|3499|lyfalmen|||00|12|0|Vistor hf|Novartis Healthcare A/S-|| 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|5132|7348|lyfsjukr|||02|25|0|Vistor hf|LEO Pharma A/S|| 035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|10055|15125|lyfalmen|||10|300|0|Vistor hf|Ferring|100| 035333|L01BB0502|Fludara (Lyfjaver)|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.05.2006||R|A|2|0|1|0|1|LVR|0|0|0|100|SEK|58251|74390|lyfsjukr|||00|20|0|Lyfjaver ehf|Lyfjaver ehf|| 035342|L01BB0502|Fludara (Lyfjaver)|filmhtfl|10|mg|15|stk|1|þpakki||L01BB05|01.05.2006||R|A|2|0|1|0|1|LVR|0|0|0|100|SEK|43603|56153|lyfsjukr|||00|15|0|Lyfjaver ehf|Lyfjaver ehf|| 035351|L01BB0502|Fludara (Lyfjaver)|sts|50|mg/hgl|50|mg|5|hgl||L01BB05|01.05.2006||R|A|3|0|1|0|1|LVR|0|0|0|100|SEK|89099|112796|lyfsjukr|||00|250|0|Lyfjaver ehf|Lyfjaver ehf|| 035524|N03AX0903|Lamotrin|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|4612|7639|lyfalmen|V0705|7639|00|56|0|Actavis Group hf|Actavis hf|18,67| 035542|S01LA0301|Macugen|stl|0,3|mg/spr|1|spr|1|pakki|lausn|S01LA03|01.06.2006||R|A|1,5|0|1|0|1|PFI|0|0|0|100|DKK|69742|88696|lyfsjukr|||00|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 035675|B05BA0201|Intralipid 100 mg/ml|irl|100|mg/ml|500|ml|12|fl||B05BA02|01.05.1999||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|15665|21370|lyfsjukr|||00|6000|0|Icepharma hf|Fresenius Kabi|6| 035832|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|fl||B05BA02|01.08.1980||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|26124|34392|lyfsjukr|||00|6000|0|Icepharma hf|Fresenius Kabi|6| 035840|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.03.1978||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|645|1403|lyfalmen|||00|60|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|12| 035865|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.08.1978||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|344|777|lyfalmen|||00|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|100| 036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|126732|159649|lyfsjukr|||00|30|0|Vistor hf|Pfizer Limited|| 036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|253082|316955|lyfsjukr|||00|30|0|Vistor hf|Pfizer Limited|| 036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|505090|630705|lyfsjukr|||00|30|0|Vistor hf|Pfizer Limited|| 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|788|1701|lyfalmen|||08|60|0|Vistor hf|AstraZeneca A/S DK|3| 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|1554|3095|lyfalmen|||08|125|0|Vistor hf|AstraZeneca A/S DK|6,25| 037061|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.05.2006||R|A|3|0|0|E|0|MNA|0|0|0|100|SEK|4624|7657|lyfalmen|V0437|7657|00|90|0|Merck NM|Merck NM AB|90| 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|A|4|0|0|E|0|ROC|0|0|0|100|DKK|2136|3979|lyfalmen|||00|100|0|Icepharma hf|Roche|16,6667| 037754|J01EA0102|Monotrim|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.1980||R|A|5|0|0|0|0|HEX|0|0|1|100|DKK|390|873|lyfalmen|||00|30|0|Vistor hf|Hexal A/S|7,5| 037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|539|1183|lyfalmen|||10|100|0|Vistor hf|LEO Pharma A/S|25| 037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|1141|2435|lyfalmen|||10|250|0|Vistor hf|LEO Pharma A/S|62,5| 037929|J01EA0102|Monotrim|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.1980||R|A|5|0|0|0|0|HEX|0|0|1|100|DKK|1067|2281|lyfalmen|||00|100|0|Vistor hf|Hexal A/S|25| 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|377|846|lyfalmen|||00|50|0|Icepharma hf|Smith & Nephew|50| 038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|123516|155645|lyfsjukr|||00|0,6|0|Vistor hf|Amgen Europe B.V.|| 038828|C09AA0401|Coversyl|töflur|4|mg|90|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|5769|9277|lyfalmen|||00|90|0|Icepharma hf|Servier|90| 038877|N07CA0101|Betaserc|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.1982||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|2541|4594|lyfalmen|||00|100|0|Medico ehf|Solvay Duphar |33,3333| 038915|J01FA1004|Zitromax UNO|forðakyr|| |2|g|1|fl||J01FA10|01.10.2007||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1718|3344|lyfalmen|||00|2|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|6,67| 039005|L01XA0301|Eloxatin|irþ|5|mg/ml|10|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|23785|31480|lyfsjukr|||00|10|0|Vistor hf|Sanofi-aventis Norge AS|| 039014|L01XA0301|Eloxatin|irþ|5|mg/ml|20|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|41386|53393|lyfsjukr|||00|20|0|Vistor hf|Sanofi-aventis Norge AS|| 039669|C01BA0302|Durbis Retard|forðatfl|250|mg|100|stk|1|glas||C01BA03|01.05.1983||R|A|1|0|0|B|0|SNO|0|0|0|100|NOK|3692|6299|lyfalmen|||10|100|0|Vistor hf|Sanofi-aventis Norge AS|62,5| 039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|852|1834|lyfalmen|||00|15|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|2| 039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1306|2718|lyfalmen|||00|22,5|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|3| 039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|183|262|lyfsjukr|||00|1|0|Icepharma hf|Baxter Medical AB|| 039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|414|593|lyfsjukr|||00|1|0|Icepharma hf|Baxter Medical AB|| 040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|699|1001|lyfsjukr|||02|1|0|Icepharma hf|Baxter Medical AB|| 040287|N03AF0104|Tegretol|töflur|200|mg|200|stk|1|þpakki||N03AF01|01.04.1993||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|2166|4024|lyfalmen|||00|200|0|Vistor hf|Novartis Healthcare A/S-|40| 041005|L04AB0102|Enbrel (Lyjaver)|sts|| |25|mg|4|hgl|+ leysir|L04AB01|01.05.2006||R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|54396|69591|lyfsjukr|||00|100|0|Lyfjaver ehf|Lyfjaver ehf|14,29| 041059|J07BH0101|Rotarix|mixtduft|| |1|hgl|1|pakki|+áf.munnspr.m/leysi|J07BH01|01.07.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|5967|9553|lyfalmen|||00|1|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|| 041423|G03AA1203|Yasminelle|töflur|| |63|stk|1|þpakki|3+0,02 mg|G03AA12|01.12.2006||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1818|3496|lyfalmen|||00|63|0|Icepharma hf|Bayer Schering Pharma AG|| 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|K|3|0|0|0|0|INI|0|0|0|100|DKK|2125|3677|vetorma|||AA|100|0|Icepharma hf|Intervet International B.V.|| 041806|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|10|fl|30+30+60+6|QI04AB01|01.05.1998||R|K|3|0|0|0|0|INI|0|0|0|100|DKK|20335|35191|vetorma|||AA|1000|0|Icepharma hf|Intervet International B.V.|| 041815|V08CA1101|Vasovist|stl|0,25|mmol/ml|10|ml|10|hgl|lausn|V08CA11|01.12.2006||R|A|3|0|0|0|0|SAG|0|0|0|100|SEK|111663|142071|lyfalmen|||02|100|0|Icepharma hf|Schering AG|| 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2104|3012|lyfsjukr|||00|10000|0|Icepharma hf|Fresenius Kabi|| 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2725|3902|lyfsjukr|||00|7500|0|Icepharma hf|Fresenius Kabi|| 042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2507|3589|lyfsjukr|||00|10000|0|Icepharma hf|Fresenius Kabi|| 042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3801|5442|lyfsjukr|||00|7500|0|Icepharma hf|Fresenius Kabi|| 042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|4364|6248|lyfsjukr|||00|7500|0|Icepharma hf|Fresenius Kabi|| 042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BA03|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4773|6834|lyfsjukr|||00|4000|0|Icepharma hf|Fresenius Kabi|4| 042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2535|3629|lyfsjukr|||00|7500|0|Icepharma hf|Fresenius Kabi|| 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|1860|2663|lyfsjukr|||00|10000|0|Icepharma hf|Fresenius Kabi|| 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1603|2295|lyfsjukr|||02|10000|0|Icepharma hf|Fresenius Kabi|| 042442|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|40|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|5602|8021|lyfsjukr|||00|2000|0|Icepharma hf|Fresenius Kabi|| 042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|2268|3247|lyfsjukr|||00|7500|0|Icepharma hf|Fresenius Kabi|| 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|1265|1811|lyfsjukr|||00|10000|0|Icepharma hf|Fresenius Kabi|| 042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BB01|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4181|5986|lyfsjukr|||00|4000|0|Icepharma hf|Fresenius Kabi|4| 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|| |1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1418|2030|lyfsjukr|||00|10000|0|Icepharma hf|Fresenius Kabi|| 042549|J07BF0301|Imovax Polio|bóluefni|| |0,5|ml|1|dæla|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|447|992|lyfalmen|||02|0,5|0|Icepharma hf|Sanofi Pasteur MSD|| 042556|J07BF0301|Imovax Polio|bóluefni|| |0,5|ml|20|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|8542|13110|lyfalmen|||02|10|0|Icepharma hf|Sanofi Pasteur MSD|| 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1970|2821|lyfsjukr|||00|10000|0|Icepharma hf|Fresenius Kabi|| 043232|N05CD0305|Flunitrazepam Merck NM|töflur|1|mg|30|stk|1|þpakki||N05CD03|01.10.1992||R|A|5|1|0|0|0|MNA|0|0|0|100|SEK|207|493|lyfalmen|||00|30|0|Merck NM|Merck NM AB|30| 043379|R03AC1201|Serevent|innúðal|25|mcg/sk|120|sk|1|stauk|HFA 134a|R03AC12|01.04.2007||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2559|4621|lyfalmen|||24|120|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30| 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|326|740|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|15| 043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.07.1989||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|696|1509|lyfalmen|||10|30|0|Icepharma hf|N.V. Organon|30| 043919|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyflausa|||02|200|0|Icepharma hf|Fresenius Kabi|| 043935|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|| |10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||00|200|0|Icepharma hf|Fresenius Kabi|| 044360|B03AC0203|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.05.2006||R|A|3|0|0|E|0|LVR|0|0|1|100|NOK|8139|12573|lyfalmen|||00|25|0|Lyfjaver ehf|Lyfjaver ehf|5| 044624|G04BE0303|Viagra (D.A.C.)|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.11.2006||R|A|5|0|0|0|0|DAC|0|0|0|100|DKK|2939|5199|lyfalmen|V1300|5199|00|4|0|D.A.C. ehf|D.A.C. ehf|8| 045013|L01XX1902|Campto|irþ|20|mg/ml|5|ml|1|hgl||L01XX19|01.01.1999||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|21860|29083|lyfsjukr|||00|5|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 045104|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|905|1944|lyfalmen|||10|50|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|8,3333| 045385|J07BF0301|Imovax Polio|bóluefni|| |0,5|ml|10|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|4270|7141|lyfalmen|||02|5|0|Icepharma hf|Sanofi Pasteur MSD|| 046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|K|2|0|0|0|0|PFV|0|0|0|100|DKK|12205|23420|vetalmen|||27|10|0|Icepharma hf|Pfizer vet.|| 047159|C07AA0704|Sotalol Merck NM|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|557|1220|lyfalmen|||00|100|0|Merck NM|Merck NM AB|25| 047340|J01CA0406|Flemoxin Solutab|lausnart|500|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|638|1389|lyfalmen|||23|14|0|Vistor hf|Astellas Pharma A/S|7| 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|2976|4261|lyfsjukr|||02|250|0|Icepharma hf|Baxter Medical AB|| 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|4573|6547|lyfsjukr|||02|100|0|Icepharma hf|Baxter Medical AB|| 048199|A03CA0201|Librax|töflur|| |100|stk|1|glas||A03CA02|01.12.1972||R|A|5|0|0|E|0|VAL|0|0|0|100|DKK|1226|2597|lyfalmen|||00|100|0|Icepharma hf|Valeant Pharmaceuticals B.V.|| 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|þpakki|100+12,5 mg|C09DA01|01.06.2007||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|10501|15719|lyfalmen|||00|98|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|196| 048355|C01DA0801|Sorbangil|töflur|40|mg|100|stk|1|glas||C01DA08|01.10.1988||R|A|3|0|0|B|0|REP|0|0|0|100|DKK|2288|4210|lyfalmen|||00|100|0|Vistor hf|Recip AB|66,6667| 048447|G03AA0901|Marvelon|töflur|| |63|stk|1|þpakki||G03AA09|01.07.1986||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1054|2254|lyfalmen|||23|63|0|Icepharma hf|N.V. Organon|84| 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|37473|49704|lyfalmen|||00|150|0|Icepharma hf|Roche|37,5| 048520|N04BD0103|Selegilin NM Pharma|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|A|1.5|0|0|E|0|MNA|0|0|0|100|SEK|1630|3210|lyfalmen|||00|100|0|Merck NM|Merck NM AB|100| 048611|N04BD0103|Selegilin NM Pharma|töflur|10|mg|100|stk|1|glas||N04BD01|01.07.1994||R|A|1.5|0|0|E|0|MNA|0|0|0|100|SEK|5375|8727|lyfalmen|||00|100|0|Merck NM|Merck NM AB|200| 048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|A|4|0|0|0|0|GCH|0|0|1|100|DKK|246|574|lyfalmen|V0772|486|00|100|0|Icepharma hf|GlaxoSmithKline CH A/S|16,6667| 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|11024|16416|lyfalmen|||00|3|0|Icepharma hf|Roche Registration Limited|0,5| 049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|1521|3045|lyfalmen|||00|100|0|Vistor hf|Boehringer Ingelheim|25| 049502|D01AC0801|Fungoral|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1993||L|A|3|0|0|0|0|JAS|0|0|1|100|SEK|||lyfalmen|||23|60|0|Vistor hf|Janssen-Cilag AB|60| 049524|S01ED5110|Duotrav|augndr|| |2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|1822|3502|lyfalmen|||00|2,5|0|K.Pétursson hf|Alcon|| 049533|S01ED5110|Duotrav|augndr|| |2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|5363|8711|lyfalmen|||00|7,5|0|K.Pétursson hf|Alcon|| 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|A|3|0|0|0|0|GAN|0|0|1|100|CHF|4173|7000|lyfalmen|||23|5|0|Icepharma hf|Galderma Nordic AB|5| 049552|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|28|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|0|0|POF|0|0|0|100|IKR|1400|2861|lyfalmen|V0459|2861|00|28|0|PortFarma ehf|PortFarma |18,6667| 049570|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|28|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|0|0|POF|0|0|0|100|IKR|1855|3552|lyfalmen|V0458|3552|00|28|0|PortFarma ehf|PortFarma |37,3333| 049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|6181|9851|lyfalmen|V0343|5685|00|28|0|Vistor hf|Novartis Healthcare A/S-|28| 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||R|A|5|0|0|0|0|NHE|0|0|1|100|DKK|1166|2487|lyfalmen|||00|30|0|Artasan ehf|Novartis Healthcare A/S-A|30| 049750|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|25|mg|30|stk|1|þpakki||L04AD01|01.04.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|2897|5135|lyfalmen|||10|30|0|D.A.C. ehf|D.A.C. ehf|3| 049760|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|100|mg|30|stk|1|þpakki||L04AD01|01.04.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|10630|15891|lyfalmen|||10|30|0|D.A.C. ehf|D.A.C. ehf|12| 049778|M05BA0405|Fosamax (D.A.C.) |töflur|70|mg|12|stk|1|þpakki||M05BA04|01.04.2006||R|A|3|0|0|E|0|DAC|0|0|0|100|XEU|8064|12473|lyfalmen|V0718|12473|00|12|0|D.A.C. ehf|D.A.C. ehf|84| 049832|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|lykja||J06BA01|01.06.2007||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|7875|11275|lyfsjukr|||17|10|0|Vistor hf|Octapharma AB|| 049842|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|lykjur||J06BA01|01.06.2007||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|78754|99916|lyfsjukr|||17|100|0|Vistor hf|Octapharma AB|| 049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|45453|59639|lyfalmen|||00|300|0|Icepharma hf|Roche|37,5| 050179|N01AF0301|Pentothal Natrium|sts|2,5|g|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|4604|6592|lyfsjukr|||02|12|0|Vistor hf|Hospira Enterprises B.V.|| 050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.12.2006||R|A|2,5|0|1|0|1|BHC|0|0|0|100|DKK|388976|486143|lyfsjukr|||00|112|0|Vistor hf|Bayer HealthCare AG|| 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2166|4024|lyfalmen|||00|14|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|56| 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|7726|12006|lyfalmen|||00|56|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|42| 050651|C02CA0402|Carduran Retard|forðatfl|4|mg|30|stk|1|þpakki||C02CA04|01.01.2007||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|1794|3459|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30| 050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|5413|8780|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|100| 050914|N02BE0101|Panodil|eþ-stil|1|g|10|stk|1|pakki||N02BE01|01.10.1989||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|259|601|lyfalmen|||04|10|0|Icepharma hf|GlaxoSmithKline CH A/S|3,3333| 051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|1002|2146|lyfalmen|||10|100|0|Vistor hf|Desitin Artzneimittel|10| 051076|D05AX5202|Daivobet (D.A.C.)|smyrsli|| |60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.01.2007||R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|5234|8531|lyfalmen|V0391|8531|00|60|0|D.A.C. ehf|D.A.C. ehf|| 051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|1308|2721|lyfalmen|||10|100|0|Vistor hf|Desitin Artzneimittel|20| 051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|A|2|0|1|0|1|UCB|0|0|0|100|DKK|20220|27041|lyfsjukr|||00|50|0|Vistor hf|U.C.B|3,33| 051713|A02BC0504|Nexium Mups (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.04.2006||R|A|3|0|0|E|0|DAC|0|0|0|30|IKR|2546|4602|lyfalmen|V0084|4524|00|28|0|D.A.C. ehf|D.A.C. ehf|18,67| 052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|222668|279089|lyfsjukr|||00|60|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd || 052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|448641|560426|lyfsjukr|||00|60|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd || 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|453772|566814|lyfsjukr|||00|60|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd || 052498|V03AF0302|Rescuvolin|sts|15|mg|1|stk|25|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|19168|25732|lyfsjukr|||63|25|0|Actavis Group hf|Pharmachemie|6,25| 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|23600|31250|lyfsjukr|||00|8212|0|Icepharma hf|Fresenius Kabi|8,2| 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|18961|25474|lyfsjukr|||00|7698|0|Icepharma hf|Fresenius Kabi|7,71| 052522|V03AF0302|Rescuvolin|sts|50|mg|1|stk|10|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|25591|33728|lyfsjukr|||63|10|0|Actavis Group hf|Pharmachemie|8,3333| 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|21940|29183|lyfsjukr|||00|7680|0|Icepharma hf|Fresenius Kabi|7,68| 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|18227|24560|lyfsjukr|||00|7200|0|Icepharma hf|Fresenius Kabi|7,2| 052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|24712|32634|lyfsjukr|||00|7880|0|Icepharma hf|Fresenius Kabi|7,9| 052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|22991|30491|lyfsjukr|||00|7616|0|Icepharma hf|Fresenius Kabi|7,6| 053006|N05CF0203|Zolpidem Merck NM|filmhtfl|10|mg|100|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MNA|0|0|0|100|SEK|1786|3447|lyfalmen|V0903|3447|00|100|0|Merck NM|Merck NM AB|100| 053025|G03HB0102|Diane mite|töflur|| |63|stk|1|þpakki||G03HB01|01.07.1989||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|1618|3192|lyfalmen|||23|63|0|Icepharma hf|Bayer Schering Pharma AG|63| 053043|J05AE0601|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AE06|01.11.2006||R|A|2|0|1|0|1|ABT|0|0|0|100|DKK|49733|63785|lyfsjukr|||00|120|0|Vistor hf|Abbott Laboratories Ltd|30| 053231|J07BB0201|Fluarix|bóluefni|| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|4123|6927|lyfalmen|||02|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 053270|A08AX0101|Acomplia|filmhtfl|20|mg|28|stk|1|þpakki||A08AX01|01.11.2006||R|A|3|0|0|0|0|SAA|0|0|0|100|NOK|8173|12618|lyfalmen|||00|28|0|Vistor hf|Sanofi - Aventis|28| 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|E|0|SDE|0|0|0|100|NOK|21531|29856|lyfalmen|||00|100|0|Vistor hf|Sanofi - aventis Deutschland GmbH|50| 053397|L04AA1301|Arava|töflur|20|mg|30|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|E|0|SDE|0|0|0|100|NOK|6671|10535|lyfalmen|||00|30|0|Vistor hf|Sanofi - aventis Deutschland GmbH|30| 053413|L04AA1301|Arava|töflur|20|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|E|0|SDE|0|0|0|100|NOK|20597|28694|lyfalmen|||00|100|0|Vistor hf|Sanofi - aventis Deutschland GmbH|100| 053546|L04AA1301|Arava|töflur|100|mg|3|stk|1|þpakki||L04AA13|01.11.2000||R|A|3|0|1|E|0|SDE|0|0|0|100|NOK|3201|5584|lyfalmen|||00|3|0|Vistor hf|Sanofi - aventis Deutschland GmbH|20| 053680|J05AE1001|Prezista|filmhtfl|300|mg|120|stk|1|plglas||J05AE10|01.04.2007||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|73677|93595|lyfsjukr|||43|120|0|Vistor hf|Janssen-Cilag International N.V.|| 053689|N05CF0203|Zolpidem Merck NM|filmhtfl|10|mg|20|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|380|852|lyfalmen|V0902|852|00|20|0|Merck NM|Merck NM AB|20| 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|A|2|1|0|0|0|MAP|0|0|0|100|GBP|10535|15765|lyfalmen|||00|10|0|Icepharma hf|Martindale Pharmaceuticals|50| 053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburður, lausn|D10AF01|01.07.1985||R|A|2,5|0|0|0|0|PFI|0|0|0|100|DKK|669|1453|lyfalmen|||20|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30| 054130|J01CA0405|Flemoxin|mixtúrud|50|mg/ml|100|ml|1|glas||J01CA04|01.11.1979||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|795|1715|lyfalmen|||08|100|0|Vistor hf|Astellas Pharma A/S|5| 054148|J01CA0405|Flemoxin|dropar|100|mg/ml|20|ml|1|glas||J01CA04|01.11.1979||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|462|1023|lyfalmen|||28|20|0|Vistor hf|Astellas Pharma A/S|2| 054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|1514|3034|lyfalmen|||02|0,5|0|Icepharma hf|Aventis Pasteur MSD A/S|| 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|A|3|0|1|0|1|RRL|0|0|0|30|DKK|41769|53870|lyfsjukr|||00|56|0|Icepharma hf|Roche Registration Limited|22,4| 054601|QB03AC9001|Idofer, vet.|stl|200|mg/ml|100|ml|5|fl|plastfl.|QB03AC90|01.05.1999||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|7449|14360|vetalmen|||27|500|0|Vistor hf|Boehringer Ingelheim Danmark|| 054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|A|5|0|0|0|0|PFA|1|0|0|100|DKK|4503|7793|vetorma|||16|20|0|Icepharma hf|Pfizer Animal Health|| 055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|þpakki||J01FA01|01.01.1986||R|A|3|0|0|0|0|ARA|0|0|1|100|SEK|455|1008|lyfalmen|||10|20|0|Vistor hf|Astra|5| 055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|6814|10734|lyfalmen|||10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|60| 055434|P03AC0401|Nix|krem|50|mg/g|30|g|1|túpa||P03AC04|01.01.1996||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|921|1977|lyfalmen|||00|30|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30| 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|þpakki||J01FA01|01.01.1986||R|A|3|0|0|0|0|ARA|0|0|1|100|SEK|741|1603|lyfalmen|||10|40|0|Vistor hf|Astra|10| 056879|V07AY02|Palacos cum Gentamicin (Paranova)|sement|500|mg|40,5|g|2|pakkar|+ leysir|V07AY|01.06.1997||R|A|4|0|0|0|1|PAN|0|0|0|100|DKK|15286|20899|lyfsjukr|||00|81|0|xxxxx|Paranova A/S|| 056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|K|2|0|1|0|1|EPI|0|0|0|100|XEU|173630|218037|lyfsjukr|||00|15|0|Meda AB|Elan Pharma International|30| 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|K|4|0|1|0|1|NOH|0|0|0|100|DKK|10886|15421|lyfsjukr|||02|5|0|Vistor hf|Novartis Healthcare A/S-|1,43| 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|5|0|1|0|1|NOH|0|0|0|100|DKK|5784|8281|lyfsjukr|||02|5|0|Vistor hf|Novartis Healthcare A/S-|0,71| 057422|B05XA3102|Tracel|irþ|| |10|ml|20|plastl||B05XA31|01.01.1987||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3766|5392|lyfsjukr|||00|200|0|Icepharma hf|Fresenius Kabi|0,2| 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|5|0|1|0|1|NOH|0|0|0|100|DKK|3199|4580|lyfsjukr|||02|5|0|Vistor hf|Novartis Healthcare A/S-|0,36| 057703|J01DD0401|Rocephalin|irþ|2|g|5|hgl|1|pakki|lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|14499|19919|lyfsjukr|||00|5|0|Icepharma hf|Roche|5| 057924|C09DA0401|CoAprovel|filmhtfl|325|mg|28|stk|1|þpakki|300+25 mg|C09DA04|01.03.2007||R|A|2|0|0|B|0|SBM|0|0|0|100|NOK|3208|5594|lyfalmen|||00|28|0|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|56| 057933|C09DA0401|CoAprovel|filmhtfl|325|mg|98|stk|1|þpakki|300+25 mg|C09DA04|01.03.2007||R|A|2|0|0|B|0|SBM|0|0|0|100|NOK|11113|16535|lyfalmen|||00|98|0|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|196| 057978|N07BA0301|Champix|filmhtfl|| |25|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.01.2007||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|2945|5208|lyfalmen|||00|25|0|Vistor hf|Pfizer Limited|9,75| 057987|N07BA0301|Champix|filmhtfl|1|mg|28|stk|1|þpakki||N07BA03|01.01.2007||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|3355|5808|lyfalmen|||00|28|0|Vistor hf|Pfizer Limited|14| 057996|N07BA0301|Champix|filmhtfl|1|mg|56|stk|1|þpakki||N07BA03|01.01.2007||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|6819|10741|lyfalmen|||00|56|0|Vistor hf|Pfizer Limited|28| 058024|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|50|ml|10|fl|30+30+60+6|QI04AB01|01.05.1997||R|K|3|0|0|0|0|INI|0|0|0|100|DKK|10977|18996|vetorma|||AA|500|0|Icepharma hf|Intervet International B.V.|| 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|250|582|lyfalmen|||02|5|0|Vistor hf|Boehringer Ingelheim|1,6667| 058397|J07BM0101|Gardasil|stl|| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|11787|17433|lyfalmen|||02|0,5|0|Icepharma hf|Sanofi Pasteur MSD|| 058503|J01EA0105|Trimetoprim AstraZeneca|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|563|1233|lyfalmen|||00|100|0|Vistor hf|AstraZeneca A/S DK|2,5| 058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|66268|84371|lyfsjukr|||00|210|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |21| 058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|925|1985|lyfalmen|||43|100|0|Vistor hf|Sanofi-aventis Norge AS|75| 058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|1432|2910|lyfalmen|||43|100|0|Vistor hf|Sanofi-aventis Norge AS|150| 058958|J07CA0601|Infanrix-Polio + Hib|bóluefni|| |0,5|ml|1|dæla|einnota dæla|J07CA06|01.03.1999||R|K|3|0|0|0|0|GSK|0|0|0|100|SEK|3016|5315|lyfalmen|||51|0,5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 059204|C01DA0801|Sorbangil|töflur|5|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|DKK|835|1798|lyfalmen|||00|250|0|Vistor hf|Recip AB|20,83| 059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|| |0,5|ml|10|spr||J07CA06|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|22269|30775|lyfalmen|||51|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 059823|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.05.2007||R|A|3|1|1|0|1|SCP|0|0|0|100|DKK|4231|6058|lyfsjukr|||00|28|0|Vistor hf|Schering-Plough|7| 059824|C07AB0310|Atenolol Merck NM|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|502|1106|lyfalmen|V0290|1106|00|98|0|Merck NM|Merck NM AB|32,6667| 059842|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2007||R|A|3|1|1|0|1|SCP|0|0|0|100|DKK|9605|13752|lyfsjukr|||00|28|0|Vistor hf|Schering-Plough|28| 060087|L04AC0101|Zenapax|irþ|5|mg/ml|5|ml|3|hgl||L04AC01|01.04.2005||R|K|3|0|0|0|1|RRL|0|0|0|100|DKK|99812|126133|lyfsjukr|||00|15|0|Icepharma hf|Roche Registration Limited|0,21| 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|228821|287932|lyfalmen|||00|84|0|Vistor hf|Novartis Europharm Ltd|| 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|115882|147323|lyfalmen|||00|84|0|Vistor hf|Novartis Europharm Ltd|| 060578|V03AC0301|Exjade|dreifit.|125|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|57941|75187|lyfalmen|||00|84|0|Vistor hf|Novartis Europharm Ltd|| 060848|N06AA0402|Anafranil Retard|forðatfl|75|mg|100|stk|1|þpakki||N06AA04|01.10.1989||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|4454|7409|lyfalmen|||10|100|0|Vistor hf|Novartis Healthcare A/S-|75| 060905|C01DA0204|Nitromex|tungur.t|0,5|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|880|1892|lyfalmen|||22|120|0|Actavis Group hf|Actavis Group hf|24| 060913|C01DA0204|Nitromex|tungur.t|0,25|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|880|1892|lyfalmen|||22|120|0|Actavis Group hf|Actavis Group hf|12| 061460|G03CX0102|Livial (D.A.C.)|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.08.2006||R|A|2|0|0|E|0|DAC|0|0|0|100|DKK|4374|7293|lyfalmen|V1030|7293|00|84|0|D.A.C. ehf|D.A.C. ehf|84| 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PFI|0|0|1|100|DKK|||lyfalmen|||23|50|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|4464|7424|lyfalmen|V1030|7293|00|84|0|Icepharma hf|N.V. Organon|84| 061580|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|1|spr||QP52AF02|01.04.1992||L|A|1|0|0|0|0|PFI|0|0|0|100|DKK|619|1071|vetorma|||16|26|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|3856|5521|lyfsjukr|||00|10|0|Vistor hf|Novartis Healthcare A/S-|2| 061961|J01XX0901|Cubicin|irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|10131|14481|lyfsjukr|||00|1|0|Vistor hf|Novartis Europharm Ltd|1,25| 061970|J01XX0901|Cubicin|irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|14340|19721|lyfsjukr|||00|1|0|Vistor hf|Novartis Europharm Ltd|1,79| 062117|N05BA1204|Tafil Retard|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|296|678|lyfalmen|||10|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|15| 062407|G03AA1202|Yasmin (D.A.C.)|töflur|| |63|stk|1|þpakki|3+0,03 mg|G03AA12|01.08.2006||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|1684|3292|lyfalmen|V1040|3292|00|63|0|D.A.C. ehf|D.A.C. ehf|84| 062638|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|4099|5869|lyfsjukr|||02|20|0|Icepharma hf|Wyeth AB|| 062661|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|464|664|lyfsjukr|||02|1|0|Icepharma hf|Wyeth AB|| 062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|623|1358|lyfalmen|||10|60|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30| 062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|9750|16873|vetorma|||16|1000|0|Vistor hf|Bayer HealthCare AG|| 062987|J07BM0201|Cervarix|stl|| |0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|11206|16659|lyfalmen|||02|0,5|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|| 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|30|DKK|3085|5415|lyfalmen|||00|10|0|Vistor hf|Novartis Healthcare A/S-|1,6667| 063453|J01CA0406|Flemoxin Solutab|lausnart|750|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1213|2577|lyfalmen|||23|14|0|Vistor hf|Astellas Pharma A/S|10,5| 063560|J07AH0301|Meningovax A+C|bóluefni|| |0,5|ml|10|hgl||J07AH03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|12101|18116|lyfalmen|||02|5|0|Icepharma hf|Sanofi Pasteur MSD|| 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|glas||D01BA02|01.11.2006||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|3270|5685|lyfalmen|V0343|5685|00|28|0|Actavis Group hf|Actavis hf|28| 063706|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.11.2006||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|1211|2574|lyfalmen|V1901|2574|00|30|0|D.A.C. ehf|D.A.C. ehf|30| 063715|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.11.2006||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|2918|5167|lyfalmen|V1902|5167|00|100|0|D.A.C. ehf|D.A.C. ehf|100| 063724|A10BG0202|Avandia (D.A.C.)|töflur|4|mg|56|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.11.2006||R|A|2|0|0|*|0|DAC|0|0|0|100|SEK|5266|8575|lyfalmen|V0005|8575|00|56|0|D.A.C. ehf|D.A.C. ehf|37,3333| 063923|QP54AB5207|Equest Pramox vet|hlaup|| |11,8|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|A|1,5|0|0|0|0|FDV|0|0|0|100|XEU|1442|2495|vetorma|||16|11,8|0|Vistor hf|Fort Dodge Veterinär GmbH|| 063941|N05BA1204|Tafil Retard|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|623|1358|lyfalmen|||10|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30| 063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|1267|2659|lyfalmen|||10|60|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|60| 064170|N05BA1204|Tafil Retard|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|1370|2815|lyfalmen|||10|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|60| 064733|J07BB0203|Vaxigrip|bóluefni|| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1985||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|511|1125|lyfalmen|||51|0,5|0|Icepharma hf|Sanofi Pasteur MSD|| 065032|D10AF5101|Duac|hlaup|| |25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|A|1,5|0|0|0|0|SLL|0|0|0|100|DKK|1421|2893|lyfalmen|||38|25|0|Vistor hf|Stiefel Laboratories (UK) Ltd.|| 065060|J07BD5202|MMR II|bóluefni|| |0,5|ml|10|hgl|+ leysir|J07BD52|01.11.1998||R|K|2|0|0|0|0|MEX|0|0|0|100|XEU|7652|11902|lyfalmen|||51|5|0|Icepharma hf|Aventis Pasteur MSD A/S|| 065201|B05BA0106|Vamin 18 g N/l elektrolytfri|irl|| |500|ml|1|fl||B05BA01|01.01.1985||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|1753|2510|lyfsjukr|||00|500|0|Icepharma hf|Fresenius Kabi|| 065314|G01AF0201|Canesten|sk-stil|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|A|4|0|0|0|0|BAS|0|0|0|100|DKK|||lyfalmen|||25|6|0|Vistor hf|Bayer A/S|6| 065332|G01AF0201|Canesten|sk-stil|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|A|5|0|0|0|0|BAS|0|0|0|100|DKK|||lyfalmen|||25|1|0|Vistor hf|Bayer A/S|5| 065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|K|3|0|0|*|0|PFI|0|0|0|100|DKK|1595|3157|lyfalmen|||06|2,5|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|25| 065888|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|50|ml|100|fl|30+30+60+6|QI04AB01|01.05.1997||R|K|3|0|0|0|0|INI|0|0|0|100|DKK|98826|171023|vetorma|||AA|5000|0|Icepharma hf|Intervet International B.V.|| 065896|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|100|fl|30+30+60+6|QI04AB01|01.05.1998||R|K|3|0|0|0|0|INI|0|0|0|100|DKK|183448|317466|vetorma|||AA|10000|0|Icepharma hf|Intervet International B.V.|| 065979|C09CA0101|Cozaar|töflur|12,5|mg|28|stk|1|þpakki||C09CA01|01.03.1999||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|1223|2592|lyfalmen|V0195|2125|00|28|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|7| 066050|C08DA0101|Geangin|töflur|120|mg|100|stk|1|glas||C08DA01|01.04.1985||R|A|5|0|0|B|0|GEA|0|0|0|100|DKK|1320|2739|lyfalmen|||00|100|0|Vistor hf|Gea|50| 066068|C08DA0101|Geangin|töflur|80|mg|100|stk|1|glas||C08DA01|01.04.1985||R|A|5|0|0|B|0|GEA|0|0|0|100|DKK|1031|2206|lyfalmen|V0340|1116|00|100|0|Vistor hf|Gea|33,3333| 066076|C08DA0101|Geangin|töflur|40|mg|100|stk|1|glas||C08DA01|01.04.1985||R|A|5|0|0|B|0|GEA|0|0|0|100|DKK|519|1141|lyfalmen|V0336|640|00|100|0|Vistor hf|Gea|16,6667| 066548|QG03FA0401|Prid, vet.|lykkja|10|mg|10|stk|1|pakki|m. hylki|QG03FA04|01.08.1984||R|A|2|0|0|0|0|CES|1|0|0|100|XEU|12251|23508|vetalmen|||16|10|0|Icepharma hf|Ceva Sante Animale|| 066563|N06AA0404|Klomipramin NM Pharma|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|348|786|lyfalmen|||00|100|0|Merck NM|Merck NM AB|10| 066621|N06AA0404|Klomipramin NM Pharma|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|519|1141|lyfalmen|V0908|1141|00|100|0|Merck NM|Merck NM AB|25| 066751|C01BD0103|Cordarone (D.A.C.)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.11.2006||R|K|5|0|0|B|0|DAC|0|0|0|100|NOK|1442|2925|lyfalmen|V0144|2925|70|30|0|D.A.C. ehf|D.A.C. ehf|15| 066760|C01BD0103|Cordarone (D.A.C.)|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.11.2006||R|A|5|0|0|B|0|DAC|0|0|0|100|NOK|656|1426|lyfalmen|V0143|1397|70|30|0|D.A.C. ehf|D.A.C. ehf|30| 067025|J01CA0406|Flemoxin Solutab|lausnart|125|mg|20|stk|1|þpakki||J01CA04|01.01.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|377|846|lyfalmen|||23|20|0|Vistor hf|Astellas Pharma A/S|2,5| 067124|N07CA0101|Betaserc|töflur|16|mg|84|stk|1|þpakki||N07CA01|01.04.1993||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|4155|6974|lyfalmen|||00|84|0|Medico ehf|Solvay Duphar |56| 067579|N05BB0101|Atarax|töflur|25|mg|25|stk|1|þpakki||N05BB01|01.04.1995||R|A|5|0|0|0|0|UCB|0|0|1|100|SEK|231|543|lyfalmen|||00|25|0|Vistor hf|U.C.B|8,3333| 067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|þpakki||N05BB01|01.07.1994||R|A|5|0|0|0|0|UCB|0|0|0|100|SEK|809|1744|lyfalmen|||00|100|0|Vistor hf|U.C.B|33,3333| 067641|N05CD0204|Mogadon (D.A.C.)|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.11.2006||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|442|981|lyfalmen|V0901|981|00|50|0|D.A.C. ehf|D.A.C. ehf|50| 067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1891|3607|lyfalmen|V0551|3607|10|7|0|Actavis Group hf|Actavis hf|1,75| 068023|QJ51CF0201|Latocillin, vet.|spenalyf|500|mg/dælu|1|stk|1|stk|spenadæla|QJ51CF02|01.01.1991||R|A|2|0|0|0|0|VEQ|0|0|0|100|CHF|195|385|vetalmen|||16|1|0|Icepharma hf|Vétoquinol AG|| 068312|QN01AX0302|Narketan, vet.|stl|100|mg/ml|50|ml|1|hgl||QN01AX03|01.01.1991||R|A|2,5|1|0|0|0|VEQ|1|0|0|100|XEU|3573|6977|vetalmen|||27|50|0|Icepharma hf|Vétoquinol AG|| 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|DKK|1207|2568|lyfalmen|||00|20|0|Vistor hf|Meda AB (V)|10| 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|DKK|3562|6110|lyfalmen|||00|100|0|Vistor hf|Meda AB (V)|50| 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|A|5|0|0|0|0|NHE|0|0|1|100|DKK|||lyfalmen|||00|15|0|Artasan ehf|Novartis Healthcare A/S-A|15| 069807|D01BA0201|Lamisil|töflur|250|mg|14|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|3648|6235|lyfalmen|||00|14|0|Vistor hf|Novartis Healthcare A/S-|14| 069815|D01BA0201|Lamisil|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|23493|32299|lyfalmen|||00|98|0|Vistor hf|Novartis Healthcare A/S-|98| 070359|L01DB0701|Novantrone|irþ|2|mg/ml|10|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|17210|23294|lyfsjukr|||00|10|0|Icepharma hf|Wyeth AB|| 070514|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|4138|5925|lyfsjukr|||00|7500|0|Icepharma hf|Fresenius Kabi|| 070523|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|3024|4330|lyfsjukr|||00|10000|0|Icepharma hf|Fresenius Kabi|| 070533|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5170|7402|lyfsjukr|||00|7500|0|Icepharma hf|Fresenius Kabi|| 070542|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3380|4839|lyfsjukr|||00|10000|0|Icepharma hf|Fresenius Kabi|| 070557|QH01BB0203|Partoxin vet.|stl|17|mcg|10|ml|10|hgl||QH01BB02|01.12.2006||R|A|2|0|0|0|0|PSW|1|0|0|100|SEK|3342|6537|vetalmen|||27|100|0|Vistor hf|Pharmaxim Sweden AB|| 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|10252|15388|lyfalmen|||00|100|0|Vistor hf|Janssen-Cilag AB|20| 071076|QA12CE9902|Selevitan, vet.|kyrni|| |1250|g|1|plbrús||QA12CE99|01.12.2006||R|A|3|0|0|0|0|PSW|0|0|0|100|SEK|3444|6731|vetalmen|||16|1250|0|Vistor hf|Pharmaxim Sweden AB|| 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|36366|47143|lyfsjukr|||00|1|0|Vistor hf|Eisai Ltd|8,33| 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|181832|228248|lyfsjukr|||00|5|0|Vistor hf|Eisai Ltd|41,65| 071670|J01CF0101|Diclocil|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.07.1991||R|A|1,5|0|0|0|0|BRS|0|0|1|100|DKK|1070|2287|lyfalmen|V0452|1630|10|30|0|Vistor hf|Bristol-Myers Squibb|3,75| 071712|J01CF0101|Diclocil|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.07.1991||R|A|1,5|0|0|0|0|BRS|0|0|1|100|DKK|1286|2688|lyfalmen|V0460|2299|10|30|0|Vistor hf|Bristol-Myers Squibb|7,5| 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|A|5|0|0|0|0|ORF|1|0|0|100|DKK|4551|8840|vetalmen|||27|5|0|Vistor hf|Orion-Farmos|| 072371|A04AA0201|Kytril|stl|1|mg/ml|3|ml|5|lykjur||A04AA02|01.04.1993||R|A|3|0|0|0|1|ROA|0|0|0|100|DKK|8087|11579|lyfsjukr|||00|15|0|Icepharma hf|Roche as|5| 072520|V01AA1104|Alutard SQ, hrossaværur|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|11170|16611|lyfalmen|||02|5|0|Vistor hf|ALK-Abello A/S|| 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|366|524|lyfsjukr|||02|10|0|Vistor hf|Janssen-Cilag AB|| 072770|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar||L04AB04|01.06.2007||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|116274|146629|lyfsjukr|||00|1,6|0|Vistor hf|Abbott|27,59| 072892|N01AH0301|Sufenta|stl|50|mcg/ml|1|ml|5|lykjur||N01AH03|01.10.1992||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1139|1631|lyfsjukr|||02|5|0|Vistor hf|Janssen-Cilag AB|| 072978|A10BX0401|Byetta|stl|5|mcg/pen|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|0|0|ELN|0|0|0|100|IKR|10000|15052|lyfalmen|||00|1,2|0|A. Karlsson hf |Eli Lilly Nederland|0,33| 072996|A10BX0401|Byetta|stl|10|mcg/pen|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|0|0|ELN|0|0|0|100|IKR|10000|15052|lyfalmen|||00|2,4|0|A. Karlsson hf |Eli Lilly Nederland|0,67| 073224|A09AA0205|Creon|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.01.2008||R|A|2|0|0|E|0|SOY|0|0|0|100|XEU|1887|3601|lyfalmen|||10|100|0|Medico ehf|Solvay Pharmaceuticals GmbH|100| 073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|178|432|lyfalmen|V0844|306|00|20|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|5| 073833|N05BA1203|Tafil|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|480|1060|lyfalmen|V0848|574|00|50|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|12,5| 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|696|1509|lyfalmen|V0852|1021|00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|25| 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|302|690|lyfalmen|V0856|476|00|20|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|10| 073866|N05BA1203|Tafil|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|523|1150|lyfalmen|V0860|977|00|50|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|25| 073869|G02BB0102|NuvaRing (D.A.C.)|sk-innl|| |3|stk|1|pakki||G02BB01|01.01.2007||R|K|3|0|0|0|0|DAC|0|0|0|100|DKK|2307|4239|lyfalmen|V1060|4239|00|3|0|D.A.C. ehf|D.A.C. ehf|84| 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|1057|2260|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|50| 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|2097|3920|lyfalmen|||00|28|0|Vistor hf|Novartis Europharm Ltd|| 074051|C09DB0101|Exforge|filmhtfl|85|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|6108|9750|lyfalmen|||00|98|0|Vistor hf|Novartis Europharm Ltd|| 074060|C09DB0101|Exforge|filmhtfl|165|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|2749|4910|lyfalmen|||00|28|0|Vistor hf|Novartis Europharm Ltd|| 074069|C09DB0101|Exforge|filmhtfl|165|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|8841|13508|lyfalmen|||00|98|0|Vistor hf|Novartis Europharm Ltd|| 074078|C09DB0101|Exforge|filmhtfl|170|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|2749|4910|lyfalmen|||00|28|0|Vistor hf|Novartis Europharm Ltd|| 074087|C09DB0101|Exforge|filmhtfl|170|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|8841|13508|lyfalmen|||00|98|0|Vistor hf|Novartis Europharm Ltd|| 074229|A08AA1001|Reductil|hylki|10|mg|28|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|3725|6347|lyfalmen|||00|28|0|Vistor hf|Abbott Laboratories A/S|28| 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|134|341|lyfalmen|||00|25|0|Actavis Group hf|Actavis Group hf|12,5| 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|272|628|lyfalmen|||00|50|0|Actavis Group hf|Actavis Group hf|25| 074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|| |1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|K|2|0|0|0|0|SCA|1|0|0|100|DKK|12094|20929|vetorma|||58|25|0|Vistor hf|Scan Vet Animal Health AS|| 074732|A08AA1001|Reductil|hylki|15|mg|28|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|3725|6347|lyfalmen|||00|28|0|Vistor hf|Abbott Laboratories A/S|42| 074922|R06AX2601|Telfast|töflur|120|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1134|2420|lyfalmen|||00|30|0|Vistor hf|Sanofi-aventis Norge AS|30| 075028|C09AA0901|Monopril|töflur|10|mg|98|stk|1|þpakki||C09AA09|01.04.1995||R|A|2|0|0|B|0|BRS|0|0|0|100|DKK|5055|8281|lyfalmen|||00|98|0|Vistor hf|Bristol-Myers Squibb|65,3333| 075044|J02AB0201|Fungoral|töflur|200|mg|10|stk|1|þpakki||J02AB02|01.01.1985||R|A|5|0|0|0|0|JAS|0|0|1|100|SEK|944|2025|lyfalmen|||69|10|0|Vistor hf|Janssen-Cilag AB|10| 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1517|3039|lyfalmen|||00|30|0|Vistor hf|Sanofi-aventis Norge AS|45| 075101|C09AA0901|Monopril|töflur|20|mg|98|stk|1|þpakki||C09AA09|01.04.1995||R|A|2|0|0|B|0|BRS|0|0|0|100|DKK|7706|11978|lyfalmen|||00|98|0|Vistor hf|Bristol-Myers Squibb|130,6667| 075382|V01AA0503|Soluprick SQ, rauðölur|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|4336|7237|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S|| 075408|V01AA0504|Soluprick SQ, graölur|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|4336|7237|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S|| 075424|V01AA0501|Soluprick SQ, birkifrjo|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|4336|7237|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S|| 075440|V01AA0502|Soluprick SQ, hesliviður|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|4336|7237|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S|| 075465|V04CL0006|Soluprick SQ, haliðagras|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|4336|7237|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S|| 075481|V04CL0004|Soluprick SQ, hafrar|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|4336|7237|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S|| 075507|V04CL0005|Soluprick SQ, axhnoðapunktur|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|4336|7237|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S|| 075523|V04CL0002|Soluprick SQ, havingull|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|4336|7237|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S|| 075549|V04CL0008|Soluprick SQ, vallarrygresi|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|4336|7237|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S|| 075564|V04CL0003|Soluprick SQ, vallarfoxgras|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|4336|7237|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S|| 075580|V04CL0007|Soluprick SQ, vallarsveifgras|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|4336|7237|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S|| 075606|V04CL0001|Soluprick SQ, rugur|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|4336|7237|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S|| 075663|V01AA0302|Soluprick SQ, derm.pter.|lausn|10|HEP|3|ml|1|hgl||V01AA03|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|4336|7237|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S|| 075689|V01AA1103|Soluprick SQ, hrossaværur|lausn|10|HEP|3|ml|1|hgl||V01AA11|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|4336|7237|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S|| 075705|V01AA1102|Soluprick SQ, hundahar|lausn|10|HEP|3|ml|1|hgl||V01AA11|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|4336|7237|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S|| 075721|V01AA1101|Soluprick SQ, kattahar|lausn|10|HEP|3|ml|1|hgl||V01AA11|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|4336|7237|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S|| 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|A|3|0|0|*|0|MSD|0|0|0|100|XEU|14950|21663|lyfalmen|||00|98|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|| 076281|R01AX0301|Atrovent|nefúði|21|mcg/sk|30|ml|1|stauk|380 sk.|R01AX03|01.01.2000||R|A|2|0|0|E|0|BOI|0|0|1|100|DKK|1497|3008|lyfalmen|||24|30|0|Vistor hf|Boehringer Ingelheim|33,25| 076752|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|100|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|4169|7215|vetorma|||27|100|0|Vistor hf|Merial (MSD)|| 077230|R01AD0103|Beconase Aqua|nefúði|50|mcg/sk|20|ml|1|stauk|200 sk|R01AD01|01.07.1986||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|822|1771|lyfalmen|||24|20|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|25| 077533|S01LA0401|Lucentis|stl|10|mg/ml|0,3|ml|1|hgl|lausn|S01LA04|01.03.2007||R|A|1,5|0|1|0|1|NOE|0|0|0|100|DKK|101621|128386|lyfsjukr|||00|0,3|0|Vistor hf|Novartis Europharm Ltd|| 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|A|3|0|0|E|0|GSK|0|0|0|30|GBP|479|1058|lyfalmen|||02|10|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|0,8333| 077951|M01AB0514|Voltfast (D.A.C.)|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.04.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|694|1505|lyfalmen|V0609|1200|10|30|0|D.A.C. ehf|D.A.C. ehf|15| 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|290|665|lyfalmen|||00|20|0|Vistor hf|AstraZeneca A/S DK|2,5| 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|442|981|lyfalmen|||00|40|0|Vistor hf|AstraZeneca A/S DK|5| 078766|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.10.1992||R|A|3|0|1|0|1|MAY|0|0|0|100|SEK|2855|4088|lyfsjukr|||00|5|0|Icepharma hf|Mayne Pharma Plc|| 078774|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1992||R|A|3|0|1|0|1|MAY|0|0|0|100|SEK|2344|3356|lyfsjukr|||00|10|0|Icepharma hf|Mayne Pharma Plc|| 078782|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|3430|4911|lyfsjukr|||00|5|0|Icepharma hf|Mayne Pharma Plc|| 078790|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|10104|14447|lyfsjukr|||00|15|0|Icepharma hf|Mayne Pharma Plc|| 078824|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|18147|24461|lyfsjukr|||00|45|0|Icepharma hf|Mayne Pharma Plc|| 078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|A|2|0|1|0|1|SAG|0|0|0|100|SEK|88094|111545|lyfsjukr|||00|15|0|Icepharma hf|Schering AG|30| 079053|C09CA0101|Cozaar|töflur|50|mg|28|stk|1|þpakki||C09CA01|01.01.1995||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|2132|3973|lyfalmen|V0196|3362|00|28|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|28| 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|6415|10178|lyfalmen|V0197|8649|00|98|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|98| 079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|1313|1880|lyfsjukr|||00|1|0|Icepharma hf|Baxter Medical AB|| 079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|2268|3247|lyfsjukr|||00|1|0|Icepharma hf|Baxter Medical AB|| 079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|4074|5833|lyfsjukr|||00|1|0|Icepharma hf|Baxter Medical AB|| 079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|þpakki||J05AH02|01.11.2002||R|A|5|0|0|0|0|RRL|0|0|0|100|DKK|1952|3699|lyfalmen|||00|10|0|Icepharma hf|Roche Registration Limited|4,67| 079236|L01CA0206|Vincristine Mayne|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|K|2|0|1|0|1|MAY|0|0|0|100|SEK|4584|6563|lyfsjukr|||02|5|0|Icepharma hf|Mayne Pharma Plc|| 079269|N05AB0302|Trilafon decanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|A|3|0|0|*|0|SCP|0|1|0|100|DKK|12129|18151|lyfalmen|||02|10|0|Vistor hf|Schering-Plough|154,5714| 079616|L01CA0206|Vincristine Mayne|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|K|2|0|1|0|1|MAY|0|0|0|100|SEK|7175|10273|lyfsjukr|||02|10|0|Icepharma hf|Mayne Pharma Plc|| 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|1207|1728|lyfsjukr|||03|5|0|Vistor hf|Bristol-Myers Squibb|2,5| 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|A|5|0|0|B|0|LUN|0|1|0|100|DKK|1285|2686|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|66,6667| 080524|N07BA0203|Wellbutrin Retard|töflur|300|mg|30|stk|1|þpakki|m/br. losunarhraða|N07BA02|01.07.2007||R|A|1,5|0|0|E|0|GSK|0|1|1|100|GBP|4183|7014|lyfalmen|||00|30|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30| 080542|N07BA0203|Wellbutrin Retard|töflur|150|mg|30|stk|1|þpakki|m/br. losunarhraða|N07BA02|01.07.2007||R|A|1,5|0|0|E|0|GSK|0|1|1|100|GBP|2256|4161|lyfalmen|||00|30|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|15| 080549|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|500|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|17749|30716|vetorma|||27|500|0|Vistor hf|Merial (MSD)|| 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|10710|15201|lyfsjukr|||00|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|21113|28153|lyfsjukr|||00|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 081588|C10AA0302|Pravachol|töflur|40|mg|28|stk|1|þpakki||C10AA03|01.06.1998||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|4152|6969|lyfalmen|||00|28|0|Vistor hf|Bristol-Myers Squibb|56| 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|1204|1724|lyfsjukr|||02|10|0|Icepharma hf|Roche|3,3333| 081987|A10AB0602|Apidra [solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áflylltir|A10AB06|01.01.2008||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|3312|5746|lyfalmen|||02|15|0|Vistor hf|Sanofi - Aventis|37,5| 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap||A10AE04|01.01.2008||R|K|2|0|0|0|0|SDE|0|0|0|100|NOK|5627|9079|lyfalmen|||00|15|0|Vistor hf|Sanofi - aventis Deutschland GmbH|37,5| 082354|C08DA0101|Geangin|töflur|40|mg|30|stk|1|glas||C08DA01|01.04.1985||R|A|5|0|0|B|0|GEA|0|0|0|100|DKK|221|522|lyfalmen|||00|30|0|Vistor hf|Gea|5| 082370|C08DA0101|Geangin|töflur|80|mg|30|stk|1|glas||C08DA01|01.04.1985||R|A|5|0|0|B|0|GEA|0|0|0|100|DKK|388|869|lyfalmen|||00|30|0|Vistor hf|Gea|10| 082685|R03BA0502|Flixotide Diskus|innúðadu|250|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|2145|3993|lyfalmen|||23|60|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|25| 082701|J01CA0407|Amoxicillin Scand Pharm|mixt.kyr|50|mg/ml|60|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|384|861|lyfalmen|||00|60|0|Merck NM|Merck NM AB|3| 082719|R03BA0502|Flixotide Diskus|innúðadu|500|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|3504|6025|lyfalmen|||23|60|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|50| 082792|J01CA0407|Amoxicillin Scand Pharm|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|600|1310|lyfalmen|||00|125|0|Merck NM|Merck NM AB|6,25| 082842|J01CA0407|Amoxicillin Scand Pharm|mixt.kyr|50|mg/ml|200|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|956|2050|lyfalmen|||00|200|0|Merck NM|Merck NM AB|10| 082990|N06DA0301|Exelon|hylki|1,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|17286|24571|lyfalmen|||00|112|0|Vistor hf|Novartis Healthcare A/S-|18,6667| 083204|N06DA0301|Exelon|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|16567|23676|lyfalmen|||00|112|0|Vistor hf|Novartis Healthcare A/S-|37,3333| 083360|G03GA0501|Gonal-F|sts|75|ae/lykju|10|lykjur|1|pakki|+ leysir 1 ml|G03GA05|01.04.1997||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|28836|38951|lyfalmen|||03|10|0|Gróco ehf|Serono Nordic|10| 083451|G03GA0501|Gonal-F|sts|150|ae/lykju|10|lykjur|1|pakki|+ leysir 1 ml|G03GA05|01.04.1997||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|58587|75991|lyfalmen|||03|10|0|Gróco ehf|Serono Nordic|20| 083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|K|0,5|0|1|0|1|ABL|0|0|0|100|DKK|44516|57290|lyfsjukr|||00|450|0|Vistor hf|Abbott Laboratories A/S|30| 083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|17286|24571|lyfalmen|||00|112|0|Vistor hf|Novartis Healthcare A/S-|74,6667| 083964|L02AE0101|Suprefact|nefúði|0,1|mg/sk|10|g|4|stk|+ sk-dæla|L02AE01|01.10.1987||R|A|2.5|0|1|0|1|SNO|0|0|0|100|NOK|24474|32338|lyfsjukr|||23|40|0|Vistor hf|Sanofi-aventis Norge AS|33,3333| 083980|L02AE0101|Suprefact|stl|1|mg/ml|5,5|ml|2|hgl||L02AE01|01.10.1987||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|4942|7076|lyfsjukr|||02|11|0|Vistor hf|Sanofi-aventis Norge AS|7,3333| 084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|156|387|lyfalmen|||02|10|0|Gróco ehf|Nycomed Danmark A/S|2,5| 084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|301|688|lyfalmen|||02|20|0|Gróco ehf|Nycomed Danmark A/S|5| 084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|0|0|EIS|0|0|0|100|SEK|617|1345|lyfalmen|||00|10|0|Vistor hf|Eisai Ltd|| 084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|0|0|EIS|0|0|0|100|SEK|7127|11170|lyfalmen|||00|60|0|Vistor hf|Eisai Ltd|| 084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|0|0|EIS|0|0|0|100|SEK|23758|32629|lyfalmen|||00|100|0|Vistor hf|Eisai Ltd|| 085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|11301|16785|lyfalmen|||10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|100| 085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|17286|24571|lyfalmen|||00|112|0|Vistor hf|Novartis Healthcare A/S-|56| 085407|R03AC0206|Ventoline|lausn|1|mg/ml|2,5|ml|20|lykjur|f. vél|R03AC02|01.04.1992||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|527|1158|lyfalmen|||00|50|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|5| 085423|B01AB0401|Fragmin|stl|25000|ae/ml|4|ml|1|hgl|með rotvörn|B01AB04|01.04.1993||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|7587|10863|lyfsjukr|||00|4|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|40| 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|3786|6436|lyfalmen|||00|100|0|Vistor hf|Sanofi-aventis Norge AS|100| 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|4385|7309|lyfalmen|||00|100|0|Vistor hf|Sanofi-aventis Norge AS|150| 086199|J01DD0202|Fortum|sts|500|mg/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|3443|4930|lyfsjukr|||03|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|0,63| 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|6770|9693|lyfsjukr|||03|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|1,25| 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|9649|13815|lyfsjukr|||03|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|2,5| 087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|1874|3581|lyfalmen|||00|28|0|Icepharma hf|N.V. Organon|28| 087189|N04BA0203|Sinemet 10/100|töflur|110|mg|100|stk|1|glas|10+100 mg|N04BA02|01.12.1982||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|1249|2632|lyfalmen|||00|100|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|16,6667| 087270|C07AB0309|Atenolol Actavis|töflur|50|mg|100|stk|1|glas||C07AB03|01.10.1985||R|A|4|0|0|B|0|ACA|0|0|0|100|IKR|610|1331|lyfalmen|V0298|1158|00|100|0|Actavis Group hf|Actavis hf|66,6667| 087296|C07AB0309|Atenolol Actavis|töflur|100|mg|100|stk|1|glas||C07AB03|01.10.1985||R|A|4|0|0|B|0|ACA|0|0|0|100|IKR|815|1757|lyfalmen|V0306|1673|00|100|0|Actavis Group hf|Actavis hf|133,3333| 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|161|397|lyfalmen|||00|10|0|Vistor hf|Sanofi-aventis Norge AS|10| 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|143|360|lyfalmen|V0886|360|00|30|0|Vistor hf|Sanofi-aventis Norge AS|30| 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|1675|3279|lyfalmen|||00|100|0|Vistor hf|Sanofi-aventis Norge AS|100| 087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|þpakki||G03GB02|01.07.1986||R|A|5|0|0|E|0|SER|0|0|0|100|SEK|480|1060|lyfalmen|||00|5|0|Gróco ehf|Serono|27,7778| 087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.09.2007||R|A|2|0|0|*|0|AGP|0|0|0|100|XEU|11125|16551|lyfalmen|V0560|16551|00|30|0|Actavis Group hf|Actavis Group PTC ehf|30| 087932|A02BX1301|Gaviscon|tuggutfl|| |20|stk|1|þpakki||A02BX13|01.10.1993||L|A|2|0|0|0|0|NDR|0|0|0|30|DKK|||lyflausa|||00|20|0|Vistor hf|Nordic Drugs AB|| 088051|L03AB0503|IntronA (Lyfjaver)|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|15630|21327|lyfsjukr|||00|1,2|0|Lyfjaver ehf|Lyfjaver ehf|9| 088224|L03AB0503|IntronA (Lyfjaver)|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|25457|33561|lyfsjukr|||00|1,2|0|Lyfjaver ehf|Lyfjaver ehf|15| 088233|L03AB0503|IntronA (Lyfjaver)|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|52109|66743|lyfsjukr|||00|1,2|0|Lyfjaver ehf|Lyfjaver ehf|30| 088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1025|2193|lyfalmen|||14|20|0|Icepharma hf|Meda AB|20| 088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|4995|8197|lyfalmen|||14|100|0|Icepharma hf|Meda AB|100| 088393|A03FA0101|Primperan|eþ-stil|20|mg|6|stk|1|pakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|294|674|lyfalmen|||04|6|0|Vistor hf|Sanofi-aventis Norge AS|4| 088623|C09CA0302|Diovan (D.A.C.)|töflur|80|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.05.2007||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|5986|9579|lyfalmen|V1110|7915|00|98|0|D.A.C. ehf|D.A.C. ehf|98| 088632|C09CA0302|Diovan (D.A.C.)|töflur|160|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.05.2007||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|8664|13272|lyfalmen|V1111|10921|00|98|0|D.A.C. ehf|D.A.C. ehf|196| 089003|G03CA0308|Progynon|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|800|1726|lyfalmen|V0408|1133|00|84|0|Icepharma hf|Bayer Schering Pharma AG|84| 089094|A02BX1301|Gaviscon|tuggutfl|| |120|stk|1|þpakki||A02BX13|01.01.1989||L|A|2|0|0|0|0|NDR|0|0|0|30|DKK|||lyflausa|||00|120|0|Vistor hf|Nordic Drugs AB|| 090050|M03BA5201|Somadril comp.|töflur|| |30|stk|1|þpakki||M03BA52|01.01.1986||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|346|782|lyfalmen|||00|30|0|Actavis Group hf|Actavis Group hf|4,3| 090076|C03EA0109|Sparkal|töflur|55|mg|30|stk|1|glas|5+50 mg|C03EA01|01.10.1995||R|A|2|0|0|E|0|HEX|0|0|0|100|DKK|218|516|lyfalmen|||00|30|0|Vistor hf|Hexal A/S|30| 090084|C03EA0109|Sparkal|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.10.1995||R|A|2|0|0|E|0|HEX|0|0|0|100|DKK|482|1064|lyfalmen|V0240|557|00|100|0|Vistor hf|Hexal A/S|100| 090100|C03EA0110|Sparkal mite|töflur|27,5|mg|30|stk|1|glas|2.5+25 mg|C03EA01|01.10.1995||R|A|2|0|0|E|0|HEX|0|0|0|100|DKK|188|453|lyfalmen|||00|30|0|Vistor hf|Hexal A/S|30| 090118|C03EA0110|Sparkal mite|töflur|27,5|mg|100|stk|1|glas|2.5+25 mg|C03EA01|01.10.1995||R|A|2|0|0|E|0|HEX|0|0|0|100|DKK|417|929|lyfalmen|V0232|391|00|100|0|Vistor hf|Hexal A/S|100| 090159|C08DB0101|Cardizem|töflur|60|mg|100|stk|1|glas||C08DB01|01.10.1995||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|1203|2562|lyfalmen|V0352|1530|00|100|0|Vistor hf|Ferrosan A/S|25| 090167|M03BA0201|Somadril|töflur|350|mg|30|stk|1|þpakki||M03BA02|01.01.1986||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|328|744|lyfalmen|||00|30|0|Actavis Group hf|Actavis Group hf|7,5| 090232|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|2|0|1|0|1|MRK|0|0|0|100|XEU|23582|31227|lyfsjukr|||00|20|0|Vistor hf|Merck KgaA (V)|| 090242|L01XC0601|Erbitux|irl|5|mg/ml|100|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|2|0|1|0|1|MRK|0|0|0|100|XEU|117911|148667|lyfsjukr|||00|100|0|Vistor hf|Merck KgaA (V)|| 090451|L04AB0102|Enbrel (Lyjaver)|sts|| |50|mg|4|hgl|+ leysir|L04AB01|01.06.2007||R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|106130|133999|lyfsjukr|||00|200|0|Lyfjaver ehf|Lyfjaver ehf|28,58| 090460|L04AB0102|Enbrel (Lyjaver)|stl|| |25|mg|4|áf.spr|lausn|L04AB01|01.06.2007||R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|50897|65234|lyfsjukr|||00|100|0|Lyfjaver ehf|Lyfjaver ehf|14,29| 090469|L04AB0102|Enbrel (Lyjaver)|stl|| |50|mg|4|áf.spr|lausn|L04AB01|01.06.2007||R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|106130|133999|lyfsjukr|||00|200|0|Lyfjaver ehf|Lyfjaver ehf|28,58| 090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1135|2422|lyfalmen|||24|16,5|0|Vistor hf|Sanofi-aventis Norge AS|30| 090688|A06AB0602|Senokot|töflur|7,5|mg|60|stk|1|þpakki||A06AB06|01.10.1990||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|276|636|lyfalmen|||00|60|0|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|| 091642|L03AX1302|Copaxone (Lyfjaver)|stl|20|mg/spr|28|spr|1|pakki|lausn|L03AX13|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|83616|105969|lyfsjukr|||00|28|0|Lyfjaver ehf|Lyfjaver ehf|| 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|1110|2370|lyfalmen|V0001|1975|00|90|0|Vistor hf|Aventis Pharma |45| 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|1963|3716|lyfalmen|V0002|3203|00|90|0|Vistor hf|Aventis Pharma |90| 092014|L03AB0703|Rebif (Lyfjaver)|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|83627|105983|lyfsjukr|||00|6|0|Lyfjaver ehf|Lyfjaver ehf|61,3953| 092024|L03AB0703|Rebif (Lyfjaver)|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|107688|135939|lyfsjukr|||00|6|0|Lyfjaver ehf|Lyfjaver ehf|122,7907| 092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PFV|0|0|0|100|DKK|4213|8196|vetalmen|||16|100|0|Icepharma hf|Pfizer vet.|| 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|þpakki||B01AC04|01.12.1999||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|5214|8503|lyfalmen|||00|28|0|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|28| 092750|N05AH0203|Leponex (D.A.C.)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|A|5|0|0|*|0|DAC|0|1|0|100|DKK|5934|9507|lyfalmen|V1400|9507|00|100|0|D.A.C. ehf|D.A.C. ehf|33,3333| 093215|L01XC0602|Erbitux (Lyfjaver)|irl|2|mg/ml|50|ml|1|hgl|lausn|L01XC06|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|23189|30738|lyfsjukr|||00|50|0|Lyfjaver ehf|Lyfjaver ehf|| 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|3640|6224|lyfalmen|||00|1|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|2| 093496|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.01.2003||R|A|2|0|0|B|0|SCH|0|0|0|100|SEK|4120|6923|lyfalmen|||00|60|0|Icepharma hf|Schering Oy|32| 093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|A|5|0|0|0|0|PFA|1|0|0|100|DKK|15238|26370|vetorma|||00|100|0|Icepharma hf|Pfizer Animal Health|| 093641|QN05CM9202|Xylapan, vet.|stl|20|mg/ml|50|ml|1|hgl||QN05CM92|01.04.1992||R|A|3|0|0|0|0|VEQ|1|0|0|100|CHF|2523|4977|vetalmen|||00|50|0|Icepharma hf|Vétoquinol AG|| 093708|L01DB0701|Novantrone|irþ|2|mg/ml|5|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|8678|12425|lyfsjukr|||00|5|0|Icepharma hf|Wyeth AB|| 093757|N02AA0501|Oxycontin|forðatfl|80|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|10207|15328|lyfalmen|||10|28|0|Icepharma hf|Norpharma |29,87| 093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|33652|44947|lyfalmen|||10|98|0|Icepharma hf|Norpharma |261,33| 093823|S01EC0102|Diamox Depot|forðahlk|250|mg|100|stk|1|hylki||S01EC01|01.04.1998||R|A|2|0|0|*|0|GPL|0|0|0|100|USD|1101|2351|lyfalmen|||10|100|0|Icepharma hf|Goldshield Pharmaceuticals Ltd|33,3333| 093849|S01EC0102|Diamox Depot|forðahlk|500|mg|100|stk|1|hylki||S01EC01|01.12.1972||R|A|2|0|0|*|0|GPL|0|0|0|100|USD|2165|4023|lyfalmen|||10|100|0|Icepharma hf|Goldshield Pharmaceuticals Ltd|66,6667| 093969|G03FB0507|Trisekvens (D.A.C.)|töflur|| |84|stk|1|skífup||G03FB05|01.05.2007||R|A|4|0|0|E|0|DAC|0|0|0|100|DKK|1510|3028|lyfalmen|V0385|3028|23|84|0|D.A.C. ehf|D.A.C. ehf|84| 094287|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APG|0|0|0|100|XEU|7503|11695|lyfalmen|||00|50|0|Vistor hf|Astellas Pharma GmbH|5| 094296|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APG|0|0|0|100|XEU|10747|16047|lyfalmen|||00|50|0|Vistor hf|Astellas Pharma GmbH|10| 094305|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APG|0|0|0|100|XEU|48361|63260|lyfalmen|||00|50|0|Vistor hf|Astellas Pharma GmbH|10| 095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|0|100|DKK|1905|3628|lyfalmen|||00|50|0|Actavis Group hf|Actavis Group hf|100| 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHP|0|0|0|100|XEU|2100|4144|vetalmen|||00|100|0|Icepharma hf|Chanelle Pharmaceuticals || 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHP|0|0|0|100|XEU|2846|5592|vetalmen|||00|100|0|Icepharma hf|Chanelle Pharmaceuticals || 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHP|0|0|0|100|XEU|5045|9781|vetalmen|||00|100|0|Icepharma hf|Chanelle Pharmaceuticals || 096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|1512|2165|lyfsjukr|||02|60|0|Icepharma hf|Baxter Medical AB|| 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|A|2|0|0|0|0|GGL|0|0|1|100|GBP|975|2089|lyfalmen|||00|5|0|GlaxoSmithKline ehf|Glaxo Group Limited|| 096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|9260|14066|lyfalmen|||00|30|0|Vistor hf|Novartis Europharm Ltd|| 096351|S01AA1302|Fucithalmic (D.A.C.)|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.06.2007||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|454|1006|lyfalmen|V1500|1006|07|5|0|D.A.C. ehf|D.A.C. ehf|| 096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|9260|14066|lyfalmen|||00|30|0|Vistor hf|Novartis Europharm Ltd|| 096685|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|30|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|885|1902|lyfalmen|||00|30|0|Icepharma hf|Servier|18| 096688|N06DA0301|Exelon|forðapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|18521|26109|lyfalmen|||00|60|0|Vistor hf|Novartis Europharm Ltd|| 097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.06.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|1948|3693|lyfalmen|V0426|3693|00|20|0|D.A.C. ehf|D.A.C. ehf|5| 097297|L02BG0402|Femar (D.A.C.)|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.06.2007||R|A|5|0|0|*|0|DAC|0|0|0|100|DKK|35550|47310|lyfalmen|V0563|47310|00|100|0|D.A.C. ehf|D.A.C. ehf|100| 097642|J07AJ5201|Infanrix|bóluefni|| |0,5|ml|1|spr|einnota glerspr.|J07AJ52|01.04.1998||R|K|3|0|0|0|0|GSK|0|0|0|100|SEK|1218|2585|lyfalmen|||02|0,5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 097790|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.04.1995||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|5022|8235|lyfalmen|V0714|6340|10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|16,6667| 097816|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.04.1995||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|6579|10406|lyfalmen|V0715|8316|10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|22,2222| 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|2618|4711|lyfalmen|V0003|4028|00|90|0|Vistor hf|Aventis Pharma |135| 097887|N02CC0104|Sumacta|húðuðtfl|50|mg|12|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|3380|5845|lyfalmen|V0831|5845|00|12|0|Actavis Group hf|Actavis Group PTC ehf|12| 097896|N02CC0104|Sumacta|húðuðtfl|100|mg|6|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|2315|4251|lyfalmen|V0832|4251|00|6|0|Actavis Group hf|Actavis Group PTC ehf|12| 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|960|2058|lyfalmen|V1151|2058|00|30|0|Actavis Group hf|Actavis Group PTC ehf|15| 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|AGT|0|0|0|100|XEU|4801|7915|lyfalmen|V1110|7915|00|98|0|Actavis Group hf|Actavis Group hf|98| 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|AGT|0|0|0|100|XEU|6948|10921|lyfalmen|V1111|10921|00|98|0|Actavis Group hf|Actavis Group hf|196| 098228|J07AJ5201|Infanrix|bóluefni|| |0,5|ml|10|spr|einnota glerspr.|J07AJ52|01.04.1998||R|K|3|0|0|0|0|GSK|0|0|0|100|SEK|11855|17523|lyfalmen|||02|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 099242|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.04.1988||R|A|3|0|0|E|0|LEP|0|0|1|100|DKK|466|1031|lyfalmen|V1500|1006|07|5|0|Vistor hf|LEO Pharma A/S|| 099620|N02AX0210|Nobligan (D.A.C.)|hylki|50|mg|20|stk|1|pakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|329|746|lyfalmen|V0730|671|10|20|0|D.A.C. ehf|D.A.C. ehf|3,3333| 099861|H01AC0104|Saizen|sts|| |3,33|mg|10|hgl|+ leysir|H01AC01|01.07.1992||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|80841|102515|lyfsjukr|||02|33,3|0|Gróco ehf|Serono Nordic|50| 100008|V08AB0501|Ultravist|stl/irl|300|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|28204|36981|lyfsjukr|||02|500|0|Icepharma hf|Bayer Schering Pharma AG|| 100016|V08AB0501|Ultravist|stl/irl|300|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|41750|53846|lyfsjukr|||02|1000|0|Icepharma hf|Bayer Schering Pharma AG|| 100024|V08AB0501|Ultravist|stl/irl|370|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|30538|39887|lyfsjukr|||02|500|0|Icepharma hf|Bayer Schering Pharma AG|| 100032|V08AB0501|Ultravist|stl/irl|370|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|67806|86286|lyfsjukr|||02|1000|0|Icepharma hf|Bayer Schering Pharma AG|| 100305|G03GA0701|Luveris|sts|75|ae/hgl|1|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|8155|12594|lyfalmen|||00|1|0|Gróco ehf|Ares-Serono|1| 100412|M01AC0101|Felden|töflur|20|mg|30|stk|1|þpakki||M01AC01|01.01.1997||R|A|4|0|0|E|0|PFI|0|0|1|100|DKK|1174|2503|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30| 101386|R06AX1301|Clarityn|mixtúra|1|mg/ml|100|ml|1|glas||R06AX13|01.10.1995||L|A|3|0|0|E|0|SCP|0|0|1|100|DKK|469|1037|lyfalmen|||00|100|0|Vistor hf|Schering-Plough|10| 101543|G03GA0701|Luveris|sts|75|ae/hgl|3|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|24464|33508|lyfalmen|||00|3|0|Gróco ehf|Ares-Serono|3| 101550|G03GA0701|Luveris|sts|75|ae/hgl|10|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|81547|104576|lyfalmen|||00|10|0|Gróco ehf|Ares-Serono|10| 101691|C08CA0502|Adalat Oros|forðatfl|20|mg|28|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BHC|0|0|0|100|DKK|1218|2585|lyfalmen|||00|28|0|Vistor hf|Bayer HealthCare AG|18,6667| 101709|C08CA0502|Adalat Oros|forðatfl|20|mg|98|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BHC|0|0|0|100|DKK|3821|6487|lyfalmen|||00|98|0|Vistor hf|Bayer HealthCare AG|65,3333| 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|1531|3060|lyfalmen|V1152|3060|00|30|0|Actavis Group hf|Actavis Group PTC ehf|30| 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|5447|8828|lyfalmen|V1153|8828|00|96|0|Actavis Group hf|Actavis Group PTC ehf|96| 101769|N02AX0211|Nobligan Retard (D.A.C.)|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|5041|8262|lyfalmen|V0736|7896|00|100|0|D.A.C. ehf|D.A.C. ehf|50| 103678|N06AX1604|Venlafaxin Portfarma|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|USD|7578|11799|lyfalmen|V0955|11799|00|100|0|PortFarma ehf|PortFarma |75| 103687|N06AX1604|Venlafaxin Portfarma|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|USD|14422|21006|lyfalmen|V0956|21006|00|100|0|PortFarma ehf|PortFarma |150| 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|A|2|0|0|0|0|ERC|0|0|0|100|DKK|390|873|lyfalmen|||56|25|0|Vistor hf|Orion Pharma|5| 103952|A06AG0201|Toilax|innhl/tf|| |1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|A|2|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||00|1|0|Vistor hf|Orion Pharma|1| 104179|N06AB0603|Zoloft (D.A.C.)|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.09.2007||R|A|5|0|0|B|0|DAC|0|1|0|30|DKK|7478|11660|lyfalmen|V0933|8732|00|98|0|D.A.C. ehf|D.A.C. ehf|98| 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|K|3|0|0|E|0|FEL|0|0|0|100|DKK|2136|3979|lyfalmen|||23|2,5|0|Vistor hf|Ferring Lægemidler A/S|10| 104498|N05CH0101|Circadin|forðatfl|2|mg|21|stk|1|þpakki||N05CH01|01.11.2007||R|A|5|0|0|0|0|NEU|0|0|1|100|DKK|1474|2973|lyfalmen|||00|21|0|Gróco ehf|Neurim Pharmaceuticals EEC Ltd|0| 104760|A07EC0202|Pentasa|eþ-stil|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|6453|10231|lyfalmen|||04|28|0|Vistor hf|Ferring|18,6667| 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|3127|5476|lyfalmen|||56|700|0|Vistor hf|Ferring|4,6667| 104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|3831|6502|lyfalmen|||10|100|0|Vistor hf|Ferring|33,3333| 105278|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.09.2007||R|A|3|0|0|E|0|DAC|0|0|0|30|IKR|2495|4524|lyfalmen|V0084|4524|00|28|0|D.A.C. ehf|D.A.C. ehf|18,67| 105287|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.09.2007||R|A|3|0|0|E|0|DAC|0|0|0|30|IKR|5062|8291|lyfalmen|V0086|8291|00|56|0|D.A.C. ehf|D.A.C. ehf|37,33| 105379|N03AG0601|Gabitril|töflur|10|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|12235|18283|lyfalmen|||00|100|0|Icepharma hf|Cephalon France|33,3333| 105387|N03AG0601|Gabitril|töflur|15|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|10094|15177|lyfalmen|||00|50|0|Icepharma hf|Cephalon France|25| 105395|N03AG0601|Gabitril|töflur|15|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|18354|25901|lyfalmen|||00|100|0|Icepharma hf|Cephalon France|50| 105403|N03AG0601|Gabitril|töflur|5|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|5047|8270|lyfalmen|||00|50|0|Icepharma hf|Cephalon France|8,3333| 105437|N03AG0601|Gabitril|töflur|5|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|9176|13954|lyfalmen|||00|100|0|Icepharma hf|Cephalon France|16,6667| 105445|N03AG0601|Gabitril|töflur|10|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|6729|10615|lyfalmen|||00|50|0|Icepharma hf|Cephalon France|16,6667| 105586|C09XA02|Rasilez|filmhtfl|150|mg|28|stk|1|þpakki||C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|2749|4910|lyfalmen|||00|28|0|Vistor hf|Novartis Europharm Ltd|| 105597|C09XA02|Rasilez|filmhtfl|150|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|8301|12789|lyfalmen|||00|98|0|Vistor hf|Novartis Europharm Ltd|| 105608|C09XA02|Rasilez|filmhtfl|300|mg|28|stk|1|þpakki||C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|2749|4910|lyfalmen|||00|28|0|Vistor hf|Novartis Europharm Ltd|| 105620|C09XA02|Rasilez|filmhtfl|300|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|8841|13508|lyfalmen|||00|98|0|Vistor hf|Novartis Europharm Ltd|| 105939|M05BA0703|Optinate Septimum (D.A.C.)|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.10.2007||R|A|3|0|0|E|0|DAC|0|0|0|100|NOK|8182|12630|lyfalmen|V1080|12630|00|12|0|D.A.C. ehf|D.A.C. ehf|84| 106021|J01FA0901|Klacid|töflur|250|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|1919|3649|lyfalmen|||63|14|0|Vistor hf|Abbott Scandinavia AB|7| 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|A|5|0|0|0|1|GSK|0|0|0|30|GBP|12507|17439|lyfsjukr|||00|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|0,625| 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|A|5|0|0|0|1|GSK|0|0|0|30|GBP|6916|9902|lyfsjukr|||00|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|0,3125| 106963|M05BA0201|Bonefos|töflur|800|mg|30|stk|1|þpakki||M05BA02|01.03.2004||R|A|3|0|0|E|0|LEI|0|0|0|100|SEK|10896|16246|lyfalmen|||10|30|0|Icepharma hf|Leiras Oy|15| 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|A|5|0|0|B|0|PFI|0|0|0|100|DKK|1138|2428|lyfalmen|||10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|25| 107268|M05BA0201|Bonefos|töflur|800|mg|30|stk|1|glas||M05BA02|01.01.1997||R|A|3|0|0|E|0|LEI|0|0|0|100|SEK|10896|16246|lyfalmen|||10|30|0|Icepharma hf|Leiras Oy|15| 108029|R03AK0604|Seretide Diskus (D.A.C.)|innúðadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.09.2007||R|A|1,5|0|0|B|0|DAC|0|0|0|100|GBP|5157|8423|lyfalmen|V0993|8423|23|60|0|D.A.C. ehf|D.A.C. ehf|30| 108308|C08CA0501|Adalat|töflur|10|mg|100|stk|1|þpakki||C08CA05|01.01.1991||R|A|4|0|0|B|0|BHC|0|0|0|100|DKK|1870|3575|lyfalmen|||63|100|0|Vistor hf|Bayer HealthCare AG|33,3333| 108803|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|12|hgl|20mg/ml+36mcg/ml|QN01BB52|01.12.2003||R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|709|1399|vetalmen|||27|1200|0|Icepharma hf|Kela Laboratoria NV|| 109207|N02AA5901|Panocod|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|135|343|lyfalmen|V0775|293|00|20|0|Vistor hf|Sanofi-aventis Norge AS|6,6667| 109223|N02AA5901|Panocod|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|1|0|0|0|SNO|0|0|1|100|NOK|518|1139|lyfalmen|V0780|946|00|100|0|Vistor hf|Sanofi-aventis Norge AS|33,3333| 109421|V01AA0303|Alutard SQ, derm.farinae|stl|| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|13952|20420|lyfalmen|||02|20|0|Vistor hf|ALK-Abello A/S|| 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|11170|16611|lyfalmen|||02|5|0|Vistor hf|ALK-Abello A/S|| 109462|V01AA0301|Soluprick SQ, derm.farinae|lausn|10|HEP|3|ml|1|hgl||V01AA03|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|4336|7237|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S|| 110072|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|368|827|lyfalmen|||06|5|0|Icepharma hf|Santen Oy|25| 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|411|917|lyfalmen|||06|5|0|Icepharma hf|Santen Oy|25| 110395|G03AA0902|Mercilon|töflur|| |63|stk|1|þpakki||G03AA09|01.07.1990||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|901|1936|lyfalmen|||23|63|0|Icepharma hf|N.V. Organon|84| 110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|A|4|0|0|B|0|ORC|0|0|0|100|DKK|2663|4779|lyfalmen|||10|100|0|Vistor hf|Orion Corporation|83,3333| 111229|G02BA0301|Levonova|lykkja|20|mcg/sólh|1|stk|1|pakki|í leg|G02BA03|01.04.1994||R|A|3|0|0|0|0|SCH|0|0|0|100|SEK|9960|14999|lyfalmen|||23|1|0|Icepharma hf|Schering Oy|1825| 111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|430|956|lyfalmen|||00|100|0|Icepharma hf|GlaxoSmithKline CH A/S|33,33| 112359|S01AA1101|Garamycin|augndr|3|mg/ml|5|ml|1|glas||S01AA11|01.03.1977||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|463|1025|lyfalmen|||06|5|0|Vistor hf|Schering-Plough|| 112441|A10BB0701|Mindiab|töflur|2,5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|736|1593|lyfalmen|||68|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|25| 112615|C01DA0201|Discotrine|forðapl|15|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|DKK|2069|3877|lyfalmen|||23|30|0|Vistor hf|Meda AB (V)|90| 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|2100|3924|lyfalmen|||00|2|0|Vistor hf|Sanofi-aventis Norge AS|10| 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|3374|5836|lyfalmen|||00|4|0|Vistor hf|Sanofi-aventis Norge AS|20| 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|390|873|lyfalmen|||00|20|0|Vistor hf|AstraZeneca A/S DK|10| 114033|R03AC0210|Ventolin Diskus|innúðadu|200|mcg/sk|60|skammtar|1|stk|Diskus tæki|R03AC02|01.03.1999||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|531|1166|lyfalmen|||23|60|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|15| 114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíð 20 mg|S01ED51|01.03.1999||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|1480|2983|lyfalmen|V0989|2925|06|5|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|| 115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|1024|2191|lyfalmen|V1090|2150|06|5|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|16,6667| 115808|R06AX0201|Periactin|töflur|4|mg|100|stk|1|þpakki||R06AX02|01.10.2005||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|699|1516|lyfalmen|||00|100|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|33,3333| 115931|R03AC1202|Serevent Diskus|innúðadu|50|mcg/sk|60|sk|1|pakki||R03AC12|01.01.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2448|4453|lyfalmen|||23|60|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30| 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|2626|3760|lyfsjukr|||03|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|2,5| 116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|1373|1966|lyfsjukr|||03|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|1,25| 116137|D07AC1301|Elocon|krem|1|mg/g|20|g|1|túpa|feitt|D07AC13|01.04.1994||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|512|1127|lyfalmen|||20|20|0|Vistor hf|Schering-Plough|20| 116160|D07AC1301|Elocon|krem|1|mg/g|50|g|1|túpa|feitt|D07AC13|01.04.1994||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1132|2416|lyfalmen|||20|50|0|Vistor hf|Schering-Plough|50| 116368|D07AC1301|Elocon|smyrsli|1|mg/g|20|g|1|túpa||D07AC13|01.04.1994||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|512|1127|lyfalmen|||20|20|0|Vistor hf|Schering-Plough|20| 116400|D07AC1301|Elocon|smyrsli|1|mg/g|50|g|1|túpa||D07AC13|01.04.1994||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1146|2445|lyfalmen|||20|50|0|Vistor hf|Schering-Plough|50| 117408|QA12AX0001|Calcimag vet. Kela|irl|| |500|ml|12|plastf||QA12AX00|01.04.2004||R|A|2|0|0|0|0|KEL|1|0|0|100|NOK|5786|11193|vetalmen|||00|6000|0|Icepharma hf|Kela Laboratoria NV|| 117515|M01AE0303|Orudis|forðahlk|200|mg|100|stk|1|hylki||M01AE03|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|4941|8119|lyfalmen|||10|100|0|Vistor hf|Sanofi-aventis Norge AS|133,3333| 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3355|5808|lyfalmen|||00|100|0|Icepharma hf|Roche|33,3333| 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|1383|2835|lyfalmen|||10|100|0|Icepharma hf|Roche|8,3333| 117721|D11AF01|Verucid|hlaup|| |5|g|1|túpa||D11AF|01.08.1984||L|A|2|0|0|0|0|GAN|0|0|0|100|DKK|||lyflausa|||23|5|0|Icepharma hf|Galderma Nordic AB|5| 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|A|5|0|0|0|0|BHC|0|0|0|100|DKK|5271|9122|vetorma|||00|250|0|Vistor hf|Bayer HealthCare AG|| 117788|C08CA0502|Adalat Oros|forðatfl|30|mg|28|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|DKK|1713|3336|lyfalmen|||61|28|0|Vistor hf|Bayer HealthCare AG|28| 117796|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|DKK|3238|5638|lyfalmen|||61|98|0|Vistor hf|Bayer HealthCare AG|98| 117820|C08CA0502|Adalat Oros|forðatfl|60|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|DKK|7228|11311|lyfalmen|||61|98|0|Vistor hf|Bayer HealthCare AG|196| 117929|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|4042|7871|vetalmen|||00|1200|0|Icepharma hf|Kela Laboratoria NV|| 117937|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|7089|13675|vetalmen|||00|6000|0|Icepharma hf|Kela Laboratoria NV|| 118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|1182|2520|lyfalmen|||65|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|5| 118315|M01AB0505|Voltaren|eþ-stil|100|mg|5|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|409|913|lyfalmen|||04|5|0|Vistor hf|Novartis Healthcare A/S-|5| 118323|M01AB0505|Voltaren|eþ-stil|100|mg|50|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|4098|6891|lyfalmen|||04|50|0|Vistor hf|Novartis Healthcare A/S-|50| 118349|D07AC1301|Elocon|áburður|1|mg/g|20|ml|1|glas||D07AC13|01.04.1994||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|512|1127|lyfalmen|||20|20|0|Vistor hf|Schering-Plough|20| 118570|A07EC0203|Pentasa Sachets|forðakyr|1|g|50|stk|1|pakki||A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|5283|8599|lyfalmen|||00|50|0|Vistor hf|Ferring|33,3333| 118612|A07EC0203|Pentasa Sachets|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|15540|22398|lyfalmen|||00|150|0|Vistor hf|Ferring|100| 119305|B05BA0109|Vamin Glukos|irl|| |1000|ml|6|fl||B05BA01|01.09.1998||R|A|1.5|0|0|0|1|FRP|0|0|0|100|DKK|11224|15841|lyfsjukr|||00|6000|0|Icepharma hf|Fresenius Kabi|6| 119719|C09BA0801|Inhibace Comp.|töflur|17,5|mg|98|stk|1|pakki|þp ( 5+ 12,5 mg)|C09BA08|01.12.1997||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|7297|11407|lyfalmen|||00|98|0|Icepharma hf|Roche|98| 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|A|2|0|0|E|0|ALC|0|0|0|100|USD|500|1102|lyfalmen|||06|10|0|K.Pétursson hf|Alcon|| 121269|N05CD0505|Triazolam NM Pharma|töflur|0,25|mg|100|stk|1|glas||N05CD05|01.07.1991||R|A|4|0|0|0|0|MNA|0|0|0|100|SEK|469|1037|lyfalmen|||00|100|0|Merck NM|Merck NM AB|100| 121327|R03AC0204|Ventolin|innúðal|0,1|mg/sk|200|sk|1|stauk||R03AC02|01.12.1972||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|241|563|lyfalmen|||24|200|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|25| 121562|B03BB0103|Folinsyra Actavis|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.01.2008||R|A|2|0|0|E|0|AUK|0|0|1|100|GBP|438|973|lyfalmen|||00|28|0|Actavis Group hf|Actavis UK Ltd.|28| 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.03.1977||R|A|5|0|0|B|0|NOH|0|1|0|100|IKR|596|1301|lyfalmen|V0908|1141|00|100|0|Vistor hf|Novartis Healthcare A/S-|25| 121863|A07EC0204|Asacol|eþ-stil|500|mg|30|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|SCH|0|0|0|100|SEK|2033|3822|lyfalmen|||98|30|0|Icepharma hf|Schering Oy|10| 123216|N05BA0105|Stesolid|eþ-stil|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|317|721|lyfalmen|||04|10|0|Actavis Group hf|Actavis Group hf|5| 123224|N05BA0105|Stesolid|eþ-stil|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|495|1091|lyfalmen|||04|10|0|Actavis Group hf|Actavis Group hf|10| 123414|C01AA0504|Lanoxin mite|töflur|62,5|mcg|100|stk|1|glas||C01AA05|01.03.1978||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|217|513|lyfalmen|||00|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|25| 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|A|3|0|0|E|0|AVS|0|0|0|100|NOK|27775|37630|lyfalmen|||00|56|0|Vistor hf|Aventis Pharma SA|28| 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|þpakki||G02AB01|01.03.1980||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|575|1258|lyfalmen|||00|30|0|Vistor hf|Novartis Healthcare A/S-|18,75| 126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|þpakki||A07DA03|01.10.1991||L|A|5|0|0|0|0|JAS|0|0|0|100|SEK|||lyfalmen|||10|16|0|Vistor hf|Janssen-Cilag AB|3,2| 126540|J01GB0303|Gentacoll|vsvamp|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|14597|20041|lyfsjukr|||00|1|0|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|0,5417| 126649|J01GB0303|Gentacoll|vsvamp|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|4866|6967|lyfsjukr|||00|1|0|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|0,1354| 126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|JAS|0|0|0|100|SEK|1072|2291|lyfalmen|||10|100|0|Vistor hf|Janssen-Cilag AB|20| 128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|IKR|5638|9094|lyfalmen|V0810|8779|00|28|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|14| 128173|C08DA0107|Verapamil Merck NM|töflur|40|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|278|640|lyfalmen|V0336|640|00|100|0|Merck NM|Merck NM AB|16,6667| 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|| |100|stk|1|glas||C03AB01|01.05.1999||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|708|1534|lyfalmen|||10|100|0|Vistor hf|LEO Pharma A/S|50| 128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|2604|3728|lyfsjukr|||02|100|0|Icepharma hf|Baxter Medical AB|| 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH00|01.08.2005||L|A|5|0|0|0|0|REP|0|0|0|100|SEK|901|1936|lyfalmen|||00|100|0|Vistor hf|Recip AB|| 129817|R03BB0101|Atrovent|innúðal|0,25|mg/ml|2|ml|60|plastl|í vél|R03BB01|01.04.1989||R|A|3|0|0|B|0|BOI|0|0|0|100|DKK|3114|5457|lyfalmen|||00|120|0|Vistor hf|Boehringer Ingelheim|100| 130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|2297|4223|lyfalmen|||02|125|0|Gróco ehf|Nycomed Danmark A/S|31,25| 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|256|595|lyfalmen|||00|100|0|Vistor hf|Recip AB|33,3333| 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|490|1081|lyfalmen|||00|100|0|Vistor hf|Recip AB|15| 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|537|1179|lyfalmen|||00|100|0|Vistor hf|Recip AB|50| 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|594|1297|lyfalmen|||00|100|0|Vistor hf|Recip AB|100| 131565|G03CA0306|Evorel|forðapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3582|6139|lyfalmen|||23|26|0|Vistor hf|Janssen-Cilag AB|182| 132464|M03BA0201|Somadril|töflur|350|mg|50|stk|1|þpakki||M03BA02|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|547|1200|lyfalmen|||00|50|0|Actavis Group hf|Actavis Group hf|12,5| 132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|A|5|1|0|E|0|REP|0|0|1|100|SEK|960|2058|lyfalmen|||00|100|0|Vistor hf|Recip AB|25| 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|K|2|0|0|0|0|ALC|0|0|0|100|USD|570|1247|lyfalmen|||06|15|0|K.Pétursson hf|Alcon|| 132902|G03AB0402|Trinovum 28|töflur|| |84|stk|1|þpakki||G03AB04|01.01.1993||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|536|1177|lyfalmen|||23|84|0|Vistor hf|Janssen-Cilag AB|84| 133074|L03AA1001|Granocyte|sts|33,6|millj ae|1|stk|5|hgl|+ leysir|L03AA10|01.07.1994||R|A|2|0|1|0|1|CSA|0|0|0|100|NOK|50967|65321|lyfsjukr|||02|5|0|Vistor hf|Chugai sanofi-aventis|3,7571| 133736|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|SEK|5741|9238|lyfalmen|||10|100|0|Icepharma hf|Sandoz GmbH|25| 134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|1362|2803|lyfalmen|||00|50|0|Vistor hf|Abbott Scandinavia AB|5| 135095|M01AC0101|Felden|töflur|20|mg|60|stk|1|þpakki||M01AC01|01.01.1997||R|A|4|0|0|E|0|PFI|0|0|1|100|DKK|2454|4462|lyfalmen|||00|60|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|60| 135111|H01AC0101|Genotropin|sts|| |12|mg|1|rörlyk|tvíhólfa|H01AC01|01.04.1992||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|41383|53389|lyfsjukr|||00|12|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|17,991| 135319|C08DA0106|Verapamil NM Pharma|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|507|1116|lyfalmen|V0340|1116|00|100|0|Merck NM|Merck NM AB|33,3333| 135368|J01CA0405|Flemoxin|mixtúrud|25|mg/ml|100|ml|1|glas||J01CA04|01.11.1979||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|481|1062|lyfalmen|||08|100|0|Vistor hf|Astellas Pharma A/S|2,5| 135434|R03BA0502|Flixotide Diskus|innúðadu|100|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|1501|3014|lyfalmen|||23|60|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|10| 136168|G03AB0401|Trinovum|töflur|| |63|stk|1|þpakki||G03AB04|01.10.1988||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|536|1177|lyfalmen|||23|63|0|Vistor hf|Janssen-Cilag AB|84| 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|3984|6725|lyfalmen|||00|100|0|Vistor hf|Recip AB|100| 136564|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|10|hgl|röntgenskuggaefni|V08CA01|01.01.1993||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|65439|83339|lyfsjukr|||02|150|0|Icepharma hf|Bayer Schering Pharma AG|| 136572|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|10|hgl|röntgenskuggaefni|V08CA01|01.06.1997||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|48457|62196|lyfsjukr|||02|100|0|Icepharma hf|Bayer Schering Pharma AG|| 137141|N02BA5102|Treo|freyðit|| |20|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||14|20|0|Vistor hf|Pfizer Denmark PCH ApS|3,3333| 137158|N02BA5102|Treo|freyðit|| |60|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||14|60|0|Vistor hf|Pfizer Denmark PCH ApS|10| 137364|N05AB0301|Trilafon|töflur|4|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|853|1836|lyfalmen|||00|100|0|Vistor hf|Schering-Plough|13,3333| 137455|N05AB0301|Trilafon|töflur|2|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|565|1237|lyfalmen|||00|100|0|Vistor hf|Schering-Plough|6,6667| 137521|S01XA2011|Oculac|augndr|| |0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|450|998|lyfalmen|||00|8|0|Vistor hf|Novartis Healthcare A/S-|| 137679|A09AA0205|Creon|sh-hylki|| |100|stk|1|glas|plastglas|A09AA02|01.04.1990||R|A|2|0|0|E|0|KAC|0|0|0|100|XEU|1887|3601|lyfalmen|||10|100|0|Medico ehf|Kali-Chemie|100| 137992|J01XA0103|Vancomycin Abbott|irs|500|mg/hgl|500|mg|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|1231|1762|lyfsjukr|||00|500|0|Vistor hf|Hospira Enterprises B.V.|0,25| 138073|J01XA0103|Vancomycin Abbott|irs|1|g/hgl|1|g|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|1674|2397|lyfsjukr|||00|1|0|Vistor hf|Hospira Enterprises B.V.|0,5| 138560|S01ED0105|Optimol|augndr|2,5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|1135|2422|lyfalmen|||00|15|0|Icepharma hf|Santen Oy|60| 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,5|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|1226|2597|lyfalmen|||00|30|0|Icepharma hf|Santen Oy|60| 139410|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|250|ml|1|fl||QP52AC13|01.07.1987||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1558|2696|vetorma|||13|250|0|Icepharma hf|Intervet International B.V.|| 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.08.1981||R|A|5|0|0|E|0|NHE|0|0|1|100|DKK|1713|3336|lyfalmen|||00|100|0|Artasan ehf|Novartis Healthcare A/S-A|50| 140186|R03BB0101|Atrovent|innúðadu|40|mcg|100|stk|1|þpakki||R03BB01|01.10.1988||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|1441|2923|lyfalmen|||19|100|0|Vistor hf|Boehringer Ingelheim|33,3333| 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|992|2125|lyfalmen|||00|30|0|Vistor hf|Boehringer Ingelheim Internationl |1,06| 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|A|2|0|0|0|1|LUN|0|1|0|100|DKK|8079|11567|lyfsjukr|||02|10|0|Lundbeck Export A/S|Lundbeck|33,3333| 140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|364|521|lyfsjukr|||02|5|0|Vistor hf|Novartis Healthcare A/S-|3,3333| 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|spr|einnotaspr|H02AB04|01.04.1994||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|771|1665|lyfalmen|||03|2|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|4| 141432|N04BC0502|Sifrol|töflur|0,18|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A||0|0|E|0|BII|0|0|0|100|DKK|1885|3598|lyfalmen|||00|30|0|Vistor hf|Boehringer Ingelheim Internationl |2,16| 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|5195|8476|lyfalmen|||00|100|0|Vistor hf|Boehringer Ingelheim Internationl |7,2| 142059|C07AA0509|Propranolol Merck NM|töflur|10|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|167|409|lyfalmen|||00|100|0|Merck NM|Merck NM AB|6,25| 142190|C07AA0509|Propranolol Merck NM|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|366|823|lyfalmen|||00|100|0|Merck NM|Merck NM AB|25| 142299|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|10|lykjur||C01BD01|01.04.1987||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|4901|7017|lyfsjukr|||02|30|0|Vistor hf|Sanofi-aventis Norge AS|7,5| 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|669|1453|lyfalmen|V0143|1397|70|30|0|Vistor hf|Sanofi-aventis Norge AS|30| 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|A|5|0|0|0|0|MEB|0|0|1|100|DKK|1384|2837|lyfalmen|||00|100|0|Vistor hf|Meda AB (V)|50| 142422|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|12|plpok||B05BA03|01.01.1994||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1675|2398|lyfsjukr|||00|6000|0|Icepharma hf|Fresenius Kabi|6| 142596|C07AA0506|Propranolol NM Pharma|töflur|80|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|507|1116|lyfalmen|||00|100|0|Merck NM|Merck NM AB|50| 142604|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|8|plpok||B05BA03|01.01.1994||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1193|1708|lyfsjukr|||00|8000|0|Icepharma hf|Fresenius Kabi|| 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1174|2503|lyfalmen|||03|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|6,25| 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|2771|3967|lyfsjukr|||03|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|25| 143412|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|418|931|lyfalmen|||07|5|0|Vistor hf|Novartis Healthcare A/S-|| 143511|J07BC2002|Twinrix Peadriatric|bóluefni|| |0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|SEK|2332|4277|lyfalmen|||00|0,5|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|| 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|471|1042|lyfalmen|||06|15|0|K.Pétursson hf|Alcon|| 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1131|2414|lyfalmen|||00|2|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|3,3333| 143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|þpakki||N02CX02|01.04.1974||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|1275|2671|lyfalmen|||00|100|0|Vistor hf|Boehringer Ingelheim|25| 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|528|1160|lyfalmen|||20|30|0|Vistor hf|Astellas Pharma A/S|30| 143776|B05BA0203|Intralipid 300 mg/ml|irl|300|mg/ml|333|ml|1|fl||B05BA02|01.04.1992||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2405|3443|lyfsjukr|||00|333|0|Icepharma hf|Fresenius Kabi|0,333| 143800|N05AN0101|Litarex|forðatfl|564|mg|100|stk|1|glas||N05AN01|01.04.1974||R|A|5|0|0|*|0|AGT|0|1|0|100|DKK|688|1493|lyfalmen|||10|100|0|Actavis Group hf|Actavis Group hf|25| 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1613|3185|lyfalmen|V0429|3112|00|3|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|5| 143917|L01DB0301|Farmorubicin|stl|2|mg/ml|5|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|2414|3456|lyfsjukr|||02|5|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 143933|L01DB0301|Farmorubicin|stl|2|mg/ml|10|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|4640|6643|lyfsjukr|||02|10|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 144030|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|A|2|0|0|E|0|MSD|0|0|0|100|XEU|2161|4017|lyfalmen|||10|100|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|16,6667| 144089|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2798|4984|lyfalmen|||51|1|0|Icepharma hf|Sanofi Pasteur MSD|| 144105|L01DB0301|Farmorubicin|stl|2|mg/ml|25|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|8513|12188|lyfsjukr|||02|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|54892|70208|lyfsjukr|||AC|1,5|0|Vistor hf|Novo-Nordisk|22,4888| 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|34465|44776|lyfsjukr|||AC|1,5|0|Vistor hf|Novo-Nordisk|15,0675| 144543|B05BA0203|Intralipid 300 mg/ml|irl|300|mg/ml|500|ml|1|fl||B05BA02|01.04.1992||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3292|4713|lyfsjukr|||00|500|0|Icepharma hf|Fresenius Kabi|0,5| 144618|B05BB0115|Ringer-acetat Fresenius Kabi|irl|| |500|ml|12|plpok||B05BB01|01.01.1994||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1874|2683|lyfsjukr|||00|6000|0|Icepharma hf|Fresenius Kabi|| 144642|B05BB0115|Ringer-acetat Fresenius Kabi|irl|| |1000|ml|8|plpok||B05BB01|01.01.1994||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1297|1857|lyfsjukr|||00|8000|0|Icepharma hf|Fresenius Kabi|| 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|22410|29768|lyfsjukr|||AC|1,5|0|Vistor hf|Novo-Nordisk|7,4213| 144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|515|1133|lyfalmen|||20|30|0|Vistor hf|Astellas Pharma A/S|30| 144972|B05BB0115|Ringer-acetat Fresenius Kabi|irl|| |2000|ml|4|plpok||B05BB01|01.01.1994||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1308|1873|lyfsjukr|||00|8000|0|Icepharma hf|Fresenius Kabi|| 145086|B05BB0115|Ringer-acetat Fresenius Kabi|irl|| |5000|ml|2|plpok||B05BB01|01.01.1994||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1565|2241|lyfsjukr|||00|10000|0|Icepharma hf|Fresenius Kabi|| 145292|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|1823|3504|lyfalmen|||51|0,5|0|Icepharma hf|Sanofi Pasteur MSD|| 145482|D07AC0104|Diproderm|krem|0,5|mg/g|20|g|1|túpa||D07AC01|01.03.1977||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|610|1331|lyfalmen|||20|20|0|Vistor hf|Schering-Plough|20| 145490|D07AC0104|Diproderm|krem|0,5|mg/g|50|g|1|túpa||D07AC01|01.03.1977||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|1563|3109|lyfalmen|||20|50|0|Vistor hf|Schering-Plough|50| 145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|2900|5139|lyfalmen|||20|100|0|Vistor hf|Schering-Plough|100| 145540|P02CX0101|Vanquin|mixtúra|10|mg/ml|30|ml|1|glas||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|DKK|||lyfalmen|||24|30|0|Vistor hf|Recip AB|| 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|DKK|||lyfalmen|||23|8|0|Vistor hf|Recip AB|| 145631|P02CX0101|Vanquin|töflur|50|mg|32|stk|1|þpakki||P02CX01|01.01.1995||L|A|3|0|0|0|0|REP|0|0|0|100|DKK|||lyfalmen|||23|32|0|Vistor hf|Recip AB|| 145714|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|12|poki||B05BA03|01.01.1994||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1771|2536|lyfsjukr|||00|6000|0|Icepharma hf|Fresenius Kabi|| 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|480|1060|lyfalmen|||41|10|0|Vistor hf|Sanofi-aventis Norge AS|2| 147447|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|8|plpok||B05BA03|01.01.1994||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1276|1827|lyfsjukr|||00|8000|0|Icepharma hf|Fresenius Kabi|| 147512|G03DA0202|Perlutex|töflur|5|mg|50|stk|1|þpakki||G03DA02|01.03.1981||R|A|5|0|0|E|0|LEP|0|0|0|100|DKK|728|1576|lyfalmen|||00|50|0|Vistor hf|LEO Pharma A/S|50| 147520|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|12|poki||B05BA03|01.01.1994||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2600|3723|lyfsjukr|||00|6000|0|Icepharma hf|Fresenius Kabi|| 147538|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|8|plpok||B05BA03|01.01.1994||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1760|2520|lyfsjukr|||00|8000|0|Icepharma hf|Fresenius Kabi|| 147702|B05AA0501|Macrodex 60 mg/ml med glukos|irl|| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|7937|11364|lyfsjukr|||00|6000|0|Icepharma hf|Meda AB|6| 147728|B05AA0508|Rheomacrodex med glukos|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|12687|17663|lyfsjukr|||00|6000|0|Icepharma hf|Meda AB|6| 147926|J01GB0301|Garamycin|stl|40|mg/ml|2|ml|100|hgl||J01GB03|01.12.1975||R|A|5|0|0|0|1|SCP|0|0|0|100|DKK|23221|30778|lyfsjukr|||02|200|0|Vistor hf|Schering-Plough|33,3333| 148171|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|| |1000|ml|8|plpok||B05BB02|01.07.1995||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1281|1834|lyfsjukr|||02|8000|0|Icepharma hf|Fresenius Kabi|| 148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|K|2|0|0|0|0|ROA|0|0|1|100|DKK|76773|98633|lyfalmen|||00|750|0|Icepharma hf|Roche as|30| 148221|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|| |2000|ml|4|plpok||B05BB02|01.07.1995||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1456|2085|lyfsjukr|||02|8000|0|Icepharma hf|Fresenius Kabi|| 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|A|5|0|0|*|0|LFS|0|1|0|100|DKK|607|1324|lyfalmen|||00|100|0|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|20| 148650|G03AA0703|Neogynon|töflur|| |63|stk|1|þpakki||G03AA07|01.12.1974||R|A|5|0|0|0|0|SAG|0|0|0|100|SEK|623|1358|lyfalmen|||23|63|0|Icepharma hf|Schering AG|84| 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|A|3,25|0|0|0|0|BHC|1|0|0|100|DKK|2082|4108|vetalmen|||27|25|0|Vistor hf|Bayer HealthCare AG|| 150243|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|SEK|8884|13565|lyfalmen|||10|100|0|Icepharma hf|Sandoz GmbH|50| 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|A|4|0|0|*|0|LUN|0|1|0|100|DKK|4109|6907|lyfalmen|||02|10|0|Lundbeck Export A/S|Lundbeck|50| 151217|G01AF0102|Flagyl|sk-stil|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|646|1405|lyfalmen|||05|10|0|Vistor hf|Sanofi-aventis Norge AS|10| 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|937|2010|lyfalmen|||10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|25| 151944|N06AA1201|Sinquan|hylki|10|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|635|1383|lyfalmen|||10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|10| 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|401|574|lyfsjukr|||02|5|0|Vistor hf|Novartis Healthcare A/S-|0,45| 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PFI|0|0|1|100|DKK|||lyfalmen|||23|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|þpakki||J02AC02|01.01.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|1009|2160|lyfalmen|||10|4|0|Vistor hf|Janssen-Cilag AB|2| 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|A|3|0|0|0|1|GSC|0|0|0|100|DKK|212442|266358|lyfsjukr|||00|10|0|Swedish Orphan International AB|Gilead Science International (S) |14,2857| 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki||J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|3472|5979|lyfalmen|||10|15|0|Vistor hf|Janssen-Cilag AB|7,5| 153593|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|5|lykjur||B03BA03|01.12.1972||R|A|2|0|0|E|0|HEX|0|0|1|100|DKK|3923|6636|lyfalmen|||02|5|0|Vistor hf|Hexal A/S|250| 154484|G04CA0102|Xatral Uno|forðatfl|10|mg|30|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|3417|5899|lyfalmen|||00|30|0|Vistor hf|Sanofi-aventis Norge AS|40| 154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|773|1669|lyfalmen|||10|20|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|10| 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|3027|5331|lyfalmen|||10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|50| 154732|G04CA0102|Xatral Uno|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|7447|11617|lyfalmen|||00|90|0|Vistor hf|Sanofi-aventis Norge AS|120| 155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|K|3|0|0|*|0|GSK|0|0|0|100|GBP|857|1844|lyfalmen|||00|25|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LUN|0|1|0|100|DKK|983|2106|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|16,6667| 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LUN|0|1|0|100|DKK|299|684|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|5| 155580|J07AH0301|Meningovax A+C|bóluefni|| |0,5|ml|1|hgl||J07AH03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|1273|2668|lyfalmen|||02|0,5|0|Icepharma hf|Sanofi Pasteur MSD|| 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki||J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|6569|10392|lyfalmen|||00|28|0|Vistor hf|Janssen-Cilag AB|14| 155903|J05AF0101|Retrovir|mixtúra|10|mg/ml|200|ml|1|glas||J05AF01|01.07.1995||R|A|2|0|1|0|1|GSK|0|0|0|100|GBP|3908|5595|lyfsjukr|||63|200|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|3,3333| 156505|A08AB0101|Xenical|hylki|120|mg|42|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|3631|6210|lyfalmen|||00|42|0|Icepharma hf|Roche|14| 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|5311|8638|lyfalmen|V0133|8490|00|84|0|Icepharma hf|Roche|28| 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|A|5|0|0|0|0|JAS|0|0|0|100|SEK|212|503|lyfalmen|||00|6|0|Vistor hf|Janssen-Cilag AB|3| 157206|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|10|spr|.|QP52AF02|01.04.1992||R|A|1|0|0|0|0|PFI|0|0|0|100|DKK|4186|7244|vetorma|||16|260|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 157909|D07XC0101|Diprosalic|áburður|| |100|ml|1|glas||D07XC01|01.01.1987||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1933|3671|lyfalmen|||20|100|0|Vistor hf|Schering-Plough|100| 158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|þpakki||N03AF01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|578|1264|lyfalmen|||00|50|0|Vistor hf|Novartis Healthcare A/S-|10| 158337|R06AA0401|Tavegyl|töflur|1|mg|20|stk|1|þpakki||R06AA04|01.12.1972||R|A|5|0|0|E|0|NHE|0|0|1|100|DKK|364|819|lyfalmen|||00|20|0|Artasan ehf|Novartis Healthcare A/S-A|10| 158683|H01BB0201|Syntocinon|nefúði|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|K|4|0|0|E|0|NOH|0|0|0|100|DKK|643|1399|lyfalmen|||23|5|0|Vistor hf|Novartis Healthcare A/S-|13,3333| 159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LUN|0|1|0|30|DKK|3805|6464|lyfalmen|V0925|4151|00|56|0|Lundbeck Export A/S|Lundbeck|56| 159533|L02BG0601|Aromasin|töflur|25|mg|30|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PFI|0|0|0|100|DKK|14769|21438|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30| 159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LUN|0|1|0|30|DKK|9619|14545|lyfalmen|V0929|10903|00|56|0|Lundbeck Export A/S|Lundbeck|112| 159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LUN|0|1|0|30|DKK|1413|2881|lyfalmen|V0921|2171|00|28|0|Lundbeck Export A/S|Lundbeck|14| 159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LUN|0|1|0|30|DKK|1907|3631|lyfalmen|V0923|3254|00|28|0|Lundbeck Export A/S|Lundbeck|28| 159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LUN|0|1|0|30|DKK|4440|7389|lyfalmen|V0927|4380|00|28|0|Lundbeck Export A/S|Lundbeck|56| 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|97575|123348|lyfsjukr|||00|2|0|Icepharma hf|Roche|1| 159806|QG51BE0001|Streptoc. m/sulfadim., vet.|legstil|| |50|stk|50|stilar||QG51BE00|01.11.1979||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|5817|11252|vetalmen|||00|2500|0|Vistor hf|Boehringer Ingelheim Danmark|| 160051|C07AA0701|Sotacor|töflur|160|mg|100|stk|1|þpakki||C07AA07|01.05.1983||R|A|4|0|0|B|0|BRS|0|0|0|100|DKK|1232|2606|lyfalmen|V0274|2399|00|100|0|Vistor hf|Bristol-Myers Squibb|100| 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|A|3|0|0|0|1|AGT|0|0|0|100|DKK|1305|1868|lyfsjukr|||02|50|0|Actavis Group hf|Actavis Group hf|25| 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|547|1200|lyfalmen|||00|100|0|Vistor hf|Sanofi-aventis Norge AS|5| 160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|A|5|0|0|0|0|BRS|0|0|0|100|DKK|1360|2800|lyfalmen|||42|50|0|Vistor hf|Bristol-Myers Squibb|14,2857| 160945|N02AA5901|Panocod|freyðit|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|213|505|lyfalmen|||14|20|0|Vistor hf|Sanofi-aventis Norge AS|6,6667| 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|440|977|lyfalmen|||03|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|2| 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|1048|1500|lyfsjukr|||03|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|8,3333| 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|1766|2528|lyfsjukr|||03|5|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|16,6667| 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|403|900|lyfalmen|||03|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|3,3333| 161133|G03CA0306|Evorel|forðapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3188|5565|lyfalmen|||23|26|0|Vistor hf|Janssen-Cilag AB|136,5| 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PFI|0|0|0|100|DKK|47900|62686|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|100| 161802|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|USD|1486|2128|lyfsjukr|||00|2,5|0|Icepharma hf|Wyeth AB|0,8333| 161901|D11AC0301|Selsun|hársápa|25|mg/ml|120|ml|1|glas||D11AC03|01.12.1972||L|A|3|0|0|0|0|CHT|0|0|0|100|DKK|||lyflausa|||01|120|0|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|120| 162008|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|hgl||L01DB01|01.04.1990||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|1900|2720|lyfsjukr|||02|5|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 162016|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|USD|3119|4466|lyfsjukr|||00|5|0|Icepharma hf|Wyeth AB|1,6667| 162263|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|hgl||L01DB01|01.04.1990||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|3700|5297|lyfsjukr|||02|10|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 162305|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|USD|8119|11624|lyfsjukr|||00|17,5|0|Icepharma hf|Wyeth AB|5,8333| 162313|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|hgl||L01DB01|01.04.1990||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|6565|9399|lyfsjukr|||02|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|0|100|DKK|1360|2800|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|25| 162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|1501|3014|lyfalmen|||24|120|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|10| 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|A|2|1|0|0|0|NOH|0|0|0|100|DKK|685|1486|lyfalmen|V0953|1486|00|30|0|Vistor hf|Novartis Healthcare A/S-|10| 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|1074|2295|lyfalmen|||41|30|0|Vistor hf|Sanofi-aventis Norge AS|6| 163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2001|3774|lyfalmen|||24|120|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|25| 164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|1888|3602|lyfalmen|||00|25|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 164590|V03AB1401|Protaminsulfat Leo|stl|10|mg/ml|5|ml|1|hgl||V03AB14|01.12.1980||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|788|1128|lyfsjukr|||02|5|0|Vistor hf|LEO Pharma A/S|| 164871|A07EC0204|Asacol|eþ-stil|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|SCH|0|0|0|100|SEK|3982|6722|lyfalmen|V0299|6722|98|60|0|Icepharma hf|Schering Oy|20| 165001|C05AA0102|Proctosedyl|eþ-stil|| |12|stk|1|pakki||C05AA01|01.12.1972||L|K|1,5|0|0|0|0|SNO|0|0|0|100|NOK|||lyfalmen|||04|12|0|Vistor hf|Sanofi-aventis Norge AS|| 165449|C08CA0202|Plendil|forðatfl|10|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|3179|5552|lyfalmen|V0324|4978|43|98|0|Vistor hf|AstraZeneca A/S DK|196| 165548|C08CA0202|Plendil|forðatfl|5|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|2052|3851|lyfalmen|V0316|3469|43|98|0|Vistor hf|AstraZeneca A/S DK|98| 165589|QH02AB0602|Prednisolonacetat, vet."Intervet"|stl|10|mg/ml|50|ml|5|hgl||QH02AB06|01.12.1972||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|3958|7711|vetalmen|||58|250|0|Icepharma hf|Intervet International B.V.|| 165639|H01CA0201|Synarela|nefúði|200|mcg/sk|4|ml|1|stauk|30 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PFI|0|0|0|100|DKK|8299|12786|lyfalmen|||23|4|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|15| 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCB|0|0|1|100|SEK|561|1229|lyfalmen|||00|100|0|Vistor hf|U.C.B|50| 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCB|0|0|1|100|SEK|199|476|lyfalmen|||00|25|0|Vistor hf|U.C.B|12,5| 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972||L|A|5|0|0|0|0|UCB|0|0|1|100|SEK|||lyfalmen|||00|10|0|Vistor hf|U.C.B|5| 166033|R06AB0201|Polaramin|forðatfl|6|mg|100|stk|1|þpakki||R06AB02|01.06.1980||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|1425|2899|lyfalmen|||10|100|0|Vistor hf|Schering-Plough|100| 166090|N05AA0401|Plegicil|töflur|10|mg|10|stk|1|glas||N05AA04|01.03.2007||R|A|5|0|0|0|0|PSW|0|0|0|100|SEK|582|1272|lyfalmen|||00|10|0|Vistor hf|Pharmaxim Sweden AB|1| 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|1452|2940|lyfalmen|||00|100|0|Vistor hf|Sanofi-aventis Norge AS|38,7597| 166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PFI|0|0|0|100|DKK|14864|21556|lyfalmen|||23|8|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30| 166918|J02AA0102|Amphocil|irs|50|mg/hgl|1|hgl|1|pakki||J02AA01|01.04.1996||R|A|2|0|0|0|1|TRP|0|0|0|100|SEK|16451|22349|lyfsjukr|||00|1|0|Vitaflo Scandinavia AB|Three Rivers Pharmaceuticals Limited|1,4286| 167007|J02AA0102|Amphocil|irs|100|mg/hgl|1|hgl|1|pakki||J02AA01|01.04.1996||R|A|2|0|0|0|1|TRP|0|0|0|100|SEK|32902|42830|lyfsjukr|||00|1|0|Vitaflo Scandinavia AB|Three Rivers Pharmaceuticals Limited|2,8571| 168716|N03AF0105|Tegretol Retard|forðatfl|200|mg|50|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|660|1434|lyfalmen|||10|50|0|Vistor hf|Novartis Healthcare A/S-|10| 168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|2146|3994|lyfalmen|V0789|3976|10|200|0|Vistor hf|Novartis Healthcare A/S-|40| 168815|N03AF0105|Tegretol Retard|forðatfl|400|mg|30|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|690|1497|lyfalmen|||10|30|0|Vistor hf|Novartis Healthcare A/S-|12| 168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|4010|6762|lyfalmen|V0713|6591|10|200|0|Vistor hf|Novartis Healthcare A/S-|80| 168997|L01CA0401|Navelbine|irþ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|29638|38767|lyfsjukr|||00|10|0|Vistor hf|Pierre Fabre Pharma|| 169433|L01CA0401|Navelbine|irþ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|134611|169458|lyfsjukr|||00|50|0|Vistor hf|Pierre Fabre Pharma|| 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|A|3|0|0|0|1|ROA|0|0|0|30|DKK|13968|19258|lyfsjukr|||00|5|0|Icepharma hf|Roche as|5| 169664|J07BK0101|Varilrix|bóluefni|| |0,5|ml|1|hgl|þurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|K|2|0|0|0|0|GSK|0|0|0|100|SEK|3762|6401|lyfalmen|||02|0,5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 170092|J07BC2001|Twinrix Adult|bóluefni|| |1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|SEK|3353|5805|lyfalmen|||00|1|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|| 170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|2894|5130|lyfalmen|||59|100|0|Vistor hf|Abbott Scandinavia AB|50| 170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|5173|8446|lyfalmen|||59|100|0|Vistor hf|Abbott Scandinavia AB|100| 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|2877|5104|lyfalmen|V0709|5085|00|60|0|Vistor hf|Janssen-Cilag AB|5| 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4064|6841|lyfalmen|V0710|6841|00|60|0|Vistor hf|Janssen-Cilag AB|10| 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|29744|38899|lyfsjukr|||02|75|0|Icepharma hf|Bayer Schering Pharma AG|| 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|25551|33678|lyfsjukr|||02|50|0|Icepharma hf|Bayer Schering Pharma AG|| 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|8102|12524|lyfalmen|V0711|12147|00|60|0|Vistor hf|Janssen-Cilag AB|20| 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|14824|21506|lyfalmen|||00|60|0|Vistor hf|Janssen-Cilag AB|40| 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|44408|57155|lyfsjukr|||02|100|0|Icepharma hf|Bayer Schering Pharma AG|| 172619|L01AB0101|Myleran|töflur|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|A|3|0|0|*|0|GSK|0|0|0|100|GBP|1907|3631|lyfalmen|||00|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 172684|N02AA0303|Palladon|forðahlk|4|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|3825|6493|lyfalmen|||10|56|0|Icepharma hf|Norpharma |11,2| 172692|N02AA0303|Palladon|forðahlk|8|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|7301|11413|lyfalmen|||10|56|0|Icepharma hf|Norpharma |22,4| 172759|N02AA0303|Palladon|forðahlk|16|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|12144|18170|lyfalmen|||10|56|0|Icepharma hf|Norpharma |44,8| 172767|J07AJ5204|DiTeKik|bóluefni|| |0,5|ml|1|hgl||J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|1320|2739|lyfalmen|||51|0,5|0|Icepharma hf|Statens Serum Institut|| 172775|J07AJ5204|DiTeKik|bóluefni|| |0,5|ml|1|spr|einnota sprauta|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|1320|2739|lyfalmen|||51|0,5|0|Icepharma hf|Statens Serum Institut|| 172825|J07CA0203|DiTeKiPol|bóluefni|| |0,5|ml|1|spr|einnota sprauta|J07CA02|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|1880|3590|lyfalmen|||51|0,5|0|Icepharma hf|Statens Serum Institut|| 172874|D01AC0801|Fungoral|krem|20|mg/g|30|g|1|túpa||D01AC08|01.10.1989||R|A|5|0|0|0|0|JAS|0|0|1|100|SEK|551|1208|lyfalmen|||00|30|0|Vistor hf|Janssen-Cilag AB|30| 172916|N02AA0303|Palladon|forðahlk|24|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|13941|20407|lyfalmen|||10|56|0|Icepharma hf|Norpharma |67,2| 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.12.1972||R|A|5|0|0|0|0|VAL|0|0|1|100|DKK|451|1000|lyfalmen|V0901|981|00|50|0|Icepharma hf|Valeant Pharmaceuticals B.V.|50| 173344|A06AG1101|Microlax|innhl|| |5|ml|12|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|PFD|0|0|0|100|DKK|1112|2374|lyfalmen|||56|60|0|Vistor hf|Pfizer Denmark PCH ApS|12| 173856|N05CF0104|Zopiklon Merck NM|töflur|5|mg|30|stk|1|þpakki||N05CF01|01.10.2001||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|192|461|lyfalmen|||00|30|0|Merck NM|Merck NM AB|20| 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|793|1135|lyfsjukr|||02|20|0|Actavis Group hf|Actavis Group hf|10| 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|367|825|lyfalmen|||00|14|0|Vistor hf|AstraZeneca A/S DK|5,6| 174615|N05CF0104|Zopiklon Merck NM|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.09.1999||R|A|2|0|0|0|0|MNA|0|0|0|100|SEK|179|434|lyfalmen|V0886|360|00|30|0|Merck NM|Merck NM AB|30| 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|30|GBP|2071|3880|lyfalmen|V0507|3818|00|10|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|1,6667| 176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|A|2|0|0|*|0|ELD|0|1|0|100|IKR|4074|6856|lyfalmen|V0809|6618|00|28|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|7| 176792|N05AA0101|Largactil|töflur|100|mg|100|stk|1|þpakki||N05AA01|01.10.1995||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|1162|2478|lyfalmen|||10|100|0|Vistor hf|Sanofi-aventis Norge AS|33,3333| 177022|J01MA0101|Tarivid|töflur|200|mg|20|stk|1|þpakki||J01MA01|01.10.1988||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|2574|4644|lyfalmen|||00|20|0|Vistor hf|Sanofi-aventis Norge AS|10| 177253|N03AG0101|Depakine|sh-tfl|200|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|450|998|lyfalmen|||43|40|0|Vistor hf|Sanofi-aventis Norge AS|5,3333| 177311|QJ51RC2202|Nafpenzal vet.|spenalyf|| |3|g|4|spr||QJ51RC22|01.04.1985||R|A|2|0|0|0|0|INI|0|0|0|100|XEU|365|720|vetalmen|||16|12|0|Icepharma hf|Intervet International B.V.|| 177360|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SPL|0|0|1|100|DKK|422|940|lyfalmen|||03|1|0|Vistor hf|Schering-Plough Europe|4,67| 177741|D07CB0102|Kenalog Comp med Mycostatin|smyrsli|| |15|g|1|túpa||D07CB01|01.12.1972||R|A|4|0|0|B|0|BRS|0|0|1|100|DKK|274|632|lyfalmen|||00|15|0|Vistor hf|Bristol-Myers Squibb|15| 179044|B05BA0201|Intralipid 100 mg/ml|irl|100|mg/ml|500|ml|1|fl||B05BA02|01.06.1984||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|1323|1894|lyfsjukr|||00|500|0|Icepharma hf|Fresenius Kabi|0,5| 179267|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|12|hgl||M03AC09|01.01.1997||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|6066|8685|lyfsjukr|||00|60|0|Icepharma hf|N.V. Organon|| 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|A|5|0|0|B|0|UCB|0|0|0|100|DKK|3315|5750|lyfalmen|||10|100|0|Vistor hf|U.C.B|25| 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|| |5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|501|1104|lyfalmen|||30|5|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|A|3|0|0|0|0|BAS|0|0|0|100|DKK|||lyfalmen|||23|50|0|Vistor hf|Bayer A/S|5| 181552|QJ51DA3201|Pathozone, vet.|spenalyf|250|mg/dælu|10|ml|10|dælur|dæla + rýja|QJ51DA32|01.10.1995||R|A|1,5|0|0|0|0|PFV|0|0|0|100|DKK|4292|8347|vetalmen|||16|100|0|Icepharma hf|Pfizer vet.|| 181750|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|16433|22327|lyfsjukr|||00|10|0|Icepharma hf|Wyeth AB|| 181990|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|50|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|22397|29752|lyfsjukr|||00|50|0|Icepharma hf|Wyeth AB|| 182170|QM01AG9001|Finadyne, vet.|kyrni|25|mg/g|10|g|10|skammt||QM01AG90|01.01.1991||R|A|2|0|0|0|0|SPA|0|0|0|100|DKK|2888|5672|vetalmen|||16|100|0|Vistor hf|Schering-Plough A/S|| 183293|D08AG0201|Betadine|smyrsli|100|mg/g|40|g|1|túpa||D08AG02|01.07.1988||L|A|3|0|0|0|0|NAP|0|0|0|100|CHF|||lyflausa|||00|40|0|Icepharma hf|Napp|40| 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|A|2|0|0|0|0|SPA|1|0|0|100|DKK|3192|6251|vetalmen|||27|50|0|Vistor hf|Schering-Plough A/S|| 183749|N05AF0101|Fluanxol|töflur|1|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|3|0|0|*|0|LUN|0|1|0|100|DKK|956|2050|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|16,6667| 183772|N05AF0101|Fluanxol|töflur|0,5|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|3|0|0|*|0|LUN|0|1|0|100|DKK|763|1649|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|8,3333| 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|K|2|0|0|B|0|BRS|0|0|0|100|DKK|685|1486|lyfalmen|||00|100|0|Vistor hf|Bristol-Myers Squibb|100| 183947|P01AB0102|Flagyl|töflur|200|mg|21|stk|1|þpakki||P01AB01|01.10.1995||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|527|1158|lyfalmen|||41|21|0|Vistor hf|Sanofi-aventis Norge AS|2,1| 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|A|3|0|0|B|0|SCH|0|0|0|100|SEK|2837|5044|lyfalmen|||98|700|0|Icepharma hf|Schering Oy|4,6667| 184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|13434|19776|lyfalmen|||00|30|0|Vistor hf|Novartis Healthcare A/S-|30| 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|36275|48213|lyfalmen|V0563|47310|00|100|0|Vistor hf|Novartis Healthcare A/S-|100| 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|1690|3301|lyfalmen|||00|250|0|Vistor hf|Desitin Artzneimittel|10| 188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|A|4|0|0|*|0|GPL|0|0|0|100|XEU|1154|2462|lyfalmen|||00|100|0|Icepharma hf|Goldshield Pharmaceuticals Ltd|33,3333| 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|A|4|0|0|0|1|NOV|0|0|0|100|DKK|5998|8588|lyfsjukr|||00|10|0|Icepharma hf|Novartis Healthcare A/S|| 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1750|3393|lyfalmen|||03|5|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|10| 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|749|1620|lyfalmen|||03|2|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|4| 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|392|877|lyfalmen|||03|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|2| 190702|M01AB0101|Confortid|eþ-stil|100|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|465|1029|lyfalmen|||04|10|0|Actavis Group hf|Actavis Group hf|10| 190728|M01AB0101|Confortid|eþ-stil|50|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|252|586|lyfalmen|||04|10|0|Actavis Group hf|Actavis Group hf|5| 190751|M01AB0101|Confortid|hylki|25|mg|100|stk|1|glas||M01AB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|1021|2185|lyfalmen|||10|100|0|Actavis Group hf|Actavis Group hf|25| 191064|B05XC03|Vitalipid Infant|irþ|| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|2646|3788|lyfsjukr|||00|100|0|Icepharma hf|Fresenius Kabi|0,1| 191247|B05XC02|Vitalipid Adult|irþ|| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|2699|3864|lyfsjukr|||00|100|0|Icepharma hf|Fresenius Kabi|0,1| 191254|B05XC01|Soluvit|irs|| |10|ml|10|hgl||B05XC|01.10.1985||R|K||0|0|0|1|FRP|0|0|0|100|DKK|3302|4728|lyfsjukr|||00|100|0|Icepharma hf|Fresenius Kabi|0,1| 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|286|657|lyfalmen|||07|4|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|| |100|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|942|2021|lyfalmen|||10|100|0|Vistor hf|LEO Pharma A/S|100| 192625|C03AB0101|Centyl med kaliumklorid|sh-tfl|| |25|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|258|599|lyfalmen|||10|25|0|Vistor hf|LEO Pharma A/S|25| 193573|R06AB0201|Polaramin|forðatfl|6|mg|25|stk|1|þpakki||R06AB02|01.10.1991||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|388|869|lyfalmen|||10|25|0|Vistor hf|Schering-Plough|25| 193862|A12AA0201|Calcium Sandoz|stl|100|mg/ml|10|ml|5|lykjur||A12AA02|01.12.1972||R|A|5|0|0|0|0|NHE|0|0|0|100|DKK|649|1412|lyfalmen|||02|50|0|Artasan ehf|Novartis Healthcare A/S-A|2,5091| 194209|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|2|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|646|925|lyfsjukr|||02|2|0|Icepharma hf|Wyeth AB|| 194258|A03BB0101|Buscopan|töflur|10|mg|100|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|1185|2526|lyfalmen|||00|100|0|Vistor hf|Boehringer Ingelheim|16,6667| 194266|A03BB0101|Buscopan|töflur|10|mg|20|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|285|655|lyfalmen|||00|20|0|Vistor hf|Boehringer Ingelheim|3,3333| 194472|L01CD0101|Taxol|irþ|6|mg/ml|16,7|ml|1|hgl||L01CD01|01.04.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|45871|58977|lyfsjukr|||00|16,7|0|Vistor hf|Bristol-Myers Squibb|| 194795|M05BA0301|Aredia|irs|90|mg/hgl|1|hgl|1|pakki|+ 10 ml leysir|M05BA03|01.03.1998||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|24949|32929|lyfsjukr|||00|1|0|Vistor hf|Novartis Healthcare A/S-|1,5| 194977|J01MA0202|Ciproxin|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1988||R|A|5|0|0|0|0|BHC|0|0|1|100|DKK|1159|2472|lyfalmen|V0514|1358|00|10|0|Vistor hf|Bayer HealthCare AG|2,5| 194985|J01MA0202|Ciproxin|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1988||R|A|5|0|0|0|0|BHC|0|0|1|100|DKK|2514|4553|lyfalmen|V0518|2366|00|20|0|Vistor hf|Bayer HealthCare AG|5| 195032|J01MA0202|Ciproxin|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.01.1991||R|A|5|0|0|0|0|BHC|0|0|1|100|DKK|2463|4476|lyfalmen|V0522|2571|00|10|0|Vistor hf|Bayer HealthCare AG|5| 195065|J01MA0202|Ciproxin|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1991||R|A|5|0|0|0|0|BHC|0|0|1|100|DKK|4775|7877|lyfalmen|V0526|4091|00|20|0|Vistor hf|Bayer HealthCare AG|10| 195149|B03BA0201|Betolvex |stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.11.1981||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|1819|3497|lyfalmen|||03|5|0|Actavis Group hf|Actavis Group hf|250| 195156|B03BA0201|Betolvex |stl|1|mg/ml|1|ml|1|lykja||B03BA02|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|453|1004|lyfalmen|||03|1|0|Actavis Group hf|Actavis Group hf|50| 195354|A07DA0301|Imodium|töflur|2|mg|40|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|JAS|0|0|0|100|SEK|566|1239|lyfalmen|||10|40|0|Vistor hf|Janssen-Cilag AB|8| 195610|G03AC0801|Implanon|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2001||R|A|5|0|0|0|0|ORG|0|0|0|100|DKK|12501|18614|lyfalmen|||00|1|0|Icepharma hf|N.V. Organon|1014,9254| 195669|D01AC2002|Pevisone|krem|| |15|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|295|676|lyfalmen|||20|15|0|Vistor hf|Janssen-Cilag AB|15| 195768|R01BA0101|Rinexin|forðatfl|50|mg|30|stk|1|þpakki||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|210|499|lyfalmen|||10|30|0|Vistor hf|Recip AB|15| 195776|R01BA0101|Rinexin|forðatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|498|1098|lyfalmen|||10|100|0|Vistor hf|Recip AB|50| 196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|þp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|794|1713|lyfalmen|||23|63|0|Icepharma hf|Bayer Schering Pharma AG|84| 196543|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|A|3|0|0|0|0|UCB|0|0|1|100|SEK|809|1744|lyfalmen|||00|200|0|Vistor hf|U.C.B|5,3333| 197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|1473|2907|vetalmen|||27|10|0|Icepharma hf|Intervet International B.V.|| 197111|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|5|hgl||QH01CA90|01.07.1986||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|7013|13530|vetalmen|||27|50|0|Icepharma hf|Intervet International B.V.|| 197343|D11AX0101|Regaine|húðlausn|20|mg/ml|60|ml|1|glas||D11AX01|01.10.1988||L|A|4|0|0|0|0|PFD|0|0|0|100|DKK|2143|3990|lyfalmen|||00|60|0|Vistor hf|Pfizer Denmark PCH ApS|60| 197400|S01GA5101|Antistina-Privin|augndr|5,25|mg/ml|10|ml|1|glas|5+0,25 mg|S01GA51|01.03.1981||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|438|973|lyfalmen|||06|10|0|Vistor hf|Novartis Healthcare A/S-|| 197533|N03AX0901|Lamictal|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.01.1996||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|4612|7639|lyfalmen|V0705|7639|00|56|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|18,6667| 197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|490|1081|lyfalmen|||00|20|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|20| 197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|2323|4263|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|100| 198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001||R|K|2|0|1|*|0|GSK|0|0|0|100|GBP|1152|2457|lyfalmen|||00|25|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|5849|8374|lyfsjukr|||02|200|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 198861|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|lykjur||N04AA02|01.12.1975||R|A|5|0|0|0|1|LFS|0|1|0|100|DKK|240|344|lyfsjukr|||02|5|0|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|2,5| 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|21351|29632|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|A|4|0|0|0|0|PFI|0|0|1|100|DKK|508|1118|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30| 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|4415|7352|lyfalmen|||44|8|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|4| 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|329|471|lyfsjukr|||02|1|0|Icepharma hf|Roche|0,5| 370353|V08AB0501|Ultravist|stl/irl|300|mg J/ml|20|ml|10|hgl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|11494|16178|lyfsjukr|||02|200|0|Icepharma hf|Bayer Schering Pharma AG|| 372037|N05AL0501|Solian|töflur|50|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|1763|3412|lyfalmen|||00|30|0|Vistor hf|Sanofi-aventis Norge AS|3,75| 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|4942|8120|lyfalmen|||00|90|0|Vistor hf|Sanofi-aventis Norge AS|11,25| 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2369|4333|lyfalmen|||00|100|0|Icepharma hf|Roche|16,6667| 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||00|42|0|Vistor hf|Pfizer Denmark PCH ApS|7| 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||00|18|0|Vistor hf|Pfizer Denmark PCH ApS|3| 372615|M05BA0401|Fosamax|töflur|10|mg|98|stk|1|þpakki||M05BA04|01.01.1996||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|10604|15857|lyfalmen|||00|98|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|98| 372714|N05AL0501|Solian|töflur|200|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|5893|9450|lyfalmen|||00|30|0|Vistor hf|Sanofi-aventis Norge AS|15| 372722|B02BD0801|NovoSeven|sts|1,2|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|79333|100637|lyfsjukr|||00|1|0|Vistor hf|Novo-Nordisk|| 372730|B02BD0801|NovoSeven|sts|2,4|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|158409|199087|lyfsjukr|||00|1|0|Vistor hf|Novo-Nordisk|| 372748|B02BD0801|NovoSeven|sts|4,8|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|316463|395864|lyfsjukr|||00|1|0|Vistor hf|Novo-Nordisk|| 373001|G03AB0501|Gracial|töflur|| |66|stk|1|pakki|þp 3 x (15+7 stk)|G03AB05|01.07.1998||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1436|2916|lyfalmen|||23|66|0|Icepharma hf|N.V. Organon|88| 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|15627|22506|lyfalmen|||00|90|0|Vistor hf|Sanofi-aventis Norge AS|45| 373324|R03AK0602|Seretide Diskus|innúðadu|150|mcg/sk|60|sk|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|3000|5291|lyfalmen|||23|60|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30| 373340|R03AK0602|Seretide Diskus|innúðadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|3892|6591|lyfalmen|V0992|6477|23|60|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30| 373365|R03AK0602|Seretide Diskus|innúðadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|5262|8570|lyfalmen|V0993|8423|23|60|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30| 373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|1676|3280|lyfalmen|||44|2|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|1| 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|A|5|0|0|*|0|MCK|0|0|0|100|XEU|451|1000|lyfalmen|||00|100|0|Icepharma hf|Merck Santé s.a.s.|25| 374348|G04CA0201|Omnic|forðahlk|0,4|mg|30|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|2925|5177|lyfalmen|||00|30|0|Vistor hf|Yamanouchi Europe|30| 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|A|2|0|0|E|0|GSK|0|0|1|30|GBP|7669|11926|lyfalmen|||00|60|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|5| 374520|L02BB0301|Casodex|töflur|50|mg|30|stk|1|þpakki||L02BB03|01.04.1997||R|A|5|0|0|*|0|ASZ|0|0|0|100|IKR|14114|20622|lyfalmen|V0560|16551|00|30|0|Vistor hf|AstraZeneca UK Ltd|30| 374579|R01AC0101|Lomudal Nasal|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.10.1992||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1591|3151|lyfalmen|||23|15|0|Vistor hf|Sanofi-aventis Norge AS|15| 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|4569|7577|lyfalmen|||00|6|0|Vistor hf|Sanofi-aventis Norge AS|30| 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|5143|8404|lyfalmen|||00|8|0|Vistor hf|Sanofi-aventis Norge AS|40| 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|6927|10892|lyfalmen|||00|10|0|Vistor hf|Sanofi-aventis Norge AS|50| 377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|2653|4764|lyfalmen|||63|14|0|Vistor hf|Abbott Scandinavia AB|14| 377259|J01FA0901|Klacid|töflur|500|mg|100|stk|1|glas||J01FA09|01.04.1992||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|21050|29258|lyfalmen|||63|100|0|Vistor hf|Abbott Scandinavia AB|100| 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|30|GBP|8647|13250|lyfalmen|V0508|13021|00|42|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|7| 379669|H01CB0202|Sandostatin Lar|sts|5|mg/ml|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|90348|114351|lyfsjukr|||00|2|0|Vistor hf|Novartis Healthcare A/S-|14,29| 379677|H01CB0202|Sandostatin Lar|sts|10|mg/ml|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|106980|135058|lyfsjukr|||00|2|0|Vistor hf|Novartis Healthcare A/S-|28,57| 379685|H01CB0202|Sandostatin Lar|sts|15|mg/ml|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|126577|159456|lyfsjukr|||00|2|0|Vistor hf|Novartis Healthcare A/S-|42,86| 379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|865|1861|lyfalmen|||00|12,5|0|Actavis Group hf|Actavis Group hf|2,5| 379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1070|2287|lyfalmen|||00|12,5|0|Actavis Group hf|Actavis Group hf|5| 379925|L01CD0201|Taxotere|irs|40|mg/ml|0,5|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|1,5|0|1|0|1|AVS|0|0|0|100|NOK|16722|22686|lyfsjukr|||00|0,5|0|Vistor hf|Aventis Pharma SA|| 379933|L01CD0201|Taxotere|irs|40|mg/ml|2|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|2|0|1|0|1|AVS|0|0|0|100|NOK|67041|85334|lyfsjukr|||00|2|0|Vistor hf|Aventis Pharma SA|| 382531|C10AA0101|Zocor|töflur|40|mg|98|stk|1|þpakki||C10AA01|01.07.1995||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|8610|13200|lyfalmen|V0367|6120|00|98|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|261,3333| 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||L|A|5|0|0|0|0|BHC|0|0|0|100|DKK|567|981|vetorma|||00|2|0|Vistor hf|Bayer HealthCare AG|| 383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||R|A|5|0|0|0|0|BHC|0|0|0|100|DKK|4309|7457|vetorma|||00|20|0|Vistor hf|Bayer HealthCare AG|| 387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|A|3|0|0|0|0|ICE|0|0|0|100|XEU|420|829|vetalmen|||00|100|0|Icepharma hf|Icepharma hf|| 387746|J02AA0101|Abelcet|irþ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|K|2|0|0|0|1|ZPL|0|0|0|100|DKK|128626|162007|lyfsjukr|||00|200|0|Zeneus Pharma Limited|Zeneus Pharma Limited|28,5714| 388439|M05BB0101|Didronate/Calcium Procter & Gamble|töflur|400|mg|90|stk|1|pakki|þp (14 + 76 stk)|M05BB01|01.06.1998||R|A|3|0|0|E|0|PGA|0|0|0|100|DKK|6008|9610|lyfalmen|||00|90|0|Sofus Consulting AB|Procter & Gamble-|90| 389106|G03FA0103|Femanor|töflur|| |84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|1364|2806|lyfalmen|V0388|2806|23|84|0|Vistor hf|BioPhausia AB|84| 389122|G03FB0503|Femasekvens|töflur|| |84|stk|1|pakki|þp samsett pk. |G03FB05|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|1245|2626|lyfalmen|||23|84|0|Vistor hf|BioPhausia AB|84| 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|515|1133|lyfalmen|V0408|1133|00|84|0|Vistor hf|BioPhausia AB|84| 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|366|823|lyfalmen|||00|84|0|Vistor hf|BioPhausia AB|42| 389361|V08AB0501|Ultravist|stl/irl|300|mg J/ml|500|ml|8|fl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|201348|252546|lyfsjukr|||02|4000|0|Icepharma hf|Bayer Schering Pharma AG|| 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|557|1220|lyfalmen|||00|3|0|Vistor hf|Novartis Healthcare A/S-|| 389577|A04AA0201|Kytril|töflur|2|mg|5|stk|1|þpakki||A04AA02|01.10.1994||R|A|3|0|0|0|1|ROA|0|0|0|100|DKK|7612|10898|lyfsjukr|||00|5|0|Icepharma hf|Roche as|5| 390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|K|1|0|0|E|0|BRS|0|0|1|100|DKK|1943|3686|lyfalmen|||01|100|0|Vistor hf|Bristol-Myers Squibb|6,6667| 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|4411|7347|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|50| 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1726|3356|lyfalmen|||00|20|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|20| 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|8112|12537|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|100| 393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dælu|1|stk|24|spr||QJ51CF02|01.09.1983||R|S|4|0|0|0|0|PFV|0|0|0|100|XEU|2966|5821|vetalmen|||16|24|0|Icepharma hf|Pfizer vet.|| 395715|D10AD0301|Differin|hlaup|0,1|%|30|g|1|túpa||D10AD03|01.07.2001||R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|609|1328|lyfalmen|||00|30|0|Icepharma hf|Galderma Nordic AB|30| 395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|130107|163851|lyfsjukr|||02|300|0|Icepharma hf|Bayer Schering Pharma AG|| 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|6175|8841|lyfsjukr|||00|60|0|Icepharma hf|Roche|| 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|35798|46436|lyfsjukr|||00|120|0|Icepharma hf|Roche|| 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|6223|9910|lyfalmen|||02|3|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30| 399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|A|3|0|0|0|0|NHE|0|0|1|100|DKK|||lyfalmen|||00|2|0|Artasan ehf|Novartis Healthcare A/S-A|2| 400044|S03CA0102|Sofradex|aug.eydr|| |8|ml|1|glas||S03CA01|01.03.1980||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|998|2137|lyfalmen|||06|8|0|Vistor hf|Sanofi-aventis Norge AS|| 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|3290|5714|lyfalmen|||10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|25| 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|208|495|lyfalmen|||00|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|12,5| 400275|N05BA0402|Sobril|töflur|15|mg|250|stk|1|glas||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|1325|2747|lyfalmen|||00|250|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|75| 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|339|767|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30| 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|148|370|lyfalmen|||00|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|7,5| 400804|N07BA0103|Nicorette|forðapl|15|mg/16kls|7|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||23|7|0|Vistor hf|Pfizer Denmark PCH ApS|7,5| 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LUN|0|1|0|100|DKK|436|969|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|13,3333| 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LUN|0|1|0|100|DKK|698|1513|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|33,3333| 402651|J07BB0205|Influvac|bóluefni|| |0,5|ml|1|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOP|0|0|0|100|XEU|376|844|lyfalmen|||51|0,5|0|Icepharma hf|Solvay Pharmaceuticals|| 402743|QJ01RA0102|Streptocillin, vet.|stl|| |100|ml|1|hgl||QJ01RA01|01.11.1979||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|931|1837|vetalmen|||58|100|0|Vistor hf|Boehringer Ingelheim Danmark|| 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|A|2|0|0|0|0|SPA|1|0|0|100|DKK|3036|5954|vetalmen|||27|20|0|Vistor hf|Schering-Plough A/S|| 403550|C08CA0302|Lomir Retard|forðahlk|2,5|mg|100|stk|1|þpakki||C08CA03|01.10.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|4026|6786|lyfalmen|||10|100|0|Vistor hf|Novartis Healthcare A/S-|50| 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|784|1692|lyfalmen|||06|13,5|0|Vistor hf|Sanofi-aventis Norge AS|| 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|A|2,5|0|0|E|0|SAO|0|0|0|100|XEU|369|829|lyfalmen|||00|10|0|Icepharma hf|Santen Oy|| 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|A|3|0|0|0|1|BOI|0|0|0|100|DKK|56955|72776|lyfsjukr|||02|1|0|Vistor hf|Boehringer Ingelheim|0,5| 404640|A07AA0904|Vancomycin Alpharma|hylki|125|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996||R|A|2|0|0|E|0|ALP|0|0|1|100|DKK|11702|17319|lyfalmen|V0125|14049|00|28|0|Actavis Group hf|Alpharma ApS|1,75| 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|360|515|lyfsjukr|||02|5|0|Icepharma hf|Roche|2,5| 405001|J01FA0101|Abboticin|sts/irs|1|g|1|stk|1|hgl||J01FA01|01.11.1981||R|A|4|0|0|0|1|ABS|0|0|0|100|DKK|857|1227|lyfsjukr|||03|1|0|Vistor hf|Abbott Scandinavia AB|1| 405589|J07BD5203|Priorix|bóluefni|| |0,5|ml|1|hgl|+ einnota dæla|J07BD52|01.03.1999||R|K|2|0|0|0|0|GSK|0|0|0|100|SEK|1202|2560|lyfalmen|||00|0,5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 405597|J07BD5203|Priorix|bóluefni|| |0,5|ml|10|hgl||J07BD52|01.11.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|SEK|14824|21506|lyfalmen|||00|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LUN|0|1|0|100|DKK|11860|17530|lyfalmen|||00|28|0|Lundbeck Export A/S|Lundbeck|21| 406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LUN|0|1|0|100|DKK|11860|17530|lyfalmen|||00|28|0|Lundbeck Export A/S|Lundbeck|28| 406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LUN|0|1|0|100|DKK|11860|17530|lyfalmen|||00|28|0|Lundbeck Export A/S|Lundbeck|35| 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LUN|0|1|0|100|DKK|11979|17688|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|25| 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LUN|0|1|0|100|DKK|36113|48011|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|75| 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LUN|0|1|0|100|DKK|39169|51816|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|100| 406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LUN|0|1|0|100|DKK|42224|55619|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|125| 406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LUN|0|1|0|100|DKK|4003|6752|lyfalmen|||00|30|0|Lundbeck Export A/S|Lundbeck|7,5| 406751|M01AB0101|Confortid|hylki|25|mg|30|stk|1|þpakki||M01AB01|01.05.1974||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|329|746|lyfalmen|||10|30|0|Actavis Group hf|Actavis Group hf|7,5| 407395|N02CA7201|Anervan|töflur|160,5|mg|100|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|1241|2620|lyfalmen|||00|100|0|Vistor hf|Recip AB|50| 407403|A01AB0402|Fungizone|sogtfl|10|mg|60|stk|1|þpakki||A01AB04|01.04.1993||R|A|1,5|0|0|E|0|BRS|0|0|1|100|DKK|624|1360|lyfalmen|||00|60|0|Vistor hf|Bristol-Myers Squibb|15| 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PFI|0|0|1|100|DKK|140|353|lyfalmen|||00|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|5| 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PFI|0|0|0|100|DKK|395|884|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|20| 408724|D07AC0104|Diproderm|smyrsli|0,5|mg/g|20|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|610|1331|lyfalmen|||20|20|0|Vistor hf|Schering-Plough|20| 408732|D07AC0104|Diproderm|smyrsli|0,5|mg/g|50|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1528|3055|lyfalmen|||20|50|0|Vistor hf|Schering-Plough|50| 408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|2878|5106|lyfalmen|||20|100|0|Vistor hf|Schering-Plough|100| 408757|D07AC0104|Diproderm|áburður|0,5|mg/ml|20|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|610|1331|lyfalmen|||20|20|0|Vistor hf|Schering-Plough|20| 408765|D07AC0104|Diproderm|áburður|0,5|mg/ml|50|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1409|2875|lyfalmen|||20|50|0|Vistor hf|Schering-Plough|50| 408773|D07AC0104|Diproderm|áburður|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1668|3268|lyfalmen|||20|100|0|Vistor hf|Schering-Plough|100| 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|3081|5409|lyfalmen|||08|35|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|1,75| 409193|N02BE0101|Panodil|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.07.1975||L|A|5|0|0|0|0|GCH|0|0|1|100|DKK|||lyfalmen|||00|20|0|Icepharma hf|GlaxoSmithKline CH A/S|3,3333| 409532|QN05AA0402|Plegicil vet.|stl|10|mg/ml|20|ml|6|hgl||QN05AA04|01.11.2007||R|A|3|0|0|0|0|PSW|1|0|0|100|DKK|6089|11770|vetalmen|||27|120|0|Vistor hf|Pharmaxim Sweden AB|| 409631|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|glas||C07AB03|01.04.1987||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|575|1258|lyfalmen|V0290|1129|00|100|0|Actavis Group hf|Actavis hf|33,3333| 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|þpakki||P01BA01|01.08.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|721|1561|lyfalmen|||00|20|0|Vistor hf|Recip AB|10| 410712|D10AD0102|Aberela|krem|0,05|%|30|g|1|túpa||D10AD01|01.10.2007||R|A|2|0|0|0|0|JAS|0|0|0|100|SEK|422|940|lyfalmen|||23|30|0|Vistor hf|Janssen-Cilag AB|30| 411033|M03BX0102|Baklofen NM Pharma|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|A|3|0|0|E|0|MNA|0|0|1|100|SEK|369|829|lyfalmen|||00|50|0|Merck NM|Merck NM AB|10| 411157|M03BX0102|Baklofen NM Pharma|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|A|3|0|0|E|0|MNA|0|0|1|100|SEK|1042|2229|lyfalmen|V0712|2229|00|50|0|Merck NM|Merck NM AB|25| 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|4207|6023|lyfsjukr|||02|50|0|Icepharma hf|Roche|16,6667| 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|16918|22930|lyfsjukr|||00|60|0|GlaxoSmithKline ehf|Glaxo Group Limited|30| 411918|N02CC0101|Imigran|nefúði|20|mg/sk|6|sk|1|pakki||N02CC01|01.07.2000||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|5292|8612|lyfalmen|||98|6|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|6| 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|2031|2908|lyfsjukr|||00|3|0|Vistor hf|Sanofi-aventis Norge AS|15| 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|1|0|0|100|DKK|5757|11137|vetalmen|||02|100|0|Vistor hf|Merial|| 412825|L02BA0106|Tamoxifen NM Pharma|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|1225|2595|lyfalmen|||00|100|0|Merck NM|Merck NM AB|50| 412833|L02BA0106|Tamoxifen NM Pharma|töflur|20|mg|30|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|782|1688|lyfalmen|||00|30|0|Merck NM|Merck NM AB|30| 413245|J06BA0205|Sandoglobulin|irs|12|g/fl|12|g|1|sett|leys+áhöld|J06BA02|01.04.1993||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|68780|87499|lyfsjukr|||00|12|0|Icepharma hf|CSL Denmark ApS|| 413252|N05BE0106|Buspiron Actavis|töflur|10|mg|100|stk|1|glas||N05BE01|01.04.1995||R|A|5|0|0|E|0|ACA|0|0|1|100|DKK|4769|7868|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|33,3333| 413369|S01AX1201|Noroxin|augndr|3|mg/ml|5|ml|1|glas||S01AX12|01.04.1992||R|A|3|0|0|E|0|LBO|0|0|1|100|XEU|373|838|lyfalmen|||06|5|0|Laboratories THEA|Laboratories THEA|| 413856|M05BA0301|Aredia|irs|15|mg/hgl|4|hgl|1|pakki|+ 4 x 5 ml leysir|M05BA03|01.04.1998||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|18942|25450|lyfsjukr|||00|4|0|Vistor hf|Novartis Healthcare A/S-|1| 413864|M05BA0301|Aredia|irs|30|mg/hgl|2|hgl|1|pakki|+ 2 x 10 ml leysir|M05BA03|01.04.1998||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|18942|25450|lyfsjukr|||00|2|0|Vistor hf|Novartis Healthcare A/S-|1| 413898|N05BE0104|Buspirone OF|töflur|5|mg|100|stk|1|glas||N05BE01|01.04.1995||R|A|5|0|0|E|0|ACA|0|0|1|100|DKK|3324|5763|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|16,6667| 414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|2612|4702|lyfalmen|||00|90|0|Icepharma hf|Servier|54| 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|834|1796|lyfalmen|||00|300|0|Vistor hf|Novartis Healthcare A/S-|6| 415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki|+stjaka|G03CA03|01.01.1995||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|1177|2509|lyfalmen|V0418|2418|05|15|0|Vistor hf|Novo-Nordisk|15| 415687|V08BA0101|E-Z-HD|mixtduft|| |12|0z|24|stk|plastdósir|V08BA01|01.01.1988||R|A|4|0|0|0|1|EZE|0|0|0|100|USD|8759|12541|lyfsjukr|||08|288|0|Icepharma hf|E-Z-Em|| 415711|V08BA0102|Polibar ACB|innhl|933|mg/g|16|0z|24|stk|plastpokar|V08BA01|01.01.1988||R|A|2|0|0|0|1|EZE|0|0|0|100|USD|24624|32524|lyfsjukr|||00|384|0|Icepharma hf|E-Z-Em|| 415737|V08BA0102|Polibar ACB|innhl|933|mg/g|20|0z|24|stk|plastpokar|V08BA01|01.01.1988||R|A|2|0|0|0|1|EZE|0|0|0|100|USD|30780|40189|lyfsjukr|||00|480|0|Icepharma hf|E-Z-Em|| 416222|C09DA0101|Cozaar Comp|töflur|62,5|mg|28|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|2132|3973|lyfalmen|||00|28|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|28| 416446|C09DA0101|Cozaar Comp|töflur|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|6420|10185|lyfalmen|V0198|10006|00|98|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|98| 416859|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|1665|3264|lyfalmen|||23|10|0|Icepharma hf|Colgate Palmolive A/S|| 416867|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|30|ml|5|túpa||A01AA01|01.10.1988||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|14000|20480|lyfalmen|||23|150|0|Icepharma hf|Colgate Palmolive A/S|| 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|A|5|0|0|0|0|IGB|0|0|0|100|SEK|669|1453|lyfalmen|||00|30|0|Icepharma hf|Intendis GmbH Berlin|30| 417238|QM01AE0301|Romefen, vet.|töflur|10|mg|10|stk|1|þpakki||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|0|0|0|100|XEU|305|602|vetalmen|||00|10|0|Vistor hf|Merial|| 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|27690|36342|lyfsjukr|||00|60|0|GlaxoSmithKline ehf|Glaxo Group Limited|30| 418483|A07EC0201|Mesasal|sh-tfl|250|mg|100|stk|1|þpakki||A07EC02|01.10.1991||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|2737|4892|lyfalmen|||10|100|0|Vistor hf|Sanofi-aventis Norge AS|16,6667| 418665|D07XC0101|Diprosalic|smyrsli|| |50|g|1|túpa||D07XC01|01.11.1979||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|1019|2181|lyfalmen|||20|50|0|Vistor hf|Schering-Plough|50| 418731|A07EC0201|Mesasal|eþ-stil|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|A|4|0|0|B|0|SNO|0|0|0|100|NOK|5419|8789|lyfalmen|V0299|6722|00|60|0|Vistor hf|Sanofi-aventis Norge AS|20| 418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|1140|2250|vetalmen|||13|200|0|Vistor hf|Boehringer Ingelheim Danmark|| 418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dæla|QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|1454|2869|vetalmen|||13|200|0|Vistor hf|Boehringer Ingelheim Danmark|| 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|2348|4301|lyfalmen|||10|100|0|Vistor hf|LEO Pharma A/S|25| 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|5546|8966|lyfalmen|||10|100|0|Vistor hf|LEO Pharma A/S|100| 419440|L01DB0103|Caelyx|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.05.1999||R|K|1,6|0|1|0|1|SCP|0|0|0|100|DKK|45279|58240|lyfsjukr|||00|10|0|Vistor hf|Schering-Plough|| 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|A|3|0|1|0|1|MSD|0|0|0|100|XEU|31908|41593|lyfsjukr|||00|180|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|30| 419945|D07AD0101|Dermovat|áburður|0,5|mg/ml|25|ml|1|glas|í hársvörð|D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|560|1227|lyfalmen|||20|25|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|25| 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|6935|10903|lyfalmen|||02|10|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|40| 420356|B01AB0401|Fragmin|stl|2500|ae/ml|4|ml|10|hgl||B01AB04|01.04.1993||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|6947|9946|lyfsjukr|||00|40|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|40| 420471|B01AB0401|Fragmin|stl|12500|ae/ml|0,2|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|3103|5441|lyfalmen|||02|2|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|10| 420497|B01AB0401|Fragmin|stl|25000|ae/ml|0,2|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|4386|7310|lyfalmen|||02|2|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|20| 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|1471|2969|lyfalmen|V0144|2925|70|30|0|Vistor hf|Sanofi-aventis Norge AS|15| 422402|G03FB0505|Estracomb|forðapl|| |8|stk|1|pakki|samsett pk|G03FB05|01.04.1993||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1475|2975|lyfalmen|||23|8|0|Vistor hf|Novartis Healthcare A/S-|28| 422659|G02CB0102|Parlodel|töflur|2,5|mg|100|stk|1|glas||G02CB01|01.11.1979||R|A|3|0|0|E|0|MAS|0|0|0|100|DKK|4612|7639|lyfalmen|||49|100|0|Icepharma hf|Meda AS|50| 424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dæl||QP52AC13|01.05.1999||L|A|3|0|0|0|0|INI|0|0|0|100|DKK|673|1165|vetorma|||16|24|0|Icepharma hf|Intervet International B.V.|| 425181|N05CD0302|Flunitrazepam NM Pharma|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|A|5|1|0|0|0|MNA|0|0|0|100|SEK|580|1268|lyfalmen|||00|100|0|Merck NM|Merck NM AB|100| 425538|N04BC0102|Parlodel |hylki|10|mg|100|stk|1|þpakki||N04BC01|01.11.1979||R|A|4|0|0|E|0|MAS|0|0|0|100|DKK|16006|22978|lyfalmen|||52|100|0|Icepharma hf|Meda AS|25| 426312|J02AC0101|Diflucan|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.04.1993||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|1967|3722|lyfalmen|V0555|3166|10|2|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|1,5| 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|367|825|lyfalmen|||00|20|0|Vistor hf|AstraZeneca A/S DK|5| 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|479|1058|lyfalmen|||00|30|0|Vistor hf|AstraZeneca A/S DK|7,5| 427351|N07BA0103|Nicorette|forðapl|5|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||23|14|0|Vistor hf|Pfizer Denmark PCH ApS|5| 427369|N07BA0103|Nicorette|forðapl|10|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||23|14|0|Vistor hf|Pfizer Denmark PCH ApS|10| 427377|N07BA0103|Nicorette|forðapl|15|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||23|14|0|Vistor hf|Pfizer Denmark PCH ApS|15| 428565|J01MA0202|Ciproxin|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.01.1990||R|A|3|0|0|0|1|BHC|0|0|0|100|DKK|18939|25447|lyfsjukr|||00|1000|0|Vistor hf|Bayer HealthCare AG|4| 428656|J01MA0202|Ciproxin|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.01.1990||R|A|3|0|0|0|1|BHC|0|0|0|100|DKK|29659|38793|lyfsjukr|||00|2000|0|Vistor hf|Bayer HealthCare AG|8| 428672|J01CA0406|Flemoxin Solutab|lausnart|125|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|289|663|lyfalmen|||23|14|0|Vistor hf|Astellas Pharma A/S|1,75| 428680|J01CA0406|Flemoxin Solutab|lausnart|250|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|477|1054|lyfalmen|||23|14|0|Vistor hf|Astellas Pharma A/S|3,5| 429167|J07CA0602|Pentavac|bóluefni|| |0,5|ml|1|hgl|+ dreifa í dælu|J07CA06|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|3200|5583|lyfalmen|||AC|0,5|0|Icepharma hf|Sanofi Pasteur MSD|| 429225|J07CA0602|Pentavac|bóluefni|| |0,5|ml|10|hgl||J07CA06|01.12.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|23933|32847|lyfalmen|||AC|5|0|Icepharma hf|Sanofi Pasteur MSD|| 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|þpakki||C03DA01|01.11.1981||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|3387|5855|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|133,3333| 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1044|1495|lyfsjukr|||02|50|0|Vistor hf|Janssen-Cilag AB|| 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|1121|1605|lyfsjukr|||02|50|0|Icepharma hf|Roche|3,3333| 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|A|3|0|0|0|0|SPA|0|0|0|100|DKK|2201|4343|vetalmen|||27|100|0|Vistor hf|Schering-Plough A/S|| 430710|J07AP0301|Typhim Vi|bóluefni|| |0,5|ml|1|spr|einnotaspr|J07AP03|01.07.1994||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|1463|2957|lyfalmen|||02|0,5|0|Icepharma hf|Sanofi Pasteur MSD|| 430967|N07BA0105|Nicorette Mint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.1993||L|A|2.5|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||23|30|0|Vistor hf|Pfizer Denmark PCH ApS|2| 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|438|973|lyfalmen|||20|15|0|Vistor hf|LEO Pharma A/S|15| 431049|C01DA0801|Sorbangil|töflur|10|mg|100|stk|1|þpakki||C01DA08|01.07.1989||R|A|3|0|0|B|0|REP|0|0|0|100|DKK|660|1434|lyfalmen|||00|100|0|Vistor hf|Recip AB|16,6667| 431106|N07BA0105|Nicorette Mint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.10.1995||L|A|2.5|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||00|210|0|Vistor hf|Pfizer Denmark PCH ApS|14| 431122|N07BA0105|Nicorette Mint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.1993||L|A|2.5|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||23|30|0|Vistor hf|Pfizer Denmark PCH ApS|4| 431171|N07BA0105|Nicorette Mint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.10.1995||L|A|2.5|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||00|210|0|Vistor hf|Pfizer Denmark PCH ApS|28| 431403|B05BA0201|Intralipid 100 mg/ml|irl|100|mg/ml|100|ml|1|fl||B05BA02|01.10.1989||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|582|833|lyfsjukr|||00|100|0|Icepharma hf|Fresenius Kabi|0,1| 432336|J01GB0701|Netilyn|stl/irþ|10|mg/ml|1,5|ml|10|lykjur||J01GB07|01.01.1986||R|A|5|0|0|0|1|SCP|0|0|0|100|DKK|1512|2165|lyfsjukr|||02|15|0|Vistor hf|Schering-Plough|0,4286| 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|8400|12921|lyfalmen|V0729|12697|00|100|0|Vistor hf|Orion Corporation|20| 433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1427|2902|lyfalmen|||00|28|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|8,4| 433300|N02AA0106|Contalgin Uno|forðahlk|60|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|2688|4817|lyfalmen|||00|28|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|16,8| 433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|3499|6018|lyfalmen|||00|28|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|25,2| 433326|N02AA0106|Contalgin Uno|forðahlk|120|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|4381|7303|lyfalmen|||00|28|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|33,6| 433342|N02AA0106|Contalgin Uno|forðahlk|150|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|5047|8270|lyfalmen|||00|28|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|42| 433359|N02AA0106|Contalgin Uno|forðahlk|200|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|6814|10734|lyfalmen|||00|28|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|56| 434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|428|741|vetorma|||99|10|0|Icepharma hf|Intervet International B.V.|| 434670|D01AC2001|Daktacort|krem|| |50|g|1|túpa||D01AC20|01.10.1988||R|K|3|0|0|0|0|JAS|0|0|1|100|SEK|916|1967|lyfalmen|||20|50|0|Vistor hf|Janssen-Cilag AB|50| 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,7|0|0|B|0|ALK|0|0|1|100|DKK|4160|6981|lyfalmen|||00|1|0|Vistor hf|ALK-Abello A/S|0,6| 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,75|0|0|B|0|ALK|0|0|1|100|DKK|4160|6981|lyfalmen|||00|1|0|Vistor hf|ALK-Abello A/S|0,3| 435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|DKK|1535|3066|lyfalmen|||00|250|0|Vistor hf|Recip AB|41,67| 436022|C09DA0305|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|2141|3987|lyfalmen|||00|28|0|Vistor hf|Novartis Healthcare A/S-|28| 436030|C09DA0305|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|98|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|6135|9787|lyfalmen|||00|98|0|Vistor hf|Novartis Healthcare A/S-|98| 436071|N04BC0401|Requip|töflur|0,25|mg|210|stk|1|þpakki||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|SEK|4078|6862|lyfalmen|||00|210|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|8,75| 436139|N04BC0401|Requip|töflur|0,5|mg|21|stk|1|þpakki||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|SEK|686|1489|lyfalmen|||00|21|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|1,75| 436147|M01AE0216|Naproxen-E Merck NM |sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|A|5|0|0|E|0|MNA|0|0|1|100|SEK|318|723|lyfalmen|||10|20|0|Merck NM|Merck NM AB|10| 436238|N04BC0401|Requip|töflur|1|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|SEK|4489|7460|lyfalmen|||00|84|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|14| 436279|N04BC0401|Requip|töflur|2|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|SEK|8140|12574|lyfalmen|V0728|12356|00|84|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|28| 436295|N04BC0401|Requip|töflur|5|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|SEK|17302|24591|lyfalmen|||00|84|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|70| 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|426|948|lyfalmen|||20|15|0|Vistor hf|LEO Pharma A/S|15| 436527|M01AE0216|Naproxen-E Merck NM |sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|1208|2569|lyfalmen|||10|100|0|Merck NM|Merck NM AB|50| 436550|M01AE0211|Naproxen-E NM Pharma|sh-tfl|375|mg|20|stk|1|þpakki||M01AE02|01.01.1995||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|484|1069|lyfalmen|||10|20|0|Merck NM|Merck NM AB|15| 436626|M01AE0211|Naproxen-E NM Pharma|sh-tfl|375|mg|100|stk|1|glas||M01AE02|01.01.1995||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|2000|3772|lyfalmen|||10|100|0|Merck NM|Merck NM AB|75| 436808|M01AE0216|Naproxen-E Merck NM |sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|2287|4208|lyfalmen|||10|100|0|Merck NM|Merck NM AB|100| 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|563|1233|lyfalmen|||00|100|0|Vistor hf|Janssen-Cilag AB|12,5| 436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|1973|3731|lyfalmen|||00|100|0|Vistor hf|Janssen-Cilag AB|50| 438002|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|A|3|0|0|0|1|FEL|0|0|0|100|DKK|21374|28478|lyfsjukr|||00|5|0|Vistor hf|Ferring Lægemidler A/S|0,42| 438218|N06AX1602|Efexor Depot|forðahlk|75|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|8210|12668|lyfalmen|V0955|11799|00|100|0|Icepharma hf|Wyeth AB|75| 438333|N06AX1602|Efexor Depot|forðahlk|150|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|4573|7583|lyfalmen|V0954|7217|00|28|0|Icepharma hf|Wyeth AB|42| 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|| |10|ml|1|túpa|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|A|2|0|0|E|0|ALC|0|0|1|100|USD|630|1372|lyfalmen|||00|10|0|K.Pétursson hf|Alcon|| 438424|N06AX1602|Efexor Depot|forðahlk|75|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|2308|4240|lyfalmen|||00|28|0|Icepharma hf|Wyeth AB|21| 438432|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|7825|12144|lyfalmen|V0955|11563|00|98|0|Icepharma hf|Wyeth AB|73,5| 438457|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|15019|21749|lyfalmen|V0956|20586|00|98|0|Icepharma hf|Wyeth AB|147| 438465|N06AX1602|Efexor Depot|forðahlk|150|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|15545|22404|lyfalmen|V0956|21006|00|100|0|Icepharma hf|Wyeth AB|150| 438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|1148|2449|lyfalmen|V0982|1678|00|30|0|Vistor hf|Schering-Plough|30| 438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|3406|5883|lyfalmen|V0984|3892|00|100|0|Vistor hf|Schering-Plough|100| 439174|J01DC0203|Zinnat|töflur|125|mg|14|stk|1|þpakki||J01DC02|01.10.1990||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|843|1815|lyfalmen|||66|14|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|3,5| 439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|þpakki||J01DC02|01.10.1990||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|1537|3069|lyfalmen|||66|14|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|7| 440123|S01BA0401|Ultracortenol|augndr|5|mg/ml|5|ml|1|glas||S01BA04|01.12.1972||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|418|931|lyfalmen|||29|5|0|Vistor hf|Novartis Healthcare A/S-|| 440677|J01CE0105|Penicillin Alpharma|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|852|1220|lyfsjukr|||00|10|0|Actavis Group hf|Actavis Group hf|1,67| 440693|J01CE0105|Penicillin Alpharma|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|1344|1924|lyfsjukr|||00|10|0|Actavis Group hf|Actavis Group hf|3,33| 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|þpakki||C03DA01|01.12.1972||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|832|1792|lyfalmen|V0221|1784|00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|33,3333| 441279|D01AC2002|Pevisone|krem|| |30|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|531|1166|lyfalmen|||20|30|0|Vistor hf|Janssen-Cilag AB|30| 441634|P03AC0401|Nix|hársápa|10|mg/ml|59|ml|1|pakki||P03AC04|01.01.1996||L|A|2|0|0|0|0|ACH|0|0|0|100|GBP|||lyflausa|||00|59|0|GlaxoSmithKline ehf|ACO Hud AB|| 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|glas||G03DC02|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|543|1191|lyfalmen|||00|30|0|Icepharma hf|Bayer Schering Pharma AG|30| 442152|J05AF0101|Retrovir|hylki|250|mg|40|stk|1|þpakki||J05AF01|01.07.1995||R|A|5|0|1|0|1|GSK|0|0|0|100|GBP|20356|27211|lyfsjukr|||61|40|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|16,6667| 442350|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|15|plpok||B05BA03|01.01.1994||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2080|2978|lyfsjukr|||00|3750|0|Icepharma hf|Fresenius Kabi|3,75| 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dæla|H04AA01|01.01.1989||R|K|3|0|0|*|0|NON|0|0|1|100|DKK|2108|3936|lyfalmen|||02|1|0|Vistor hf|Novo-Nordisk|1| 443333|N02AA0101|Contalgin|forðatfl|200|mg|30|stk|1|þpakki||N02AA01|01.04.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|6232|9922|lyfalmen|||10|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|60| 443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|18239|25758|lyfalmen|||10|90|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|180| 444240|J05AF0401|Zerit|hylki|30|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|25952|34178|lyfsjukr|||00|56|0|Vistor hf|Bristol-Myers Squibb|21| 444299|J05AF0401|Zerit|hylki|40|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|26323|34640|lyfsjukr|||00|56|0|Vistor hf|Bristol-Myers Squibb|28| 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|1641|3227|lyfalmen|||00|100|0|Icepharma hf|Roche|8,3333| 444927|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|1|hgl||M05BA06|01.04.2006||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|10656|15134|lyfsjukr|||00|2|0|Icepharma hf|Roche|0,33| 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|A|3|0|0|B|0|LEO|0|0|1|100|DKK|1055|2256|lyfalmen|||00|30|0|Vistor hf|LEO A/S|30| 445759|G04CB0101|Proscar|töflur|5|mg|98|stk|1|þpakki||G04CB01|01.04.1993||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|8830|13493|lyfalmen|V0411|8146|10|98|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|98| 445965|H01AC0104|Saizen|sts|| |1,33|mg|1|hgl|+ leysir|H01AC01|01.07.1992||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|3322|4756|lyfsjukr|||02|1,33|0|Gróco ehf|Serono Nordic|2| 446187|QA12CX9001|Tonophosphan, vet.|stl|200|mg/ml|50|ml|1|hgl||QA12CX90|01.12.1972||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|831|1640|vetalmen|||27|50|0|Icepharma hf|Intervet International B.V.|| 446807|J02AC0101|Diflucan|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|2324|4264|lyfalmen|V0551|3607|10|7|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|1,75| 446930|J02AC0101|Diflucan|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|1008|2158|lyfalmen|V0554|1767|10|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|0,75| 447235|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|1|fl||B05BA02|01.12.1980||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|710|1017|lyfsjukr|||00|100|0|Icepharma hf|Fresenius Kabi|0,1| 448217|C05AA0801|Doloproct|eþ-stil|| |10|stk|1|pakki||C05AA08|01.01.1991||R|A|4|0|0|E|0|IGB|0|0|0|100|SEK|343|775|lyfalmen|||04|10|0|Icepharma hf|Intendis GmbH Berlin|| 448233|C05AA0802|Doloproct Comp.|eþ-krem|| |30|g|1|túpa||C05AA08|01.01.1991||R|A|3|0|0|E|0|IGB|0|0|0|100|SEK|672|1459|lyfalmen|||00|30|0|Icepharma hf|Intendis GmbH Berlin|| 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|1|100|IKR|1095|2339|lyfalmen|V0712|2229|00|50|0|Vistor hf|Novartis Healthcare A/S-|25| 449595|C07AB0305|Atenolol NM Pharma|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|516|1135|lyfalmen|V0298|1135|00|98|0|Merck NM|Merck NM AB|65,3333| 449611|C07AB0305|Atenolol NM Pharma|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|759|1640|lyfalmen|V0306|1640|00|98|0|Merck NM|Merck NM AB|130,6667| 449819|J01CE0105|Penicillin Alpharma|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|3188|4564|lyfsjukr|||00|10|0|Actavis Group hf|Actavis Group hf|8,33| 450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|pakki|þp 875+125 mg|J01CR02|01.01.1997||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1137|2426|lyfalmen|V0466|2426|00|12|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|10,5| 450734|N05CF0201|Stilnoct|töflur|10|mg|20|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|685|1486|lyfalmen|V0902|852|00|20|0|Vistor hf|Sanofi-aventis Norge AS|20| 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|2617|4710|lyfalmen|V0903|3447|00|100|0|Vistor hf|Sanofi-aventis Norge AS|100| 451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|þpakki||N06AB04|01.11.1999||R|A|3|0|0|B|0|LUN|0|1|0|30|DKK|3744|6375|lyfalmen|||00|28|0|Lundbeck Export A/S|Lundbeck|42| 451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|A|3|0|0|B|0|LUN|0|1|0|30|DKK|13237|19530|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|150| 452268|J02AC0101|Diflucan|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|9540|14439|lyfalmen|V0552|12059|10|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|7,5| 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|A|3|0|0|E|0|ROA|0|0|1|100|DKK|668|1451|lyfalmen|||00|5|0|Icepharma hf|Roche as|5| 452300|J02AC0101|Diflucan|hylki|50|mg|100|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|31949|42827|lyfalmen|||10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|25| 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|A|2|0|0|0|0|LAB|0|0|1|100|DKK|7473|11653|lyfalmen|||00|3000|0|Vistor hf|Laboratories 3M Santé|3| 452896|A06AD1701|Phosphoral|mixtúra|| |45|ml|2|fl||A06AD17|01.03.1999||L|A|3|0|0|0|0|LCF|0|0|0|100|IKR|||lyfalmen|||00|90|0|Vistor hf|Laboratorios Casen-Fleet S.L.U.|| 452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|1470|2967|lyfalmen|||10|28|0|Icepharma hf|Norpharma |3,73| 452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|4837|7967|lyfalmen|||10|98|0|Icepharma hf|Norpharma |13,07| 452953|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|1761|3409|lyfalmen|||10|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|33,3333| 452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2851|5065|lyfalmen|||10|28|0|Icepharma hf|Norpharma |7,47| 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||L|A|3|0|0|0|0|MEF|0|0|0|100|XEU|849|1469|vetorma|||16|6,4|0|Vistor hf|Merial (MSD)|| 453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|8788|13437|lyfalmen|||10|98|0|Icepharma hf|Norpharma |26,13| 453498|N02AA0501|Oxycontin|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|5591|9029|lyfalmen|||10|28|0|Icepharma hf|Norpharma |14,93| 453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|18253|25775|lyfalmen|||10|98|0|Icepharma hf|Norpharma |52,27| 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|A|3|0|0|0|1|PFI|0|1|0|100|DKK|2076|2972|lyfsjukr|||02|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|0,5| 453795|J07AL0102|Pneumo 23|bóluefni|| |0,5|ml|1|dæla||J07AL01|01.09.2003||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|1324|2746|lyfalmen|||00|0,5|0|Icepharma hf|Sanofi Pasteur MSD|| 454165|C10AA0101|Zocor|töflur|10|mg|98|stk|1|þpakki||C10AA01|01.01.1991||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|4874|8021|lyfalmen|V0358|3633|00|98|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|65,3333| 454199|C10AA0101|Zocor|töflur|20|mg|98|stk|1|þpakki||C10AA01|01.01.1991||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|5680|9153|lyfalmen|V0365|4239|00|98|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|130,6667| 454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|8840|13507|lyfalmen|||00|28|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|18,6667| 454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|27561|37364|lyfalmen|V0375|37364|00|98|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|65,3333| 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|9974|15017|lyfalmen|||00|28|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|37,3333| 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|29917|40297|lyfalmen|V0376|40297|00|98|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|130,6667| 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|A|3|0|1|0|1|GSK|0|0|0|100|SEK|35899|46562|lyfsjukr|||00|1|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|629|1241|vetalmen|||16|100|0|Vistor hf|Boehringer Ingelheim Danmark|| 455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|þpakki||A10BF01|01.12.1997||R|A|4|0|0|*|0|BHC|0|0|0|100|DKK|554|1214|lyfalmen|||00|30|0|Vistor hf|Bayer HealthCare AG|5| 455337|A10BF0101|Glucobay|töflur|50|mg|120|stk|1|þpakki||A10BF01|01.12.1997||R|A|4|0|0|*|0|BHC|0|0|0|100|DKK|1990|3757|lyfalmen|||00|120|0|Vistor hf|Bayer HealthCare AG|20| 455428|B03XA0103|NeoRecormon |sts|10000|ae/rörly|1|ml|3|rörlyk|+leysir|B03XA01|01.02.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|36788|47669|lyfsjukr|||00|3|0|Icepharma hf|Roche|30| 455527|B03XA0103|NeoRecormon |sts|20000|ae/rörly|1|ml|3|rörlyk|+leysir|B03XA01|01.02.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|73145|92933|lyfsjukr|||00|3|0|Icepharma hf|Roche|60| 455576|B03XA0103|NeoRecormon |sts|100000|ae/hgl|5|ml|1|hgl|+leysir|B03XA01|01.02.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|119679|150868|lyfsjukr|||00|5|0|Icepharma hf|Roche|10| 455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|30|DKK|12613|18753|lyfalmen|||00|21|0|Vistor hf|Novartis Healthcare A/S-|14| 455717|C05AD0102|Sulgan|eþ-smyr|| |30|g|1|túpa||C05AD01|01.12.1972||L|A|5|0|0|0|0|DOE|0|0|0|100|CHF|||lyfalmen|||00|30|0|Icepharma hf|Doetsch Grether|| 455725|C05AD0102|Sulgan|eþ-stil|| |10|stk|1|pakki||C05AD01|01.12.1972||L|A|5|0|0|0|0|DOE|0|0|0|100|CHF|||lyfalmen|||00|10|0|Icepharma hf|Doetsch Grether|| 456079|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|6000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|2734|3914|lyfsjukr|||00|12000|0|Icepharma hf|Baxter|12| 456202|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|6000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|2734|3914|lyfsjukr|||00|12000|0|Icepharma hf|Baxter|12| 456277|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|5000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|2984|4272|lyfsjukr|||00|10000|0|Icepharma hf|Baxter|| 456392|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|5000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|2984|4272|lyfsjukr|||00|10000|0|Icepharma hf|Baxter|| 457002|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4349|6227|lyfsjukr|||00|10000|0|Icepharma hf|Baxter|10| 457036|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4349|6227|lyfsjukr|||00|10000|0|Icepharma hf|Baxter|10| 457069|B05DB0001|Dianeal PD1 Glucose|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4349|6227|lyfsjukr|||00|10000|0|Icepharma hf|Baxter|10| 457119|B05DA0002|Dianeal PD1 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|5444|7794|lyfsjukr|||00|10000|0|Icepharma hf|Baxter|10| 457242|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|5307|7598|lyfsjukr|||00|10000|0|Icepharma hf|Baxter|10| 457291|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7056|10102|lyfsjukr|||00|10000|0|Icepharma hf|Baxter|10| 457366|L01DB0101|Adriamycin|stl|2|mg/ml|100|ml|1|hgl||L01DB01|01.10.1990||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|32648|42514|lyfsjukr|||02|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|1070|2287|lyfalmen|||43|20|0|Vistor hf|LEO Pharma A/S|6,6667| 458356|J01CA0801|Selexid|töflur|200|mg|30|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|1522|3046|lyfalmen|||43|30|0|Vistor hf|LEO Pharma A/S|10| 458422|J01CA0801|Selexid|töflur|200|mg|100|stk|1|þpakki||J01CA08|01.12.2007||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|5025|8239|lyfalmen|V0456|8239|00|100|0|Vistor hf|LEO Pharma A/S|33,3333| 458737|B05DA0003|Dianeal PD4 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7111|10181|lyfsjukr|||00|10000|0|Icepharma hf|Baxter|10| 458778|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7111|10181|lyfsjukr|||00|10000|0|Icepharma hf|Baxter|10| 458794|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7111|10181|lyfsjukr|||00|10000|0|Icepharma hf|Baxter|10| 459214|B05DB0004|Nutrineal PD4 1,1% Amino Acids Clear|kvið.sk|| |2000|ml|5|pokar||B05DB00|01.06.2004||R|S|2|0|0|0|1|BAM|0|0|0|100|SEK|8461|12114|lyfsjukr|||00|10000|0|Icepharma hf|Baxter Medical AB|10| 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|818|1171|lyfsjukr|||02|2|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|0,1667| 459412|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|5|lykjur||M05BA06|01.02.2002||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|49130|63034|lyfsjukr|||00|10|0|Icepharma hf|Roche|1,67| 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|1021|1462|lyfsjukr|||02|4|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|0,3333| 459727|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|1144|2441|lyfalmen|||06|15|0|Icepharma hf|Santen Oy|75| 459743|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|1276|2673|lyfalmen|||06|15|0|Icepharma hf|Santen Oy|75| 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|DKK|1290|2694|lyfalmen|||00|30|0|Icepharma hf|Meda AS|7,5| 459867|B02AA0201|Cyklokapron|töflur|500|mg|60|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|DKK|2623|4719|lyfalmen|||00|60|0|Icepharma hf|Meda AS|15| 460071|J01CA0406|Flemoxin Solutab|lausnart|250|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|580|1268|lyfalmen|||23|20|0|Vistor hf|Astellas Pharma A/S|5| 460170|J07BC0202|Avaxim|bóluefni|| |0,5|ml|1|dæla|einnota dæla|J07BC02|01.04.1998||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|2445|4448|lyfalmen|||51|0,5|0|Icepharma hf|Aventis Pasteur MSD A/S|| 460196|J01CA0406|Flemoxin Solutab|lausnart|500|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|867|1865|lyfalmen|||23|20|0|Vistor hf|Astellas Pharma A/S|10| 460303|J01CA0406|Flemoxin Solutab|lausnart|750|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1577|3130|lyfalmen|||23|20|0|Vistor hf|Astellas Pharma A/S|15| 460618|L01AX0301|Temodal|hylki|5|mg|20|stk|1|glas| |L01AX03|01.05.2001||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|10416|14835|lyfsjukr|||00|20|0|Vistor hf|Schering-Plough|| 460782|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.10.1992||L|A|3|0|0|0|0|JAS|0|0|1|100|SEK|1120|2391|lyfalmen|V0355|2058|23|120|0|Vistor hf|Janssen-Cilag AB|120| 460972|J07BB0205|Influvac|bóluefni|| |0,5|ml|10|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOP|0|0|0|100|XEU|3497|6015|lyfalmen|||51|5|0|Icepharma hf|Solvay Pharmaceuticals|| 461178|L01AX0301|Temodal|hylki|20|mg|20|stk|1|glas| |L01AX03|01.05.2001||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|41661|53735|lyfsjukr|||00|20|0|Vistor hf|Schering-Plough|| 461335|L01AX0301|Temodal|hylki|100|mg|5|stk|1|glas| |L01AX03|01.05.2001||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|50933|65279|lyfsjukr|||00|5|0|Vistor hf|Schering-Plough|| 461467|L01AX0301|Temodal|hylki|250|mg|5|stk|1|glas| |L01AX03|01.05.2001||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|130189|163953|lyfsjukr|||00|5|0|Vistor hf|Schering-Plough|| 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|447|992|lyfalmen|||20|25|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|25| 462036|D07AD0101|Dermovat|krem|0,5|mg/g|100|g|1|túpa||D07AD01|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1758|3405|lyfalmen|||20|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|100| 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|447|992|lyfalmen|||20|25|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|25| 462051|D07AD0101|Dermovat|smyrsli|0,5|mg/g|100|g|1|túpa||D07AD01|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1758|3405|lyfalmen|||20|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|100| 462143|B05AA0703|Hemohes 10%|irl|100|mg/ml|500|ml|10|fl||B05AA07|01.11.1999||R|A|3|0|0|0|1|BRA|0|0|0|100|XEU|12355|17249|lyfsjukr|||00|5000|0|Actavis Group hf|Braun|5| 462226|B05AA0702|Hemohes 6%|irl|60|mg/ml|500|ml|10|fl||B05AA07|01.11.1999||R|A|3|0|0|0|1|BRA|0|0|0|100|XEU|9308|13327|lyfsjukr|||00|5000|0|Actavis Group hf|Braun|5| 462358|A07EA0601|Entocort|innhl|20|mcg/ml|7|stk|1|pakki|samsett pk|A07EA06|01.04.1993||R|A|2|0|0|B|0|AZD|0|0|0|100|IKR|3871|6560|lyfalmen|V0297|6448|56|7|0|Vistor hf|AstraZeneca A/S DK|7| 462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|K|3|0|0|0|0|PFI|1|0|0|100|DKK|3857|7518|vetalmen|||02|20|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|3161|6192|vetalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 464370|N05AD0301|Buronil|töflur|25|mg|100|stk|1|glas||N05AD03|01.12.1972||R|A|5|0|0|*|0|OVA|0|1|0|100|DKK|1036|2216|lyfalmen|||00|100|0|Swedish Orphan International AB|Ovation Healthcare International Ltd.|8,3333| 464677|B05BA0106|Vamin 18 g N/l elektrolytfri|irl|| |500|ml|12|fl||B05BA01|01.09.1998||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|16111|21926|lyfsjukr|||00|6000|0|Icepharma hf|Fresenius Kabi|6| 464800|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|12|fl||B05BA02|01.05.1999||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|10668|15149|lyfsjukr|||00|1200|0|Icepharma hf|Fresenius Kabi|1,2| 465203|QJ01RA0103|Depomycine, vet.|stl|| |100|ml|1|hgl||QJ01RA01|01.12.1982||R|S|3|0|0|0|0|INI|0|0|0|100|DKK|683|1348|vetalmen|||58|100|0|Icepharma hf|Intervet International B.V.|| 465237|QJ01CR5001|Duplocillin L.A., vet.|stl|| |100|ml|1|hgl||QJ01CR50|01.05.1983||R|S|3|0|0|0|0|INI|1|0|0|100|DKK|646|1275|vetalmen|||58|100|0|Icepharma hf|Intervet International B.V.|| 465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|A|3|0|0|0|0|INI|0|0|0|100|DKK|692|1366|vetalmen|||27|100|0|Icepharma hf|Intervet International B.V.|| 465278|QJ51RC2301|Nafpenzal DC, vet.|spenalyf|| |3|g|4|spr||QJ51RC23|01.04.1985||R|A|3|0|0|0|0|INI|0|0|0|100|XEU|365|720|vetalmen|||16|12|0|Icepharma hf|Intervet International B.V.|| 466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|432|960|lyfalmen|||10|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|2,5| 466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1515|3036|lyfalmen|||10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|10| 466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|934|2004|lyfalmen|||10|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|7,5| 466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|3685|6289|lyfalmen|||10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30| 466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1766|3417|lyfalmen|||10|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|15| 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|4926|8097|lyfalmen|||10|50|0|Vistor hf|Novartis Healthcare A/S-|5| 466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|2904|5145|lyfalmen|||10|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|25| 467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2|0|1|0|1|AEU|0|0|0|100|DKK|9128|13069|lyfsjukr|||00|0,5|0|Vistor hf|Amgen Europe B.V.|0,86| 467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2|0|1|0|1|AEU|0|0|0|100|DKK|14305|19677|lyfsjukr|||00|0,5|0|Vistor hf|Amgen Europe B.V.|1,37| 467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|15490|21153|lyfsjukr|||00|1,2|0|Vistor hf|Schering-Plough|9| 467498|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|25229|33278|lyfsjukr|||00|1,2|0|Vistor hf|Schering-Plough|15| 467514|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.04.2004||R|A|2|0|1|0|1|WTE|0|0|0|100|USD|20522|27417|lyfsjukr|||00|60|0|Icepharma hf|Wyeth Europe|20| 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|9551|14454|lyfalmen|||10|50|0|Vistor hf|Novartis Healthcare A/S-|10| 467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|51644|66164|lyfsjukr|||00|1,2|0|Vistor hf|Schering-Plough|30| 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|18078|25557|lyfalmen|||10|50|0|Vistor hf|Novartis Healthcare A/S-|20| 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|A|5|0|0|0|1|JAS|0|1|0|100|SEK|455|651|lyfsjukr|||00|5|0|Vistor hf|Janssen-Cilag AB|3,125| 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LUN|0|1|0|30|DKK|4924|8094|lyfalmen|V0922|5797|00|100|0|Lundbeck Export A/S|Lundbeck|50| 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|265|379|lyfsjukr|||02|10|0|Vistor hf|Janssen-Cilag AB|| 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LUN|0|1|0|30|DKK|6563|10384|lyfalmen|V0926|6075|00|100|0|Lundbeck Export A/S|Lundbeck|100| 468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LUN|0|1|0|30|DKK|17303|24592|lyfalmen|V0930|12068|00|100|0|Lundbeck Export A/S|Lundbeck|200| 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|5847|9386|lyfalmen|||00|98|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|49| 469742|N02AX0206|Nobligan Retard|forðatfl|200|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1670|3271|lyfalmen|||00|20|0|Icepharma hf|Grunenthal|13,3333| 469817|N02AX0206|Nobligan Retard|forðatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|6805|10721|lyfalmen|V0738|10024|00|100|0|Icepharma hf|Grunenthal|66,6667| 469866|N02AX0206|Nobligan Retard|forðatfl|150|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1305|2717|lyfalmen|||00|20|0|Icepharma hf|Grunenthal|10| 469874|N02AX0206|Nobligan Retard|forðatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|5168|8439|lyfalmen|V0736|7896|00|100|0|Icepharma hf|Grunenthal|50| 469890|N02AX0206|Nobligan Retard|forðatfl|100|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|887|1906|lyfalmen|V0733|1771|00|20|0|Icepharma hf|Grunenthal|6,6667| 469932|N02AX0206|Nobligan Retard|forðatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|3530|6063|lyfalmen|V0734|5718|00|100|0|Icepharma hf|Grunenthal|33,3333| 470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|sk|1|stauk||R03BA05|01.04.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|3610|6180|lyfalmen|||24|120|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|50| 471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|1145|2443|lyfalmen|||68|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|50| 471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|777|1345|vetorma|||99|20|0|Icepharma hf|Intervet International B.V.|| 471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.01.1988||R|A|3|0|0|*|0|BAM|0|0|0|100|SEK|1341|2771|lyfalmen|||00|100|0|Icepharma hf|Baxter Medical AB|| 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|A|3|0|0|0|0|ORC|1|0|0|100|DKK|2814|5531|vetalmen|||27|10|0|Vistor hf|Orion Corporation|| 472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|K|3|0|0|0|0|GSK|0|0|0|100|SEK|1682|3289|lyfalmen|||02|0,5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|8434|12075|lyfsjukr|||00|400|0|Icepharma hf|Meda AB|0,4| 474106|M02AA1301|Deep Relief |hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|GBP|||lyflausa|||00|50|0|Icepharma hf|Mentholatum Company Ltd.|| 474114|N02CA7201|Anervan|töflur|160,5|mg|30|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|605|1320|lyfalmen|||00|30|0|Vistor hf|Recip AB|15| 474197|M02AA1301|Deep Relief |hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|GBP|||lyflausa|||00|15|0|Icepharma hf|Mentholatum Company Ltd.|| 474395|J05AG0101|Viramune|töflur|200|mg|60|stk|1|þpakki||J05AG01|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|23969|31709|lyfsjukr|||00|60|0|Vistor hf|Boehringer Ingelheim Internationl |30| 474551|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.05.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|1129|2410|lyfalmen|||00|140|0|Vistor hf|Schering-Plough|35| 475467|G03CA0306|Evorel|forðapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|2461|4473|lyfalmen|||23|26|0|Vistor hf|Janssen-Cilag AB|91| 475756|C09AA0801|Inhibace|töflur|2,5|mg|98|stk|1|þpakki||C09AA08|01.07.1991||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|3588|6148|lyfalmen|||00|98|0|Icepharma hf|Roche|98| 475889|C09AA0801|Inhibace|töflur|5|mg|98|stk|1|þpakki||C09AA08|01.07.1991||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|6881|10827|lyfalmen|||00|98|0|Icepharma hf|Roche|196| 476580|R03AC0206|Ventoline|lausn|2|mg/ml|2,5|ml|20|lykjur|f. vél|R03AC02|01.04.1992||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|771|1665|lyfalmen|||00|50|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|10| 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|glas|250 + 100 mg|P01BB51|01.02.2006||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|3110|5451|lyfalmen|||00|12|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|3| 477752|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||02|200|0|Icepharma hf|Fresenius Kabi|| 477760|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||02|500|0|Icepharma hf|Fresenius Kabi|| 477786|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||02|1000|0|Icepharma hf|Fresenius Kabi|| 478438|C08CA0101|Norvasc|töflur|5|mg|200|stk|1|glas||C08CA01|01.03.2004||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|10147|15248|lyfalmen|||00|200|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|200| 479626|N04BA0206|Sinemet depot|forðatfl|250|mg|100|stk|1|glas|50+200 mg|N04BA02|01.07.1990||R|A|2|0|0|E|0|MSD|0|0|0|100|XEU|3301|5730|lyfalmen|||10|100|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|33,3333| 479691|C09AA0701|Cibacen|töflur|10|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|B|0|MAS|0|0|0|100|DKK|5351|8694|lyfalmen|||00|98|0|Icepharma hf|Meda AS|130,6667| 479717|C09AA0701|Cibacen|töflur|20|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|B|0|MAS|0|0|0|100|DKK|11480|17024|lyfalmen|||00|98|0|Icepharma hf|Meda AS|261,3333| 480525|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.03.1999||R|A|1,75|0|0|B|0|ALK|0|0|1|100|DKK|4160|6981|lyfalmen|||00|1|0|Vistor hf|ALK-Abello A/S|0,3| 480541|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.03.1999||R|A|1,7|0|0|B|0|ALK|0|0|1|100|DKK|4160|6981|lyfalmen|||00|1|0|Vistor hf|ALK-Abello A/S|0,6| 481168|N07BA0201|Zyban|forðatfl|150|mg|60|stk|1|þpakki||N07BA02|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|5070|8302|lyfalmen|||00|60|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30| 481176|N07BA0201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N07BA02|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|7825|12144|lyfalmen|||00|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|50| 481598|M03AX0102|Dysport|sts|500|ein|1|hgl|1|pakki||M03AX01|01.05.2003||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|22820|30278|lyfsjukr|||02|1|0|Icepharma hf|Institut Produits Synthése (IPSEN) AB|| 483552|J02AC0101|Diflucan|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.08.2000||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|35709|47508|lyfalmen|V0557|36618|10|28|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|28| 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|2070|2964|lyfsjukr|||00|50|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|0,5| 483636|N07BA0103|Nicorette|tungur.t|2|mg|30|stk|1|þpakki||N07BA01|01.02.1999||L|A|3|0|0|0|0|PFD|0|0|1|100|DKK|||lyfalmen|||23|30|0|Vistor hf|Pfizer Denmark PCH ApS|2| 483644|N07BA0103|Nicorette|tungur.t|2|mg|105|stk|1|þpakki||N07BA01|01.02.1999||L|A|3|0|0|0|0|PFI|0|0|1|100|DKK|||lyfalmen|||23|105|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|7| 483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|4090|5856|lyfsjukr|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|1| 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|47342|60808|lyfsjukr|||00|3|0|Vistor hf|Ferring|83,9552| 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|þpakki||D11AX10|01.08.1999||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|3629|6207|lyfalmen|||00|28|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|28| 484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|A|3|0|0|E|0|MEB|0|0|1|100|DKK|706|1530|lyfalmen|||00|300|0|Vistor hf|Meda AB (V)|| 486779|M01AE0215|Naproxen Merck NM|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|A|4|0|0|E|0|MNA|0|0|1|100|SEK|144|362|lyfalmen|||00|20|0|Merck NM|Merck NM AB|10| 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|349|788|lyfalmen|||29|5|0|K.Pétursson hf|Alcon|| 486886|S01CA0101|Maxitrol|augndr|| |5|ml|1|glas||S01CA01|01.07.1990||R|A|2|0|0|E|0|ALC|0|0|1|100|USD|343|775|lyfalmen|||29|5|0|K.Pétursson hf|Alcon|| 487264|C09AA0401|Coversyl|töflur|2|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|1432|2910|lyfalmen|||00|30|0|Icepharma hf|Servier|15| 487280|C09AA0401|Coversyl|töflur|4|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|2090|3909|lyfalmen|||00|30|0|Icepharma hf|Servier|30| 487900|J01XE0101|Furadantin|töflur|50|mg|25|stk|1|þpakki||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|481|1062|lyfalmen|||00|25|0|Vistor hf|Recip AB|6,25| 488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|518|1139|lyfalmen|||00|20|0|Icepharma hf|Meda AB|10| 488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1542|3077|lyfalmen|||00|60|0|Icepharma hf|Meda AB|30| 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|ROC|0|0|0|100|DKK|5601|9043|lyfalmen|||67|50|0|Icepharma hf|Roche|14,2857| 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|ROC|0|0|0|100|DKK|10110|15199|lyfalmen|||67|50|0|Icepharma hf|Roche|35,7143| 489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|þpakki||M01AB05|01.01.1996||R|A|5|0|0|0|0|NOH|0|0|1|100|DKK|249|580|lyfalmen|||67|10|0|Vistor hf|Novartis Healthcare A/S-|5| 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|þpakki||M01AB05|01.01.1996||R|A|5|0|0|0|0|NOH|0|0|1|100|DKK|707|1532|lyfalmen|V0609|1200|67|30|0|Vistor hf|Novartis Healthcare A/S-|15| 490417|G03FB0504|Evorel Sequi|forðapl|| |8|stk|1|pakki||G03FB05|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|1450|2937|lyfalmen|||23|8|0|Vistor hf|Janssen-Cilag AB|28| 490425|G03FA0104|Evorel Conti|forðapl|| |8|stk|1|pakki||G03FA01|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|1699|3315|lyfalmen|||23|8|0|Vistor hf|Janssen-Cilag AB|28| 490557|A04AA0201|Kytril|stl|1|mg/ml|1|ml|5|lykjur||A04AA02|01.10.1999||R|A|3|0|0|0|1|ROA|0|0|0|100|DKK|4935|7066|lyfsjukr|||00|5|0|Icepharma hf|Roche as|1,6667| 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|2789|4971|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30| 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|6227|9915|lyfalmen|V0337|8383|00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|100| 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|4213|7058|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|60| 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|8837|13503|lyfalmen|V0338|11380|00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|200| 490839|C10AA0501|Zarator|töflur|40|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|6540|10352|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|120| 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|11240|16704|lyfalmen|V0339|14060|00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|400| 491639|N06DA0301|Exelon|mixtúra|2|mg/ml|120|ml|1|fl||N06DA03|01.05.2003||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|12680|18837|lyfalmen|||00|120|0|Vistor hf|Novartis Europharm Ltd|26,67| 491753|C10AC0102|Questran Loc|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1992||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|1503|3017|lyfalmen|||00|50|0|Vistor hf|Bristol-Myers Squibb|14,2857| 491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|K|1|0|1|0|1|ORG|0|0|0|100|DKK|27844|36533|lyfsjukr|||00|3|0|Icepharma hf|N.V. Organon|21,0084| 492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|hylki|100+25 mg|N04BA02|01.01.1991||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|1953|3701|lyfalmen|||10|100|0|Icepharma hf|Roche|16,6667| 492587|N06AX0303|Mianserin NM Pharma|töflur|10|mg|100|stk|1|glas||N06AX03|01.01.1994||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|852|1834|lyfalmen|||00|100|0|Merck NM|Merck NM AB|16,6667| 492678|N06AX0303|Mianserin NM Pharma|töflur|30|mg|100|stk|1|glas||N06AX03|01.01.1994||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|2264|4173|lyfalmen|||00|100|0|Merck NM|Merck NM AB|50| 493148|C10AA0302|Pravachol|töflur|20|mg|28|stk|1|þpakki||C10AA03|01.07.1989||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|2464|4477|lyfalmen|||00|28|0|Vistor hf|Bristol-Myers Squibb|28| 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|A|5|0|0|B|0|SNO|0|1|0|100|NOK|949|2035|lyfalmen|||00|100|0|Vistor hf|Sanofi-aventis Norge AS|16,6667| 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|2259|4166|lyfalmen|||00|100|0|Vistor hf|Novartis Healthcare A/S-|33,3333| 494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|50259|64440|lyfsjukr|||00|20|0|Icepharma hf|Roche Registration Limited|| 494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|125648|158299|lyfsjukr|||00|50|0|Icepharma hf|Roche Registration Limited|| 494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburður, fleyti|D10AF01|01.10.1995||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|1305|2717|lyfalmen|||00|60|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|60| 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|1488|2995|lyfalmen|V0408|1133|23|84|0|Vistor hf|Novo-Nordisk|84| 494724|G03FA0102|Kliogest|töflur|| |84|stk|1|skífup||G03FA01|01.10.1986||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|1888|3602|lyfalmen|V0388|2806|23|84|0|Vistor hf|Novo-Nordisk|84| 494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1819|3497|lyfalmen|||00|60|0|Vistor hf|Boehringer Ingelheim Internationl |30| 495259|A02BA0205|Zantac|freyðit|150|mg|15|stk|2|stauk|2 x 15 stk.|A02BA02|01.04.1990||L|A|2|0|0|E|0|GSK|0|0|0|30|GBP|2133|3974|lyfalmen|||14|30|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|15| 495267|A04AA0101|Zofran|töflur|4|mg|100|stk|1|glas||A04AA01|01.01.1991||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|57529|73491|lyfsjukr|||00|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|25| 495275|A04AA0101|Zofran|töflur|8|mg|100|stk|1|glas||A04AA01|01.01.1991||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|81043|102766|lyfsjukr|||00|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|50| 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|12425|17337|lyfsjukr|||00|15|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|7,5| 495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|4832|6918|lyfsjukr|||02|10|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|1,25| 495390|A04AA0101|Zofran|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|6904|9885|lyfsjukr|||02|20|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|2,5| 495572|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.04.2002||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|9872|14882|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|33,33| 495580|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.04.2002||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|16641|23768|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|44,44| 495820|J05AH0101|Relenza|innúðadu|5|mg/úðask|20|sk|1|stauk|+diskhaler|J05AH01|01.02.2000||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|1896|3614|lyfalmen|||00|20|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|5| 496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2738|4893|lyfalmen|||02|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|0,8333| 496554|C07AG0101|Trandate|töflur|100|mg|50|stk|1|glas||C07AG01|01.02.1982||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|691|1499|lyfalmen|||00|50|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|8,3333| 496752|C07AG0101|Trandate|töflur|200|mg|100|stk|1|glas||C07AG01|01.01.1986||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|2170|4031|lyfalmen|||00|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|33,3333| 496935|N02AG0201|Ketogan|eþ-stil|| |10|stk|1|pakki||N02AG02|01.07.1994||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|321|730|lyfalmen|||04|10|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|4| 496950|N02AG0201|Ketogan|töflur|| |20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PFI|0|0|0|100|DKK|487|1075|lyfalmen|||00|20|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|2| 497099|N02AG0201|Ketogan|töflur|| |100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PFI|0|0|0|100|DKK|1856|3554|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|10| 497511|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.12.1983||L|A|3|0|0|0|0|BIG|0|0|0|100|SEK|||lyflausa|||00|250|0|Icepharma hf|Bioglan AB|250| 497818|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3|0|0|B|0|BIG|0|0|1|100|SEK|479|1058|lyfalmen|||20|30|0|Icepharma hf|Bioglan AB|30| 498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|782|1688|lyfalmen|||03|2|0|Vistor hf|Schering-Plough|35| 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|10532|15761|lyfalmen|||00|56|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|14| 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|11354|16856|lyfalmen|||00|56|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|28| 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|15364|22178|lyfalmen|||00|56|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|42| 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|17656|25032|lyfalmen|||00|56|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|56| 500314|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3,5|0|0|B|0|BIG|0|0|1|100|SEK|479|1058|lyfalmen|||20|30|0|Icepharma hf|Bioglan AB|30| 500751|M01AB0101|Confortid|hylki|50|mg|30|stk|1|plglas||M01AB01|01.01.1977||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|549|1204|lyfalmen|||10|30|0|Actavis Group hf|Actavis Group hf|15| 500769|M01AB0101|Confortid|hylki|50|mg|100|stk|1|glas||M01AB01|01.01.1977||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|1687|3297|lyfalmen|||10|100|0|Actavis Group hf|Actavis Group hf|50| 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2038|3830|lyfalmen|||10|100|0|Icepharma hf|Roche|16,6667| 502187|D07AB0201|Locoid|lausn|1|mg/ml|100|ml|1|glas||D07AB02|01.03.1977||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|1213|2577|lyfalmen|||20|100|0|Vistor hf|Astellas Pharma A/S|100| 502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|þpakki||N06AA21|01.06.1977||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|1716|3341|lyfalmen|||00|100|0|Vistor hf|Novartis Healthcare A/S-|25| 502930|N05AB0301|Trilafon|töflur|16|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|2500|4532|lyfalmen|||00|100|0|Vistor hf|Schering-Plough|53,3333| 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|17762|23981|lyfsjukr|||00|1|0|Vistor hf|Ferring|27,9851| 503722|A01AC0102|Kenalog|munnh.pa|1|mg/g|10|g|1|túpa||A01AC01|01.05.1998||R|A|5|0|0|E|0|BRS|0|0|1|100|DKK|651|1416|lyfalmen|||20|10|0|Vistor hf|Bristol-Myers Squibb|| 503961|D07AC0301|Ibaril|krem|2,5|mg/g|50|g|1|túpa||D07AC03|01.10.1976||R|A|5|0|0|B|0|SNO|0|0|1|100|NOK|1299|2708|lyfalmen|||20|50|0|Vistor hf|Sanofi-aventis Norge AS|50| 504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.01.1988||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|1278|2676|lyfalmen|||00|90|0|Icepharma hf|N.V. Organon|45| 504746|R06AB0201|Polaramin|forðatfl|6|mg|50|stk|1|þpakki||R06AB02|01.01.1977||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|744|1609|lyfalmen|||10|50|0|Vistor hf|Schering-Plough|50| 504753|R06AB0201|Polaramin|töflur|2|mg|50|stk|1|pakki|þp|R06AB02|01.06.2007||R|A|5|0|0|E|0|SCP|0|0|0|100|DKK|347|784|lyfalmen|||00|50|0|Vistor hf|Schering-Plough|| 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|glas||N05BA08|01.01.1987||R|A|5|0|0|0|0|ROC|0|0|1|100|DKK|734|1588|lyfalmen|||00|100|0|Icepharma hf|Roche|30| 505644|A01AA0104|Fluorette|tyggigúm|0,25|mg|90|stk|1|stk||A01AA01|01.01.1996||L|A|1,5|0|0|0|0|FET|0|0|1|100|DKK|||lyfalmen|||00|90|0|Icepharma hf|Fertin A/S|20,4545| 505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|þpakki||N06AA21|01.05.1978||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|4721|7798|lyfalmen|||00|100|0|Vistor hf|Novartis Healthcare A/S-|75| 505867|D07XB0202|Kenalog med Salicylsyre|áburður|| |30|ml|1|glas|í hárssvörð|D07XB02|01.12.1972||R|A|2|0|0|B|0|BRS|0|0|1|100|DKK|562|1231|lyfalmen|||33|30|0|Vistor hf|Bristol-Myers Squibb|30| 506113|QS02CA0101|Fucidin comp., vet.|eyrnadr|| |25|ml|1|glas||QS02CA01|01.12.1982||R|A|3|0|0|0|0|VEX|0|0|0|100|DKK|973|1920|vetalmen|||13|25|0|Vistor hf|VetXX A/S|| 506774|J01GB0301|Garamycin|stl|10|mg/ml|2|ml|10|lykjur||J01GB03|01.11.1977||R|A|5|0|0|0|1|SCP|0|0|0|100|DKK|1797|2573|lyfsjukr|||02|20|0|Vistor hf|Schering-Plough|0,8333| 506949|N01AB0601|Forene|innönd.l|| |250|ml|1|stauk||N01AB06|01.10.1993||R|A|5|0|0|0|1|ABS|0|0|0|100|DKK|16658|22607|lyfsjukr|||00|250|0|Vistor hf|Abbott Scandinavia AB|| 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|1408|2873|lyfalmen|||10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|50| 506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|þpakki||A06AB02|01.12.1975||L|A|3|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||10|25|0|Vistor hf|Orion Pharma|12,5| 507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|þpakki||A06AB02|01.12.1975||R|A|3|0|0|0|0|ERC|0|0|0|100|DKK|230|540|lyfalmen|||10|100|0|Vistor hf|Orion Pharma|50| 507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PFI|0|0|0|100|DKK|379|656|vetorma|||16|24|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 507111|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|5|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PFI|0|0|0|100|DKK|1611|2788|vetorma|||16|120|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|5227|9046|vetorma|||13|1000|0|Icepharma hf|Intervet International B.V.|| 507582|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|50|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.06.1999||R|A|3|0|0|0|0|SPA|0|0|0|100|DKK|1446|2853|vetalmen|||27|50|0|Vistor hf|Schering-Plough A/S|| 508622|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|3071|5395|lyfalmen|||10|98|0|Vistor hf|Abbott Scandinavia AB|98| 508952|G03FB0902|Nuvelle|töflur|| |84|stk|1|þpakki||G03FB09|01.08.1997||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|1983|3747|lyfalmen|||00|84|0|Icepharma hf|Bayer Schering Pharma AG|84| 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|A|3|0|0|*|0|LUN|0|1|0|100|DKK|5740|9236|lyfalmen|||02|10|0|Lundbeck Export A/S|Lundbeck|133,3333| 509091|J01CF0101|Diclocil|hylki|500|mg|100|stk|1|þpakki||J01CF01|01.09.1977||R|A|1,5|0|0|0|0|BRS|0|0|1|100|DKK|5386|8743|lyfalmen|||10|100|0|Vistor hf|Bristol-Myers Squibb|25| 509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|774|1672|lyfalmen|||00|15|0|Icepharma hf|N.V. Organon|75| 509448|D10AE0102|Panoxyl|hlaup|50|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|236|553|lyfalmen|||23|40|0|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|40| 509455|D10AE0102|Panoxyl|hlaup|100|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|266|615|lyfalmen|||23|40|0|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|40| 509463|D10AE0102|Panoxyl|áburður|50|mg/ml|30|ml|1|fl||D10AE01|01.12.1982||R|A|3|0|0|0|0|STI|0|0|0|100|XEU|195|468|lyfalmen|||23|30|0|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|30| 509471|D10AE0102|Panoxyl|krem|50|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|236|553|lyfalmen|||23|40|0|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|40| 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|32136|41877|lyfsjukr|||00|60|0|GlaxoSmithKline ehf|Glaxo Group Limited|| 510248|B03XA0103|NeoRecormon |stl|1000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|7557|10820|lyfsjukr|||00|1,8|0|Icepharma hf|Roche|6| 510255|B03XA0103|NeoRecormon |stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|15115|20686|lyfsjukr|||00|1,8|0|Icepharma hf|Roche|12| 510263|B03XA0103|NeoRecormon |stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|22065|29338|lyfsjukr|||00|1,8|0|Icepharma hf|Roche|18| 510271|B03XA0103|NeoRecormon |stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|37271|48270|lyfsjukr|||00|1,8|0|Icepharma hf|Roche|30| 510305|B03XA0103|NeoRecormon |stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|69041|87824|lyfsjukr|||00|3,6|0|Icepharma hf|Roche|60| 510321|B03XA0103|NeoRecormon |stl|20000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|141342|177838|lyfsjukr|||00|3,6|0|Icepharma hf|Roche|120| 511303|G03FB0501|Trisekvens|töflur|| |84|stk|1|skífup||G03FB05|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|1548|3086|lyfalmen|V0385|3028|23|84|0|Vistor hf|Novo-Nordisk|84| 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|12687|17663|lyfsjukr|||00|6000|0|Icepharma hf|Meda AB|6| 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|7937|11364|lyfsjukr|||00|6000|0|Icepharma hf|Meda AB|6| 512608|B05XA3101|Peditrace|irþ|| |10|ml|10|hgl||B05XA31|01.07.1993||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|5468|7829|lyfsjukr|||00|100|0|Icepharma hf|Fresenius Kabi|0,1| 515031|N06AX1801|Edronax|töflur|4|mg|20|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|1207|2568|lyfalmen|||00|20|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|10| 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|3013|5310|lyfalmen|||00|60|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30| 517334|C10AA0101|Zocor|töflur|80|mg|98|stk|1|þpakki||C10AA01|01.03.1999||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|9717|14675|lyfalmen|V0369|14620|00|98|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|522,6667| 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|2267|4178|lyfalmen|||00|90|0|Vistor hf|Novo-Nordisk|11,25| 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|2733|4886|lyfalmen|||00|90|0|Vistor hf|Novo-Nordisk|22,5| 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|3273|5689|lyfalmen|||00|90|0|Vistor hf|Novo-Nordisk|45| 518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|528|1160|lyfalmen|||00|20|0|Actavis Group hf|Actavis Group hf|15| 518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|2508|4544|lyfalmen|||00|100|0|Actavis Group hf|Actavis Group hf|75| 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1198|2553|lyfalmen|||23|84|0|Icepharma hf|N.V. Organon|84| 518894|J01CA0410|Amoxicillin Merck NM|töflur|750|mg|20|stk|1|örglas||J01CA04|01.10.1998||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|1101|2351|lyfalmen|||00|20|0|Merck NM|Merck NM AB|15| 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|601|1312|lyfalmen|||08|125|0|Vistor hf|AstraZeneca A/S DK|3,125| 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|4758|7852|lyfalmen|||02|2|0|Gróco ehf|Nycomed Danmark A/S|5,7222| 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|2768|4939|lyfalmen|||00|4|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|2| 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|3125|5473|lyfalmen|||00|4|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|4| 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|9479|14358|lyfalmen|||00|12|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|12| 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|3354|5807|lyfalmen|V1300|5199|00|4|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|8| 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|10036|15100|lyfalmen|||00|12|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|24| 520635|S01AA0102|Isopto Fenicol 0.5 %|augndr|5|mg/ml|15|ml|1|glas||S01AA01|01.06.1982||R|K|3|0|0|E|0|ALC|0|0|1|100|USD|220|520|lyfalmen|||06|15|0|K.Pétursson hf|Alcon|| 520759|M03BC5101|Norgesic|töflur|| |30|stk|1|þpakki||M03BC51|01.03.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|DKK|215|509|lyfalmen|||00|30|0|Vistor hf|Meda AB (V)|8,75| 521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|19597|27449|lyfalmen|||00|100|0|Vistor hf|Boehringer Ingelheim Internationl |28| 522003|QJ51RC2302|Streptocillin, vet.|spenalyf|| |8|g|40|spr||QJ51RC23|01.12.1982||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|4593|8920|vetalmen|||16|320|0|Vistor hf|Boehringer Ingelheim Danmark|| 522599|J07CA0202|Tetravac|bóluefni|| |0,5|ml|1|spr|einnota dæla|J07CA02|01.10.1999||R|K|3,5|0|0|0|0|SPM|0|0|0|100|XEU|1913|3640|lyfalmen|||AC|0,5|0|Icepharma hf|Sanofi Pasteur MSD|| 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|K|1,5|0|1|0|1|NOE|0|0|0|100|DKK|152748|192039|lyfsjukr|||00|1|0|Vistor hf|Novartis Europharm Ltd|0,5| 522730|N02AX0204|Tradolan|töflur|50|mg|20|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|265|613|lyfalmen|||00|20|0|Vistor hf|Lannacher Heimittel Gmbh|3,33| 522771|N02AX0204|Tradolan|töflur|50|mg|100|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|1114|2378|lyfalmen|||00|100|0|Vistor hf|Lannacher Heimittel Gmbh|16,67| 522797|N02AX0204|Tradolan|töflur|50|mg|250|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|5598|9038|lyfalmen|||00|250|0|Vistor hf|Lannacher Heimittel Gmbh|208,3333| 522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|495|1091|lyfalmen|V0732|1091|02|10|0|Vistor hf|Lannacher Heimittel Gmbh|1,6667| 522839|D05AX0201|Daivonex|lausn|50|mcg/ml|120|ml|1|glas|í hársvörð|D05AX02|01.12.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|5110|8358|lyfalmen|||00|120|0|Vistor hf|LEO Pharma A/S|| 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|710|1538|lyfalmen|||00|100|0|Vistor hf|Sanofi-aventis Norge AS|100| 523886|L02BB0101|Eulexin|töflur|250|mg|84|stk|1|þpakki||L02BB01|01.01.1993||R|A|5|0|0|*|0|SCP|0|0|0|100|DKK|13721|20133|lyfalmen|||00|84|0|Vistor hf|Schering-Plough|28| 524694|C01DA0204|Nitromex|tungur.t|0,25|mg|30|stk|1|glas||C01DA02|01.12.1983||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|240|561|lyfalmen|||22|30|0|Actavis Group hf|Actavis Group hf|3| 524710|C01DA0204|Nitromex|tungur.t|0,5|mg|30|stk|1|glas||C01DA02|01.11.1981||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|223|526|lyfalmen|||22|30|0|Actavis Group hf|Actavis Group hf|6| 525014|M03BC5101|Norgesic|töflur|| |100|stk|1|þpakki||M03BC51|01.06.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|DKK|591|1291|lyfalmen|||00|100|0|Vistor hf|Meda AB (V)|29,2| 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|581|1270|lyfalmen|||00|15|0|Vistor hf|Novartis Healthcare A/S-|| 525147|M01AB0504|Klofen-L |forðahlk|100|mg|30|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|1532|3062|lyfalmen|||10|30|0|Actavis Group hf|Actavis hf|30| 525170|M01AB0504|Klofen-L |forðahlk|100|mg|100|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|5105|8351|lyfalmen|||10|100|0|Actavis Group hf|Actavis hf|100| 525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.03.2002||R|A|5|0|0|0|0|CPF|0|0|0|100|DKK|6350|10087|lyfalmen|||00|30|0|Icepharma hf|Cephalon France|10| 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|4193|7029|lyfalmen|||00|100|0|Icepharma hf|Roche|33,3333| 526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|2719|4864|lyfalmen|||10|100|0|Vistor hf|Desitin Artzneimittel|20| 526384|QJ01EW1001|Tribrissen, vet.|pasta|400|mg/g|37,5|g|5|spr|til inntöku|QJ01EW10|01.03.2007||R|A|5|0|0|0|0|SPA|0|0|0|100|DKK|3831|7469|vetalmen|||16|187,5|0|Vistor hf|Schering-Plough A/S|| 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|2348|4301|lyfalmen|||10|100|0|Vistor hf|Desitin Artzneimittel|40| 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|A|3|0|0|0|1|SNO|0|0|0|100|NOK|8719|12483|lyfsjukr|||00|2000|0|Vistor hf|Sanofi-aventis Norge AS|6,6667| 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|A|2,5|0|0|E|0|ALC|0|0|0|100|USD|636|1385|lyfalmen|||00|5|0|K.Pétursson hf|Alcon|| 529263|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|SCP|0|0|0|100|DKK|1122|1606|lyfsjukr|||00|7|0|Vistor hf|Schering-Plough|1,75| 529438|QJ51RC2002|Ampiclox vet.|spenalyf|| |3|g|24|spr|spenadælur|QJ51RC20|01.06.1998||R|A|1.5|0|0|0|0|PFV|0|0|0|100|DKK|2458|4850|vetalmen|||16|72|0|Icepharma hf|Pfizer vet.|| 529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PFV|0|0|0|100|DKK|2117|4178|vetalmen|||16|100|0|Icepharma hf|Pfizer vet.|| 529586|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|SCP|0|0|0|100|DKK|2897|4148|lyfsjukr|||00|7|0|Vistor hf|Schering-Plough|7| 529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|K|2|0|0|0|1|PFI|0|0|0|100|DKK|45948|59073|lyfsjukr|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|11,1| 530030|J06BA0205|Sandoglobulin|irs|1|g/fl|1|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|6341|9079|lyfsjukr|||00|1|0|Icepharma hf|CSL Denmark ApS|| 530048|J06BA0205|Sandoglobulin|irs|3|g/fl|3|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|17195|23275|lyfsjukr|||00|3|0|Icepharma hf|CSL Denmark ApS|| 530055|J06BA0205|Sandoglobulin|irs|6|g/fl|6|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|34390|44683|lyfsjukr|||00|6|0|Icepharma hf|CSL Denmark ApS|| 530741|G03FA0105|Activelle|töflur|| |84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|1984|3748|lyfalmen|||23|84|0|Vistor hf|Novo-Nordisk|84| 531913|J05AG0101|Viramune|mixtúra|10|mg/ml|240|ml|1|fl||J05AG01|01.03.2007||R|A|2|0|1|0|1|BII|0|0|0|100|DKK|5208|7457|lyfsjukr|||00|240|0|Vistor hf|Boehringer Ingelheim Internationl |6| 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|A|5|0|0|0|0|JAS|0|0|0|100|SEK|206|491|lyfalmen|||01|30|0|Vistor hf|Janssen-Cilag AB|3| 535898|G04BD0401|Ditropan|töflur|5|mg|84|stk|1|þpakki||G04BD04|01.06.1998||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|3590|6151|lyfalmen|||00|84|0|Vistor hf|Sanofi-aventis Norge AS|28| 536029|S01EB0105|Isopto Carpine|augndr|10|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|185|447|lyfalmen|||06|10|0|K.Pétursson hf|Alcon|25| 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|224|528|lyfalmen|||06|10|0|K.Pétursson hf|Alcon|25| 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|286|657|lyfalmen|||06|10|0|K.Pétursson hf|Alcon|25| 536938|N04BC0102|Parlodel |hylki|5|mg|100|stk|1|þpakki||N04BC01|01.05.1983||R|A|4|0|0|E|0|MAS|0|0|0|100|DKK|8300|12787|lyfalmen|||52|100|0|Icepharma hf|Meda AS|12,5| 537373|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|2|g|1|spr||QP52AF02|01.07.1995||L|A|3|0|0|0|0|PFI|0|0|0|100|DKK|208|360|vetorma|||16|2|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 537811|G03CA0401|Ovestin|sk-stil|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|601|1312|lyfalmen|||05|15|0|Icepharma hf|N.V. Organon|37,5| 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|81735|103628|lyfsjukr|||00|6|0|Gróco ehf|Serono Nordic|61,3953| 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|A|5|0|1|E|0|SNO|0|0|0|100|NOK|6470|10254|lyfalmen|||00|100|0|Vistor hf|Sanofi-aventis Norge AS|25| 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|101|272|lyfalmen|||00|25|0|Actavis Group hf|Actavis Group hf|5| 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|0|100|DKK|219|518|lyfalmen|||00|100|0|Actavis Group hf|Actavis Group hf|20| 539783|D01AC2001|Daktacort|krem|| |15|g|1|túpa||D01AC20|01.04.1986||L|K|3|0|0|0|0|JAS|0|0|1|100|SEK|||lyfalmen|||20|15|0|Vistor hf|Janssen-Cilag AB|15| 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|1462|2955|lyfalmen|||23|40|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|8| 540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|999|2139|lyfalmen|||00|250|0|Icepharma hf|Smith & Nephew|250| 540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.07.2000||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|4442|7392|lyfalmen|||06|15|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|| 541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|5465|8853|lyfalmen|||10|200|0|Swedish Orphan International AB|Sandoz GmbH (S)|60| 541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|12.10.2004||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|8852|13523|lyfalmen|||10|200|0|Swedish Orphan International AB|Sandoz GmbH (S)|100| 542803|C08DA0103|Isoptin retard|forðatfl|240|mg|28|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|860|1850|lyfalmen|||10|28|0|Vistor hf|Abbott Scandinavia AB|28| 543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|þpakki||C07AA03|01.12.1983||R|A|5|0|0|B|0|NOH|0|0|0|100|DKK|2529|4576|lyfalmen|||00|98|0|Vistor hf|Novartis Healthcare A/S-|65,3333| 543686|B02BD0203|ReFacto|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2003||R|K|2|0|0|0|1|WTE|0|0|0|100|USD|13396|18546|lyfsjukr|||00|1|0|Icepharma hf|Wyeth Europe|0,5| 543827|B02BD0203|ReFacto|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2003||R|K|2|0|0|0|1|WTE|0|0|0|100|USD|26545|34916|lyfsjukr|||00|1|0|Icepharma hf|Wyeth Europe|1,43| 543835|B02BD0203|ReFacto|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2003||R|K|2|0|0|0|1|WTE|0|0|0|100|USD|52732|67519|lyfsjukr|||00|1|0|Icepharma hf|Wyeth Europe|2| 543850|B02BD0203|ReFacto|sts|2000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.04.2004||R|K|2|0|0|0|1|WTE|0|0|0|100|USD|95877|121234|lyfsjukr|||00|1|0|Icepharma hf|Wyeth Europe|4| 543926|D11AC0302|Selsun Blue|hársápa|10|mg/ml|120|ml|1|glas||D11AC03|01.08.1984||L|A|3|0|0|0|0|CHT|0|0|0|100|DKK|||lyflausa|||01|120|0|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|120| 544502|G03GA0501|Gonal-F|sts|37,5|ae/lykju|10|lyk|1|pakki|+ leysir 1 ml|G03GA05|01.02.2002||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|15125|21881|lyfalmen|||00|10|0|Gróco ehf|Serono Nordic|5| 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|A|2|0|0|0|0|GSK|0|0|1|100|SEK|495|1091|lyfalmen|||00|15|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|15| 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LUN|0|1|0|100|DKK|684|1484|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|6,6667| 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|5|0|0|*|0|LUN|0|1|0|100|DKK|1819|3497|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|33,3333| 545996|V01AA0507|Alutard SQ, birkifrjo|stl|| |5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|17371|24677|lyfalmen|||02|20|0|Vistor hf|ALK-Abello A/S|| 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|14005|20486|lyfalmen|||02|5|0|Vistor hf|ALK-Abello A/S|| 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|| |5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|17474|24805|lyfalmen|||02|20|0|Vistor hf|ALK-Abello A/S|| 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|14844|21531|lyfalmen|||02|5|0|Vistor hf|ALK-Abello A/S|| 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|A|5|0|0|0|0|ORC|0|0|0|30|DKK|1437|2917|lyfalmen|||23|60|0|Vistor hf|Orion Corporation|15| 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|DKK|7012|10039|lyfsjukr|||00|100|0|GlaxoSmithKline ehf|Glaxo Group Limited|0,38| 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|DKK|2311|3309|lyfsjukr|||00|10|0|GlaxoSmithKline ehf|Glaxo Group Limited|0,1| 547729|G03GA0601|Puregon|stl|100|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|4926|8097|lyfalmen|||63|0,5|0|Icepharma hf|N.V. Organon|0,6667| 547869|G03GA0601|Puregon|stl|150|ae/hgl|0,5|ml|5|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|30631|41186|lyfalmen|||63|2,5|0|Icepharma hf|N.V. Organon|5| 547893|G03GA0601|Puregon|stl|50|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|2530|4577|lyfalmen|||63|0,5|0|Icepharma hf|N.V. Organon|0,3333| 547901|G03GA0601|Puregon|stl|50|ae/hgl|0,5|ml|5|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|12316|18384|lyfalmen|||63|2,5|0|Icepharma hf|N.V. Organon|1,6667| 548297|A08AA1001|Reductil|hylki|10|mg|98|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|9881|14894|lyfalmen|||00|98|0|Vistor hf|Abbott Laboratories A/S|98| 548347|A08AA1001|Reductil|hylki|15|mg|98|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|9881|14894|lyfalmen|||00|98|0|Vistor hf|Abbott Laboratories A/S|147| 548511|J01CF0101|Diclocil|sts/irs|500|mg|1|stk|10|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|1207|1728|lyfsjukr|||03|10|0|Vistor hf|Bristol-Myers Squibb|2,5| 548776|M05BA0701|Optinate|filmhtfl|5|mg|28|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|AVP|0|0|0|100|NOK|3359|5814|lyfalmen|||00|28|0|Vistor hf|Aventis Pharma |28| 548784|M05BA0701|Optinate|filmhtfl|5|mg|84|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|AVP|0|0|0|100|NOK|9170|13946|lyfalmen|||00|84|0|Vistor hf|Aventis Pharma |84| 548792|M05BA0701|Optinate|filmhtfl|30|mg|28|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|AVP|0|0|0|100|NOK|23505|32314|lyfalmen|||00|28|0|Vistor hf|Aventis Pharma |168| 549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|59622|76097|lyfsjukr|||17|1|0|Vistor hf|Abbott Laboratories Ltd|| 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|5160|8428|lyfalmen|||02|5|0|Vistor hf|Janssen-Cilag AB|151,5152| 549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|99185|125353|lyfsjukr|||17|1|0|Vistor hf|Abbott Laboratories Ltd|| 550020|J07AP0302|Typherix|bóluefni|50|mcg/ml|0,5|ml|1|spr|einnota sprauta|J07AP03|01.10.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|SEK|1442|2925|lyfalmen|||00|0,5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 550061|N02BE0102|Panodil Brus|freyðit|500|mg|24|stk|1|þpakki||N02BE01|01.04.1992||L|A|4|0|0|0|0|GCH|0|0|1|100|DKK|||lyfalmen|||00|24|0|Icepharma hf|GlaxoSmithKline CH A/S|4| 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|A|3|0|0|0|0|GCH|0|0|1|100|DKK|||lyfalmen|||00|60|0|Icepharma hf|GlaxoSmithKline CH A/S|0,48| 550731|N02BE0103|Panodil Junior|eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GCH|0|0|1|100|DKK|||lyfalmen|||00|10|0|Icepharma hf|GlaxoSmithKline CH A/S|0,4167| 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|1012|2166|lyfalmen|||03|1|0|Icepharma hf|Meda AB|2,6667| 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|2534|4583|lyfalmen|||00|100|0|Icepharma hf|Meda AB|50| 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|JAS|0|0|0|30|SEK|1671|3273|lyfalmen|||00|28|0|Vistor hf|Janssen-Cilag AB|14| 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|JAS|0|0|0|30|SEK|2792|4975|lyfalmen|||00|56|0|Vistor hf|Janssen-Cilag AB|28| 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|A|2|0|0|E|0|JAS|0|0|0|30|SEK|1480|2983|lyfalmen|||00|14|0|Vistor hf|Janssen-Cilag AB|14| 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|JAS|0|0|0|30|SEK|2586|4662|lyfalmen|||00|28|0|Vistor hf|Janssen-Cilag AB|28| 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|JAS|0|0|0|30|SEK|5174|8447|lyfalmen|||00|56|0|Vistor hf|Janssen-Cilag AB|56| 551960|H01CB0301|Ipstyl Depot|sts|| |30|mg|1|hgl|+ lykja m/leysi|H01CB03|01.05.2000||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|53937|69019|lyfsjukr|||00|30|0|Icepharma hf|Institut Produits Synthése (IPSEN) AB|10| 552224|C08CA0501|Adalat|töflur|20|mg|100|stk|1|þpakki||C08CA05|01.04.1985||R|A|5|0|0|B|0|BHC|0|0|0|100|DKK|2339|4287|lyfalmen|||63|100|0|Vistor hf|Bayer HealthCare AG|66,6667| 552703|M01AB0509|Modifenac|forðahlk|75|mg|10|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|345|780|lyfalmen|||00|10|0|Actavis Group hf|Actavis Group hf|7,5| 552877|N05CF0104|Zopiklon Merck NM|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|A|2|0|0|0|0|MNA|0|0|0|100|SEK|2982|5264|lyfalmen|||00|500|0|Merck NM|Merck NM AB|500| 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|2009|3786|lyfalmen|||00|100|0|Vistor hf|Novartis Healthcare A/S-|15| 552919|N03AF0201|Trileptal|filmhtfl|300|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1994|3763|lyfalmen|||00|50|0|Vistor hf|Novartis Healthcare A/S-|15| 553313|N02CC0601|Relpax|töflur|40|mg|3|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|1369|2814|lyfalmen|||00|3|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|3| 553339|N02CC0601|Relpax|töflur|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2718|4863|lyfalmen|||00|6|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|6| 554154|QA12CE9902|Selevitan, vet.|stl|| |100|ml|5|hgl||QA12CE99|01.05.1983||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|4164|8103|vetalmen|||27|500|0|Vistor hf|Boehringer Ingelheim Danmark|| 554832|N02BE0101|Panodil|töflur|500|mg|48|stk|1|þpakki||N02BE01|01.07.1994||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|155|385|lyfalmen|||00|48|0|Icepharma hf|GlaxoSmithKline CH A/S|8| 555607|N06AB0601|Zoloft|mixtúra|20|mg/ml|60|ml|1|fl||N06AB06|01.03.2001||R|A|3|0|0|B|0|PFI|0|1|0|30|DKK|2883|5114|lyfalmen|||00|60|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|24| 556571|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|| |500|ml|12|plpok|Excel umbúðir|B05BB02|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2245|3214|lyfsjukr|||00|6000|0|Icepharma hf|Fresenius Kabi|6| 556589|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1814|2597|lyfsjukr|||00|6000|0|Icepharma hf|Fresenius Kabi|6| 556654|B05BA0313|Glucos 500 mg/ml Fresenius Kabi|irl|500|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.05.2004||R|A|1|0|0|0|1|FRP|0|0|0|100|DKK|3491|4998|lyfsjukr|||00|6000|0|Icepharma hf|Fresenius Kabi|6| 556662|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3041|4354|lyfsjukr|||00|6000|0|Icepharma hf|Fresenius Kabi|| 556738|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2181|3123|lyfsjukr|||00|6000|0|Icepharma hf|Fresenius Kabi|6| 556753|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2028|2904|lyfsjukr|||00|6000|0|Icepharma hf|Fresenius Kabi|6| 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3331|5773|lyfalmen|||00|100|0|Vistor hf|Novartis Healthcare A/S-|30| 556944|N03AF0201|Trileptal|filmhtfl|600|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3866|6553|lyfalmen|||00|50|0|Vistor hf|Novartis Healthcare A/S-|30| 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|6882|10829|lyfalmen|||00|100|0|Vistor hf|Novartis Healthcare A/S-|60| 557546|D10AF0202|Zineryt|áburður|| |30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|A|2|0|0|0|0|ASP|0|0|0|100|XEU|935|2006|lyfalmen|||38|30|0|Vistor hf|Astellas Pharma A/S|30| 558585|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|10|hgl|röntgenskuggaefni|V08CA01|01.07.1992||R|A|5|0|0|0|1|SAG|0|0|0|100|SEK|99185|125353|lyfsjukr|||02|200|0|Icepharma hf|Schering AG|| 559013|C08DA0103|Isoptin retard|forðatfl|120|mg|28|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|563|1233|lyfalmen|||10|28|0|Vistor hf|Abbott Scandinavia AB|14| 559021|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|1350|2785|lyfalmen|||10|98|0|Vistor hf|Abbott Scandinavia AB|49| 559062|N02AX0201|Nobligan|hylki|50|mg|100|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|814|1755|lyfalmen|V0731|1110|10|100|0|Icepharma hf|Grunenthal|16,6667| 559070|N02AX0201|Nobligan|hylki|50|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|337|763|lyfalmen|V0730|671|10|20|0|Icepharma hf|Grunenthal|3,3333| 559104|N02AX0201|Nobligan|eþ-stil|100|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|957|2052|lyfalmen|||04|20|0|Icepharma hf|Grunenthal|6,6667| 559120|N02AX0201|Nobligan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|540|1185|lyfalmen|V0732|1091|02|10|0|Icepharma hf|Grunenthal|1,6667| 559146|J06BA0201|Gammagard S/D|irs|0,5|g/fl|1|fl|1|pakki|+ leysir 10 ml|J06BA02|01.10.1991||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|2258|3233|lyfsjukr|||00|1|0|Icepharma hf|Baxter|| 559153|J06BA0201|Gammagard S/D|irs|2,5|g/fl|1|fl|1|pakki|+ leysir 50 ml|J06BA02|01.10.1991||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|11292|15926|lyfsjukr|||00|1|0|Icepharma hf|Baxter|| 559161|J06BA0201|Gammagard S/D|irs|5|g/fl|1|fl|1|pakki|+ leysir 96 ml|J06BA02|01.10.1991||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|22587|29988|lyfsjukr|||00|1|0|Icepharma hf|Baxter|| 559187|J06BA0201|Gammagard S/D|irs|10|g/fl|1|fl|1|pakki|+ leysir 192 ml|J06BA02|01.10.1991||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|45167|58100|lyfsjukr|||00|1|0|Icepharma hf|Baxter|| 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|XEU|||lyfalmen|||00|100|0|Icepharma hf|STADA Arzneimittel AG|100| 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|1395|2853|lyfalmen|||06|5|0|Icepharma hf|Santen Oy|| 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|XEU|||lyfalmen|||00|100|0|Icepharma hf|STADA Arzneimittel AG|| 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|4076|6859|lyfalmen|||23|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|90| 559963|C01DA0201|Discotrine|forðapl|5|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|DKK|1529|3057|lyfalmen|||23|30|0|Vistor hf|Meda AB (V)|30| 559971|C01DA0201|Discotrine|forðapl|10|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|DKK|1688|3298|lyfalmen|||23|30|0|Vistor hf|Meda AB (V)|60| 559989|N01AB0701|Suprane|innönd.l|| |240|ml|1|fl||N01AB07|01.01.1995||R|A|3|0|0|0|1|BAX|0|0|0|100|DKK|5703|8165|lyfsjukr|||00|240|0|Icepharma hf|Baxter|| 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|A|3|0|0|E|0|GEM|0|0|0|100|XEU|369|829|lyfalmen|||07|10|0|Actavis Group hf|Gerhard Mann|| 560193|C09AA0101|Capoten|töflur|12,5|mg|100|stk|1|þpakki||C09AA01|01.07.1990||R|A|4|0|0|B|0|BRS|0|0|0|100|DKK|1092|2333|lyfalmen|||00|100|0|Vistor hf|Bristol-Myers Squibb|25| 560235|C09AA0101|Capoten|töflur|25|mg|100|stk|1|þpakki||C09AA01|01.04.1995||R|A|4|0|0|B|0|BRS|0|0|0|100|DKK|1629|3209|lyfalmen|V0162|2747|00|100|0|Vistor hf|Bristol-Myers Squibb|50| 560250|C09AA0101|Capoten|töflur|50|mg|100|stk|1|þpakki||C09AA01|01.04.1995||R|A|4|0|0|B|0|BRS|0|0|0|100|DKK|2793|4977|lyfalmen|V0166|4187|00|100|0|Vistor hf|Bristol-Myers Squibb|100| 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.07.1989||R|A|5|0|0|E|0|GSK|0|0|1|30|GBP|2044|3839|lyfalmen|||00|25|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|1,25| 560334|J05AB0102|Zovir|töflur|200|mg|100|stk|1|þpakki||J05AB01|01.07.1994||R|A|5|0|0|E|0|GSK|0|0|1|30|GBP|8050|12454|lyfalmen|||00|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|5| 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|1166|2487|lyfalmen|||07|4,5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|30|GBP|3896|6596|lyfalmen|||00|125|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|1,25| 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|30|GBP|4225|7076|lyfalmen|||00|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|2| 560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|K|3|0|1|0|1|ABS|0|0|0|100|DKK|62216|79326|lyfsjukr|||00|5|0|Vistor hf|Abbott Scandinavia AB|1,14| 560557|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|K|3|0|1|0|1|ABS|0|0|0|100|DKK|327920|410128|lyfsjukr|||00|20|0|Vistor hf|Abbott Scandinavia AB|4,55| 560615|L01CD0101|Taxol|stl/irþ|6|mg/ml|50|ml|1|hgl||L01CD01|01.06.2001||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|141819|178432|lyfsjukr|||00|50|0|Vistor hf|Bristol-Myers Squibb|| 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|1399|2859|lyfalmen|||06|5|0|Icepharma hf|Santen Oy|| 561571|N06AX1101|Remeron|töflur|30|mg|250|stk|1|glas|til notkunar vélskömmtun lyfja|N06AX11|01.11.2002||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|19142|26882|lyfalmen|||00|250|0|Icepharma hf|N.V. Organon|250| 563346|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|3|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|14305|20860|lyfalmen|||02|6|0|Gróco ehf|Nycomed Danmark A/S|17,1667| 563361|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|5|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|22021|30466|lyfalmen|||02|10|0|Gróco ehf|Nycomed Danmark A/S|28,6111| 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|455|1008|lyfalmen|||20|30|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30| 563387|D07AC1701|Cutivat|krem|0,5|mg/g|100|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1411|2878|lyfalmen|||20|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|100| 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|455|1008|lyfalmen|||20|30|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30| 563403|D07AC1701|Cutivat|smyrsli|50|mcg/g|100|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1411|2878|lyfalmen|||20|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|100| 563494|N02AA0101|Contalgin|forðatfl|5|mg|25|stk|1|þpakki||N02AA01|01.10.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|316|719|lyfalmen|||10|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|1,25| 563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|948|2033|lyfalmen|||10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|5| 563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|118294|150326|lyfalmen|||02|60|0|Gróco ehf|Nycomed Danmark A/S|171,6667| 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|2805|4995|lyfalmen|||00|15|0|Icepharma hf|Santen Oy|| 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|2955|5223|lyfalmen|||00|15|0|Icepharma hf|Santen Oy|| 563684|C10AA0401|Lescol|hylki|20|mg|98|stk|1|þpakki||C10AA04|01.10.1997||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|5075|8309|lyfalmen|||00|98|0|Vistor hf|Novartis Healthcare A/S-|49| 563700|C10AA0401|Lescol|hylki|40|mg|98|stk|1|þpakki||C10AA04|01.10.1997||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|6425|10192|lyfalmen|||00|98|0|Vistor hf|Novartis Healthcare A/S-|98| 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|þpakki|hart|J05AB04|01.02.2002||R|A|2|0|1|0|1|SCP|0|0|0|30|DKK|87236|110476|lyfsjukr|||00|168|0|Vistor hf|Schering-Plough|33,6| 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|A|4|0|0|B|0|UCB|0|0|0|100|DKK|6638|10489|lyfalmen|||00|100|0|Vistor hf|U.C.B|50| 566018|D01BA0201|Lamisil|töflur|125|mg|14|stk|1|þpakki||D01BA02|01.07.1995||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|2313|4248|lyfalmen|||00|14|0|Vistor hf|Novartis Healthcare A/S-|7| 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|710|1538|lyfalmen|||06|5|0|K.Pétursson hf|Alcon|25| 566661|L04AB0101|Enbrel|sts|| |25|mg|4|hgl|+ leysir|L04AB01|01.11.2000||R|K|3|0|1|0|1|WTE|0|0|0|100|USD|45943|59067|lyfsjukr|||00|100|0|Icepharma hf|Wyeth Europe|14,29| 566984|A10BG0201|Avandia|töflur|4|mg|28|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|SEK|3231|5628|lyfalmen|||00|28|0|GlaxoSmithKline ehf|SmithKline Beecham PLC|18,6667| 566992|J02AC0101|Diflucan|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.10.1993||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|3322|5760|lyfalmen|V0556|4954|10|4|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|3| 567016|R06AD0201|Phenergan|mixtúra|1|mg/ml|100|ml|1|glas||R06AD02|01.10.1995||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|943|2023|lyfalmen|||00|100|0|Vistor hf|Sanofi-aventis Norge AS|4| 567073|A10BG0201|Avandia|töflur|4|mg|56|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|SEK|5372|8723|lyfalmen|V0005|8575|00|56|0|GlaxoSmithKline ehf|SmithKline Beecham PLC|37,3333| 567149|A10BG0201|Avandia|töflur|8|mg|28|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|SEK|4793|7903|lyfalmen|||00|28|0|GlaxoSmithKline ehf|SmithKline Beecham PLC|37,3333| 567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|3703|6315|lyfalmen|V0791|5577|00|60|0|Vistor hf|Janssen-Cilag AB|12| 567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|8152|12590|lyfalmen|V0793|10353|00|60|0|Vistor hf|Janssen-Cilag AB|24| 567529|N05AX0801|Risperdal|töflur|3|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|13549|19919|lyfalmen|V0794|13952|00|60|0|Vistor hf|Janssen-Cilag AB|36| 567537|N05AX0801|Risperdal|töflur|4|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|17952|25400|lyfalmen|V0795|21546|00|60|0|Vistor hf|Janssen-Cilag AB|48| 567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|A|3|0|0|0|0|JAS|0|0|1|100|SEK|||lyfalmen|||24|15|0|Vistor hf|Janssen-Cilag AB|12,5| 567719|C10AA0302|Pravachol|töflur|40|mg|98|stk|1|þpakki||C10AA03|01.06.1998||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|12051|18054|lyfalmen|||00|98|0|Vistor hf|Bristol-Myers Squibb|196| 568238|A02BC0401|Pariet|sh-tfl|20|mg|120|stk|1|þpakki||A02BC04|01.05.2002||R|A|2|0|0|E|0|JAS|0|0|0|30|SEK|10569|15810|lyfalmen|||00|120|0|Vistor hf|Janssen-Cilag AB|120| 568493|L01CD0101|Taxol|irþ|6|mg/ml|5|ml|1|hgl||L01CD01|01.04.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|14640|20094|lyfsjukr|||00|5|0|Vistor hf|Bristol-Myers Squibb|| 568501|L01CD0101|Taxol|irþ|6|mg/ml|5|ml|10|hgl||L01CD01|01.04.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|148176|186347|lyfsjukr|||00|50|0|Vistor hf|Bristol-Myers Squibb|| 568519|N05AB0301|Trilafon|töflur|8|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|1157|2468|lyfalmen|||00|100|0|Vistor hf|Schering-Plough|26,6667| 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|A|3|0|0|0|0|GSK|0|0|1|100|SEK|736|1593|lyfalmen|||00|3|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|10220|14591|lyfsjukr|||02|5|0|Vistor hf|Novartis Healthcare A/S-|18,18| 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|5|0|0|0|1|NOH|0|0|0|100|DKK|10220|14591|lyfsjukr|||02|20|0|Vistor hf|Novartis Healthcare A/S-|18,18| 569897|J07AJ5204|DiTeKik|bóluefni|| |0,5|ml|1|spr|án nálar|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|1320|2739|lyfalmen|||51|0,5|0|Icepharma hf|Statens Serum Institut|| 569913|J07CA0203|DiTeKiPol|bóluefni|| |0,5|ml|1|spr|án nálar|J07CA02|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|1880|3590|lyfalmen|||51|0,5|0|Icepharma hf|Statens Serum Institut|| 572768|B02BC1001|Tisseel Duo Quick|vefjalím|| |0,5|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|80989|102699|lyfsjukr|||00|5|0|Icepharma hf|Baxter|| 572776|B02BC1001|Tisseel Duo Quick|vefjalím|| |1|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|106009|133849|lyfsjukr|||00|10|0|Icepharma hf|Baxter|| 572784|B02BC1001|Tisseel Duo Quick|vefjalím|| |2|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|199431|250159|lyfsjukr|||00|20|0|Icepharma hf|Baxter|| 573287|G03CA0306|Evorel|forðapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|2203|4081|lyfalmen|||23|26|0|Vistor hf|Janssen-Cilag AB|45,5| 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|58700|74949|lyfsjukr|||00|1|0|Icepharma hf|Roche|| 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|þpakki||M01AB05|01.01.1996||R|A|5|0|0|0|0|NOH|0|0|1|100|DKK|2030|3818|lyfalmen|V0610|3090|67|100|0|Vistor hf|Novartis Healthcare A/S-|50| 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PFI|0|1|0|30|DKK|2271|4184|lyfalmen|V0931|3084|00|28|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|28| 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PFI|0|1|0|30|DKK|7630|11872|lyfalmen|V0933|8732|00|98|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|98| 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PFI|0|1|0|30|DKK|3545|6085|lyfalmen|V0935|4755|00|28|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|56| 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PFI|0|1|0|30|DKK|12280|18339|lyfalmen|V0937|14070|00|98|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|196| 575506|C01EB1001|Adenocor|stl|3|mg/ml|2|ml|6|hgl||C01EB10|01.11.2007||R|A|3|0|0|0|1|SAA|0|0|0|100|NOK|3583|5130|lyfsjukr|||00|12|0|Vistor hf|Sanofi - Aventis|| 575787|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.12.2000||R|K|3|0|1|0|1|CEO|0|0|0|100|DKK|54774|70061|lyfsjukr|||00|1|0|Vistor hf|Centocor B.V.|26,67| 577494|M05BA0101|Didronate|töflur|200|mg|28|stk|1|þpakki||M05BA01|01.04.1996||R|A|4|0|0|E|0|PGA|0|0|0|100|DKK|3666|6261|lyfalmen|||00|28|0|Sofus Consulting AB|Procter & Gamble-|14| 579854|L04AX0301|Methotrexate Wyeth Lederle|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|A|3|0|0|*|0|WAB|0|0|0|100|USD|452|1002|lyfalmen|||00|30|0|Icepharma hf|Wyeth AB|30| 582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PFV|1|0|0|100|DKK|2932|5074|vetorma|||16|50|0|Icepharma hf|Pfizer vet.|| 582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PFV|1|0|0|100|DKK|10755|18612|vetorma|||16|200|0|Icepharma hf|Pfizer vet.|| 583443|C07AA0704|Sotalol Merck NM|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|646|1405|lyfalmen|V0272|1405|00|100|0|Merck NM|Merck NM AB|50| 583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2758|3949|lyfsjukr|||00|5000|0|Icepharma hf|Fresenius Kabi|5| 583856|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1138|1629|lyfsjukr|||00|9000|0|Icepharma hf|Fresenius Kabi|9| 583914|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|30|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|4201|6015|lyfsjukr|||00|1500|0|Icepharma hf|Fresenius Kabi|| 583922|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3355|4804|lyfsjukr|||00|5000|0|Icepharma hf|Fresenius Kabi|5| 583930|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1674|2397|lyfsjukr|||00|9000|0|Icepharma hf|Fresenius Kabi|9| 584011|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|30|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4786|6852|lyfsjukr|||00|3000|0|Icepharma hf|Fresenius Kabi|3| 584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1893|2710|lyfsjukr|||00|9000|0|Icepharma hf|Fresenius Kabi|9| 584102|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2257|3231|lyfsjukr|||00|9000|0|Icepharma hf|Fresenius Kabi|| 584276|B05BB0115|Ringer-acetat Fresenius Kabi|irl|| |1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1276|1827|lyfsjukr|||00|9000|0|Icepharma hf|Fresenius Kabi|9| 585646|B01AB0101|Heparin Leo|stl|25000|ae/ml|2|ml|10|hgl||B01AB01|01.11.1981||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|5714|8181|lyfsjukr|||02|20|0|Vistor hf|LEO Pharma A/S|50| 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|2081|2979|lyfsjukr|||02|25|0|Vistor hf|LEO Pharma A/S|12,5| 585844|J01DH5101|Tienam|irs|500|mg|12|hgl|1|pakki|monovial|J01DH51|01.04.1988||R|A|2|0|0|0|1|MSD|0|0|0|100|XEU|20476|27360|lyfsjukr|||00|12|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|3| 585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|K|3|0|0|0|0|GSK|0|0|0|100|SEK|2441|4442|lyfalmen|||02|1|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|19815|27720|lyfalmen|||00|50|0|Vistor hf|Novartis Healthcare A/S-|20| 586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|1509|3027|lyfalmen|||20|100|0|Vistor hf|Astellas Pharma A/S|100| 587667|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|| |1000|ml|9|plpok|Excel umbúðir|B05BB02|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1774|2540|lyfsjukr|||00|9000|0|Icepharma hf|Fresenius Kabi|9| 588152|S01GX0401|Tilavist|augndr|20|mg/ml|5|ml|1|glas||S01GX04|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|862|1854|lyfalmen|||06|5|0|Vistor hf|Sanofi-aventis Norge AS|| 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|2018|3800|lyfalmen|V0426|3693|43|20|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|5| 588590|B01AC0501|Ticlid|töflur|250|mg|30|stk|1|þpakki||B01AC05|01.04.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|2413|4400|lyfalmen|||00|30|0|Vistor hf|Sanofi-aventis Norge AS|15| 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|þpakki||B01AC05|01.04.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|7602|11833|lyfalmen|||00|100|0|Vistor hf|Sanofi-aventis Norge AS|50| 588772|H05BA0103|Miacalcic Nasal|nefúði|200|ae/sk|2|ml|1|úðagl|14 skammt|H05BA01|01.03.2002||R|K|3|0|0|E|0|NOH|0|0|0|100|DKK|5029|8245|lyfalmen|||23|2|0|Vistor hf|Novartis Healthcare A/S-|14| 589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3400|5884|vetorma|||16|3|0|Icepharma hf|Pfizer Animal Health|| 589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|1354|2343|vetorma|||16|0,75|0|Icepharma hf|Pfizer Animal Health|| 589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3369|5830|vetorma|||16|6|0|Icepharma hf|Pfizer Animal Health|| 589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|1820|3150|vetorma|||16|0,75|0|Icepharma hf|Pfizer Animal Health|| 589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|1891|3272|vetorma|||16|1,5|0|Icepharma hf|Pfizer Animal Health|| 589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|1464|2534|vetorma|||16|2,25|0|Icepharma hf|Pfizer Animal Health|| 589911|L01BB0501|Fludara|sts|50|mg/hgl|50|mg|5|hgl||L01BB05|01.01.1996||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|89436|113215|lyfsjukr|||00|250|0|Icepharma hf|Bayer Schering Pharma AG|| 590315|J05AE0301|Norvir|hylki|100|mg|84|stk|4|glös|mjúk hylki|J05AE03|01.08.2003||R|K|2|0|1|0|1|ABL|0|0|0|100|DKK|49172|63087|lyfsjukr|||00|336|0|Vistor hf|Abbott Laboratories A/S|28| 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|A|3|0|0|0|0|BAS|0|0|1|100|DKK|||lyfalmen|||00|20|0|Vistor hf|Bayer A/S|20| 590752|N05AF0102|Fluanxol Depot|stl|100|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1979||R|A|4|0|0|*|0|LUN|0|1|0|100|DKK|15185|21956|lyfalmen|||02|10|0|Lundbeck Export A/S|Lundbeck|250| 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|A|2|0|0|0|1|BOI|0|0|0|100|DKK|111986|141290|lyfsjukr|||00|1|0|Vistor hf|Boehringer Ingelheim|1,25| 592097|N01AF0301|Pentothal Natrium|sts|500|mg|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|1864|2669|lyfsjukr|||02|12|0|Vistor hf|Hospira Enterprises B.V.|| 592147|D05AX0301|Silkis|smyrsli|3|mcg/g|100|g|1|túpa||D05AX03|01.06.2001||R|A|3|0|0|B|0|GAN|0|0|0|100|XEU|3597|6161|lyfalmen|||00|100|0|Icepharma hf|Galderma Nordic AB|| 592378|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|500|ml|1|glas||D08AC02|01.10.1976||L|A|3|0|0|0|0|REM|0|0|0|100|SEK|||lyflausa|||00|500|0|Vistor hf|Regent Medical Overseas Limited|500| 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|371|834|lyfalmen|||00|50|0|Icepharma hf|Roche|3,125| 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|756|1634|lyfalmen|||00|150|0|Icepharma hf|Roche|9,375| 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|1002|2146|lyfalmen|||00|100|0|Icepharma hf|Roche|25| 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|11657|17259|lyfalmen|||03|12|0|Icepharma hf|Meda AB|32| 594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PFI|0|0|0|100|DKK|193|334|vetorma|||16|10|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 594721|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|10|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PFI|0|0|0|100|DKK|1611|2788|vetorma|||16|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|| 594903|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|1634|2339|lyfsjukr|||02|9000|0|Icepharma hf|Fresenius Kabi|| 594945|QA12CE9903|Selenevit, vet.|stl|26|mg/ml|100|ml|1|hgl|1+25 mg/ml|QA12CE99|01.09.1982||R|A|5|0|0|0|0|INI|0|0|0|100|CHF|436|860|vetalmen|||27|100|0|Icepharma hf|Intervet International B.V.|| 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|4990|7144|lyfsjukr|||02|5|0|Vistor hf|Novartis Healthcare A/S-|5| 595991|J07BB0201|Fluarix|bóluefni|| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|413|921|lyfalmen|||02|0,5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|| 596023|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|250|ml|1|glas||D08AC02|01.06.1982||L|A|3|0|0|0|0|REM|0|0|0|100|SEK|||lyflausa|||00|250|0|Vistor hf|Regent Medical Overseas Limited|250| 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|2226|4116|lyfalmen|||43|24|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|3| 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|573|1254|lyfalmen|||00|150|0|Vistor hf|Sanofi-aventis Norge AS|25| 908048|J07AM5201|Immunoglob. mot tetanus |bóluefni|250|ae|1,2|ml|1|hgl||J07AM52|01.01.1998||R|K||0|0|0|0|LDR|0|0|1|100|SEK|6324|10051|lyfalmen|||00|1,2|1|Parlogis hf|Parlogis - óskráð lyf|| 951005|G03CA0102|Etinylestradiol|töflur|25|mcg|21|stk|1|pakki||G03CA01|01.09.2002||R|A||0|0|E|0|LDR|0|0|0|100|IKR|405|904|lyfalmen|||00|21|1|Parlogis hf|Parlogis - óskráð lyf|21| 102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1994||R|A|2|0|0|0|1|ASZ|0|0|0|100|IKR|1272|1821|lyfsjukr|||02|50|0|Vistor hf|AstraZeneca UK Ltd|| 007609|C09CA0601|Atacand|töflur|4|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|1433|2911|lyfalmen|||00|28|0|Vistor hf|AstraZeneca A/S DK|14| 069842|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|932|2000|lyfalmen|||00|20|0|Icepharma hf|NordMedica A/S|5| 045896|N07BA0124|Nicotinell Mint (Lyfjaver) |tyggigúm|2|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|84|0|Lyfjaver ehf|Lyfjaver ehf|5,6| 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|IKR|5650|9111|lyfalmen|||00|12|0|Vistor hf|AstraZeneca UK Ltd|12| 043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|IKR|1831|2622|lyfsjukr|||00|100|0|Vistor hf|AstraZeneca A/S DK|| 370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|A|2|0|0|0|1|NOM|0|0|0|100|IKR|336|481|lyfsjukr|||03|1|0|Icepharma hf|NordMedica ApS|0,3333| 081589|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|1|0|Ísaga ehf|AGA AB|| 409748|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|1462|2955|lyfalmen|||43|98|0|Vistor hf|AstraZeneca A/S DK|73,5| 480863|G03XC0101|Evista|töflur|60|mg|28|stk|1|þpakki||G03XC01|01.02.1999||R|A|2|0|0|E|0|ELD|0|0|0|100|IKR|3063|5383|lyfalmen|||00|28|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|28| 414458|V04CF0102|Tuberkulin|stl|2|TU/0,1ml|1,5|ml|1|hgl||V04CF01|01.01.1998||R|K||0|0|0|0|LDR|0|0|0|100|IKR|1456|2946|lyfalmen|||00|1,5|1|Parlogis hf|Parlogis - óskráð lyf|| 045605|N07BA0122|Nicorette (Lyfjaver) |innsogsl|10|mg|42|rör|1|þpakki|+ munnstk|N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|42|0|Lyfjaver ehf|Lyfjaver ehf|7| 443655|L02AB0101|Megace|töflur|160|mg|112|stk|1|glas||L02AB01|01.05.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|28479|37324|lyfsjukr|||00|112|1|Vistor hf|Vistor - óskráð lyf|112| 066241|C03EA0103|Hydramil |töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.08.1984||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|238|557|lyfalmen|V0240|557|00|100|0|Actavis Group hf|Actavis hf|100| 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|E|0|ACA|0|0|1|100|IKR|254|590|lyfalmen|||00|10|0|Actavis Group hf|Actavis hf|10| 000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|IKR|11653|17254|lyfalmen|V0813|16944|00|28|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|28| 137513|S01XA2011|Oculac|augndr|| |10|ml|1|glas|með rotvörn|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|IKR|263|609|lyfalmen|||00|10|0|Vistor hf|Novartis Healthcare A/S-|| 476648|N05AH0401|Seroquel|töflur|100|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|IKR|4730|7811|lyfalmen|||00|30|0|Vistor hf|AstraZeneca UK Ltd|7,5| 108878|N02AX0203|Tramol|hylki|50|mg|100|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|504|1110|lyfalmen|V0731|1110|00|100|0|Actavis Group hf|Actavis hf|16,6667| 492876|G03BA0304|Atmos|forðapl|5|mg/sólh|30|stk|1|pakki||G03BA03|01.10.1998||R|A|2|0|0|0|0|AZD|0|0|0|100|IKR|5287|8605|lyfalmen|||00|30|0|Vistor hf|AstraZeneca A/S DK|50| 497305|C09AA0201|Daren |töflur|20|mg|30|stk|1|glas||C09AA02|01.07.1990||R|A|1,5|0|0|B|0|ACA|0|0|0|100|IKR|1157|2468|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|60| 129098|N05AH0301|Zyprexa|húðuðtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|IKR|17190|24452|lyfalmen|V0811|23595|00|56|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|42| 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|2079|3892|lyfalmen|V0984|3892|00|100|0|Actavis Group hf|Actavis hf|100| 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|K|3|0|0|0|1|CET|0|0|0|100|IKR|32643|42508|lyfsjukr|||00|5|0|Icepharma hf|Centocor -|0,4| 002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|IKR|9133|13897|lyfalmen|V0087|13653|00|100|0|Vistor hf|AstraZeneca A/S DK|66,67| 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|AZD|0|0|1|100|IKR|365|821|lyfalmen|||00|14|0|Vistor hf|AstraZeneca A/S DK|7| 166272|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|fl|plastfl.|V08AB09|01.05.1999||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|Icepharma hf|GE Healthcare AS|| 037192|M01AB0507|Vostar |sþ-tfl|50|mg|100|stk|1|glas||M01AB05|01.04.1988||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|890|1913|lyfalmen|V0608|1913|10|100|0|Actavis Group hf|Actavis hf|50| 336792|A03AA0701|Dicykloverinklorid |mixtúra|1|mg/ml|100|ml|1|glas|sykurlaus|A03AA07|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2125|3962|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|1,25| 388652|C09BA0201|Darazið|töflur|22,5|mg|30|stk|1|glas|10+12.5 mg|C09BA02|01.04.1998||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|960|2058|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|30| 589497|D11AF0102|Canthacur|lausn|0,7|%|7,5|ml|1|glas||D11AF01|01.01.1998||R|A||0|0|0|0|AUO|0|0|0|100|IKR|1578|3131|lyfalmen|||00|7,5|1|Icepharma hf|Icepharma - óskráð lyf|7,5| 107607|A02BA0201|Asyran |töflur|150|mg|60|stk|1|þpakki||A02BA02|01.07.1986||R|A|3|0|0|E|0|ACA|0|0|0|30|IKR|1214|2578|lyfalmen|||00|60|0|Actavis Group hf|Actavis hf|30| 193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|A|3|0|0|0|0|NHE|0|0|0|100|IKR|608|1326|lyfalmen|||14|20|0|Artasan ehf|Novartis Healthcare A/S-A|21,6| 189126|L02BB0301|Casodex|töflur|150|mg|30|stk|1|þpakki||L02BB03|01.05.2000||R|A|4|0|0|*|0|ASZ|0|0|0|100|IKR|36517|48514|lyfalmen|||00|30|0|Vistor hf|AstraZeneca UK Ltd|90| 012643|D10BA0102|Decutan|hylki|10|mg|50|stk|1|þpakki||D10BA01|01.04.2003||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|4108|6905|lyfalmen|||67|50|0|Actavis Group hf|Actavis hf|16,6667| 008334|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|5358|8704|lyfalmen|||00|98|0|Vistor hf|AstraZeneca A/S DK|98| 428813|C07AB0309|Atenolol Actavis|töflur|25|mg|30|stk|1|glas||C07AB03|01.01.1992||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|180|436|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|10| 001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|2967|5241|lyfalmen|||10|100|0|Actavis Group hf|Actavis hf|100| 076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|3196|5577|lyfalmen|V0791|5577|00|60|0|PortFarma ehf|PortFarma |12| 936825|D02AX0102|Lac Hydrin Vistor|áburður|5|%|113|g|1|plbrús||D02AX01|01.01.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|881|1894|lyfalmen|||00|113|1|Vistor hf|Vistor - óskráð lyf|113| 071134|N05AN0104|Litiumsitrat Actavis|töflur|500|mg|100|stk|1|glas||N05AN01|01.10.1995||R|A|5|0|0|*|0|ACA|0|1|0|100|IKR|728|1576|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|22,1631| 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|A|3|0|0|0|0|MET|0|0|0|100|IKR|||lyfalmen|||00|100|0|Vistor hf|Medic Team|| 475434|B01AA0301|Kovar |töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|562|1231|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|26,6667| 338236|C01CA0301|Noradrenalin|stl|1|mg/ml|2|ml|10|lykjur||C01CA03|01.01.2000||R|A||0|0|0|1|LDR|0|0|0|100|IKR|3940|5641|lyfsjukr|||00|20|1|Parlogis hf|Parlogis - óskráð lyf|3,3333| 043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|IKR|3346|4791|lyfsjukr|||00|100|0|Vistor hf|AstraZeneca A/S DK|| 051732|C08CA0104|Amlódipín PortFarma|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|2,5|0|0|B|0|POF|0|0|0|100|IKR|2246|4146|lyfalmen|V0308|4146|00|100|0|PortFarma ehf|PortFarma || 004481|J01MA0203|Siprox |töflur|500|mg|10|stk|1|glas||J01MA02|01.01.1994||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1209|2571|lyfalmen|V0522|2571|00|10|0|Actavis Group hf|Actavis hf|5| 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|IKR|3275|5692|lyfalmen|||00|28|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|28| 406025|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27592|lyfsjukr|||02|500|0|Icepharma hf|GE Healthcare AS|| 937203|D02AX0103|Lac Hydrin Parlogis|áburður|12|%|400|g|1|plbrús||D02AX01|01.05.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|7018|11018|lyfalmen|||00|400|1|Parlogis hf|Parlogis - óskráð lyf|400| 959801|N06BA0405|Ritalin LA|forðahlk|10|mg|100|stk|1|pakki||N06BA04|30.11.2007||R|A||1|0|0|0|PCO|0|0|0|100|IKR|7377|11519|lyfalmen|||00|100|0|Vistor hf|Vistor - óskráð lyf|33,33| 045915|N07BA0124|Nicotinell Mint (Lyfjaver) |tyggigúm|4|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|84|0|Lyfjaver ehf|Lyfjaver ehf|11,2| 152421|R03BA0202|Pulmicort Turbuhaler|innúðadu|400|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|ASZ|0|0|0|100|IKR|6277|9985|lyfalmen|||23|200|0|Vistor hf|AstraZeneca UK Ltd|100| 001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|14856|21546|lyfalmen|V0795|21546|00|60|0|Actavis Group hf|Actavis hf|48| 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|9263|14070|lyfalmen|V0937|14070|00|98|0|Actavis Group hf|Actavis hf|196| 955239|A11GA0108|Vitamin C 500|stl|100|mg/ml|5|ml|5|lykjur||A11GA01|01.01.2006||R|A||0|0|0|0|LDR|0|0|0|100|IKR|353|796|lyfalmen|||00|25|1|Parlogis hf|Parlogis - óskráð lyf|12,5| 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|682|1480|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|30| 194720|N03AX0901|Lamictal|dreifit.|5|mg|28|stk|1|þpakki||N03AX09|01.01.1996||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|639|1391|lyfalmen|||00|28|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|0,4667| 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|| |20|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||00|200|0|Icepharma hf|Fresenius Kabi|| 045960|N07BA0125|Nicotinell Fruit (Lyfjaver) |tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|204|0|Lyfjaver ehf|Lyfjaver ehf|27,2| 370254|N05BA0204|Klordiazepoxið Actavis|töflur|10|mg|25|stk|1|glas||N05BA02|01.10.1995||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|254|590|lyfalmen|||00|25|0|Actavis Group hf|Actavis hf|8,3333| 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|A|3|0|0|0|0|MUN|0|0|0|100|IKR|||lyfalmen|||00|500|0|Icepharma hf|Mundipharma|500| 939366|G03DA0402|Gestone|stl|50|mg/ml|1|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|7055|11070|lyfalmen|||00|10|1|Vistor hf|Vistor - óskráð lyf|100| 067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|7764|12059|lyfalmen|V0552|12059|10|30|0|Actavis Group hf|Actavis hf|7,5| 118307|A02BA0201|Asyran |töflur|150|mg|30|stk|1|þpakki||A02BA02|01.04.1994||L|A|3|0|0|E|0|ACA|0|0|0|30|IKR|981|2102|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|15| 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|IKR|8223|12685|lyfalmen|||00|28|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|14| 070342|V08AB0201|Omnipaque|stl|350|mg J/ml|100|ml|10|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|44276|56991|lyfsjukr|||02|1000|0|Icepharma hf|GE Healthcare AS|| 016744|N05AH0402|Seroquel (Lyfjaver)|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.09.2003||R|A|3|0|0|*|0|LVR|0|1|0|100|IKR|11248|16715|lyfalmen|V0726|16715|00|100|0|Lyfjaver ehf|Lyfjaver ehf|25| 107581|N02BE0106|Parasupp |eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.06.1984||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||04|10|0|Actavis Group hf|Actavis hf|0,4167| 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|Artasan ehf|Novartis Healthcare A/S-A|6,4| 020180|C03CC0101|Edecrin|sts|| |50|mg|1|hgl||C03CC01|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|337|482|lyfsjukr|||00|50|1|Parlogis hf|Parlogis - óskráð lyf|1| 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|7771|12068|lyfalmen|V0930|12068|00|100|0|Actavis Group hf|Actavis hf|200| 016693|N05AH0303|Zyprexa (Lyfjaver)|húðuðtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.09.2003||R|A|3|0|0|*|0|LVR|0|1|0|100|IKR|16502|23595|lyfalmen|V0811|23595|00|56|0|Lyfjaver ehf|Lyfjaver ehf|42| 116244|D11AF01|Verucid|áburður|| |10|ml|1|glas||D11AF|01.11.1981||L|K|2|0|0|0|0|GAN|0|0|0|100|IKR|||lyfalmen|||23|10|0|Icepharma hf|Galderma Nordic AB|10| 005330|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|fl|sprittl.|D08AG02|01.09.1982||L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyfalmen|||00|500|0|Icepharma hf|Napp|500| 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|53298|68224|lyfsjukr|||02|2000|0|Icepharma hf|GE Healthcare AS|| 016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|IKR|8120|12548|lyfalmen|||00|100|0|Vistor hf|AstraZeneca A/S DK|100| 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|777|1678|lyfalmen|V0982|1678|00|30|0|Actavis Group hf|Actavis hf|30| 953449|H02AB0904|Hydrocortone|töflur|20|mg|30|stk|1|glas||H02AB09|01.05.2004||R|A||0|0|E|0|LDR|0|0|1|100|IKR|406|906|lyfalmen|||00|30|1|Parlogis hf|Parlogis - óskráð lyf|20,1| 016066|R02AA0303|Strepsils Sukkerfri med Citron og Örter|sogtfl|| |24|stk|1|þpakki||R02AA03|01.10.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|| 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|IKR|2590|3708|lyfsjukr|||02|20|0|Vistor hf|AstraZeneca A/S DK|| 082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|DRL|0|0|0|100|IKR|2979|5259|lyfalmen|||00|100|0|Vistor hf|Draco Lakemedel AB|6,25| 104158|A02AD0101|Alminox|tuggutfl|600|mg|20|stk|1|glas|500+100mg|A02AD01|01.01.1986||L|A|5|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||11|20|0|Actavis Group hf|Actavis hf|2| 084699|P01BC0103|Kinin Actavis|töflur|250|mg|100|stk|1|glas||P01BC01|01.10.1995||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1626|3204|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|16,6667| 001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|1067|2281|lyfalmen|||10|30|0|Actavis Group hf|Actavis hf|30| 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|ASZ|0|0|0|100|IKR|31427|40994|lyfsjukr|||00|10|0|Vistor hf|AstraZeneca UK Ltd|5| 575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|S|2|0|0|0|0|NOP|0|0|0|100|IKR|||lyfalmen|||23|40|0|Icepharma hf|Norpharma || 557603|C08DB0108|Korzem-R |forðatfl|120|mg|100|stk|1|þpakki||C08DB01|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2295|4220|lyfalmen|||10|100|0|Actavis Group hf|Actavis hf|50| 383737|R06AX1301|Clarityn|freyðit|10|mg|10|stk|1|þpakki||R06AX13|01.10.1995||L|A|2|0|0|E|0|SCP|0|0|1|100|IKR|454|1006|lyfalmen|||00|10|0|Vistor hf|Schering-Plough|10| 108183|N02BE0106|Parasupp |eþ-stil|250|mg|10|stk|1|pakki||N02BE01|01.06.1984||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||04|10|0|Actavis Group hf|Actavis hf|0,8333| 535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|S|3|0|0|0|0|BPA|0|0|0|100|IKR|||lyfalmen|||00|100|0|Icepharma hf|Bioglan Pharma AB|| 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|E|0|ACA|0|0|1|100|IKR|295|676|lyfalmen|||00|10|0|Actavis Group hf|Actavis hf|10| 021046|L02AE0303|Zoladex Trimestral (D.A.C.)|vefjalyf|10,8|mg|1|stk|1|glas|+ dæla|L02AE03|01.11.2004||R|A|3|0|1|*|0|DAC|0|0|0|100|IKR|35161|46826|lyfalmen|V0438|46826|00|1|0|D.A.C. ehf|D.A.C. ehf|10,6| 947236|N06BC0101|Koffein|töflur|200|mg|50|stk|1|glas||N06BC01|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|749|1620|lyfalmen|||00|50|1|Parlogis hf|Parlogis - óskráð lyf|25| 938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|7401|11553|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|2| 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|Artasan ehf|Novartis Healthcare A/S-A|1,6| 944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|A||0|0|E|0|PCO|0|0|1|100|IKR|2969|5244|lyfalmen|||00|100|1|Vistor hf|Vistor - óskráð lyf|13,33| 252783|N02AA0201|Opium|dropar|100|mg/ml|90|g|1|glas||N02AA02|01.01.1998||R|A||1|0|E|0|LDR|0|0|0|100|IKR|2918|5167|lyfalmen|||00|90|1|Parlogis hf|Parlogis - óskráð lyf|| 021780|A07EA0602|Entocord (D.A.C.)|forðahlk|3|mg|50|stk|1|glas||A07EA06|01.05.2005||R|A|3|0|0|B|0|DAC|0|0|0|100|IKR|5199|8482|lyfalmen|||00|50|0|D.A.C. ehf|D.A.C. ehf|16,67| 952251|J01CA0101|Ampicillin |sts|| |500|mg|10|hgl||J01CA01|01.07.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1374|1967|lyfsjukr|||00|5000|1|Parlogis hf|Parlogis - óskráð lyf|2,5| 078717|N06AB0303|Serol |töflur|10|mg|100|stk|1|glas||N06AB03|01.04.1994||R|A|5|0|0|B|0|ACA|0|1|0|30|IKR|4110|6908|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|50| 582213|R01AA0503|Nezeril|nefúði|0,1|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|7,5|0|Vistor hf|AstraZeneca A/S DK|1,875| 582783|C07AB0205|Seloken|töflur|100|mg|28|stk|1|þpakki||C07AB02|01.12.2001||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|511|1125|lyfalmen|||00|28|0|Vistor hf|AstraZeneca A/S DK|18,6667| 181396|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|glas||M01AE01|01.01.1988||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|345|780|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|15| 401901|C09AA0103|Katopril|töflur|50|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2273|4187|lyfalmen|V0166|4187|00|100|0|Actavis Group hf|Actavis hf|100| 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1625|3203|lyfalmen|V0002|3203|00|90|0|Actavis Group hf|Actavis hf|90| 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|S|2|0|0|0|0|AZD|0|0|1|100|IKR|702|1522|lyfalmen|||17|100|0|Vistor hf|AstraZeneca A/S DK|| 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||23|60|0|Actavis Group hf|Actavis hf|60| 938376|N07BC0201|Metadon|hylki|40|mg|100|stk|1|glas||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|8233|12698|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|160| 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|Artasan ehf|Novartis Healthcare A/S-A|1,6| 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|36|0|Artasan ehf|Novartis Healthcare A/S-A|1,2| 099184|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|12|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|12|0|Artasan ehf|Novartis Healthcare A/S-A|0,8| 179333|R02AA0304|Strepsils Menthol|sogtfl|| |24|stk|1|þpakki||R02AA03|01.12.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|| 108845|R01AD0501|Rhinocort Aqua|nefúði|32|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|IKR|560|1227|lyfalmen|||24|120|0|Vistor hf|AstraZeneca A/S DK|19,2| 521757|L01XX0501|Hydrea|hylki|500|mg|100|stk|1|glas||L01XX05|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|8676|12422|lyfsjukr|||00|100|1|Vistor hf|Vistor - óskráð lyf|| 045924|N07BA0124|Nicotinell Mint (Lyfjaver) |tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|204|0|Lyfjaver ehf|Lyfjaver ehf|27,2| 011409|R03AK0703|Symbicort forte Turbuhaler|innúðadu|329|mcg/sk|60|sk|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|A|2|0|0|B|0|AZD|0|0|0|100|IKR|4968|8158|lyfalmen|||00|60|0|Vistor hf|AstraZeneca A/S DK|30| 462606|N05BA0204|Klordiazepoxið Actavis|töflur|25|mg|25|stk|1|glas||N05BA02|01.10.1995||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|440|977|lyfalmen|||00|25|0|Actavis Group hf|Actavis hf|20,8333| 045587|N07BA0122|Nicorette (Lyfjaver) |tungur.t|2|mg|105|stk|1|þpakki||N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|105|0|Lyfjaver ehf|Lyfjaver ehf|7| 021221|R03AC0303|Terbasmin Turbuhaler (D.A.C.)|innönddu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.11.2004||R|A|2|0|0|B|0|DAC|0|0|1|100|IKR|1116|2383|lyfalmen|V0987|2383|23|200|0|D.A.C. ehf|D.A.C. ehf|50| 386953|L02BG0301|Arimidex|töflur|1|mg|98|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|ASZ|0|0|0|100|IKR|32538|43560|lyfalmen|||00|98|0|Vistor hf|AstraZeneca UK Ltd|98| 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|IKR|7947|12314|lyfalmen|||00|98|0|Vistor hf|AstraZeneca A/S DK|98| 002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|veski|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|IKR|6018|9624|lyfalmen|||00|50|0|Vistor hf|AstraZeneca A/S DK|66,67| 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|Icepharma hf|GE Healthcare AS|| 007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|2259|4166|lyfalmen|V1075|4166|00|60|0|Actavis Group hf|Actavis hf|6| 944993|V03AB1702|Methylen Blue|stl|10|mg/ml|10|ml|10|lykjur||V03AB17|01.11.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|10030|14355|lyfsjukr|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|| 923351|S01XA2006|Lacri - Lube|augnsm|| |3,5|g|1|túpa||S01XA20|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|306|698|lyfalmen|||00|3,5|1|Vistor hf|Vistor - óskráð lyf|| 543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|7,5|0|Vistor hf|AstraZeneca A/S DK|9,375| 081571|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|2|0|Ísaga ehf|AGA AB|| 550939|B03BB0103|Folinsyra Actavis|töflur|5|mg|100|stk|1|glas||B03BB01|01.05.2006||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|428|952|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|100| 173948|N07AA0201|Mestinon|töflur|60|mg|150|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|5478|8871|lyfalmen|||00|150|1|Parlogis hf|Parlogis - óskráð lyf|50| 000770|V08BA0104|E-Z paste|pasta|60|%|1|lbs|1|pakki|til inntöku|V08BA01|01.01.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|2590|3708|lyfsjukr|||00|1|1|Parlogis hf|Parlogis - óskráð lyf|| 542977|J04BA0201|Dapson|töflur|50|mg|100|stk|1|glas||J04BA02|01.05.1998||R|A||0|1|E|0|AUO|0|0|0|100|IKR|736|1593|lyfalmen|||00|100|1|Icepharma hf|Icepharma - óskráð lyf|100| 152397|R03BA0202|Pulmicort Turbuhaler|innúðadu|100|mcg/sk|200|sk|1|stauk||R03BA02|01.04.1991||R|A|2|0|0|B|0|AZD|0|0|0|100|IKR|2838|5045|lyfalmen|||23|200|0|Vistor hf|AstraZeneca A/S DK|25| 533737|R03CC0303|Bricanyl Retard|forðatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|1262|2651|lyfalmen|||43|100|0|Vistor hf|AstraZeneca A/S DK|33,3333| 015301|M01AX0502|Glucosamin Pharma Nord |hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|0|0|lyfalmen|||00|270|0|Icepharma hf|Pharma Nord ApS|72| 003355|D01AE1501|Lamisil|úðalausn|10|mg/g|15|ml|1|fl|úðalausn á húð|D01AE15|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|15|0|Artasan ehf|Novartis Healthcare A/S-A|15| 170712|A07AA0901|Vancocin|hylki|125|mg|30|stk|1|þpakki|hart hylki|A07AA09|01.10.1988||R|A|2|0|0|E|0|NMA|0|0|1|100|IKR|10000|15052|lyfalmen|V0125|15052|10|30|0|Icepharma hf|NordMedica A/S|1,875| 018453|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|1|spr||L02BA03|01.06.2004||R|K|3|0|1|0|1|ASZ|0|0|0|100|IKR|39841|51470|lyfsjukr|||00|5|0|Vistor hf|AstraZeneca UK Ltd|| 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|204|0|Artasan ehf|Novartis Healthcare A/S-A|6,8| 020134|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|Artasan ehf|Novartis Healthcare A/S-A|12,8| 001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|6541|10353|lyfalmen|V0793|10353|00|60|0|Actavis Group hf|Actavis hf|24| 078709|N06AB0303|Serol |töflur|10|mg|30|stk|1|glas||N06AB03|01.04.1994||R|A|5|0|0|B|0|ACA|0|1|0|30|IKR|1226|2597|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|15| 577668|C07FB0201|Logimax|forðatfl|55|mg|28|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|2109|3938|lyfalmen|||00|28|0|Vistor hf|AstraZeneca A/S DK|28| 014094|H05AA0202|Forsteo|stl|250|mcg/ml|3|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|K|2|0|0|0|0|ELD|0|0|0|100|IKR|33435|44677|lyfalmen|||AC|3|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|37,5| 010923|A02BC0107|Lomex-T|sh-tfl|20|mg|56|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|30|IKR|4178|7007|lyfalmen|||10|56|0|Actavis Group hf|Actavis hf|56| 102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|1745|3385|lyfalmen|V0139|3028|43|98|0|Vistor hf|AstraZeneca A/S DK|147| 568790|N02AA5902|Parkodin forte |eþ-stil|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.07.1993||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|489|1079|lyfalmen|||04|10|0|Actavis Group hf|Actavis hf|3,3333| 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|IKR|3016|5315|lyfalmen|||00|4|0|Eli Lilly Danmark A/S|Lilly ICOS Limited|4| 184143|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|2|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|IKR|961|2060|lyfalmen|||00|2|0|Vistor hf|AstraZeneca UK Ltd|2| 184341|J01CR0201|Amoksiklav|töflur|625|mg|16|stk|1|glas|500+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1104|2358|lyfalmen|||00|16|0|Actavis Group hf|LEK Pharmaceuticals d.d.|8| 000390|J01CR0202|Augmentin|sts|600|mg/hgl|10|hgl|1|pakki|500+100 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2534|3628|lyfsjukr|||00|10|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|5| 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|Icepharma hf|GE Healthcare AS|| 186742|R03DA0404|Theo-Dur|forðatfl|300|mg|100|stk|1|glas||R03DA04|01.11.1981||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|1172|2499|lyfalmen|||10|100|0|Vistor hf|AstraZeneca A/S DK|75| 042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|IKR|5931|8492|lyfsjukr|||00|500|0|Vistor hf|AstraZeneca A/S DK|| 411868|M01AB0505|Voltaren|sh-tfl|25|mg|100|stk|1|þpakki||M01AB05|01.11.1981||R|A|5|0|0|E|0|NOH|0|0|1|100|IKR|582|1272|lyfalmen|||67|100|0|Vistor hf|Novartis Healthcare A/S-|25| 952798|A03BA0101|Atropin|stl|1|mg/ml|1|ml|10|lykjur||A03BA01|01.07.2004||R|A||0|0|0|0|LDR|0|0|1|100|IKR|990|2121|lyfalmen|||00|10|1|Parlogis hf|Parlogis - óskráð lyf|6,67| 543413|R06AA5201|Koffinatin |töflur|| |10|stk|1|þpakki||R06AA52|01.12.1982||L|A|4|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|10|0|Actavis Group hf|Actavis hf|2,5| 045578|N07BA0122|Nicorette (Lyfjaver) |nefúði|500|mcg/sk|200|skammtar|1|glas||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|200|0|Lyfjaver ehf|Lyfjaver ehf|3,33| 081507|G04BE0802|Cialis (D.A.C.)|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.05.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|IKR|2983|5265|lyfalmen|V1350|5265|00|4|0|D.A.C. ehf|D.A.C. ehf|8| 509496|S01XA1202|Bepanthen|augnsm|50|mg/g|5|g|1|túpa||S01XA12|01.10.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|552|1210|lyfalmen|||00|5|1|Parlogis hf|Parlogis - óskráð lyf|| 102863|C01DA1401|Imdur|forðatfl|60|mg|28|stk|1|þpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|1022|2187|lyfalmen|||43|28|0|Vistor hf|AstraZeneca A/S DK|42| 471151|V08AB0201|Omnipaque|stl|300|mg J/ml|10|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|6396|9157|lyfsjukr|||02|100|0|Icepharma hf|GE Healthcare AS|| 132761|D08AG0201|Betadine|áburður|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyfalmen|||23|8|0|Icepharma hf|Napp|8| 944886|H02AB0601|Prednisolon |töflur|1|mg|28|stk|1|pakki||H02AB06|01.10.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|122|316|lyfalmen|||00|28|1|Parlogis hf|Parlogis - óskráð lyf|2,8| 127696|V07AB10|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997||L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|400|0|Actavis Group hf|Braun|| 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|IKR|3207|5593|lyfalmen|V1350|5265|00|4|0|Eli Lilly Danmark A/S|Lilly ICOS Limited|8| 374504|G01AF0502|Pevaryl Depot|krem/sti|| |15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyfalmen|||00|15|0|Vistor hf|Janssen-Cilag AB|1,5| 003325|R03AK0702|Symbicort mite Turbuhaler|innúðadu|84,5|mcg/sk|120|sk|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|A|2|0|0|B|0|AZD|0|0|0|100|IKR|5338|8676|lyfalmen|||00|120|0|Vistor hf|AstraZeneca A/S DK|15| 067850|A02BC0303|Lanser|sh-hylki|30|mg|28|stk|1|glas||A02BC03|01.01.1997||R|A|2|0|0|E|0|ACA|0|0|0|30|IKR|1763|3412|lyfalmen|||00|28|0|Actavis Group hf|Actavis hf|28| 440933|M01AB0507|Vostar |eþ-stil|50|mg|10|stk|1|pakki||M01AB05|01.01.1990||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|548|1202|lyfalmen|||04|10|0|Actavis Group hf|Actavis hf|5| 081680|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|4|0|Ísaga ehf|AGA AB|| 490714|M01AB0508|Vostar-R |forðatfl|75|mg|30|stk|1|glas||M01AB05|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|985|2110|lyfalmen|||67|30|0|Actavis Group hf|Actavis hf|22,5| 128306|V07AB10|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|100|ml|20|hgl|leysir f.stungulyf|V07AB|01.12.1997||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|2000|0|Actavis Group hf|Braun|| 958134|D02AX0103|Lac Hydrin Parlogis|áburður|5|%|113|g|1|plbrús||D02AX01|01.12.2006||R|A||0|0|0|0|LDR|0|0|0|100|IKR|723|1565|lyfalmen|||00|113|1|Parlogis hf|Parlogis - óskráð lyf|113| 432971|J01DC0201|Cefuroxim Scand Pharm|sts|750|mg/hgl|750|mg|1|hgl||J01DC02|01.01.1996||R|A|3|0|0|0|1|GEN|0|0|0|100|IKR|230|329|lyfsjukr|||00|750|0|NM Pharma ehf|Generics|0,25| 008938|H02AB0104|Betapred|stl|4|mg/ml|1|ml|5|lykjur||H02AB01|01.07.2004||R|A||0|0|0|0|LVE|0|0|1|100|IKR|649|1412|lyfalmen|||02|5|1|Lyfjaver ehf|Lyfjaver - óskráð lyf|13,3333| 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|Artasan ehf|Novartis Healthcare A/S-A|27,2| 007559|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|6677|10543|lyfalmen|||00|98|0|Vistor hf|AstraZeneca A/S DK|196| 003238|J07AM0101|Tetavax|stl|40|ae|0,5|ml|1|lykja||J07AM01|01.03.2006||R|K||0|0|0|0|LDR|0|0|1|100|IKR|557|1220|lyfalmen|||00|0,5|1|Parlogis hf|Parlogis - óskráð lyf|| 127647|V07AB10|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997||L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|200|0|Actavis Group hf|Braun|| 047563|R03DC0101|Accolate|töflur|20|mg|98|stk|1|þpakki||R03DC01|01.04.1998||R|A|3|0|0|B|0|ASZ|0|0|0|100|IKR|4997|8200|lyfalmen|||00|98|0|Vistor hf|AstraZeneca UK Ltd|49| 018044|D06BX0103|Rozex|hlaup|7,5|mg/g|30|g|1|túpa||D06BX01|01.01.1998||R|A||0|0|0|0|LDR|0|0|1|100|IKR|922|1979|lyfalmen|||00|30|1|Parlogis hf|Parlogis - óskráð lyf|30| 534537|J01EE0103|Primazol |töflur|480|mg|20|stk|1|glas|80+400 mg|J01EE01|01.10.1995||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|476|1052|lyfalmen|||00|20|0|Actavis Group hf|Actavis hf|5| 001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|1679|3285|lyfalmen|||43|100|0|Vistor hf|AstraZeneca A/S DK|15,83| 102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1988||R|A|2|0|0|0|1|ASZ|0|0|0|100|IKR|2545|3644|lyfsjukr|||00|50|0|Vistor hf|AstraZeneca UK Ltd|| 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|IKR|201|480|lyfalmen|||00|30|0|Vistor hf|AstraZeneca A/S DK|| 565275|C07AG0202|Dimitone|töflur|12,5|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|4100|6894|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|33,3333| 085829|S01EB0104|Pilokarpin|augndr|2|%|0,15|ml|20|skammt|án rotvarnar|S01EB01|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|1454|2943|lyfalmen|||00|3|1|Parlogis hf|Parlogis - óskráð lyf|7,5| 020193|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|Artasan ehf|Novartis Healthcare A/S-A|6,4| 113639|A02AD0105|Novaluzid|tuggutfl|500|mg|100|stk|1|þpakki||A02AD01|01.03.1983||L|A|3|0|0|0|0|BIP|0|0|0|100|IKR|||lyflausa|||11|100|0|Vistor hf|BioPhausia AB|10| 012278|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|7|0|Artasan ehf|Novartis Healthcare A/S-A|3,5| 589500|D11AF0103|Canthacur-PS|lausn|36|%|7,5|ml|1|glas|1%+30%+5%|D11AF01|01.01.1998||R|A||0|0|0|0|AUO|0|0|0|100|IKR|2067|3874|lyfalmen|||00|7,5|1|Icepharma hf|Icepharma - óskráð lyf|7,5| 007534|C09CA0601|Atacand|töflur|16|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|2094|3915|lyfalmen|||00|28|0|Vistor hf|AstraZeneca A/S DK|56| 003423|A10BG0301|Actos|töflur|15|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|IKR|3340|5787|lyfalmen|||00|28|0|Eli Lilly Danmark A/S|Takeda Europe -|14| 025311|J01DB0101|Keflex|töflur|500|mg|14|stk|1|þpakki||J01DB01|01.07.1988||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|794|1713|lyfalmen|||00|14|0|Icepharma hf|NordMedica A/S|3,5| 004696|R05DA0901|Dexomet |mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|150|0|Actavis Group hf|Actavis hf|5| 953621|R03DA0504|Theofyllamin EDA Ratiopharm|stl|120|mg/ml|1|ml|5|lykja||R03DA05|01.09.2004||R|A||0|0|0|0|LDR|0|0|0|100|IKR|289|663|lyfalmen|||00|5|1|Parlogis hf|Parlogis - óskráð lyf|1| 300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|glas||A05AA02|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|4152|6969|lyfalmen|||00|60|1|Vistor hf|Vistor - óskráð lyf|12| 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2175|3114|lyfsjukr|||00|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|5| 447912|C08DB0107|Korzem |töflur|60|mg|100|stk|1|þpakki||C08DB01|01.01.1989||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|706|1530|lyfalmen|V0352|1530|00|100|0|Actavis Group hf|Actavis hf|25| 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|4132|6940|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|400| 105306|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|E|0|DAC|0|0|0|30|IKR|11768|17407|lyfalmen|V0089|17407|00|100|0|D.A.C. ehf|D.A.C. ehf|133,33| 098582|S01ED0201|Betoptic|augndr|5|mg/ml|5|ml|1|glas||S01ED02|01.04.2006||R|A|3|0|0|*|0|ALC|0|0|0|100|IKR|669|1453|lyfalmen|||06|5|1|K.Pétursson hf|Alcon|25| 073783|L01CB0101|Vepesid|hylki|50|mg|20|stk|1|glas||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|23018|30525|lyfsjukr|||00|20|1|Vistor hf|Vistor - óskráð lyf|| 944852|A06AX0102|Glycerol infant|eþ-stil|| |12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|773|lyfalmen|||00|12|1|Parlogis hf|Parlogis - óskráð lyf|| 125054|C09AA0201|Daren |töflur|10|mg|100|stk|1|glas||C09AA02|01.01.1994||R|A|1,3|0|0|B|0|ACA|0|0|0|100|IKR|1392|2849|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|100| 035824|C01AA0503|Lanoxin|stl|0,25|mg/ml|2|ml|5|lykjur||C01AA05|01.07.2000||R|A||0|0|0|1|LDR|0|0|0|100|IKR|926|1326|lyfsjukr|||00|10|1|Parlogis hf|Parlogis - óskráð lyf|| 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|456|1010|lyfalmen|||02|10|0|Vistor hf|AstraZeneca A/S DK|0,33| 585901|B05BB0111|Natriumklorid 0,9% latexfritt|irl|9|g/1000ml|100|ml|1|poki||B05BB01|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|182|261|lyfsjukr|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|| 067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|2778|4954|lyfalmen|V0556|4954|10|4|0|Actavis Group hf|Actavis hf|3| 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|Artasan ehf|Novartis Healthcare A/S-A|13,6| 129254|V07AB09|Sterilt Vatten Braun|leysir|| |100|ml|20|hgl|leysir f.stungulyf|V07AB|01.12.1997||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||00|2000|0|Actavis Group hf|Braun|| 584284|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|| |100|ml|30|pokar|excel umbúðir|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||00|3000|0|Icepharma hf|Fresenius Kabi|| 947913|A11HA0203|Vitamin B6 Heve|stl|12,5|mg/ml|2|ml|10|lykjur||A11HA02|01.06.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|582|1272|lyfalmen|||00|20|1|Parlogis hf|Parlogis - óskráð lyf|1,5625| 005526|N05AH0301|Zyprexa|húðuðtfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|2|0|0|*|0|ELD|0|1|0|100|IKR|24020|32955|lyfalmen|||00|28|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|56| 000182|A07FA0201|Precosa|hylki|250|mg|50|stk|1|glas||A07FA02|01.12.1998||R|A|3|0|0|0|0|LAO|0|0|0|100|IKR|3834|6506|lyfalmen|||00|50|0|Vistor hf|Laboratories Biocodex|12,5| 181289|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|glas||M01AE01|01.01.1988||L|A|5|0|0|E|0|ACA|0|0|1|100|IKR|327|742|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|10| 066423|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|21|0|Artasan ehf|Novartis Healthcare A/S-A|31,5| 940264|G03CA0313|Oestradiol|vefjatfl|50|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|3132|5484|lyfalmen|||00|1|1|Parlogis hf|Parlogis - óskráð lyf|166,67| 435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|IKR|5193|8474|lyfalmen|V0725|8256|00|100|0|Vistor hf|AstraZeneca UK Ltd|6,25| 005576|R05CA1002|Tussol |mixtúra|| |150|ml|1|glas||R05CA10|01.10.2001||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||01|150|0|Actavis Group hf|Actavis hf|| 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|IKR|1938|2775|lyfsjukr|||03|10|0|Vistor hf|AstraZeneca A/S DK|5| 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|Artasan ehf|Novartis Healthcare A/S-A|27,2| 152413|R03BA0202|Pulmicort Turbuhaler|innúðadu|200|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|AZD|0|0|0|100|IKR|3352|5804|lyfalmen|||23|200|0|Vistor hf|AstraZeneca A/S DK|50| 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|96|0|Artasan ehf|Novartis Healthcare A/S-A|6,4| 081897|N05AH0305|Zyprexa Velotab (D.A.C.)|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.05.2007||R|A|3|0|0|*|0|DAC|0|1|0|100|IKR|11420|16944|lyfalmen|V0813|16944|00|28|0|D.A.C. ehf|D.A.C. ehf|28| 045933|N07BA0125|Nicotinell Fruit (Lyfjaver) |tyggigúm|2|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|84|0|Lyfjaver ehf|Lyfjaver ehf|5,6| 037176|M01AB0507|Vostar |sþ-tfl|50|mg|30|stk|1|glas||M01AB05|01.04.1988||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|361|813|lyfalmen|||10|30|0|Actavis Group hf|Actavis hf|15| 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|Artasan ehf|Novartis Healthcare A/S-A|1,6| 019491|N06AX2102|Yentreve|hylki|40|mg|140|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|IKR|9961|15000|lyfalmen|||00|140|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|| 065540|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|Icepharma hf|GE Healthcare AS|| 067835|A02BC0303|Lanser|sh-hylki|30|mg|14|stk|1|glas||A02BC03|01.01.1997||R|A|2|0|0|E|0|ACA|0|0|0|30|IKR|1123|2397|lyfalmen|||00|14|0|Actavis Group hf|Actavis hf|14| 019739|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|Artasan ehf|Novartis Healthcare A/S-A|27,2| 008318|C09CA0601|Atacand|töflur|8|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|1638|3223|lyfalmen|||00|28|0|Vistor hf|AstraZeneca A/S DK|28| 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|204|0|Artasan ehf|Novartis Healthcare A/S-A|13,6| 107532|N02BE0106|Parasupp |eþ-stil|60|mg|10|stk|1|pakki||N02BE01|01.06.1984||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||04|10|0|Actavis Group hf|Actavis hf|0,2| 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|A|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyfalmen|||00|30|0|Vistor hf|Janssen-Cilag AB|30| 099746|N07BA0125|Nicotinell Fruit (Lyfjaver) |tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.09.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|96|0|Lyfjaver ehf|Lyfjaver ehf|12,8| 075305|N02BE0108|Paratabs Retard |forðatfl|500|mg|300|stk|1|plglas||N02BE01|01.10.2007||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|1536|3068|lyfalmen|||10|300|0|Actavis Group hf|Actavis hf|50| 448498|R03DA0503|Aminophylline|stl|30|mg/ml|10|ml|10|lykjur||R03DA05|01.07.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|2398|4377|lyfalmen|||02|100|1|Parlogis hf|Parlogis - óskráð lyf|5| 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|5319|8649|lyfalmen|V0197|8649|00|98|0|Actavis Group hf|Actavis hf|98| 551739|N02AA0102|Morfin |töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|S||1|0|E|0|LDR|0|0|0|100|IKR|905|1944|lyfalmen|||00|20|1|Parlogis hf|Parlogis - óskráð lyf|2| 475921|A10AB0404|Humalog Pen|stl|100|ae/ml|3|ml|5|pennar|einnota pennar|A10AB04|01.11.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|IKR|3200|5583|lyfalmen|||00|15|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|37,5| 184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|IKR|2847|5059|lyfalmen|||00|6|0|Vistor hf|AstraZeneca UK Ltd|6| 497313|C09AA0201|Daren |töflur|20|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|1,5|0|0|B|0|ACA|0|0|0|100|IKR|3364|5821|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|200| 191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|7,5|0|Vistor hf|AstraZeneca A/S DK|4,6875| 067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|29063|39234|lyfalmen|V0557|39234|10|30|0|Actavis Group hf|Actavis hf|30| 108852|R01AD0501|Rhinocort Aqua|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|IKR|901|1936|lyfalmen|V0965|1898|24|120|0|Vistor hf|AstraZeneca A/S DK|38,4| 457192|N05BA1202|Paxal |töflur|0,5|mg|50|stk|1|glas||N05BA12|01.04.1990||R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|440|977|lyfalmen|V0860|977|00|50|0|Actavis Group hf|Actavis hf|25| 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2561|4624|lyfalmen|V0703|4547|00|56|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|9,3333| 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|Artasan ehf|Novartis Healthcare A/S-A|13,6| 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|437|971|lyfalmen|||08|100|0|Actavis Group hf|LEK Pharmaceuticals d.d.|2,5| 927361|A12AA1201|Phos-Ex|töflur|167|mg|180|stk|1|glas||A12AA12|01.01.1998||R|A||0|1|0|0|LDR|0|0|0|100|IKR|1768|3420|lyfalmen|||00|180|1|Parlogis hf|Parlogis - óskráð lyf|15,03| 081525|V03AN0101|Conoxia|innö.gas|100|%|10|l|1|hylki|MO10|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|10|0|Ísaga ehf|AGA AB|| 475533|N02AA5902|Parkodin forte |töflur|530|mg|30|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|188|453|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|10| 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyfalmen|||42|250|0|Vistor hf|Recip AB|21,7857| 131995|J01AA0203|Doxytab |töflur|100|mg|30|stk|1|glas||J01AA02|01.04.1987||R|A|4|0|0|0|0|ACA|0|0|1|100|IKR|1192|2541|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|30| 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2519|4561|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|200| 022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|2208|4088|lyfalmen|V0918|4088|00|60|0|Actavis Group hf|Actavis hf|60| 049561|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|0|0|POF|0|0|0|100|IKR|1908|3633|lyfalmen|V0358|3633|00|98|0|PortFarma ehf|PortFarma |65,3333| 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|AZD|0|0|1|100|IKR|407|908|lyfalmen|||00|20|0|Vistor hf|AstraZeneca A/S DK|8| 591008|B05BB0113|Ringer-Dextran latexfritt BRAUN|irl|| |1000|ml|1|poki||B05BB01|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1330|1904|lyfsjukr|||00|1000|1|Parlogis hf|Parlogis - óskráð lyf|| 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|27452|36045|lyfsjukr|||02|1000|0|Icepharma hf|GE Healthcare AS|| 045951|N07BA0125|Nicotinell Fruit (Lyfjaver) |tyggigúm|4|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|84|0|Lyfjaver ehf|Lyfjaver ehf|11,2| 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|547|1200|lyfalmen|V0609|1200|00|30|0|Actavis Group hf|Actavis hf|15| 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|IKR|7508|11702|lyfalmen|||00|28|0|Icepharma hf|Eli Lilly Danmark A/S|6,3| 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|2168|4028|lyfalmen|V0003|4028|00|90|0|Actavis Group hf|Actavis hf|135| 007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|glas||H02AB01|01.09.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|583|1274|lyfalmen|||00|30|1|Lyfjaver ehf|Lyfjaver - óskráð lyf|10| 001422|C10AA0102|Sivacor|töflur|20|mg|98|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2307|4239|lyfalmen|V0365|4239|00|98|0|Actavis Group hf|Actavis hf|130,6667| 014713|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.06.2005||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|8671|13282|lyfalmen|||00|98|0|Vistor hf|AstraZeneca A/S DK|392| 007978|B01AD1001|Xigris|irs|20|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|IKR|93500|118275|lyfsjukr|||00|1|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|0,5| 078121|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|A|3|0|1|0|1|ASZ|0|0|0|100|IKR|15943|21717|lyfsjukr|||00|1|0|Vistor hf|AstraZeneca UK Ltd|| 537720|L01CB0101|Vepesid|hylki|100|mg|10|stk|1|glas||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|20383|27244|lyfsjukr|||00|10|1|Vistor hf|Vistor - óskráð lyf|| 011335|C09CA0102|Lopress|töflur|12,5|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|992|2125|lyfalmen|V0195|2125|00|28|0|Actavis Group hf|Actavis hf|7| 025725|R01AD0505|Rhinocort Turbuhaler (D.A.C.)|nefúðad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.2007||R|A|2|0|0|E|0|DAC|0|0|1|100|IKR|2256|4161|lyfalmen|V0966|4161|23|200|0|D.A.C. ehf|D.A.C. ehf|100| 009688|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|5902|9462|lyfalmen|||00|98|0|Vistor hf|AstraZeneca A/S DK|196| 001792|N02BA0109|Alka-Seltzer|freyðit|324|mg|20|stk|1|pakki||N02BA01|01.08.2004||L|A|3|0|0|0|0|BAS|0|0|1|100|IKR|||lyfalmen|||00|20|0|Vistor hf|Bayer A/S|2,16| 051425|R05CB0102|Mucomyst|freyðit|200|mg|100|stk|1|glas||R05CB01|01.01.1986||R|A|2|0|0|E|0|AZD|0|0|1|100|IKR|1329|2753|lyfalmen|||72|100|0|Vistor hf|AstraZeneca A/S DK|40| 105297|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|E|0|DAC|0|0|0|30|IKR|8950|13653|lyfalmen|V0087|13653|00|100|0|D.A.C. ehf|D.A.C. ehf|66,67| 466797|N06AG0201|Aurorix|töflur|150|mg|30|stk|1|þpakki||N06AG02|01.10.1990||R|A|5|0|0|B|0|ROC|0|1|0|100|IKR|1217|2583|lyfalmen|||64|30|0|Icepharma hf|Roche|15| 546143|N02BE0108|Paratabs Retard |forðatfl|500|mg|30|stk|1|þpakki||N02BE01|01.10.1993||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||10|30|0|Actavis Group hf|Actavis hf|5| 568055|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|28937|37894|lyfsjukr|||02|1000|0|Icepharma hf|GE Healthcare AS|| 052478|D06BB0305|Zovirax (D.A.C.)|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.03.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyfalmen|||00|2|0|D.A.C. ehf|D.A.C. ehf|2| 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|A|5|0|0|B|0|AZD|0|0|0|100|IKR|769|1661|lyfalmen|||02|25|0|Vistor hf|AstraZeneca A/S DK|0,1667| 130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|IKR|11596|17178|lyfalmen|V0726|16715|00|100|0|Vistor hf|AstraZeneca UK Ltd|25| 475822|R03AC1302|Oxis Turbuhaler|innúðadu|9|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|B|0|AZD|0|0|1|100|IKR|2505|4539|lyfalmen|||00|60|0|Vistor hf|AstraZeneca A/S DK|22,5| 051067|N03AX0902|Lamictal (D.A.C.)|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.2007||R|A|3|0|0|E|0|DAC|0|0|0|100|IKR|2510|4547|lyfalmen|V0703|4547|00|56|0|D.A.C. ehf|D.A.C. ehf|9,33| 017365|J01CR0201|Amoksiklav|töflur|375|mg|20|stk|1|glas|250+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|792|1709|lyfalmen|||00|20|0|Actavis Group hf|LEK Pharmaceuticals d.d.|5| 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|þpakki||N06AG02|01.10.1990||R|A|5|0|0|B|0|ROC|0|1|0|100|IKR|2825|5025|lyfalmen|||64|100|0|Icepharma hf|Roche|50| 942468|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998||R|A||0|0|E|0|PCO|0|0|1|100|IKR|3163|5529|lyfalmen|||00|20|1|Vistor hf|Vistor - óskráð lyf|20| 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1499|3011|lyfalmen|||00|42|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|3,5| 087445|A02BX1301|Gaviscon|mixtúra|| |500|ml|1|glas||A02BX13|01.08.1984||L|A|2|0|0|0|0|NDR|0|0|0|30|IKR|||lyfalmen|||01|500|0|Vistor hf|Nordic Drugs AB|| 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.01.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|725|1570|lyfalmen|||00|30|1|Vistor hf|Vistor - óskráð lyf|45| 036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|A|3|0|0|E|0|ROC|0|0|1|100|IKR|2552|4611|lyfalmen|||00|60|0|Icepharma hf|Roche|60| 165431|C08CA0202|Plendil|forðatfl|2,5|mg|98|stk|1|þpakki||C08CA02|01.01.1992||R|A|2|0|0|B|0|AZD|0|0|0|100|IKR|3641|6225|lyfalmen|||43|98|0|Vistor hf|AstraZeneca A/S DK|49| 534552|J01EE0103|Primazol |töflur|480|mg|100|stk|1|glas|80+400 mg|J01EE01|01.10.1995||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|2062|3867|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|25| 022302|C09BA0501|Ramazið|töflur|15|mg|30|stk|1|glas|2,5+12.5 mg|C09BA05|01.08.2005||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1090|2329|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|| 005303|N02CC0303|Zomig Nasal|nefúði|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|A|2,5|0|0|E|0|ASZ|0|0|0|100|IKR|1835|3522|lyfalmen|||00|10|0|Vistor hf|AstraZeneca UK Ltd|4| 153734|L01CA0101|Velbe|sts|10|mg/hgl|1|sk|1|hgl||L01CA01|01.01.1998||R|K||0|1|0|1|LDR|0|0|0|100|IKR|2880|4123|lyfsjukr|||00|1|1|Parlogis hf|Parlogis - óskráð lyf|| 937980|C01CA2403|Adrenalin|stl|0,1|mg/ml|10|ml|1|spr||C01CA24|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|997|1427|lyfsjukr|||02|10|1|Parlogis hf|Parlogis - óskráð lyf|2| 945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|A||0|0|0|0|PCO|0|0|1|100|IKR|1383|2835|lyfalmen|||00|10|1|Vistor hf|Vistor - óskráð lyf|10| 083113|L02BG0301|Arimidex|töflur|1|mg|28|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|ASZ|0|0|0|100|IKR|11039|16436|lyfalmen|||00|28|0|Vistor hf|AstraZeneca UK Ltd|28| 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|Artasan ehf|Novartis Healthcare A/S-A|3,2| 123273|N05BA0603|Temesta|töflur|1|mg|100|stk|1|þpakki||N05BA06|01.11.2005||R|A|3|0|0|0|0|AUO|0|0|1|100|IKR|1275|2671|lyfalmen|||00|100|1|Icepharma hf|Icepharma - óskráð lyf|40| 128769|V07AB09|Sterilt Vatten Braun|leysir|| |10|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997||L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||00|200|0|Actavis Group hf|Braun|| 076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|820|1767|lyfalmen|V1070|1767|00|20|0|PortFarma ehf|PortFarma |2| 004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|2249|4151|lyfalmen|V0925|4151|00|56|0|Actavis Group hf|Actavis hf|56| 388660|C09BA0201|Darazið|töflur|22,5|mg|100|stk|1|glas|10+12.5 mg|C09BA02|01.04.1998||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2966|5240|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|100| 037861|C03AA0301|Aquazið|töflur|25|mg|100|stk|1|glas||C03AA03|01.05.1983||R|A|4|0|0|E|0|ACA|0|0|0|100|IKR|582|1272|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|100| 170233|R01AA0702|Otrivin|nefdr|0,5|mg/ml|10|ml|1|glas||R01AA07|01.12.1972||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||06|10|0|Artasan ehf|Novartis Healthcare A/S-A|6,25| 565325|C07AG0202|Dimitone|töflur|25|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|6153|9812|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|66,6667| 021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|þpakki||M01AB05|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|20|0|Artasan ehf|Novartis Healthcare A/S-A|2,5| 024037|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.09.2005||R|A|2|0|0|0|1|NOM|0|0|0|100|IKR|3359|4809|lyfsjukr|||03|10|0|Icepharma hf|NordMedica ApS|3,3333| 476093|A10AC0106|Humulin NPH Pen|stl|100|ae/ml|3|ml|5|pennar|Einnota pennar|A10AC01|01.06.1999||R|K|2|0|0|*|0|ELI|0|0|0|100|IKR|3171|5540|lyfalmen|||51|15|0|Icepharma hf|Eli Lilly Danmark A/S|37,5| 388280|N01BB2001|Emla|plástur|| |20|stk|1|pakki||N01BB20|01.04.1994||R|A|2|0|0|0|0|AZD|0|0|1|100|IKR|3858|6541|lyfalmen|||23|20|0|Vistor hf|AstraZeneca A/S DK|| 005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2002||R|A|3|0|0|*|0|ASZ|0|1|0|100|IKR|31740|42567|lyfalmen|||00|100|0|Vistor hf|AstraZeneca UK Ltd|75| 335968|A04AD0102|Skopolamin|stl|0,3|mg/ml|1|ml|10|lykjur||A04AD01|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|6034|9646|lyfalmen|||00|10|1|Parlogis hf|Parlogis - óskráð lyf|| 389783|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1985||R|A|2|0|0|0|0|AZD|0|0|1|100|IKR|1644|3232|lyfalmen|||00|30|0|Vistor hf|AstraZeneca A/S DK|7,5| 444315|N06AB0302|Fontex|lausnart|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|A|2|0|0|B|0|ELI|0|1|0|30|IKR|1500|3013|lyfalmen|V0914|2853|00|30|0|Icepharma hf|Eli Lilly Danmark A/S|30| 015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|2642|4747|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|30| 944745|G03BA0302|Testosteron|vefjatfl|25|mg|1|stk|1|pakki||G03BA03|01.01.2002||R|A||0|0|0|0|LDR|0|0|0|100|IKR|755|1632|lyfalmen|||00|1|1|Parlogis hf|Parlogis - óskráð lyf|8,333| 169524|J01AA0203|Doxytab |töflur|100|mg|14|stk|1|glas||J01AA02|01.07.1993||R|A|4|0|0|0|0|ACA|0|0|1|100|IKR|720|1559|lyfalmen|||00|14|0|Actavis Group hf|Actavis hf|14| 087787|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|210|0|Lyfjaver ehf|Lyfjaver ehf|28| 163709|V03AE0101|Resonium|duft|| |454|g|1|stauk||V03AE01|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|5041|8262|lyfalmen|||00|454|1|Parlogis hf|Parlogis - óskráð lyf|| 045388|N07BA0128|Nicorette Classic (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|210|0|Lyfjaver ehf|Lyfjaver ehf|28| 188532|R03BA0202|Pulmicort Turbuhaler|innúðadu|400|mcg/sk|50|sk|1|stauk||R03BA02|01.10.1993||R|A|2|0|0|0|1|AZD|0|0|0|100|IKR|2824|4043|lyfsjukr|||23|50|0|Vistor hf|AstraZeneca A/S DK|25| 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|200|478|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|5| 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|IKR|24150|33117|lyfalmen|||00|28|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|42| 432989|J01DC0201|Cefuroxim Scand Pharm|sts/irs|1,5|g/hgl|1,5|g|1|hgl||J01DC02|01.01.1996||R|A|3|0|0|0|1|GEN|0|0|0|100|IKR|459|657|lyfsjukr|||00|1,5|0|NM Pharma ehf|Generics|0,5| 329417|C01CA0301|Noradrenalin|stl|1|mg/ml|1|ml|10|lykjur||C01CA03|01.01.1998||R|K||0|0|0|1|LDR|0|0|0|100|IKR|3940|5641|lyfsjukr|||00|10|1|Parlogis hf|Parlogis - óskráð lyf|1,6667| 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|IKR|7508|11702|lyfalmen|||00|28|0|Icepharma hf|Eli Lilly Danmark A/S|3,5| 007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|IKR|5640|9097|lyfalmen|||00|28|0|Vistor hf|AstraZeneca A/S DK|112| 160457|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|68218|86799|lyfsjukr|||00|150|0|Icepharma hf|GE Healthcare AS|| 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|96|0|Artasan ehf|Novartis Healthcare A/S-A|3,2| 131540|B05BB0112|Ringer Acetat latexfritt BRAUN|irl|| |1000|ml|1|poki||B05BB01|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|245|351|lyfsjukr|||00|1000|1|Parlogis hf|Parlogis - óskráð lyf|| 108860|N02AX0203|Tramol|hylki|50|mg|20|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|293|671|lyfalmen|V0730|671|00|20|0|Actavis Group hf|Actavis hf|3,3333| 471144|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|7625|10917|lyfsjukr|||02|200|0|Icepharma hf|GE Healthcare AS|| 080572|N06AA0901|Amilin|töflur|10|mg|100|stk|1|glas||N06AA09|01.04.1987||R|A|4|0|0|B|0|ACA|0|1|0|100|IKR|218|516|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|13,3333| 582775|C07AB0205|Seloken|töflur|50|mg|28|stk|1|þpakki||C07AB02|01.12.2001||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|370|832|lyfalmen|||00|28|0|Vistor hf|AstraZeneca A/S DK|9,333| 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|3329|5770|lyfalmen|||00|100|0|Vistor hf|AstraZeneca A/S DK|50| 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|Artasan ehf|Novartis Healthcare A/S-A|| 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||06|10|0|Artasan ehf|Novartis Healthcare A/S-A|12,5| 391730|N01BB0203|Xylocain|úðalyf|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.1990||R|A|3|0|0|0|0|AZD|0|0|1|100|IKR|1324|2746|lyfalmen|||00|50|0|Vistor hf|AstraZeneca A/S DK|| 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|30|IKR|3334|5778|lyfalmen|V0919|5778|00|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|100| 457127|N05BA1202|Paxal |töflur|0,25|mg|20|stk|1|glas||N05BA12|01.04.1990||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|117|306|lyfalmen|V0844|306|00|20|0|Actavis Group hf|Actavis hf|5| 049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|0|0|POF|0|0|0|100|IKR|2307|4239|lyfalmen|V0365|4239|00|98|0|PortFarma ehf|PortFarma |130,667| 183319|D08AG0201|Betadine|smyrsli|100|mg/g|80|g|1|túpa||D08AG02|01.07.1988||L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyfalmen|||00|80|0|Icepharma hf|Napp|80| 958829|A06AD0002|Miralax|lausnduf|| |238|g|1|stauk||A06AD00|01.05.2007||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2093|3914|lyfalmen|||00|238|1|Parlogis hf|Parlogis - óskráð lyf|| 051193|R05CB0102|Mucomyst|freyðit|200|mg|25|stk|1|glas||R05CB01|01.01.1986||R|A|2|0|0|E|0|AZD|0|0|1|100|IKR|351|792|lyfalmen|||72|25|0|Vistor hf|AstraZeneca A/S DK|10| 130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|IKR|18356|25903|lyfalmen|V0727|25217|00|100|0|Vistor hf|AstraZeneca UK Ltd|50| 307165|N07BC0201|Metadon|töflur|5|mg|20|stk|1|glas||N07BC02|01.01.1998||R|A||1|0|0|0|LDR|0|0|0|100|IKR|347|784|lyfalmen|||00|20|1|Parlogis hf|Parlogis - óskráð lyf|4| 067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|820|1767|lyfalmen|V0554|1767|10|1|0|Actavis Group hf|Actavis hf|0,75| 045905|N07BA0124|Nicotinell Mint (Lyfjaver) |tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|204|0|Lyfjaver ehf|Lyfjaver ehf|13,6| 005578|R05FB0201|Oxeladin |mixtúra|| |150|ml|1|glas||R05FB02|01.10.2001||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||01|150|0|Actavis Group hf|Actavis hf|3,333| 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|IKR|1500|3013|lyfalmen|||00|300|0|Actavis Group hf|Actavis hf|50| 568022|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|27452|36045|lyfsjukr|||02|1000|0|Icepharma hf|GE Healthcare AS|| 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|1481|2984|lyfalmen|||67|30|0|Actavis Group hf|Actavis hf|10| 002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|IKR|12008|18000|lyfalmen|V0089|17407|00|100|0|Vistor hf|AstraZeneca A/S DK|133,33| 087805|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|210|0|Lyfjaver ehf|Lyfjaver ehf|14| 045406|N07BA0127|Nicorette Mint (Lyfjaver) |tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|210|0|Lyfjaver ehf|Lyfjaver ehf|28| 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|IKR|7231|11315|lyfalmen|||00|98|0|Vistor hf|AstraZeneca A/S DK|49| 439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|7280|11384|lyfalmen|||00|98|0|Vistor hf|AstraZeneca A/S DK|98| 007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|þpakki||A02BA02|01.09.1983||L|A|5|0|0|E|0|GSK|0|0|0|30|IKR|545|1195|lyfalmen|||00|20|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|10| 081534|V03AN0101|Conoxia|innö.gas|100|%|20|l|1|hylki|MO20|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|20|0|Ísaga ehf|AGA AB|| 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|200|478|lyfalmen|||00|100|0|Vistor hf|AstraZeneca A/S DK|2| 121681|C09AA0201|Daren |töflur|2,5|mg|100|stk|1|glas||C09AA02|01.01.1994||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1786|3447|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|25| 433722|J01EE0104|Primazol sterkar |töflur|960|mg|10|stk|1|glas|160+800 mg|J01EE01|01.07.1989||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|486|1073|lyfalmen|||00|10|0|Actavis Group hf|Actavis hf|5| 087778|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|105|0|Lyfjaver ehf|Lyfjaver ehf|14| 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|2561|4624|lyfalmen|V0703|4547|00|56|0|Actavis Group hf|Actavis hf|9,33| 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|A|2|0|0|0|0|MET|0|0|0|100|IKR|||lyfalmen|||00|500|0|Vistor hf|Medic Team|49,7761| 471177|V08AB0201|Omnipaque|stl|350|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|9600|13745|lyfsjukr|||02|200|0|Icepharma hf|GE Healthcare AS|| 590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.10.1999||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1510|3028|lyfalmen|V0139|3028|10|98|0|Actavis Group hf|Actavis hf|147| 080424|G01AF0502|Pevaryl Depot|sk-stil|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyfalmen|||05|1|0|Vistor hf|Janssen-Cilag AB|1,5| 545574|L01AX0401|Dacarbazine|sts|| |200|mg|12|hgl||L01AX04|01.05.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|25180|33217|lyfsjukr|||00|2400|1|Vistor hf|Vistor - óskráð lyf|| 047548|R03DC0101|Accolate|töflur|20|mg|28|stk|1|þpakki||R03DC01|01.04.1998||R|A|3|0|0|B|0|ASZ|0|0|0|100|IKR|1552|3092|lyfalmen|||00|28|0|Vistor hf|AstraZeneca UK Ltd|14| 013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2003||R|A|3|0|0|0|0|GSK|0|0|1|100|IKR|1248|2630|lyfalmen|V0465|2630|00|20|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|10| 402230|J01MA0203|Siprox |töflur|250|mg|10|stk|1|glas||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|623|1358|lyfalmen|V0514|1358|00|10|0|Actavis Group hf|Actavis hf|2,5| 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|A|4|0|0|E|0|ALC|0|0|0|100|IKR|289|663|lyfalmen|||06|15|0|K.Pétursson hf|Alcon|| 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|718|1555|lyfalmen|||08|80|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|4| 099755|N07BA0124|Nicotinell Mint (Lyfjaver) |tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.09.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|96|0|Lyfjaver ehf|Lyfjaver ehf|12,8| 514265|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,25|mg/sk|200|sk|1|stauk||R03AC03|01.07.1993||R|A|2|0|0|B|0|AZD|0|0|1|100|IKR|1218|2585|lyfalmen|||23|200|0|Vistor hf|AstraZeneca A/S DK|25| 095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1577|3130|lyfalmen|||00|100|1|Vistor hf|Vistor - óskráð lyf|50| 035533|N03AX0903|Lamotrin|dreifit.|200|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|8043|12445|lyfalmen|V0706|12445|00|56|0|Actavis Group hf|Actavis hf|37,34| 947690|C01CA2403|Adrenalin|stl|1|mg/ml|1|ml|10|lykjur||C01CA24|01.07.2000||R|A||0|0|0|0|LDR|0|0|1|100|IKR|659|1432|lyfalmen|||00|10|1|Parlogis hf|Parlogis - óskráð lyf|20| 005689|B01AC0601|Hjartamagnyl|töflur|75|mg|100|stk|1|plglas||B01AC06|01.06.2007||L|A|2|0|0|0|0|ACA|0|0|0|100|IKR|454|1006|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|100| 165019|C05AA0102|Proctosedyl|eþ-smyr|| |30|g|1|túpa||C05AA01|01.03.1981||L|A|3|0|0|0|0|SNO|0|0|0|100|IKR|||lyfalmen|||00|30|0|Vistor hf|Sanofi-aventis Norge AS|| 012799|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|7|0|Artasan ehf|Novartis Healthcare A/S-A|10,5| 109678|N02BE0107|Paratabs |töflur|500|mg|20|stk|1|þpakki||N02BE01|01.12.1983||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|20|0|Actavis Group hf|Actavis hf|3,3333| 004636|N06AB0402|Oropram|töflur|40|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|6935|10903|lyfalmen|V0929|10903|00|56|0|Actavis Group hf|Actavis hf|112| 412049|L02AE0301|Zoladex|vefjatfl|3,6|mg|1|stk|1|glas|+ dæla|L02AE03|01.01.1990||R|A|3|0|1|*|0|ASZ|0|0|0|100|IKR|13478|19830|lyfalmen|||00|1|0|Vistor hf|AstraZeneca UK Ltd|27,907| 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|A|2|0|0|0|1|AZD|0|0|0|30|IKR|7841|11226|lyfsjukr|||00|50|0|Vistor hf|AstraZeneca A/S DK|13,33| 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|IKR|3397|4864|lyfsjukr|||00|1|0|Icepharma hf|Eli Lilly Danmark A/S|| 541060|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.01.1989||R|A|2|0|0|B|0|AZD|0|0|1|100|IKR|1139|2430|lyfalmen|V0987|2383|23|200|0|Vistor hf|AstraZeneca A/S DK|50| 015230|R01AC0301|Lastin|nefúði|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|IKR|684|1484|lyfalmen|||00|10|0|Icepharma hf|Meda AB|17,8571| 123166|M01AE5101|Ibukod|töflur|| |100|stk|1|glas|10+200 mg|M01AE51|01.10.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|655|1424|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|16,67| 021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|IKR|2320|4258|lyfalmen|||00|28|0|Vistor hf|AstraZeneca A/S DK|14| 277749|J01GB0501|Neomycin|töflur|250|mg|20|stk|1|glas||J01GB05|01.07.2000||R|A||0|0|0|0|LDR|0|0|1|100|IKR|3871|6560|lyfalmen|||00|20|1|Parlogis hf|Parlogis - óskráð lyf|5| 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|AZD|0|0|1|100|IKR|551|1208|lyfalmen|||00|30|0|Vistor hf|AstraZeneca A/S DK|15| 194076|N02CA5201|Cafergot|töflur|| |20|stk|1|þpakki||N02CA52|01.03.1999||R|A|3|0|0|E|0|LDR|0|0|0|100|IKR|1099|2347|lyfalmen|||00|20|1|Parlogis hf|Parlogis - óskráð lyf|5| 062711|J01EE0103|Primazol |töflur|480|mg|30|stk|1|glas|80+400 mg|J01EE01|01.10.1995||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|694|1505|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|7,5| 565374|C07AG0202|Dimitone|töflur|6,25|mg|28|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|1088|2324|lyfalmen|||00|28|1|Parlogis hf|Parlogis - óskráð lyf|4,6667| 045942|N07BA0125|Nicotinell Fruit (Lyfjaver) |tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|204|0|Lyfjaver ehf|Lyfjaver ehf|13,6| 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|Artasan ehf|Novartis Healthcare A/S-A|3,2| 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2246|4146|lyfalmen|V0308|4146|00|100|0|Actavis Group hf|Actavis hf|100| 007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|IKR|2320|4258|lyfalmen|||00|28|0|Vistor hf|AstraZeneca A/S DK|28| 568865|C08CA0201|Feldil |forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|2861|5080|lyfalmen|V0324|5080|10|100|0|Actavis Group hf|Actavis hf|200| 940256|G03CA0313|Oestradiol|vefjatfl|25|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|1607|3175|lyfalmen|||00|1|1|Parlogis hf|Parlogis - óskráð lyf|83,33| 066688|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|6|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|4575|6550|lyfsjukr|||02|120|0|Icepharma hf|GE Healthcare AS|| 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|IKR|1044|2233|lyfalmen|||17|100|0|Vistor hf|AstraZeneca A/S DK|| 007758|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.09.2005||L|A|2|0|0|0|0|MET|0|0|0|100|IKR|||lyfalmen|||00|500|0|Vistor hf|Medic Team|49,7761| 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|IKR|1863|3564|lyfalmen|||17|100|0|Vistor hf|AstraZeneca A/S DK|| 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|AZD|0|0|1|100|IKR|592|1293|lyfalmen|||00|30|0|Vistor hf|AstraZeneca A/S DK|12| 081625|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|2|0|Ísaga ehf|AGA AB|| 005241|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|B|0|AZD|0|0|0|100|IKR|14840|21526|lyfalmen|||00|360|0|Vistor hf|AstraZeneca A/S DK|90| 034066|V07AB09|Sterilt Vatten Braun|leysir|| |5|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997||L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||00|100|0|Actavis Group hf|Braun|| 022313|C09BA0501|Ramazið|töflur|15|mg|100|stk|1|glas|2,5+12.5 mg|C09BA05|01.08.2005||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|3640|6224|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|| 081671|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|4|0|Ísaga ehf|AGA AB|| 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|Artasan ehf|Novartis Healthcare A/S-A|27,2| 471169|V08AB0201|Omnipaque|stl|300|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|9018|12912|lyfsjukr|||02|200|0|Icepharma hf|GE Healthcare AS|| 388256|N01BB2001|Emla|krem|| |5|g|5|túpa|+12 umbúð.|N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|IKR|1984|3748|lyfalmen|||00|25|0|Vistor hf|AstraZeneca A/S DK|5| 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|4960|8146|lyfalmen|V0411|8146|00|98|0|Actavis Group hf|Actavis hf|98| 953754|N05AA0104|Largactil forte|mixtúra|20|mg/ml|100|ml|1|fl||N05AA01|01.11.2004||R|A||0|0|0|0|LDR|0|1|0|100|IKR|610|1331|lyfalmen|||10|100|1|Parlogis hf|Parlogis - óskráð lyf|6,67| 019470|G03XC0102|Evista (Lyfjaver)|töflur|60|mg|84|stk|1|þpakki||G03XC01|01.04.2004||R|A|2|0|0|E|0|LVR|0|0|0|100|IKR|7818|12134|lyfalmen|V0377|12134|00|84|0|Lyfjaver ehf|Lyfjaver ehf|84| 371658|A02BA0201|Asyran |töflur|150|mg|10|stk|1|þpakki||A02BA02|01.10.1995||L|A|3|0|0|E|0|ACA|0|0|0|30|IKR|339|767|lyfalmen|||00|10|0|Actavis Group hf|Actavis hf|5| 938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|2510|4547|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|50| 045596|N07BA0122|Nicorette (Lyfjaver) |innsogsl|10|mg|18|rör|1|þpakki|+ munnstk|N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|18|0|Lyfjaver ehf|Lyfjaver ehf|3| 470989|V08AB0201|Omnipaque|stl|180|mg J/ml|15|ml|10|plastf||V08AB02|01.01.2005||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|6223|8910|lyfsjukr|||02|150|0|Icepharma hf|GE Healthcare AS|| 056033|C10AA0503|Atacor|töflur|40|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|9255|14060|lyfalmen|V0339|14060|00|100|0|Actavis Group hf|Actavis hf|400| 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|A|3|0|0|0|0|PFD|0|0|1|100|IKR|||lyfalmen|||00|125|0|Vistor hf|Pfizer Denmark PCH ApS|0,875| 073860|A10BG0302|Actos (D.A.C.)|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.12.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|IKR|12010|18003|lyfalmen|V0010|18003|00|98|0|D.A.C. ehf|D.A.C. ehf|98| 597575|D01AC0301|Pevaryl|húðduft|10|mg/g|30|g|1|stauk||D01AC03|01.07.1991||L|A|5|0|0|0|0|JAS|0|0|1|100|IKR|||lyfalmen|||00|30|0|Vistor hf|Janssen-Cilag AB|30| 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|960|2058|lyfalmen|V0355|2058|23|120|0|Actavis Group hf|Actavis hf|120| 951899|N04BC0705|Apo-Go Pen|stl|10|mg/ml|3|ml|3|pennar||N04BC07|01.07.2003||R|A||0|1|0|1|LDR|0|0|0|100|IKR|16327|22195|lyfsjukr|||02|9|1|Parlogis hf|Parlogis - óskráð lyf|| 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|IKR|19738|27624|lyfalmen|||00|98|0|Vistor hf|AstraZeneca A/S DK|392| 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|A|3|0|0|0|0|GSK|0|0|1|100|IKR|||lyfalmen|||20|2|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|2| 066142|N05BA0204|Klordiazepoxið Actavis|töflur|10|mg|50|stk|1|glas||N05BA02|01.10.1995||R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|345|780|lyfalmen|||00|50|0|Actavis Group hf|Actavis hf|16,6667| 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|IKR|17832|24068|lyfsjukr|||02|1|0|Icepharma hf|Eli Lilly Danmark A/S|9| 439794|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||06|10|0|Artasan ehf|Novartis Healthcare A/S-A|12,5| 045435|B03BA0102|Betolvex|töflur|1|mg|30|stk|1|glas||B03BA01|01.01.1998||R|A||0|0|0|0|LDR|0|0|1|100|IKR|660|1434|lyfalmen|||00|30|1|Parlogis hf|Parlogis - óskráð lyf|30| 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|36|0|Artasan ehf|Novartis Healthcare A/S-A|2,4| 422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|2231|4123|lyfalmen|||43|98|0|Vistor hf|AstraZeneca A/S DK|62,07| 099598|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|12|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|12|0|Artasan ehf|Novartis Healthcare A/S-A|0,8| 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|2|0|Vistor hf|AstraZeneca A/S DK|2,5| 922866|N05BA0602|Ativan|stl|4|mg/ml|1|ml|4|lykjur||N05BA06|01.11.2005||R|A||0|0|0|1|AUO|0|0|0|100|IKR|1605|2298|lyfsjukr|||00|4|1|Icepharma hf|Icepharma - óskráð lyf|| 016755|N05AH0402|Seroquel (Lyfjaver)|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.09.2003||R|A|3|0|0|*|0|LVR|0|1|0|100|IKR|5037|8256|lyfalmen|V0725|8256|00|100|0|Lyfjaver ehf|Lyfjaver ehf|6,25| 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|IKR|16795|22777|lyfsjukr|||00|1|0|Icepharma hf|Eli Lilly Danmark A/S|| 462770|N05BA0204|Klordiazepoxið Actavis|töflur|25|mg|100|stk|1|glas||N05BA02|01.10.1995||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1272|2667|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|83,3333| 187203|B01AA0101|Dicumarol|töflur|20|mg|100|stk|1|glas||B01AA01|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|3130|5481|lyfalmen|||00|100|1|Vistor hf|Vistor - óskráð lyf|20| 115980|P03AX0301|Prioderm|húðlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|A|3|0|0|0|0|NOP|0|0|0|100|IKR|||lyfalmen|||23|55|0|Icepharma hf|Norpharma || 523274|S01XA2008|Artelac|augndr|| |10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|A|3|0|0|E|0|GEM|0|0|0|100|IKR|264|611|lyfalmen|||00|10|0|Actavis Group hf|Gerhard Mann|| 081543|V03AN0101|Conoxia|innö.gas|100|%|50|l|1|hylki|Mo50|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|50|0|Ísaga ehf|AGA AB|| 140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|A|2|0|0|0|0|PFD|0|0|1|100|IKR|||lyfalmen|||23|10|0|Vistor hf|Pfizer Denmark PCH ApS|3,33| 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|A|5|0|0|0|0|AZD|0|0|1|100|IKR|410|915|lyfalmen|||00|35|0|Vistor hf|AstraZeneca A/S DK|| 859322|L02BG0101|Orimeten|töflur|250|mg|100|stk|1|glas||L02BG01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|13737|18970|lyfsjukr|||00|100|1|Vistor hf|Vistor - óskráð lyf|25| 019724|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|Artasan ehf|Novartis Healthcare A/S-A|3,2| 020763|R03AK0704|Symbicort Turbuhaler (D.A.C.)|innúðadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.08.2004||R|A|2|0|0|B|0|DAC|0|0|0|100|IKR|4799|7912|lyfalmen|V0990|7912|00|120|0|D.A.C. ehf|D.A.C. ehf|30| 953374|N05AB0602|Stelazine|töflur|1|mg|112|stk|1|glas||N05AB06|01.06.2007||R|A||0|0|*|0|LDR|0|0|0|100|IKR|1890|3605|lyfalmen|||00|112|1|Parlogis hf|Parlogis - óskráð lyf|5,6| 005503|N05AH0301|Zyprexa|húðuðtfl|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|2|0|0|*|0|ELD|0|1|0|100|IKR|16704|23847|lyfalmen|||00|28|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|42| 388264|N01BB2001|Emla|krem|| |30|g|1|túpa||N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|IKR|1820|3499|lyfalmen|||00|30|0|Vistor hf|AstraZeneca A/S DK|30| 001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|3196|5577|lyfalmen|V0791|5577|00|60|0|Actavis Group hf|Actavis hf|12| 055392|J04AK0102|Pyrazinamid|töflur|500|mg|100|stk|1|glas||J04AK01|01.04.2005||R|A||0|0|E|0|LDR|0|0|0|100|IKR|3734|6360|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|33,3333| 045614|N07BA0123|Nicotinell (Lyfjaver)|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|21|0|Lyfjaver ehf|Lyfjaver ehf|31,5| 388272|N01BB2001|Emla|plástur|| |2|stk|1|pakki||N01BB20|01.04.1994||L|A|2|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|2|0|Vistor hf|AstraZeneca A/S DK|| 143413|S01JX|Methocel 2% |lausn|20|mg/ml|30|ml|1|glas||S01|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|IKR|710|1538|lyfalmen|||00|30|1|Vistor hf|Vistor - óskráð lyf|| 000018|G01AF0501|Pevaryl|krem/sti|| |15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyfalmen|||00|15|0|Vistor hf|Janssen-Cilag AB|4,5| 056015|C10AA0503|Atacor|töflur|10|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|5128|8383|lyfalmen|V0337|8383|00|100|0|Actavis Group hf|Actavis hf|100| 529289|R02AA0301|Strepsils|sogtfl|| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|| 945602|A11EA08|Vitamin B-komplex|stl|| |2|ml|10|lykjur||A11EA|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1202|2560|lyfalmen|||00|20|1|Parlogis hf|Parlogis - óskráð lyf|| 007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|| |50|ml|50|pokar|leysir f.stungulyf|V07AB00|01.08.2005||L|A|1,5|0|0|0|0|BAM|0|0|0|100|IKR|||lyfalmen|||00|2500|0|Icepharma hf|Baxter Medical AB|| 169334|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|IKR|883|1898|lyfalmen|||02|100|0|Vistor hf|AstraZeneca A/S DK|| 153288|R06AE0704|Histasin|töflur|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|2214|4097|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|100| 544049|C01DA1402|Monit-L |forðahlk|60|mg|100|stk|1|glas||C01DA14|01.10.1992||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|2489|4515|lyfalmen|||10|100|0|Actavis Group hf|Actavis hf|150| 406355|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30654|lyfsjukr|||02|500|0|Icepharma hf|GE Healthcare AS|| 021057|J01CR0203|Augmentine (D.A.C.)|töflur|625|mg|12|stk|1|þpakki|500+125 mg|J01CR02|01.05.2005||R|A|2|0|0|0|0|DAC|0|0|1|100|IKR|765|1653|lyfalmen|||00|12|0|D.A.C. ehf|D.A.C. ehf|7,5| 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|IKR|11453|16988|lyfalmen|||00|98|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|98| 128819|V07AB09|Sterilt Vatten Braun|leysir|| |20|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997||L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||00|400|0|Actavis Group hf|Braun|| 071217|C03EA0104|Hydramil mite|töflur|27,5|mg|100|stk|1|glas|2.5+25 mg|C03EA01|01.08.1984||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|158|391|lyfalmen|V0232|391|00|100|0|Actavis Group hf|Actavis hf|100| 008300|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|4943|8122|lyfalmen|||00|98|0|Vistor hf|AstraZeneca A/S DK|49| 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|PFD|0|0|1|100|IKR|||lyfalmen|||23|210|0|Vistor hf|Pfizer Denmark PCH ApS|14| 383075|N02AA5904|Ibukod sterkar|töflur|| |20|stk|1|glas|30+200 mg|N02AA59|01.02.1999||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|253|588|lyfalmen|||00|20|0|Actavis Group hf|Actavis hf|6,6667| 124727|C09AA0201|Daren |töflur|10|mg|30|stk|1|glas||C09AA02|01.01.1994||R|A|1,3|0|0|B|0|ACA|0|0|0|100|IKR|756|1634|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|30| 591131|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|31979|41681|lyfsjukr|||00|1200|0|Icepharma hf|GE Healthcare AS|| 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|82356|104401|lyfsjukr|||02|3000|0|Icepharma hf|GE Healthcare AS|| 124248|R06AD0301|Torecan|töflur|6,5|mg|20|stk|1|þpakki||R06AD03|01.10.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|562|1231|lyfalmen|||00|20|1|Parlogis hf|Parlogis - óskráð lyf|10| 531459|R03CC0303|Bricanyl Retard|forðatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|1754|3399|lyfalmen|||43|100|0|Vistor hf|AstraZeneca A/S DK|50| 062935|G03AA1005|Harmonet|töflur|| |63|stk|1|pakki|þp 20+75 mcg|G03AA10|01.11.1998||R|A|3|0|0|0|0|WEM|0|0|0|100|IKR|1232|2606|lyfalmen|||23|63|0|Icepharma hf|Wyeth Medica|63| 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|IKR|1884|3596|lyfalmen|||02|100|0|Vistor hf|AstraZeneca A/S DK|| 170225|R01AA0702|Otrivin|nefdr|1|mg/ml|10|ml|1|glas||R01AA07|01.12.1972||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||06|10|0|Artasan ehf|Novartis Healthcare A/S-A|12,5| 087760|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|105|0|Lyfjaver ehf|Lyfjaver ehf|7| 591149|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|36833|47725|lyfsjukr|||00|1200|0|Icepharma hf|GE Healthcare AS|| 160622|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|90958|115110|lyfsjukr|||00|200|0|Icepharma hf|GE Healthcare AS|| 417220|N01AX1001|Diprivan|stl|10|mg/ml|100|ml|1|hgl||N01AX10|01.01.1994||R|A|3|0|0|0|1|ASZ|0|0|0|100|IKR|2240|3207|lyfsjukr|||02|100|0|Vistor hf|AstraZeneca UK Ltd|| 956302|N07AA0101|Neostigmin|stl|0,5|mg/ml|1|ml|10|lykjur||N07AA01|01.01.2006||R|A||0|0|0|0|LDR|0|0|0|100|IKR|476|1052|lyfalmen|||00|10|1|Parlogis hf|Parlogis - óskráð lyf|2,5| 005178|J01CF0102|Staklox |hylki|250|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|754|1630|lyfalmen|V0452|1630|10|30|0|Actavis Group hf|Actavis hf|3,75| 588723|B03AA0702|Ferlen-R |forðatfl|100|mg|60|stk|1|glas||B03AA07|01.01.1994||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||10|60|0|Actavis Group hf|Actavis hf|30| 165928|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|fl|plastfl.|V08AB09|01.05.1999||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|Icepharma hf|GE Healthcare AS|| 380642|A10AD0402|Humalog Mix50 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.12.2001||R|K|2|0|0|*|0|ELD|0|0|0|100|IKR|4230|7083|lyfalmen|||17|15|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|37,5| 007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|IKR|3633|6213|lyfalmen|||00|28|0|Vistor hf|AstraZeneca A/S DK|56| 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|K|2|0|0|*|0|ELD|0|0|0|100|IKR|2302|4231|lyfalmen|||17|10|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|25| 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|2|0|Vistor hf|AstraZeneca A/S DK|1,25| 035506|N03AX0903|Lamotrin|dreifit.|25|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1511|3030|lyfalmen|||00|56|0|Actavis Group hf|Actavis hf|4,67| 015037|M01AX0502|Glucosamin Pharma Nord |hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|0|0|lyfalmen|||00|90|0|Icepharma hf|Pharma Nord ApS|24| 947822|H02AB0203|Dexamethason|töflur|4|mg|50|stk|1|glas||H02AB02|01.11.2001||R|A||0|0|E|0|LDR|0|0|1|100|IKR|5636|9091|lyfalmen|||00|50|1|Parlogis hf|Parlogis - óskráð lyf|133,33| 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.01.1998||R|A||0|0|0|0|LDR|0|0|1|100|IKR|1797|3464|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|100| 371583|A06AG1001|Klyx|innhl|| |240|ml|1|fl||A06AG10|01.12.1978||L|A|1|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||23|240|0|Vistor hf|Ferring Lægemidler A/S|1| 021107|N05AH0403|Seroquel (D.A.C.)|töflur|100|mg|60|stk|1|þpakki||N05AH04|01.05.2005||R|A|3|0|0|*|0|DAC|0|1|0|100|IKR|6749|10643|lyfalmen|||00|60|0|D.A.C. ehf|D.A.C. ehf|15| 021548|R03BA0204|Pulmicort Turbuhaler (D.A.C.)|innúðadu|200|mcg/sk|100|sk|1|stauk||R03BA02|01.05.2005||R|A|2|0|0|B|0|DAC|0|0|0|100|IKR|1582|3137|lyfalmen|||23|100|0|D.A.C. ehf|D.A.C. ehf|25| 045397|N07BA0127|Nicorette Mint (Lyfjaver) |tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|210|0|Lyfjaver ehf|Lyfjaver ehf|14| 022215|N06AB0504|Paxetin|töflur|20|mg|20|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|830|1788|lyfalmen|V0917|1788|00|20|0|Actavis Group hf|Actavis hf|20| 065094|V08AB0901|Visipaque|stl|150|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5486|7855|lyfsjukr|||02|500|0|Icepharma hf|GE Healthcare AS|| 199307|L01CB0101|Vepesid|stl|20|mg/ml|5|ml|10|hgl||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|28074|36820|lyfsjukr|||00|50|1|Vistor hf|Vistor - óskráð lyf|| 024530|N05AH0304|Zyprexa (D.A.C.)|húðuðtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.08.2005||R|A|3|0|0|*|0|DAC|0|1|0|100|IKR|16846|24024|lyfalmen|V0811|23595|00|56|0|D.A.C. ehf|D.A.C. ehf|42| 177295|M02AA1501|Voltaren Emulgel|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|50|0|Artasan ehf|Novartis Healthcare A/S-A|| 516476|A02BC0105|Losec MUPS|sh-tfl|10|mg|14|stk|1|glas||A02BC01|01.01.1999||R|A|2|0|0|E|0|AZD|0|0|0|30|IKR|1095|2339|lyfalmen|||00|14|0|Vistor hf|AstraZeneca A/S DK|7| 592469|N02BE0107|Paratabs |lausnart|160|mg|30|stk|1|þpakki||N02BE01|01.01.1995||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||09|30|0|Actavis Group hf|Actavis hf|1,6| 568840|C08CA0201|Feldil |forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|1847|3540|lyfalmen|V0316|3540|10|100|0|Actavis Group hf|Actavis hf|100| 118406|A02BA0201|Asyran |töflur|300|mg|30|stk|1|þpakki||A02BA02|01.04.1994||R|A|3|0|0|E|0|ACA|0|0|0|30|IKR|1154|2462|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|30| 149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|þpakki||N05AG02|01.03.2004||R|A|5|0|0|0|0|PCO|0|1|0|100|IKR|1212|2575|lyfalmen|||00|75|1|Vistor hf|Vistor - óskráð lyf|18,75| 082233|V03AN0101|Conoxia|innö.gas|100|%|36|l|1|hylki|Hemlox|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|36|0|Ísaga ehf|AGA AB|| 950742|H02AB0204|Dexa-Ratiopharm|stl|4|mg/ml|1|ml|10|hgl||H02AB02|01.01.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1307|1871|lyfsjukr|||55|10|1|Parlogis hf|Parlogis - óskráð lyf|| 171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005||R|A||0|0|B|0|LDR|0|0|0|100|IKR|398|890|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|33,3333| 128280|V07AB10|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.12.1997||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|1000|0|Actavis Group hf|Braun|| 012716|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|7|0|Artasan ehf|Novartis Healthcare A/S-A|7| 083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|DRL|0|0|0|100|IKR|4409|7344|lyfalmen|||00|40|0|Vistor hf|Draco Lakemedel AB|25| 497297|C09AA0201|Daren |töflur|5|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|969|2077|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|50| 501734|M01AB0508|Vostar-R |forðatfl|75|mg|100|stk|1|glas||M01AB05|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|3199|5581|lyfalmen|||67|100|0|Actavis Group hf|Actavis hf|75| 951287|J01CA0101|Ampicillin |sts|| |1|g|10|hgl||J01CA01|01.07.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1554|2225|lyfsjukr|||00|10|1|Parlogis hf|Parlogis - óskráð lyf|5| 066399|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|21|0|Artasan ehf|Novartis Healthcare A/S-A|10,5| 590539|A01AD1101|Bonjela|hlaup|| |15|g|1|túpa|hlaup í munn|A01AD11|01.01.1996||L|A|3|0|0|0|0|REB|0|0|1|100|IKR|||lyfalmen|||00|15|0|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|| 041996|A06AG1101|Microlax|innhl|| |5|ml|4|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|PFD|0|0|0|100|IKR|||lyfalmen|||56|20|0|Vistor hf|Pfizer Denmark PCH ApS|4| 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|193|464|lyfalmen|||00|10|0|Actavis Group hf|Actavis hf|1,6667| 036541|A03AX1301|Minifom|dropar|| |30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|S|3|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||00|30|0|Vistor hf|AstraZeneca A/S DK|6| 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|IKR|3985|6726|lyfalmen|||00|56|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|| 435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|þpakki||N02CC03|01.11.1998||R|A|3|0|0|E|0|ASZ|0|0|0|100|IKR|3235|5634|lyfalmen|||00|6|0|Vistor hf|AstraZeneca UK Ltd|6| 172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|9328|14157|lyfalmen|||00|98|0|Vistor hf|AstraZeneca A/S DK|| 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|92841|117455|lyfsjukr|||02|3000|0|Icepharma hf|GE Healthcare AS|| 003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|IKR|12255|18308|lyfalmen|V0010|18003|00|98|0|Eli Lilly Danmark A/S|Takeda Europe -|98| 520486|C08CA0102|Amlo|töflur|2,5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2791|4974|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|50| 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|IKR|973|2085|lyfalmen|||00|100|0|Vistor hf|AstraZeneca A/S DK|| 082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|DRL|0|0|0|100|IKR|3331|5773|lyfalmen|||00|40|0|Vistor hf|Draco Lakemedel AB|12,5| 104174|A02AD0101|Alminox|tuggutfl|600|mg|100|stk|1|glas|500+100mg|A02AD01|01.01.1986||L|A|5|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||11|100|0|Actavis Group hf|Actavis hf|10| 003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|IKR|8266|12742|lyfalmen|||00|98|0|Eli Lilly Danmark A/S|Takeda Europe -|49| 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|IKR|7508|11702|lyfalmen|||00|28|0|Icepharma hf|Eli Lilly Danmark A/S|21| 464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyfalmen|||00|30|0|Icepharma hf|GlaxoSmithKline CH A/S|5| 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|45479|59672|lyfalmen|||00|100|0|Icepharma hf|GE Healthcare AS|| 128926|V07AB09|Sterilt Vatten Braun|leysir|| |50|ml|20|hgl|leysir f.stungulyf|V07AB|01.12.1997||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||00|1000|0|Actavis Group hf|Braun|| 016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|IKR|12381|18465|lyfalmen|||00|100|0|Vistor hf|AstraZeneca A/S DK|200| 938954|A04AD0501|Vogalene|stl|10|mg/ml|1|ml|10|lykjur||A04AD05|01.05.1998||R|A||0|0|0|1|PCO|0|0|0|100|IKR|3072|4398|lyfsjukr|||00|10|1|Vistor hf|Vistor - óskráð lyf|6,6667| 008888|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|1939|3680|lyfalmen|||00|28|0|Vistor hf|AstraZeneca A/S DK|56| 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|A|3|0|0|*|0|ELD|0|1|0|100|IKR|575|1258|lyfalmen|||00|1|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|1| 020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||43|100|0|Vistor hf|AstraZeneca A/S DK|50| 088015|N07BA0125|Nicotinell Fruit (Lyfjaver) |tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|96|0|Lyfjaver ehf|Lyfjaver ehf|6,4| 422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|4603|7626|lyfalmen|||43|98|0|Vistor hf|AstraZeneca A/S DK|124,13| 473348|A03AA0402|Spasmerin |töflur|135|mg|50|stk|1|glas||A03AA04|01.07.1990||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|742|1605|lyfalmen|||00|50|0|Actavis Group hf|Actavis hf|22,5| 916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|glas||A03FA03|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2074|3885|lyfalmen|||00|100|1|Vistor hf|Vistor - óskráð lyf|33,3333| 105023|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5432|7777|lyfsjukr|||02|200|0|Icepharma hf|GE Healthcare AS|| 473371|A03AA0402|Spasmerin |töflur|135|mg|100|stk|1|glas||A03AA04|01.07.1990||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|1302|2712|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|45| 949620|G03DA0401|Utrogestan|hylki|100|mg|30|stk|1|pakki||G03DA04|01.01.1999||R|A||0|1|E|0|ISF|0|0|0|100|IKR|948|2033|lyfalmen|||00|30|1|Icepharma hf|Icepharma hf - óskráð lyf|10| 012125|G03BA0308|Andriol|hylki|40|mg|60|stk|1|pakki||G03BA03|01.02.2006||R|A||0|1|0|0|LDR|0|0|0|100|IKR|4053|6825|lyfalmen|||00|60|1|Parlogis hf|Parlogis - óskráð lyf|20| 010890|A02BC0107|Lomex-T|sh-tfl|20|mg|28|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|30|IKR|2203|4081|lyfalmen|||10|28|0|Actavis Group hf|Actavis hf|28| 076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|2259|4166|lyfalmen|V1075|4166|00|60|0|PortFarma ehf|PortFarma |6| 006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyfalmen|||00|10|0|Icepharma hf|GlaxoSmithKline CH A/S|1,67| 523043|N02AA5902|Parkodin forte |töflur|530|mg|40|stk|1|pakki|þp 30+500 mg|N02AA59|01.11.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|220|520|lyfalmen|||00|40|0|Actavis Group hf|Actavis hf|13,3333| 475798|R03AC1302|Oxis Turbuhaler|innúðadu|4,5|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|B|0|AZD|0|0|1|100|IKR|2010|3788|lyfalmen|||00|60|0|Vistor hf|AstraZeneca A/S DK|11,25| 944985|A06AX0103|Glycerol adult|eþ-stil|| |12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|773|lyfalmen|||00|12|1|Parlogis hf|Parlogis - óskráð lyf|| 417030|A02AD0104|Balancid Novum|tuggutfl|| |30|stk|1|þpakki||A02AD01|01.10.1992||L|A|3|0|0|0|0|BIP|0|0|0|100|IKR|||lyflausa|||11|30|0|Vistor hf|BioPhausia AB|3| 038257|N06AB0501|Seroxat|töflur|20|mg|60|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|30|IKR|2208|4088|lyfalmen|V0918|4088|00|60|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|60| 567990|V08AB0901|Visipaque|stl|150|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|14023|19326|lyfsjukr|||02|1200|0|Icepharma hf|GE Healthcare AS|| 006172|S01XA2007|Simplex|augnsm|| |4|g|1|túpa|paraf+vasel án ullarf.|S01XA20|01.07.2003||R|A||0|0|E|0|LDR|0|0|0|100|IKR|456|1010|lyfalmen|||00|4|1|Parlogis hf|Parlogis - óskráð lyf|| 049588|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|30|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|0|0|POF|0|0|0|100|IKR|2815|5010|lyfalmen|V0457|5010|00|30|0|PortFarma ehf|PortFarma |30| 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|IKR|11824|17482|lyfalmen|||00|98|0|Vistor hf|AstraZeneca A/S DK|196| 950734|N04BC0704|Apo-Go|stl|10|mg/ml|2|ml|5|lykjur||N04BC07|01.07.2003||R|A||0|1|0|1|LDR|0|0|0|100|IKR|6186|8857|lyfsjukr|||00|10|1|Parlogis hf|Parlogis - óskráð lyf|| 938441|C01BG1301|Bretylium Tosylate|stl|50|mg/ml|10|ml|1|hgl||C01BG13|01.04.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|3140|4496|lyfsjukr|||02|10|1|Parlogis hf|Parlogis - óskráð lyf|| 019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|A|2|0|1|0|1|ELD|0|0|0|100|IKR|137900|173553|lyfsjukr|||00|1|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|| 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|3334|5778|lyfalmen|V0919|5778|00|100|0|Actavis Group hf|Actavis hf|100| 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30654|lyfsjukr|||02|500|0|Icepharma hf|GE Healthcare AS|| 081552|V03AN0101|Conoxia|innö.gas|100|%|5|l|1|hylki|MO5|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|5|0|Ísaga ehf|AGA AB|| 093625|B03AA0702|Ferlen-R |forðatfl|100|mg|100|stk|1|glas||B03AA07|01.04.1993||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||10|100|0|Actavis Group hf|Actavis hf|50| 173641|M01AC0202|Tilcotil|töflur|20|mg|10|stk|1|þpakki||M01AC02|01.04.1988||R|A|5|0|0|E|0|ROC|0|0|1|100|IKR|447|992|lyfalmen|||00|10|0|Icepharma hf|Roche|10| 475491|N02AA5902|Parkodin forte |töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|111|293|lyfalmen|V0775|293|00|20|0|Actavis Group hf|Actavis hf|6,6667| 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|IKR|35491|46054|lyfsjukr|||02|1|0|Icepharma hf|Eli Lilly Danmark A/S|18| 480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|þpakki||G03XC01|01.02.1999||R|A|2|0|0|E|0|ELD|0|0|0|100|IKR|7828|12148|lyfalmen|V0377|12134|00|84|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|84| 069833|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|1849|3543|lyfalmen|||00|40|0|Icepharma hf|NordMedica A/S|10| 002405|C09AA0206|Enalapril Merck NM|töflur|2,5|mg|50|stk|1|þpakki||C09AA02|01.10.2007||R|A||0|0|B|0|PCO|0|0|0|100|IKR|510|1123|lyfalmen|||00|50|1|Vistor hf|Vistor - óskráð lyf|12,5| 457150|N05BA1202|Paxal |töflur|0,5|mg|20|stk|1|glas||N05BA12|01.04.1990||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|199|476|lyfalmen|V0856|476|00|20|0|Actavis Group hf|Actavis hf|10| 327817|A03AA0701|Dicykloverinklorid |mixtúra|1|mg/ml|100|ml|1|glas|sykursaft|A03AA07|01.01.2000||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2944|5206|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|1,25| 012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|Artasan ehf|Novartis Healthcare A/S-A|3,2| 001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|IKR|764|1651|lyfalmen|||00|7|0|Vistor hf|AstraZeneca A/S DK|4,67| 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|Artasan ehf|Novartis Healthcare A/S-A|6,4| 014702|C09CA0601|Atacand|töflur|32|mg|28|stk|1|þpakki||C09CA06|01.06.2005||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|2547|4603|lyfalmen|||00|28|0|Vistor hf|AstraZeneca A/S DK|112| 424846|M04AA0103|Hexanurat|töflur|100|mg|100|stk|1|glas||M04AA01|01.02.2006||R|A||0|0|E|0|PCO|0|0|0|100|IKR|248|578|lyfalmen|||00|100|1|Vistor hf|Vistor - óskráð lyf|25| 181404|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|glas||M01AE01|01.01.1988||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|462|1023|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|50| 169367|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|IKR|1031|2206|lyfalmen|||02|100|0|Vistor hf|AstraZeneca A/S DK|| 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|IKR|3985|6726|lyfalmen|||00|56|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|| 426122|R01AA0503|Nezeril|nefdr|0,1|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|2|0|Vistor hf|AstraZeneca A/S DK|0,5| 371609|A06AG1001|Klyx|innhl|| |120|ml|1|fl||A06AG10|01.12.1978||L|A|1|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||23|120|0|Vistor hf|Ferring Lægemidler A/S|1| 109751|N02BE0107|Paratabs |töflur|500|mg|100|stk|1|þpakki||N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|204|486|lyfalmen|V0772|486|00|100|0|Actavis Group hf|Actavis hf|16,6667| 025676|L01CB0201|Vumon|stl|10|mg/ml|5|ml|10|lykjur||L01CB02|01.05.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|34429|44732|lyfsjukr|||00|50|1|Vistor hf|Vistor - óskráð lyf|| 045379|N07BA0128|Nicorette Classic (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|210|0|Lyfjaver ehf|Lyfjaver ehf|14| 568030|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5568|7972|lyfsjukr|||02|200|0|Icepharma hf|GE Healthcare AS|| 938417|N07BC0201|Metadon|stl|10|mg/ml|1,1|ml|10|lykjur||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|1770|3423|lyfalmen|||00|11|1|Parlogis hf|Parlogis - óskráð lyf|4,4| 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|IKR|2392|4368|lyfalmen|||00|28|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|14| 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|3347|5797|lyfalmen|V0922|5797|00|100|0|Actavis Group hf|Actavis hf|50| 170845|A07AA0901|Vancocin|hylki|250|mg|30|stk|1|þpakki|hart hylki|A07AA09|01.10.1988||R|A|2|0|0|E|0|NMA|0|0|1|100|IKR|20000|27950|lyfalmen|V0126|27950|10|30|0|Icepharma hf|NordMedica A/S|3,75| 165894|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|227395|284974|lyfsjukr|||00|500|0|Icepharma hf|GE Healthcare AS|| 938665|A12CX0001|K-Phos Neutral|töflur|| |100|stk|1|glas||A12CX00|01.03.2001||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2993|5281|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|| 912792|N07CA0301|Sibelium|hylki|5|mg|50|stk|1|glas||N07CA03|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|2816|5012|lyfalmen|||00|50|1|Vistor hf|Vistor - óskráð lyf|25| 005336|R01AA0704|Otrivin ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.07.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||06|10|0|Artasan ehf|Novartis Healthcare A/S-A|6,25| 005189|J01CF0102|Staklox |hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|763|1649|lyfalmen|||10|20|0|Actavis Group hf|Actavis hf|5| 947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|3266|5679|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|66,6667| 546531|N06AF0101|Marplan|töflur|10|mg|56|stk|1|glas||N06AF01|01.10.2001||R|A||0|0|E|0|LDR|0|0|0|100|IKR|6004|9605|lyfalmen|||00|56|1|Parlogis hf|Parlogis - óskráð lyf|37,3333| 016688|N05AH0303|Zyprexa (Lyfjaver)|húðuðtfl|10|mg|56|stk|1|glas||N05AH03|01.09.2003||R|A|3|0|0|*|0|LVR|0|1|0|100|IKR|20990|29183|lyfalmen|V0812|29183|00|56|0|Lyfjaver ehf|Lyfjaver ehf|56| 049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|0|0|POF|0|0|0|100|IKR|3655|6245|lyfalmen|V0367|6245|00|100|0|PortFarma ehf|PortFarma |266,67| 004580|J01MA0203|Siprox |töflur|500|mg|20|stk|1|glas||J01MA02|01.01.1994||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|2210|4091|lyfalmen|V0526|4091|00|20|0|Actavis Group hf|Actavis hf|10| 371617|A06AG1001|Klyx|innhl|| |120|ml|10|fl||A06AG10|01.12.1978||L|A|1|0|0|0|0|FEL|0|0|0|100|IKR|3013|5310|lyfalmen|||23|1200|0|Vistor hf|Ferring Lægemidler A/S|10| 433748|J01EE0104|Primazol sterkar |töflur|960|mg|50|stk|1|glas|160+800 mg|J01EE01|01.07.1989||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|2036|3827|lyfalmen|||00|50|0|Actavis Group hf|Actavis hf|25| 108209|N02BE0106|Parasupp |eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.06.1984||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||04|10|0|Actavis Group hf|Actavis hf|1,6667| 051058|M02AA1002|Orudis (D.A.C.)|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.01.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyfalmen|||00|60|0|D.A.C. ehf|D.A.C. ehf|| 064394|L01DC0301|Mutamycin|sts|20|mg/hgl|1|stk|1|hgl||L01DC03|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|10278|14664|lyfsjukr|||00|1|1|Vistor hf|Vistor - óskráð lyf|| 402289|J01MA0203|Siprox |töflur|250|mg|20|stk|1|glas||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1108|2366|lyfalmen|V0518|2366|00|20|0|Actavis Group hf|Actavis hf|5| 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|3|0|0|*|0|ELD|0|1|0|100|IKR|27530|37325|lyfalmen|||00|28|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|56| 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|IKR|1672|3274|lyfalmen|||02|100|0|Vistor hf|AstraZeneca A/S DK|| 081561|V03AN0101|Conoxia|innö.gas|100|%|50|l|12|hylki|MS5I|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|600|0|Ísaga ehf|AGA AB|| 948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.04.2005||R|A||0|0|E|0|LDR|0|0|1|100|IKR|636|1385|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|33,33| 054278|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|4|0|Artasan ehf|Novartis Healthcare A/S-A|| 457143|N05BA1202|Paxal |töflur|0,25|mg|100|stk|1|glas||N05BA12|01.04.1990||R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|461|1021|lyfalmen|V0852|1021|00|100|0|Actavis Group hf|Actavis hf|25| 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|stk|1|glas|+ dæla|L02AE03|01.04.1996||R|A|3|0|1|*|0|ASZ|0|0|0|100|IKR|35879|47720|lyfalmen|V0438|46826|00|1|0|Vistor hf|AstraZeneca UK Ltd|83,7209| 133413|N01BB0902|Naropin|stl/irl|2|mg/ml|10|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|IKR|1075|1539|lyfsjukr|||00|50|0|Vistor hf|AstraZeneca A/S DK|| 952855|N02AA0102|Morfin |eþ-stil|10|mg|12|stk|1|pakki||N02AA01|01.10.2004||R|S||1|0|E|0|LDR|0|0|0|100|IKR|1761|3409|lyfalmen|||00|12|1|Parlogis hf|Parlogis - óskráð lyf|4| 001431|C10AA0102|Sivacor|töflur|40|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2700|4836|lyfalmen|V0457|4676|00|28|0|Actavis Group hf|Actavis hf|74,6667| 198432|N02BE5102|Parkodin|eþ-stil|510|mg|10|stk|1|pakki|10+500 mg|N02BE51|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|498|1098|lyfalmen|||04|10|0|Actavis Group hf|Actavis hf|1,6667| 463778|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|glas||M01AE01|01.01.1989||L|A|5|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|20|0|Actavis Group hf|Actavis hf|3,3333| 020230|C03CC0101|Edecrin|töflur|50|mg|100|stk|1|glas||C03CC01|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1601|2292|lyfsjukr|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|100| 004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|1014|2171|lyfalmen|V0921|2171|00|28|0|Actavis Group hf|Actavis hf|14| 066407|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|21|0|Artasan ehf|Novartis Healthcare A/S-A|21| 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|Artasan ehf|Novartis Healthcare A/S-A|13,6| 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|3660|6253|lyfalmen|V0310|6253|00|100|0|Actavis Group hf|Actavis hf|200| 400101|R05DB2002|Pektolin |mixtúra|| |150|ml|1|glas||R05DB20|01.06.1981||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|150|0|Actavis Group hf|Actavis hf|| 538207|A02AD0106|Rennie|sog/tugg|| |96|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyfalmen|||00|96|0|Icepharma hf|Bayer AB|9,6| 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|IKR|2700|3866|lyfsjukr|||02|20|0|Vistor hf|AstraZeneca A/S DK|| 450080|R05DA0701|Noskapin|töflur|25|mg|50|stk|1|glas||R05DA07|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|1050|2245|lyfalmen|||00|50|1|Parlogis hf|Parlogis - óskráð lyf|10| 017556|J01CR0201|Amoksiklav|töflur|625|mg|20|stk|1|glas|500+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1350|2785|lyfalmen|V0465|2630|00|20|0|Actavis Group hf|LEK Pharmaceuticals d.d.|12,5| 434852|N06AB0302|Fontex|lausnart|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|A|2|0|0|B|0|ELI|0|1|0|30|IKR|5966|9552|lyfalmen|||00|100|0|Icepharma hf|Eli Lilly Danmark A/S|100| 087769|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.06.2004||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|210|0|Lyfjaver ehf|Lyfjaver ehf|14| 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|5378|8732|lyfalmen|V0933|8732|00|98|0|Actavis Group hf|Actavis hf|98| 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|61388|78296|lyfsjukr|||02|2000|0|Icepharma hf|GE Healthcare AS|| 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|1551|3090|lyfalmen|V0610|3090|00|100|0|Actavis Group hf|Actavis hf|50| 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|920|1975|lyfalmen|V0001|1975|00|90|0|Actavis Group hf|Actavis hf|45| 081598|V03AN0101|Conoxia|innö.gas|100|%|2,5|l|1|hylki|MO2,5c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|2,5|0|Ísaga ehf|AGA AB|| 007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|| |100|ml|50|pokar|leysir f.stungulyf|V07AB00|01.02.2006||L|A|1,5|0|0|0|0|BAX|0|0|0|100|IKR|||lyfalmen|||00|5000|0|Icepharma hf|Baxter|| 025300|J01DB0101|Keflex|mixtúrud|50|mg/ml|100|ml|1|glas||J01DB01|01.03.1983||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|722|1563|lyfalmen|||08|100|0|Icepharma hf|NordMedica A/S|2,5| 157768|S01AA3001|Terramycin Polymyxin B|augnsm|| |3,5|g|1|túpa||S01AA30|01.01.2000||R|S|5|0|0|E|0|PCO|0|0|1|100|IKR|290|665|lyfalmen|||07|3,5|1|Vistor hf|Vistor - óskráð lyf|| 075096|N02AA5902|Parkodin forte |töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|IKR|1829|3513|lyfalmen|||00|300|0|Actavis Group hf|Actavis hf|300| 003809|A10BG0301|Actos|töflur|30|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|IKR|5180|8456|lyfalmen|||00|28|0|Eli Lilly Danmark A/S|Takeda Europe -|28| 067868|A02BC0303|Lanser|sh-hylki|30|mg|56|stk|1|glas||A02BC03|01.01.1997||R|A|2|0|0|E|0|ACA|0|0|0|30|IKR|3688|6293|lyfalmen|||00|56|0|Actavis Group hf|Actavis hf|56| 002312|D01AE1501|Lamisil|hlaup|10|mg/g|15|g|1|túpa||D01AE15|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|15|0|Artasan ehf|Novartis Healthcare A/S-A|15| 532739|V07AB10|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|5|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997||L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|100|0|Actavis Group hf|Braun|| 184309|R03DA0404|Theo-Dur|forðatfl|200|mg|100|stk|1|glas||R03DA04|01.11.1981||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|869|1869|lyfalmen|||10|100|0|Vistor hf|AstraZeneca A/S DK|50| 538181|A02AD0106|Rennie|sog/tugg|| |24|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyfalmen|||00|24|0|Icepharma hf|Bayer AB|2,4| 907024|A04AD0501|Vogalene|eþ-stil|5|mg|10|stk|1|pakki||A04AD05|01.01.1998||R|A||0|0|E|0|PCO|0|0|1|100|IKR|1597|3160|lyfalmen|||00|10|1|Vistor hf|Vistor - óskráð lyf|3,3333| 019681|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|Artasan ehf|Novartis Healthcare A/S-A|1,6| 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|5429|8803|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|100| 476655|N05AH0401|Seroquel|töflur|200|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|IKR|7188|11255|lyfalmen|||00|30|0|Vistor hf|AstraZeneca UK Ltd|15| 173898|N07AA0201|Mestinon|töflur|10|mg|250|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1681|3288|lyfalmen|||00|250|1|Parlogis hf|Parlogis - óskráð lyf|13,8889| 492520|A02BC0105|Losec MUPS|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|A|3|0|0|E|0|AZD|0|0|0|30|IKR|5019|8231|lyfalmen|||00|100|0|Vistor hf|AstraZeneca A/S DK|50| 104372|N05BA0204|Klordiazepoxið Actavis|töflur|5|mg|100|stk|1|glas||N05BA02|01.10.1995||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|475|1050|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|16,6667| 056024|C10AA0503|Atacor|töflur|20|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|7277|11380|lyfalmen|V0338|11380|00|100|0|Actavis Group hf|Actavis hf|200| 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27592|lyfsjukr|||02|500|0|Icepharma hf|GE Healthcare AS|| 003310|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|B|0|AZD|0|0|0|100|IKR|4947|8127|lyfalmen|V0990|7912|00|120|0|Vistor hf|AstraZeneca A/S DK|30| 080598|N06AA0901|Amilin|töflur|25|mg|100|stk|1|glas||N06AA09|01.04.1987||R|A|4|0|0|B|0|ACA|0|1|0|100|IKR|369|829|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|33,3333| 497289|C09AA0201|Daren |töflur|5|mg|30|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|506|1114|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|15| 109728|N02BE0107|Paratabs |töflur|500|mg|30|stk|1|þpakki||N02BE01|01.07.1992||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|5| 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1943|3686|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|100| 088006|N07BA0126|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|96|0|Lyfjaver ehf|Lyfjaver ehf|6,4| 087814|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|105|0|Lyfjaver ehf|Lyfjaver ehf|14| 801120|A11HA0502|Biotin Roche|töflur|5|mg|20|stk|1|glas||A11HA05|01.12.2005||R|A||0|0|0|0|PCO|0|0|0|100|IKR|593|1295|lyfalmen|||00|20|1|Vistor hf|Vistor - óskráð lyf|| 038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|30|IKR|830|1788|lyfalmen|V0917|1788|00|20|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|20| 087796|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|105|0|Lyfjaver ehf|Lyfjaver ehf|7| 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|90958|116293|lyfalmen|||00|200|0|Icepharma hf|GE Healthcare AS|| 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|39554|51112|lyfsjukr|||02|1000|0|Icepharma hf|GE Healthcare AS|| 399527|N03AX0901|Lamictal|dreifit.|200|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|8043|12445|lyfalmen|V0706|12445|00|56|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|37,3333| 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|AZD|0|0|1|100|IKR|943|2023|lyfalmen|||00|40|0|Vistor hf|AstraZeneca A/S DK|20| 010912|A02BC0107|Lomex-T|sh-tfl|20|mg|100|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|30|IKR|7453|11625|lyfalmen|||10|100|0|Actavis Group hf|Actavis hf|100| 099705|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|brusar|vatnsl|D08AG02|01.04.1985||L|A|3|0|0|0|0|MUN|0|0|0|100|IKR|||lyfalmen|||00|500|0|Icepharma hf|Mundipharma|500| 923608|C03BA0801|Metenix|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.05.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|4460|7418|lyfalmen|||00|100|1|Vistor hf|Vistor - óskráð lyf|100| 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|505|1112|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|16,6667| 104034|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|Icepharma hf|GE Healthcare AS|| 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|IKR|6279|9988|lyfalmen|V1351|9812|00|8|0|Eli Lilly Danmark A/S|Lilly ICOS Limited|16| 940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1313|2729|lyfalmen|||00|1|1|Parlogis hf|Parlogis - óskráð lyf|1,39| 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1066|2279|lyfalmen|||00|70|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|5,6| 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|IKR|1062|2270|lyfalmen|V0608|1913|67|100|0|Vistor hf|Novartis Healthcare A/S-|50| 034616|N05CM0201|Heminevrin|mixtúra|50|mg/ml|300|ml|1|glas||N05CM02|01.07.2006||R|K|2|0|0|0|0|ARA|0|0|1|100|IKR|1255|2641|lyfalmen|||00|300|0|Vistor hf|Astra|10| 938649|C05BA0401|Elmiron|hylki|100|mg|100|stk|1|glas||C05BA04|01.05.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|29029|39191|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|| 002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|IKR|1008|2158|lyfalmen|||00|7|0|Vistor hf|AstraZeneca A/S DK|9,33| 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|3538|6075|lyfalmen|V0926|6075|00|100|0|Actavis Group hf|Actavis hf|100| 409425|R01AD0502|Rhinocort Turbuhaler|nefúðad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.1992||R|A|2|0|0|E|0|AZD|0|0|1|100|IKR|2302|4231|lyfalmen|V0966|4161|23|200|0|Vistor hf|AstraZeneca A/S DK|100| 497263|N06BA0103|Amfetamin Actavis|töflur|5|mg|30|stk|1|glas||N06BA01|01.07.1991||R|A|3|1|0|0|0|ACA|0|0|0|100|IKR|1036|2216|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|10| 001400|C10AA0102|Sivacor|töflur|10|mg|98|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1908|3633|lyfalmen|V0358|3633|00|98|0|Actavis Group hf|Actavis hf|65,3333| 129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|IKR|21865|30272|lyfalmen|V0812|29183|00|56|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|56| 178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|A|3|0|0|E|0|PCO|0|0|1|100|IKR|426|948|lyfalmen|||03|1|1|Vistor hf|Vistor - óskráð lyf|5,333| 081689|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|1|0|Ísaga ehf|AGA AB|| 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|2579|4652|lyfalmen|||67|30|0|Actavis Group hf|Actavis hf|20| 123596|N02AA5904|Ibukod sterkar|töflur|| |100|stk|1|glas|30+200 mg|N02AA59|01.10.1998||R|A|2|1|0|0|0|ACA|0|0|1|100|IKR|920|1975|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|33,3333| 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|IKR|74496|94615|lyfsjukr|||02|1|0|Icepharma hf|Eli Lilly Danmark A/S|36| 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|28937|37894|lyfsjukr|||02|1000|0|Icepharma hf|GE Healthcare AS|| 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|Artasan ehf|Novartis Healthcare A/S-A|12,8| 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|IKR|7508|11702|lyfalmen|||00|28|0|Icepharma hf|Eli Lilly Danmark A/S|8,75| 435578|N02CC0301|Zomig|töflur|2,5|mg|3|stk|1|þpakki||N02CC03|01.11.1998||R|A|3|0|0|E|0|ASZ|0|0|0|100|IKR|1623|3200|lyfalmen|||00|3|0|Vistor hf|AstraZeneca UK Ltd|3| 048452|M01AE5101|Ibukod|töflur|| |30|stk|1|glas|10+200 mg|M01AE51|01.11.2006||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|464|1027|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|5,01| 160408|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|45479|58489|lyfsjukr|||00|100|0|Icepharma hf|GE Healthcare AS|| 021559|R03BA0204|Pulmicort Turbuhaler (D.A.C.)|innúðadu|400|mcg/sk|100|sk|1|stauk||R03BA02|01.05.2005||R|A|2|0|0|B|0|DAC|0|0|0|100|IKR|2980|5261|lyfalmen|||23|100|0|D.A.C. ehf|D.A.C. ehf|50| 081539|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|glas||M01AE01|01.01.1988||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|357|805|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|33,3333| 087823|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|210|0|Lyfjaver ehf|Lyfjaver ehf|28| 938524|G04BE0201|Papaverin|stl|40|mg/ml|1|ml|10|lykjur||G04BE02|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|3002|5294|lyfalmen|||00|10|1|Parlogis hf|Parlogis - óskráð lyf|4| 145698|N05AH0301|Zyprexa|húðuðtfl|10|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|IKR|11790|17437|lyfalmen|||00|28|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|28| 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|ASZ|0|0|0|100|IKR|16408|22295|lyfsjukr|||00|5000|0|Vistor hf|AstraZeneca UK Ltd|2,5| 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|A|2|0|0|0|0|ARA|0|0|1|100|IKR|500|1102|lyfalmen|||00|25|0|Vistor hf|Astra|5| 051750|C08CA0104|Amlódipín PortFarma|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|2,5|0|0|B|0|POF|0|0|0|100|IKR|3660|6253|lyfalmen|V0310|6253|00|100|0|PortFarma ehf|PortFarma || 472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|1455|2945|lyfalmen|||43|98|0|Vistor hf|AstraZeneca A/S DK|31,03| 438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.1989||L|A|4|0|0|E|0|SCP|0|0|1|100|IKR|380|852|lyfalmen|||00|10|0|Vistor hf|Schering-Plough|10| 015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|1787|3449|lyfalmen|||00|100|1|Lyfjaver ehf|Lyfjaver - óskráð lyf|33,3333| 181131|J01EE0103|Primazol |mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.04.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|370|832|lyfalmen|||01|100|0|Actavis Group hf|Actavis hf|2,5| 008010|B01AD1001|Xigris|irs|5|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|IKR|23400|31001|lyfsjukr|||00|1|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|0,13| 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|Artasan ehf|Novartis Healthcare A/S-A|13,6| 081634|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4b|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|4|0|Ísaga ehf|AGA AB|| 433730|J01EE0104|Primazol sterkar |töflur|960|mg|20|stk|1|glas|160+800 mg|J01EE01|01.07.1989||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|929|1994|lyfalmen|||00|20|0|Actavis Group hf|Actavis hf|10| 169540|P01BB0101|Paludrin|töflur|100|mg|100|stk|1|glas||P01BB01|01.01.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|597|1304|lyfalmen|||00|100|1|Vistor hf|Vistor - óskráð lyf|50| 184978|N05AB0101|Esucos|töflur|10|mg|100|stk|1|glas||N05AB01|01.05.1998||R|A||0|0|0|1|PCO|0|1|0|100|IKR|996|1426|lyfsjukr|||00|100|1|Vistor hf|Vistor - óskráð lyf|20| 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.07.2000||R|A||0|0|E|0|LDR|0|0|0|30|IKR|3849|6528|lyfalmen|||00|300|1|Parlogis hf|Parlogis - óskráð lyf|15| 924698|G03DA0402|Gestone|stl|50|mg/ml|2|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|7055|11070|lyfalmen|||00|20|1|Vistor hf|Vistor - óskráð lyf|200| 051011|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.07.1994||L|A|2|0|0|0|0|GSK|0|0|1|100|IKR|||lyfalmen|||00|2|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|2| 432880|N02BE0107|Paratabs |töflur|500|mg|300|stk|1|glas|öryggislok|N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|519|1141|lyfalmen|||00|300|0|Actavis Group hf|Actavis hf|50| 184200|J01CR0201|Amoksiklav|töflur|375|mg|15|stk|1|glas|250+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|555|1216|lyfalmen|||00|15|0|Actavis Group hf|LEK Pharmaceuticals d.d.|3,75| 049015|A02BA0201|Asyran |töflur|300|mg|100|stk|1|þpakki||A02BA02|01.10.1987||R|A|3|0|0|E|0|ACA|0|0|0|30|IKR|3553|6097|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|100| 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|70812|90028|lyfsjukr|||02|3000|0|Icepharma hf|GE Healthcare AS|| 081513|M01AE0102|Ibufen|töflur|200|mg|100|stk|1|glas||M01AE01|01.01.1988||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|336|761|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|16,6667| 929979|J01RA0201|Pediazole|mixtduft|160|mg/ml|100|ml|1|glas|40 + 120 g/ml|J01RA02|01.01.1998||R|A||0|0|0|0|PCO|0|0|1|100|IKR|983|2106|lyfalmen|||00|100|1|Vistor hf|Vistor - óskráð lyf|| 546168|N02BE0108|Paratabs Retard |forðatfl|500|mg|100|stk|1|þpakki||N02BE01|01.10.1993||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|521|1145|lyfalmen|||10|100|0|Actavis Group hf|Actavis hf|16,6667| 011163|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|10754|16056|lyfalmen|||00|100|0|Vistor hf|AstraZeneca A/S DK|33,33| 541169|R02AA0302|Strepsils med honning og citron|sogtfl|| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|| 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|IKR|7508|11702|lyfalmen|||00|28|0|Icepharma hf|Eli Lilly Danmark A/S|14| 005200|J01CF0102|Staklox |hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1076|2299|lyfalmen|V0460|2299|10|30|0|Actavis Group hf|Actavis hf|7,5| 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|A|3|0|0|0|0|ABI|0|0|0|100|IKR|||lyfalmen|||00|100|0|Vistor hf|Abigo Medical AB|3| 074443|V08CA0301|Omniscan|stl|0,5|mmol/ml|5|ml|10|hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|22740|30179|lyfsjukr|||00|50|0|Icepharma hf|GE Healthcare AS|| 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|IKR|870|1871|lyfalmen|||02|100|0|Vistor hf|AstraZeneca A/S DK|| 002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|þpakki|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|IKR|4612|7639|lyfalmen|||00|50|0|Vistor hf|AstraZeneca A/S DK|33,33| 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|Artasan ehf|Novartis Healthcare A/S-A|12,8| 020711|G03AC0302|Postinor|töflur|1500|mcg|1|stk|1|þpakki||G03AC03|01.01.2007||L|A|4|0|0|0|0|MEI|0|0|0|100|IKR|0|0|lyfalmen|||23|1|0|Icepharma hf|Medimpex UK Limited|| 111505|G04BE0802|Cialis (D.A.C.)|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.10.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|IKR|6153|9812|lyfalmen|V1351|9812|00|8|0|D.A.C. ehf|D.A.C. ehf|16| 435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|þpakki||N02CC03|01.06.1999||R|A|3|0|0|E|0|ASZ|0|0|0|100|IKR|3499|6018|lyfalmen|||00|6|0|Vistor hf|AstraZeneca UK Ltd|12| 074674|D06BB0401|Condyline|áburður|5|mg/ml|3,5|ml|1|glas|til penslu|D06BB04|01.07.1988||R|A|2|0|0|0|0|GAN|0|0|1|100|IKR|1251|2635|lyfalmen|||23|3,5|0|Icepharma hf|Galderma Nordic AB|3,5| 021031|R05CB0102|Mucomyst|lausn|200|mg/ml|10|ml|10|hgl|innöndunarvökvi|R05CB01|01.11.2006||R|K|3|0|0|E|0|AZD|0|0|0|100|IKR|3496|6014|lyfalmen|||00|100|0|Vistor hf|AstraZeneca A/S DK|| 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|68218|87982|lyfalmen|||00|150|0|Icepharma hf|GE Healthcare AS|| 000166|A07FA0201|Precosa|hylki|250|mg|20|stk|1|glas||A07FA02|01.12.1998||R|A|3|0|0|0|0|LAO|0|0|0|100|IKR|1662|3259|lyfalmen|||00|20|0|Vistor hf|Laboratories Biocodex|5| 122606|M01AE5101|Ibukod|töflur|| |10|stk|1|glas|10+200 mg|M01AE51|01.10.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|232|545|lyfalmen|||00|10|0|Actavis Group hf|Actavis hf|1,67| 005977|A01AA0116|Fluortöflur Actavis|sog/tugg|0,25|mg|300|stk|1|glas||A01AA01|01.06.2001||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|300|0|Actavis Group hf|Actavis hf|68,1818| 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|| |50|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||00|500|0|Icepharma hf|Fresenius Kabi|| 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|795|1715|lyfalmen|||08|100|0|Actavis Group hf|LEK Pharmaceuticals d.d.|5| 131987|J01AA0203|Doxytab |töflur|100|mg|10|stk|1|glas||J01AA02|01.04.1987||R|A|4|0|0|0|0|ACA|0|0|1|100|IKR|404|902|lyfalmen|||00|10|0|Actavis Group hf|Actavis hf|10| 381194|A10AD0401|Humalog Mix25 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.09.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|IKR|3752|6387|lyfalmen|||00|15|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|37,5| 538199|A02AD0106|Rennie|sog/tugg|| |48|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyfalmen|||00|48|0|Icepharma hf|Bayer AB|4,8| 475715|N02AA5902|Parkodin forte |töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|1|0|0|0|ACA|0|0|1|100|IKR|425|946|lyfalmen|V0780|946|00|100|0|Actavis Group hf|Actavis hf|33,3333| 945488|J07BF0302|Mænusottarboluefni SVM|bóluefni|| |1|ml|12|lykjur||J07BF03|01.08.1999||R|K||0|0|0|0|LDR|0|0|0|100|IKR|4140|6952|lyfalmen|||00|12|1|Parlogis hf|Parlogis - óskráð lyf|| 484832|B05BB0118|Natrium Bicarbonat|irl|50|mg/ml|100|ml|1|fl||B05BB01|01.05.2004||R|A||0|0|0|1|LDR|0|0|0|100|IKR|543|777|lyfsjukr|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|| 431205|C08DB0107|Korzem |töflur|30|mg|100|stk|1|þpakki||C08DB01|01.01.1989||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|785|1694|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|12,5| 052944|C01DA1402|Monit-L |forðahlk|30|mg|100|stk|1|glas||C01DA14|01.01.1994||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|1770|3423|lyfalmen|||10|100|0|Actavis Group hf|Actavis hf|75| 042994|N01BB0902|Naropin|stl|10|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|IKR|3885|5562|lyfsjukr|||00|100|0|Vistor hf|AstraZeneca A/S DK|| 401877|C09AA0103|Katopril|töflur|25|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1325|2747|lyfalmen|V0162|2747|00|100|0|Actavis Group hf|Actavis hf|50| 084673|P01BC0103|Kinin Actavis|töflur|100|mg|100|stk|1|glas||P01BC01|01.10.1995||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|758|1638|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|6,6667| 326991|V03AB1502|Naloxonhydroklorid|stl|| |1|ml|10|lykjur||V03AB15|01.12.2007||R|A||0|0|0|1|PCO|0|0|0|100|IKR|12994|18045|lyfsjukr|||00|10|1|Vistor hf|Vistor - óskráð lyf|| 021417|R01AD0504|Rhinocort (D.A.C.)|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.11.2004||R|A|2|0|0|E|0|DAC|0|0|1|100|IKR|883|1898|lyfalmen|V0965|1898|24|120|0|D.A.C. ehf|D.A.C. ehf|38,4| 584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|þpakki||N06AG02|01.07.1995||R|A|5|0|0|B|0|ROC|0|1|0|100|IKR|2108|3936|lyfalmen|||64|30|0|Icepharma hf|Roche|30| 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|Artasan ehf|Novartis Healthcare A/S-A|6,4| 061762|N02BA0106|Magnyl |töflur|500|mg|50|stk|1|þpakki||N02BA01|01.12.1983||L|A|1|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|50|0|Actavis Group hf|Actavis hf|8,3333| 409524|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|IKR|702|1522|lyfalmen|||43|28|0|Vistor hf|AstraZeneca A/S DK|21| 067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1601|3166|lyfalmen|V0555|3166|10|2|0|Actavis Group hf|Actavis hf|1,5| 012260|R01AC0301|Lastin|nefúði|1|mg/ml|20|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|IKR|1343|2774|lyfalmen|||00|20|0|Icepharma hf|Meda AB|35,7143| 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|IKR|740|1601|lyfalmen|||02|100|0|Vistor hf|AstraZeneca A/S DK|| 070623|C03AA0301|Aquazið|töflur|12,5|mg|100|stk|1|glas||C03AA03|01.03.1984||R|A|4|0|0|E|0|ACA|0|0|0|100|IKR|530|1164|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|50| 457135|N05BA1202|Paxal |töflur|0,25|mg|50|stk|1|glas||N05BA12|01.04.1990||R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|246|574|lyfalmen|V0848|574|00|50|0|Actavis Group hf|Actavis hf|12,5| 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|1395|2853|lyfalmen|V0914|2853|10|30|0|Actavis Group hf|Actavis hf|30| 081315|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dælur|einnota dælur plast|M09AX01|01.11.1998||R|A|3,5|0|0|E|0|AZD|0|0|0|100|IKR|15841|22772|lyfalmen|||02|12,5|0|Vistor hf|AstraZeneca A/S DK|34,7222| 001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|9174|13952|lyfalmen|V0794|13952|00|60|0|Actavis Group hf|Actavis hf|36| 940272|G03CA0313|Oestradiol|vefjatfl|100|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|5374|8726|lyfalmen|||00|1|1|Parlogis hf|Parlogis - óskráð lyf|333,33| 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|IKR|1948|3693|lyfalmen|||17|100|0|Vistor hf|AstraZeneca A/S DK|| 104356|N05BA0204|Klordiazepoxið Actavis|töflur|5|mg|30|stk|1|glas||N05BA02|01.10.1995||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|193|464|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|5| 003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|IKR|283|651|lyfalmen|||67|20|0|Vistor hf|Novartis Healthcare A/S-|10| 016677|N05AH0402|Seroquel (Lyfjaver)|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.09.2003||R|A|3|0|0|*|0|LVR|0|1|0|100|IKR|17805|25217|lyfalmen|V0727|25217|00|100|0|Lyfjaver ehf|Lyfjaver ehf|50| 175463|N05CF0102|Zopiklon NM Pharma|töflur|7,5|mg|250|stk|1|glas||N05CF01|01.05.2000|31.12.2007|R|A|2|0|0|0|0|MNA|0|0|0|100|IKR|1807|3479|lyfalmen|||00|250|0|Merck NM|Merck NM AB|250| 436683|M01AE0211|Naproxen-E NM Pharma|sh-tfl|500|mg|10|stk|1|þpakki||M01AE02|01.07.1993|31.12.2007|R|A|5|0|0|E|0|MNA|0|0|1|100|IKR|286|657|lyfalmen|||10|10|0|Merck NM|Merck NM AB|10| 434019|M01AE0209|Naproxen NM Pharma|töflur|500|mg|10|stk|1|þpakki||M01AE02|01.04.1995|31.12.2007|R|A|4|0|0|E|0|MNA|0|0|1|100|IKR|138|349|lyfalmen|||00|10|0|Merck NM|Merck NM AB|10| 121251|N05CD0505|Triazolam NM Pharma|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.07.1991|31.12.2007|R|A|4|0|0|0|0|MNA|0|0|1|100|IKR|154|382|lyfalmen|||00|30|0|Merck NM|Merck NM AB|30| 162925|B05AA0106|Albumin Immuno|stl/irl|200|mg/ml|50|ml|1|hgl||B05AA01|01.07.1985|31.12.2007|R|A|3|0|0|0|1|BAX|0|0|0|100|DKK|2914|4172|lyfsjukr|||02|50|0|Icepharma hf|Baxter|| 511683|B05AA0106|Albumin Immuno|stl/irl|200|mg/ml|100|ml|1|hgl||B05AA01|01.07.1985|31.12.2007|R|A|3|0|0|0|1|BAX|0|0|0|100|DKK|5673|8122|lyfsjukr|||02|100|0|Icepharma hf|Baxter|| 079871|L01XA0102|Platinol|irþ|0,5|mg/ml|20|ml|10|hgl||L01XA01|01.04.1989|31.12.2007|R|A|3|0|1|0|1|BRS|0|0|0|100|DKK|8917|12767|lyfsjukr|||00|200|0|Vistor hf|Bristol-Myers Squibb|| 079897|L01XA0102|Platinol|irþ|0,5|mg/ml|100|ml|5|hgl||L01XA01|01.04.1989|31.12.2007|R|A|3|0|1|0|1|BRS|0|0|0|100|DKK|19454|26088|lyfsjukr|||00|500|0|Vistor hf|Bristol-Myers Squibb|| 405803|L01XA0102|Platinol|irþ|1|mg/ml|50|ml|1|hgl||L01XA01|01.10.1995|31.12.2007|R|A|1.5|0|1|0|1|BRS|0|0|0|100|DKK|4278|6125|lyfsjukr|||00|50|0|Vistor hf|Bristol-Myers Squibb|| 406264|L01XA0102|Platinol|irþ|1|mg/ml|100|ml|1|hgl||L01XA01|01.10.1995|31.12.2007|R|A|1.5|0|1|0|1|BRS|0|0|0|100|DKK|8558|12253|lyfsjukr|||00|100|0|Vistor hf|Bristol-Myers Squibb|| 017772|L01XA0204|Paraplatin|irs|50|mg/hgl|1|hgl|1|pakki||L01XA02|01.10.1988|31.12.2007|R|A|3|0|1|0|1|BRS|0|0|0|100|DKK|3384|4845|lyfsjukr|||00|1|0|Vistor hf|Bristol-Myers Squibb|| 017780|L01XA0204|Paraplatin|irs|150|mg/hgl|1|hgl|1|pakki||L01XA02|01.10.1988|31.12.2007|R|A|3|0|1|0|1|BRS|0|0|0|100|DKK|9703|13892|lyfsjukr|||00|1|0|Vistor hf|Bristol-Myers Squibb|| 017954|L01XA0204|Paraplatin|irs|450|mg/hgl|1|hgl|1|pakki||L01XA02|01.10.1988|31.12.2007|R|A|3|0|1|0|1|BRS|0|0|0|100|DKK|29047|38031|lyfsjukr|||00|1|0|Vistor hf|Bristol-Myers Squibb|| 394767|N02CC0401|Maxalt|töflur|5|mg|6|stk|1|þpakki||N02CC04|01.03.1999|31.12.2007|R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|3653|6242|lyfalmen|||00|6|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|3| 396051|N02CC0401|Maxalt|töflur|10|mg|6|stk|1|þpakki||N02CC04|01.03.1999|31.12.2007|R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|3653|6242|lyfalmen|||00|6|0|Merck Sharp & Dohme Ísland ehf|M.S.D.|6| 024950|N05BA0402|Sobril|töflur|10|mg|250|stk|1|glas||N05BA04|01.01.1985|31.12.2007|R|A|1,5|0|0|0|0|PFI|0|0|0|100|DKK|1107|2364|lyfalmen|||00|250|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|50| 418657|D07XC0101|Diprosalic|smyrsli|| |20|g|1|túpa||D07XC01|01.11.1979|31.12.2007|R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|425|946|lyfalmen|||20|20|0|Vistor hf|Schering-Plough|20| 418673|D07XC0101|Diprosalic|smyrsli|| |100|g|1|túpa||D07XC01|01.06.1984|31.12.2007|R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|1914|3642|lyfalmen|||20|100|0|Vistor hf|Schering-Plough|100| 022533|J01FA0101|Abboticin|mixt.kyr|40|mg/ml|100|ml|1|glas||J01FA01|01.05.1978|31.12.2007|R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|477|1054|lyfalmen|||08|100|0|Vistor hf|Abbott Scandinavia AB|4| 012989|J01FA0101|Abboticin|mixt.kyr|40|mg/ml|200|ml|1|glas||J01FA01|01.03.1979|31.12.2007|R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|905|1944|lyfalmen|||08|200|0|Vistor hf|Abbott Scandinavia AB|8| 088112|J01FA0101|Abboticin|mixt.kyr|100|mg/ml|50|ml|1|glas||J01FA01|01.10.1985|31.12.2007|R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|628|1368|lyfalmen|||08|50|0|Vistor hf|Abbott Scandinavia AB|5| 085845|J01FA0101|Abboticin|mixt.kyr|100|mg/ml|100|ml|1|glas||J01FA01|01.10.1985|31.12.2007|R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|1266|2657|lyfalmen|||08|100|0|Vistor hf|Abbott Scandinavia AB|10| 092411|B01AC0401|Plavix|töflur|75|mg|84|stk|1|þpakki||B01AC04|01.12.1999|31.12.2007|R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|13276|19579|lyfalmen|||00|84|0|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|84| 533646|A02BA0205|Zantac|töflur|150|mg|60|stk|1|þpakki||A02BA02|01.12.1983|31.12.2007|R|A|5|0|0|E|0|GSK|0|0|0|30|IKR|1150|2453|lyfalmen|||00|60|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30| 086181|A02BA0205|Zantac|töflur|300|mg|30|stk|1|þpakki||A02BA02|01.04.1987|31.12.2007|R|A|3|0|0|E|0|GSK|0|0|0|30|IKR|1100|2349|lyfalmen|||00|30|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30| 560417|D06BB0303|Zovir|krem|50|mg/g|10|g|1|túpa||D06BB03|01.01.1988|31.12.2007|R|A|3|0|0|0|0|GSK|0|0|1|100|IKR|1236|2612|lyfalmen|||20|10|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|10| 589457|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002|31.12.2007|R|A|2|0|1|0|1|SAG|0|0|0|100|SEK|83229|105488|lyfsjukr|||00|15|0|Icepharma hf|Schering AG|30| 021667|A02BC0301|Lanzo|sh-hylki|30|mg|56|stk|1|þpakki||A02BC03|01.01.1995|31.12.2007|R|A|2|0|0|E|0|WAB|0|0|0|30|USD|4197|7035|lyfalmen|||10|56|0|Icepharma hf|Wyeth AB|56| 009262|M01AH0401|Dynastat|sts|20|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002|31.12.2007|R|A|3|0|0|0|0|PFL|0|0|1|100|DKK|7623|11862|lyfalmen|||03|10|0|Vistor hf|Pfizer Limited|5| 520494|C08CA0102|Amlo|töflur|5|mg|30|stk|1|plglas||C08CA01|01.03.1998|31.12.2007|R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1361|2802|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|30| 011126|B01AC0601|Hjartamagnyl|töflur|75|mg|50|stk|1|plglas||B01AC06|01.02.2004|31.12.2007|L|A|2|0|0|0|0|ACA|0|0|0|100|IKR|||lyfalmen|||00|50|0|Actavis Group hf|Actavis hf|50| 000522|A01AA0115|Fluorlausn 2 mg/ml|lausn|2|mg/ml|500|ml|1|fl|+ mæliglas|A01AA01|01.07.1995|31.12.2007|L|A|4|0|0|0|0|ACA|0|0|1|100|IKR|388|869|lyfalmen|||00|500|0|Actavis Group hf|Actavis hf|| 000060|A01AA0114|Fluorlausn 0,5 mg/ml|lausn|0,5|mg/ml|500|ml|1|fl|+ mæliglas|A01AA01|01.07.1995|31.12.2007|L|A|4|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|500|0|Actavis Group hf|Actavis hf|| 525121|A02BC0101|Lomex |sh-hylki|20|mg|14|stk|1|glas||A02BC01|01.07.1993|31.12.2007|R|A|2|0|0|E|0|ACA|0|0|0|30|IKR|1570|3119|lyfalmen|||10|14|0|Actavis Group hf|Actavis hf|14| 525139|A02BC0101|Lomex |sh-hylki|20|mg|28|stk|1|glas||A02BC01|01.07.1993|31.12.2007|R|A|2|0|0|E|0|ACA|0|0|0|30|IKR|2011|3789|lyfalmen|||10|28|0|Actavis Group hf|Actavis hf|28| 028530|A02BC0101|Lomex |sh-hylki|20|mg|56|stk|1|glas||A02BC01|01.01.1995|31.12.2007|R|A|2|0|0|E|0|ACA|0|0|0|30|IKR|3940|6661|lyfalmen|||10|56|0|Actavis Group hf|Actavis hf|56| 580316|A02BC0101|Lomex |sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.10.1993|31.12.2007|R|A|2|0|0|E|0|ACA|0|0|0|30|IKR|9920|14945|lyfalmen|||10|100|0|Actavis Group hf|Actavis hf|100| 061754|N02BA0106|Magnyl |töflur|500|mg|20|stk|1|þpakki||N02BA01|01.12.1983|31.12.2007|L|A|1|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|20|0|Actavis Group hf|Actavis hf|3,3333| 399790|D06BB0601|Vectavir|krem|10|mg/g|5|g|1|túpa||D06BB06|01.04.1997|31.12.2007|R|A|3|0|0|0|0|NHE|0|0|1|100|DKK|1194|2545|lyfalmen|||00|5|0|Artasan ehf|Novartis Healthcare A/S-A|5| 128850|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|glas||C04AD03|01.07.1992|31.12.2007|R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|2891|5126|lyfalmen|||10|100|0|Vistor hf|Sanofi-aventis Norge AS|40| 403568|A04AD0501|Vogalene|töflur|5|mg|100|stk|1|glas||A04AD05|01.10.1995|31.12.2007|R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|3657|6248|lyfalmen|||00|100|0|Vistor hf|Sanofi-aventis Norge AS|33,3333| 160556|N05AB0401|Stemetil|eþ-stil|25|mg|5|stk|1|pakki||N05AB04|01.10.1995|31.12.2007|R|A|2|0|0|*|0|SNO|0|1|0|100|NOK|269|622|lyfalmen|||04|5|0|Vistor hf|Sanofi-aventis Norge AS|1,25| 176875|N05AA0101|Largactil|töflur|25|mg|100|stk|1|þpakki||N05AA01|01.10.1995|31.12.2007|R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|365|821|lyfalmen|||10|100|0|Vistor hf|Sanofi-aventis Norge AS|8,3333| 176834|N05AA0101|Largactil|töflur|50|mg|100|stk|1|þpakki||N05AA01|01.10.1995|31.12.2007|R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|645|1403|lyfalmen|||10|100|0|Vistor hf|Sanofi-aventis Norge AS|16,6667|